data_6tr0_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6tr0 _Structure_validation_residue.Date_analyzed 2020-05-01 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 120.764 0.316 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -59.59 -54.32 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 110.068 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -87.9 -11.45 47.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.57 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.24 25.15 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.055 0.455 . . . . 0.0 111.018 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -92.95 4.58 53.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 22.8 ttp180 -126.2 129.94 49.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 110.943 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -114.04 153.17 29.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.108 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 59.5 t80 -84.96 119.67 25.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.434 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.65 124.15 57.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.541 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.26 177.87 16.78 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.905 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 4.8 t30 66.02 30.97 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.784 0.802 . . . . 0.0 109.967 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.67 154.44 37.17 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.184 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.02 130.84 12.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.518 2.145 . . . . 0.0 111.259 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.33 108.79 2.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.107 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.52 3.31 7.92 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.585 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.36 145.6 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.082 0.467 . . . . 0.0 110.192 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.2 m -105.32 154.19 20.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.397 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.93 -58.65 4.13 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.477 0.486 . . . . 0.0 111.465 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.11 -35.86 67.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.892 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.89 -56.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.021 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 32.6 ttm -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.7 ttt -59.02 -56.89 16.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.086 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -37.44 81.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.49 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.632 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.4 m-85 -60.5 -51.8 67.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.63 -39.97 88.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -55.75 -42.46 75.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.072 0.463 . . . . 0.0 110.603 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.594 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.29 -45.96 78.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.22 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 68.5 mm-40 -59.25 -41.15 88.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.386 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.516 ' HB3' HG22 ' A' ' 179' ' ' THR . 0.0 OUTLIER -56.7 -42.66 79.5 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.875 0.369 . . . . 0.0 111.046 176.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -66.14 -41.66 90.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 58.7 mt -64.86 -49.94 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.293 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.62 0.09 86.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.906 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.3 37.84 91.09 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.771 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.5 mt -93.67 -31.17 14.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.581 0.229 . . . . 0.0 110.386 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.27 108.4 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.278 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -85.71 -29.25 24.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.028 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.0 148.95 38.44 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.619 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.13 157.06 61.66 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.246 1.964 . . . . 0.0 111.901 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.68 -147.55 18.64 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.593 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -102.29 119.52 56.14 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.861 0.363 . . . . 0.0 111.0 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -32.9 34.12 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.911 2.407 . . . . 0.0 112.227 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.73 128.8 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.92 -45.14 7.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.697 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.01 143.54 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.789 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.05 131.42 63.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.26 118.91 32.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.69 118.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.212 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.4 p90 . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.68 170.82 15.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.417 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 74.6 m-85 -127.84 134.47 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.5 mt -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.25 131.3 48.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.202 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.558 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 45.8 m-85 -110.65 156.99 20.21 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.658 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -74.5 -19.65 60.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.19 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 m -141.89 135.75 29.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.04 -31.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -70.78 -31.35 68.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.372 . . . . 0.0 110.419 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.63 -20.15 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 109.95 173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.4 m -75.59 -48.67 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.945 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -63.77 -31.63 72.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.925 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 210' ' ' GLN . 2.6 pt20 -74.39 -18.1 60.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.595 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.07 -22.58 58.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 109.611 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 14.5 mtt -71.29 -17.65 62.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.589 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.53 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 217' ' ' ILE . 10.1 m-85 -81.57 4.12 22.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.577 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.07 106.64 2.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.843 0.354 . . . . 0.0 110.713 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.23 5.58 57.09 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.194 -0.526 . . . . 0.0 112.7 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 214' ' ' PHE . 11.3 tt -96.84 153.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.882 0.372 . . . . 0.0 110.648 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 36.4 mm -108.13 100.53 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.629 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.3 m-85 -102.07 108.73 20.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.731 0.3 . . . . 0.0 110.573 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.54 36.34 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.225 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.01 -13.57 66.86 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.916 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.0 pt20 -99.4 138.94 35.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.584 0.692 . . . . 0.0 110.267 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.554 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 21.6 t -96.5 126.03 41.41 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.95 132.33 51.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.53 125.57 48.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.6 mp -128.62 126.44 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -178.772 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.405 HG13 ' HE2' ' A' ' 276' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.233 0.54 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 28.3 m -83.15 149.45 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.7 p -92.9 19.55 7.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 111.318 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.77 113.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.221 0.534 . . . . 0.0 110.53 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 304' ' ' PHE . 21.4 t -107.98 108.19 61.07 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.54 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.89 152.12 82.32 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.923 2.415 . . . . 0.0 111.796 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.92 79.48 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.861 0.838 . . . . 0.0 109.945 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.0 p -87.05 -176.44 5.72 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.379 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -81.67 1.06 35.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -123.76 30.82 6.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.263 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -70.63 133.71 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.008 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.87 142.01 51.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -118.38 130.06 55.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.067 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.6 126.8 74.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -130.54 168.65 21.61 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.04 5.91 60.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.379 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.416 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 78.4 mt -71.48 132.73 85.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.921 0.391 . . . . 0.0 111.881 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.31 134.55 59.58 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.876 2.384 . . . . 0.0 111.858 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.08 -22.47 64.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.238 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -90.54 4.84 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.79 139.19 49.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.707 0.289 . . . . 0.0 110.351 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -105.65 -177.77 3.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.81 -41.96 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.326 0.391 . . . . 0.0 111.648 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.566 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 33.1 t70 -63.07 -47.97 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 0.0 111.353 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.506 ' HA ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -65.53 -40.81 93.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.727 179.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.41 -30.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.795 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 273' ' ' ASP . 6.9 mtmp? -53.26 -39.51 63.94 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.453 0.168 . . . . 0.0 111.293 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -52.75 -34.95 55.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.761 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.31 -40.48 62.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.88 -38.43 53.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.069 0.461 . . . . 0.0 111.042 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 25.2 p -65.92 -12.49 55.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.043 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.9 m -52.63 -34.21 50.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.166 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -100.58 -40.83 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.9 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.86 162.0 35.51 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.207 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -76.84 160.1 34.25 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.962 2.441 . . . . 0.0 112.28 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 136.58 49.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 306' ' ' GLU . 18.9 ptpt -80.18 -27.92 38.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.675 0.75 . . . . 0.0 109.008 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -153.86 124.58 7.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.188 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 17.1 t80 -139.13 112.72 8.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.019 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -118.73 115.91 25.47 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.415 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 290' ' ' LEU . 9.5 tt -95.07 123.47 38.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.9 t -82.25 106.03 12.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.751 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -95.31 159.41 15.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.347 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 8.7 t70 -94.87 133.47 38.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.0 m -72.36 -18.37 61.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.382 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.42 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 82.5 p -99.44 -28.31 13.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 74.84 15.68 80.76 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.58 157.65 39.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 111.298 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.5 m -65.08 123.06 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.442 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -68.4 -18.77 64.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.406 . . . . 0.0 110.646 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 106.45 26.4 5.94 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.76 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.24 148.02 21.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.503 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.54 170.12 19.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.81 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.484 ' O ' HG21 ' A' ' 254' ' ' VAL . 98.1 m-85 -125.83 136.55 53.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.66 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.5 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 19.6 p -133.97 166.68 22.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.878 0.37 . . . . 0.0 110.897 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 286' ' ' LYS . 10.6 tt0 -143.62 120.29 11.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -74.36 147.24 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.376 0.608 . . . . 0.0 110.886 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.49 -30.26 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.858 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -116.41 151.61 35.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.05 -21.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -41.46 60.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.46 -18.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.815 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 50.5 m -52.93 -56.82 13.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.338 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.99 -22.45 36.56 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.152 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.06 -34.68 64.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.962 0.411 . . . . 0.0 111.001 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.15 -50.9 17.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.472 HG21 HG13 ' A' ' 332' ' ' VAL . 2.6 pp -61.42 -21.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.084 0.468 . . . . 0.0 110.733 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.49 86.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.023 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.34 -33.84 5.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.169 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.67 -35.85 75.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.794 0.297 . . . . 0.0 111.579 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.26 109.59 3.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.453 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.3 3.71 29.22 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 46.3 ttm -61.64 115.32 3.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.724 0.297 . . . . 0.0 110.37 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 90.53 8.0 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.89 119.76 40.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.12 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.82 -110.76 3.61 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.868 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -106.55 -13.5 15.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -114.23 147.96 38.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -93.01 120.83 33.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 164.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.49 129.24 37.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.188 0.518 . . . . 0.0 110.879 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 23.5 tp -88.53 124.82 34.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.528 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.472 HG13 HG21 ' A' ' 317' ' ' ILE . 65.9 t -131.15 108.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.17 143.65 31.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.47 -168.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -69.81 117.63 11.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.122 0.487 . . . . 0.0 110.61 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.915 -175.788 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 13.6 t . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.437 ' NE ' ' HG3' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -60.99 -22.71 64.76 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.23 -0.294 . . . . 0.0 111.57 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.437 ' HG3' ' NE ' ' A' ' 146' ' ' ARG . 82.1 mt-30 -87.3 -35.36 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.012 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.46 -31.85 67.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.902 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 145' ' ' THR . 34.0 mtm180 -80.62 2.23 26.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.686 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 34.4 ttp180 -122.02 130.54 53.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.304 0.573 . . . . 0.0 111.652 -172.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.48 154.24 32.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.077 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.8 t80 -81.45 124.4 29.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.607 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 200' ' ' LEU . 44.0 t -112.43 131.34 64.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 110.738 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.29 177.85 16.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.945 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.81 38.15 2.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.462 0.649 . . . . 0.0 110.359 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.3 pt -109.25 150.94 41.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.69 130.82 9.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.766 2.311 . . . . 0.0 111.641 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.48 118.89 10.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.39 -2.93 22.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.535 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.48 146.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 110.229 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 m -105.18 156.64 17.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 189' ' ' VAL . 24.8 mt-10 -47.51 -59.51 3.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.434 0.459 . . . . 0.0 111.715 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.88 -21.37 66.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.253 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.62 -53.12 30.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.299 0.571 . . . . 0.0 110.284 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.7 ttm -75.79 -33.96 60.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.102 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 14.5 ttt -59.55 -46.47 88.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.535 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.36 -44.51 88.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.449 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.511 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.1 m-85 -62.12 -55.66 26.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.707 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -58.71 -43.01 89.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.532 0.206 . . . . 0.0 111.368 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -59.82 -33.75 72.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.388 . . . . 0.0 111.18 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -79.16 -34.56 43.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.381 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 25.8 mm-40 -62.52 -37.76 87.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.868 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.423 ' HB3' HG22 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.5 -35.48 76.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 0.0 111.022 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.447 ' HD2' ' OG1' ' A' ' 179' ' ' THR . 28.2 mmm180 -78.41 -23.8 46.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.1 mt -76.73 -41.84 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.34 -5.55 75.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.636 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.43 36.05 83.16 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.859 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.94 -22.15 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.718 0.294 . . . . 0.0 110.772 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.447 ' OG1' ' HD2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -59.71 108.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.325 -178.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -87.88 -33.11 18.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.614 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -106.85 151.17 40.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.805 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 148.86 81.35 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.504 2.136 . . . . 0.0 111.938 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.09 -144.9 17.39 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.608 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.14 124.79 38.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.709 0.29 . . . . 0.0 111.118 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.497 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 41.2 Cg_endo -67.04 -29.51 40.15 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.153 2.569 . . . . 0.0 113.135 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.36 134.47 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.231 0.539 . . . . 0.0 110.86 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.406 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.5 mt -89.77 -49.37 6.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.134 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.14 171.26 19.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 0.2 OUTLIER -143.87 139.57 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.14 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -122.53 127.93 50.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.606 0.241 . . . . 0.0 110.786 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.68 127.56 63.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.011 -178.79 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -132.36 170.96 14.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.055 0.455 . . . . 0.0 111.087 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.427 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . 73.0 m-85 -127.3 133.44 50.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.922 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -109.78 129.32 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.3 130.12 56.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 0.0 110.499 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.639 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.4 m-85 -108.53 165.57 11.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.124 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.4 ptt180 -80.75 -18.93 46.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.276 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.9 m -138.7 132.69 31.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.156 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.6 -28.11 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.15 -32.6 72.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.361 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -82.66 -20.89 35.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.205 0.526 . . . . 0.0 110.039 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 98.0 m -71.21 -51.32 25.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 173.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.7 t -60.0 -37.63 80.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.662 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.88 -19.65 61.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.4 -28.73 52.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 110.075 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.0 mtp -71.63 -14.38 62.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.079 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.2 -22.64 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.861 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 217' ' ' ILE . 17.8 m-85 -76.91 2.82 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.999 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.09 106.68 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.99 0.424 . . . . 0.0 110.735 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.44 37.36 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.725 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -108.33 153.36 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.868 0.366 . . . . 0.0 110.523 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.0 mm -105.95 101.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.71 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.3 m-85 -112.82 129.57 56.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.477 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 60.81 21.5 11.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 111.48 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 90.54 -11.63 70.92 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.959 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.5 pt20 -97.31 140.83 31.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.031 0.416 . . . . 0.0 110.277 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.7 t -93.97 118.41 31.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.23 128.92 38.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.26 122.82 40.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.885 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.5 mp -128.03 125.77 65.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.919 0.39 . . . . 0.0 110.027 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 . . . . . 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.739 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.452 HG13 ' HD3' ' A' ' 276' ' ' LYS . 21.9 t . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 14.7 m -76.49 146.92 38.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.641 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 18.78 9.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.44 121.93 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.5 t -109.58 104.86 56.31 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.545 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.82 169.6 8.51 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.485 2.79 . . . . 0.0 112.218 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.6 79.92 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.72 . . . . 0.0 110.03 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.6 t -91.8 151.85 20.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.328 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.98 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.345 0.593 . . . . 0.0 110.063 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -113.78 31.88 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.367 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.402 ' HG3' ' HB1' ' A' ' 335' ' ' ALA . 10.3 ptpp? -68.07 141.09 56.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 16.3 mt -122.68 143.37 49.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.98 0.419 . . . . 0.0 111.635 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -117.89 132.38 56.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.855 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 331' ' ' LEU . 2.5 mp -120.0 116.6 50.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.466 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -112.22 -176.89 19.96 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.1 69.75 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.147 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.477 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.1 mt -62.93 130.16 93.81 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.29 144.84 98.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.794 2.329 . . . . 0.0 111.285 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -67.16 -18.6 65.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -92.25 -8.8 44.27 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.773 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.82 128.3 43.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.9 -175.77 2.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.599 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.9 p-10 -50.67 -41.1 55.24 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.185 0.303 . . . . 0.0 111.082 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 19.2 t70 -70.79 -32.9 70.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.99 0.424 . . . . 0.0 111.495 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.67 -41.77 26.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.065 0.46 . . . . 0.0 110.441 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.83 -29.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 25.5 mtmm -50.69 -40.26 53.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.009 0.433 . . . . 0.0 110.845 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.94 -21.68 66.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.39 -32.01 19.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 110.264 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.4 -28.98 28.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.143 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.1 p -67.97 -12.2 60.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 16.8 m -50.57 -40.25 51.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.961 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.66 -39.12 10.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.15 155.69 27.21 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.994 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.16 155.94 56.06 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.04 1.827 . . . . 0.0 111.865 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 250' ' ' VAL . 78.7 mt -102.48 138.3 39.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.927 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.558 ' HZ2' ' HB2' ' A' ' 286' ' ' LYS . 0.1 OUTLIER -85.65 -24.4 27.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.44 0.638 . . . . 0.0 109.338 176.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.62 124.61 6.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.053 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 9.9 t80 -139.27 111.39 7.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.077 0.465 . . . . 0.0 110.246 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.95 108.34 17.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.536 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -99.24 133.96 42.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.5 t -94.13 109.78 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -90.09 164.5 14.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.212 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.543 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -104.34 127.49 52.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.886 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 t -76.65 -11.95 59.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.31 -31.37 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.629 0.252 . . . . 0.0 111.372 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 69.7 p -93.46 -27.69 16.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.028 0.442 . . . . 0.0 111.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.22 14.17 82.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.03 -172.97 2.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.254 -0.473 . . . . 0.0 109.764 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 61.4 m -81.94 147.18 29.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.174 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.26 -19.5 56.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.107 0.479 . . . . 0.0 110.381 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 96.68 27.38 9.74 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.753 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 14.4 p90 -154.13 144.08 21.88 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.275 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.06 19.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.337 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 92.9 m-85 -128.14 133.18 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.396 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 29.5 p -130.05 166.11 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.265 0.555 . . . . 0.0 111.251 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.66 125.79 21.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.715 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -80.86 154.88 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.09 -35.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.955 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.81 158.02 28.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.073 0.463 . . . . 0.0 110.263 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.89 -19.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.511 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 -30.11 57.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.55 -26.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.321 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.42 HG21 HD22 ' A' ' 261' ' ' LEU . 15.6 m -54.62 -53.48 54.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.481 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.34 -31.04 68.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.14 -36.5 72.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.83 -52.79 10.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.183 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.41 HG21 HG13 ' A' ' 332' ' ' VAL . 2.8 pp -59.61 -25.28 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.493 . . . . 0.0 110.705 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.18 -45.21 81.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.455 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.11 -27.36 7.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.612 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.12 -36.27 40.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.984 0.392 . . . . 0.0 111.703 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 2.3 t-20 -68.26 112.13 4.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.68 5.14 26.09 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.745 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 40.7 ttm -62.39 115.25 4.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 0.0 110.198 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -85.06 96.55 9.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 111.28 22.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.538 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.54 -109.47 2.8 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.341 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.82 6.4 11.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.925 0.393 . . . . 0.0 111.176 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -120.74 149.08 43.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.774 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 42.6 mtpt -98.66 119.61 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.39 134.06 45.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.443 0.64 . . . . 0.0 111.388 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -88.16 121.49 30.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 53.3 t -130.48 107.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.68 160.67 42.43 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.899 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.66 130.65 40.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 260' ' ' LYS . . . . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 121.318 0.58 . . . . 0.0 110.122 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.368 0.604 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.464 ' HD2' ' HG2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -66.84 -31.03 71.38 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.014 -0.429 . . . . 0.0 111.081 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.464 ' HG2' ' HD2' ' A' ' 146' ' ' ARG . 10.9 mm100 -87.51 -5.69 58.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.904 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.03 12.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.906 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 83.5 mtt180 -79.43 -6.12 56.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.95 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.567 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 18.4 mtm180 -110.37 150.91 28.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.14 0.495 . . . . 0.0 111.1 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.06 153.09 52.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.967 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 22.4 t80 -82.03 110.3 17.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.674 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 51.1 t -96.55 116.19 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.306 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.51 171.72 14.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.468 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 62.36 55.33 2.35 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.809 0.814 . . . . 0.0 109.451 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.0 pt -112.42 147.67 37.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.476 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.428 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 57.1 Cg_endo -80.26 130.79 8.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.711 2.274 . . . . 0.0 111.318 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.73 124.95 22.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.253 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.32 -0.67 53.87 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.134 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.428 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 16.1 tt -60.88 144.69 13.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 110.202 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 m -96.98 150.0 21.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.18 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' A' ' 189' ' ' VAL . 42.1 mt-10 -48.1 -59.87 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.16 -15.72 63.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.72 -58.32 4.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.0 ptp -76.17 -29.84 57.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.128 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.0 ttt -60.07 -54.93 40.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.37 -36.59 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.655 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.2 m-85 -60.0 -52.23 66.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.283 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -64.85 -38.82 92.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.206 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -59.69 -40.28 87.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.16 -49.69 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.93 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 70.0 mm-40 -60.47 -33.47 72.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.156 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.561 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 8.4 mmt -61.63 -41.87 98.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -72.15 -38.62 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.232 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 72.2 mt -63.68 -50.6 68.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.667 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.17 -10.13 86.45 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.571 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.16 40.08 56.78 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.479 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.561 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 22.0 mt -93.34 -24.33 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.485 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -58.38 114.72 2.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.956 0.407 . . . . 0.0 111.519 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.84 -34.3 15.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.107 0.479 . . . . 0.0 110.683 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 203' ' ' ARG . . . -107.65 150.44 40.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.544 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.71 132.57 40.8 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.051 1.834 . . . . 0.0 111.489 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.97 -162.12 12.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.545 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.77 124.18 73.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.511 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 49.4 Cg_endo -70.83 -31.96 14.93 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.882 2.388 . . . . 0.0 111.957 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.78 116.73 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.8 tp -85.06 -45.12 12.4 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.381 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.01 165.44 32.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.196 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.439 ' HB ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -145.09 131.04 14.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.673 178.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.44 121.23 38.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 162' ' ' GLU . 4.5 mp -97.22 111.0 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.449 ' HE2' ' CE1' ' A' ' 199' ' ' PHE . 8.7 p90 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.278 0.561 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -131.83 164.67 25.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.258 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.449 ' CE1' ' HE2' ' A' ' 197' ' ' PHE . 25.7 m-85 -124.11 123.97 41.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.724 0.297 . . . . 0.0 110.732 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 66.2 mt -95.68 131.41 41.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.567 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 32.3 tt0 -107.03 141.7 37.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.855 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 65.0 m-85 -126.47 152.85 45.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.432 0.634 . . . . 0.0 111.581 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 39.3 ptt180 -78.05 -13.03 60.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.639 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 33.3 t -148.18 132.84 17.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.834 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.92 -24.24 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.608 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.29 -34.9 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -82.8 -21.82 34.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.095 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.6 m -65.67 -50.97 62.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.2 t -62.59 -36.86 84.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 111.687 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -76.06 -18.51 59.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.332 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.49 62.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.442 0.639 . . . . 0.0 109.631 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 31.0 mtp -68.89 -14.01 62.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.856 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.51 65.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 217' ' ' ILE . 13.1 m-85 -80.82 7.27 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.66 105.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.881 0.372 . . . . 0.0 111.387 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.71 59.58 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.196 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.7 tt -95.62 153.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 110.544 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.74 103.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.68 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 9.5 m-85 -102.88 111.96 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.734 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 59.61 30.97 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.321 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.71 -13.02 66.99 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.504 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 26.5 pt20 -94.89 137.82 33.46 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.778 0.789 . . . . 0.0 110.778 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.9 p -103.54 118.51 36.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.777 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.64 136.25 54.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 111.064 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -109.65 135.02 51.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.2 mp -121.44 105.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.258 0.552 . . . . 0.0 109.815 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.556 -178.626 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.532 0.682 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 73.5 m -101.21 159.47 15.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.287 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 p -97.22 6.26 48.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.468 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 43.0 t -103.23 100.01 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.731 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.64 107.95 27.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.752 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 31.6 Cg_exo -60.24 169.59 4.89 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.424 2.749 . . . . 0.0 112.667 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.67 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 260' ' ' LYS . 26.7 t -69.24 155.77 39.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.949 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.7 -0.61 57.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.233 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -99.68 -6.36 27.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 257' ' ' SER . 23.7 pttp -72.43 154.94 40.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 334' ' ' ARG . 11.0 mt -128.99 150.58 50.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.235 -172.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -107.3 131.14 54.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.67 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.41 121.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.929 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.62 171.54 18.31 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.574 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.91 2.27 84.19 Favored Glycine 0 N--CA 1.454 -0.15 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.662 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.524 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.4 mt -66.41 136.98 95.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 17.0 Cg_exo -67.22 145.27 71.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.786 2.324 . . . . 0.0 111.386 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 3.0 m-20 -65.53 -20.98 66.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.633 -174.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -90.51 1.4 56.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.1 mt -113.53 122.27 46.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -93.01 -175.93 4.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.986 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 290' ' ' LEU . 3.9 p30 -47.54 -48.17 27.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 29.0 t70 -63.35 -46.99 84.02 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.2 -28.97 65.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.27 -38.38 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.439 0.638 . . . . 0.0 110.382 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 288' ' ' PHE . 15.7 ttpp -60.92 -30.67 70.33 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.68 -30.42 68.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.081 0.467 . . . . 0.0 110.689 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.86 -31.74 35.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.92 -34.99 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.547 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.8 p -71.19 -12.25 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.036 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.0 m -50.51 -43.2 55.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.077 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -86.17 -41.28 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.599 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.55 154.91 26.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.055 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -71.95 155.44 57.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.138 1.892 . . . . 0.0 112.252 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.26 140.64 37.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.692 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -84.75 -25.27 28.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -155.26 127.83 7.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.941 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.624 ' CD1' ' HB2' ' A' ' 276' ' ' LYS . 17.2 t80 -138.73 108.91 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -114.83 111.69 21.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 272' ' ' ASP . 9.7 tt -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.14 116.97 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -102.71 168.2 9.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.131 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.5 130.09 47.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 13.3 m -75.43 -12.71 60.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.573 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.42 12.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.4 p -89.07 -27.85 20.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.204 0.526 . . . . 0.0 111.185 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.15 9.17 86.44 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 56.1 mt -121.23 -179.47 4.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.652 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.8 m -80.34 146.95 31.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.143 0.497 . . . . 0.0 111.435 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.56 -24.85 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.778 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 107.75 27.0 5.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.327 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.86 139.0 18.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 117.465 0.632 . . . . 0.0 110.921 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -150.02 169.51 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.537 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.18 134.86 50.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.664 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 261' ' ' LEU . 23.0 p -127.79 165.18 20.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -147.98 129.35 14.8 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -84.94 163.74 18.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 0.0 111.547 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.79 -23.67 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.846 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.04 157.35 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.875 0.369 . . . . 0.0 110.082 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.37 -29.0 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.397 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.04 -27.0 62.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.543 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.403 HG21 ' HA3' ' A' ' 283' ' ' GLY . 14.9 p -84.17 -18.39 9.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.99 0.424 . . . . 0.0 110.713 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 37.0 m -61.98 -47.98 82.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.99 -24.66 43.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.78 -32.54 59.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.32 -53.44 12.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.114 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.446 HG22 HG13 ' A' ' 332' ' ' VAL . 2.8 pp -60.37 -21.69 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 110.878 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.03 -37.43 69.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.369 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.64 -36.78 3.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.32 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.25 -34.58 65.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -66.08 117.28 8.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.66 8.56 45.65 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 330' ' ' LEU . 48.0 ttm -64.35 116.0 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 110.317 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 86.09 7.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.16 112.62 25.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.23 -112.01 3.75 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.638 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.94 -14.1 10.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -113.32 168.42 9.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.51 124.87 50.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.674 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 323' ' ' MET . 13.9 mt -74.03 138.13 43.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.129 -173.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.9 124.18 35.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.698 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 317' ' ' ILE . 41.9 t -130.54 113.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . 0.487 ' C ' ' H ' ' A' ' 335' ' ' ALA . 3.5 pt20 -137.69 168.14 20.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.447 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.542 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.3 mmm180 -74.56 34.61 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.951 0.5 . . . . 0.0 112.103 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 333' ' ' GLN . . . . . . . . 0 C--N 1.316 -0.886 0 O-C-N 124.843 1.339 . . . . 0.0 113.419 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -65.97 -17.96 65.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.147 -0.346 . . . . 0.0 111.331 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -87.31 -19.05 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.743 0.306 . . . . 0.0 110.788 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.99 -29.48 14.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 110.372 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.07 -6.16 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.855 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 40.0 ttp180 -114.28 130.11 56.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.034 0.445 . . . . 0.0 110.943 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.18 154.21 31.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.643 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 54.1 t80 -83.7 118.37 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.373 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.2 132.6 50.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.73 176.66 17.9 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.831 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 t30 68.28 30.58 5.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.443 0.639 . . . . 0.0 110.589 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.1 pt -92.65 150.24 39.38 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.82 134.1 17.71 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.502 2.134 . . . . 0.0 111.332 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -62.05 113.92 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.6 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 110.44 2.03 29.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.641 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.7 tt -57.66 146.23 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.211 0.529 . . . . 0.0 110.39 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.6 m -102.28 152.15 21.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -48.93 -58.6 4.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.515 0.509 . . . . 0.0 110.98 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.52 -37.16 72.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.885 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.28 -57.8 11.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.758 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 33.3 ttm -67.79 -39.54 84.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.502 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 15.6 ttt -60.01 -56.74 17.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.82 -38.39 85.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.053 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 1.4 m-85 -59.99 -57.81 11.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.972 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.451 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -60.36 -42.38 95.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 110.749 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.529 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.65 -44.12 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 21.8 mm-40 -62.74 -37.69 87.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.324 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 10.3 mmt -55.82 -42.92 76.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.921 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -75.79 -33.61 60.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.726 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 92.7 mt -62.81 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.47 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.86 -16.03 68.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.468 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.97 37.22 26.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.06 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.478 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 17.6 mt -90.33 -26.96 19.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 0.0 110.66 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.472 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -59.53 108.77 0.77 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 111.762 -176.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.78 -33.22 25.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.6 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.68 154.47 41.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.509 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.8 143.93 52.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.608 2.205 . . . . 0.0 111.544 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.02 -151.85 16.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.369 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -98.23 117.01 65.43 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.3 -35.43 84.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.427 2.084 . . . . 0.0 111.534 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -78.76 131.5 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.525 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 tp -98.9 -40.8 7.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.812 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.64 150.16 27.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.788 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 200' ' ' LEU . 7.3 t -126.26 125.75 68.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.627 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -118.3 112.14 19.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.444 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 191' ' ' ILE . 4.2 mp -104.62 104.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.717 -179.329 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.426 ' HE1' ' CE2' ' A' ' 199' ' ' PHE . 15.2 p90 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 120.834 0.35 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 160.1 39.68 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.426 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 54.0 m-85 -117.76 122.59 43.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.614 174.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 14.2 mt -103.93 110.22 22.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.902 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -93.92 126.36 39.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.5 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 50.1 m-85 -103.03 165.11 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -84.65 -15.65 44.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.474 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 m -148.24 136.96 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.07 -30.32 49.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.114 0.483 . . . . 0.0 110.512 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 209' ' ' THR . 4.9 m-20 -64.29 -36.23 83.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.11 -21.14 40.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.378 0.608 . . . . 0.0 109.924 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 85.9 m -70.1 -48.61 56.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.151 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 206' ' ' ASP . 14.9 t -62.5 -36.1 81.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.966 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -74.62 -18.38 60.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.729 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.8 59.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.477 0.656 . . . . 0.0 109.552 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 10.4 mtt -67.75 -17.33 64.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.961 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.36 63.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.415 ' O ' HG23 ' A' ' 217' ' ' ILE . 11.8 m-30 -77.51 -2.86 37.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.624 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.96 106.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 0.0 110.513 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.21 4.33 59.85 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.569 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.46 HD11 ' CZ ' ' A' ' 219' ' ' PHE . 7.9 tt -92.31 156.74 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.05 99.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.284 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.723 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.4 m-85 -104.5 122.82 46.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.374 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 61.59 20.08 10.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 111.383 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 93.46 -11.15 72.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.082 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.723 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 19.9 pt20 -94.98 142.95 26.88 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.336 0.589 . . . . 0.0 110.288 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.1 p -103.51 124.39 48.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.557 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.5 mt -108.34 136.77 47.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -120.99 126.68 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.866 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.01 125.5 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 12.7 tpt180 . . . . . 0 C--N 1.32 -0.678 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 12.9 m -63.92 129.22 39.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.626 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.5 p -89.28 4.22 49.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.411 0.624 . . . . 0.0 110.626 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.497 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 3.5 p -107.52 104.45 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.836 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.62 109.63 39.88 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.73 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.8 Cg_exo -60.73 144.79 99.6 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.856 2.371 . . . . 0.0 111.066 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.53 90.62 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.723 0.773 . . . . 0.0 110.627 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.7 m -96.06 168.89 10.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.585 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.89 57.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.14 0.495 . . . . 0.0 110.701 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -111.47 27.79 9.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.868 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -55.45 144.86 24.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.709 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 14.8 mt -122.36 134.45 54.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -111.6 125.81 54.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.752 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.6 mp -113.32 114.09 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.64 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -120.5 -177.79 15.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.1 89.41 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.365 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.451 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 95.7 mt -69.01 130.67 91.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.963 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.17 139.43 85.67 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.764 2.309 . . . . 0.0 111.226 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.88 -1.2 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -103.12 -6.43 22.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.3 mt -96.84 128.61 43.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -104.56 -177.18 3.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 5.5 p-10 -48.71 -43.29 37.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -60.16 -44.4 95.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.616 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.7 -42.05 51.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.455 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.58 -28.63 43.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.687 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 50.2 mtmt -56.01 -33.77 65.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 110.997 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.81 -30.49 70.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.058 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.34 -40.82 29.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 0.0 110.285 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 48.0 mt -76.0 -30.42 58.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.358 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 7.4 p -67.5 -13.62 62.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.6 m -55.54 -30.42 60.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.856 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -103.79 -40.72 6.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.597 0.237 . . . . 0.0 111.435 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.2 163.06 35.79 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.369 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -72.03 162.32 42.18 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.304 2.67 . . . . 0.0 112.058 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.27 129.19 56.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.531 0.681 . . . . 0.0 111.34 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.415 ' HB2' HG12 ' A' ' 308' ' ' VAL . 15.5 tppt? -71.09 -46.4 61.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.765 175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -143.3 128.0 18.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.842 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 21.1 t80 -138.14 109.49 6.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.17 117.28 31.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.351 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.9 126.64 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.99 121.99 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.266 0.555 . . . . 0.0 110.667 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -115.02 145.66 42.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.546 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.539 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.6 t70 -89.84 140.57 29.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.9 t -85.67 -16.09 40.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.99 -40.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 0.0 110.977 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.9 p -85.56 -28.31 24.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 110.611 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.69 20.89 77.83 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.741 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.98 174.64 9.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.966 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 21.5 m -70.63 137.46 49.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.406 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -86.05 -1.08 57.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 84.4 27.13 37.09 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.557 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 43.2 p90 -158.62 144.77 16.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.9 0.381 . . . . 0.0 110.308 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.11 168.45 23.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.033 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.58 128.68 48.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.62 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 24.4 p -124.15 158.84 31.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 110.963 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.09 110.2 10.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.697 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.34 137.57 50.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.986 0.422 . . . . 0.0 110.006 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 286' ' ' LYS . 4.5 m -60.57 -27.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.658 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 312' ' ' VAL . 13.8 m-20 -113.22 136.26 52.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.35 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.1 -14.08 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 111.306 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -82.59 -19.62 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.822 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 309' ' ' ASP . 11.0 p -87.51 -18.49 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 109.879 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 45.4 m -51.25 -51.62 52.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.885 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.02 -18.78 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.636 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -83.86 -31.84 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.03 -53.99 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.636 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.47 HG23 HG13 ' A' ' 332' ' ' VAL . 2.9 pp -58.23 -25.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.121 0.486 . . . . 0.0 110.912 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -66.87 -42.9 84.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.172 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.98 -30.54 6.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.477 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.13 -35.87 59.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.872 0.336 . . . . 0.0 111.409 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 55.7 t30 -65.39 112.21 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 0.0 110.218 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 107.26 2.25 35.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.371 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.6 ttm -65.75 116.5 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.25 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.51 87.14 6.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 110.63 21.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.865 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.03 -122.79 6.28 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.891 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -99.29 -13.65 19.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.784 0.326 . . . . 0.0 111.501 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -126.03 166.76 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.164 0.507 . . . . 0.0 111.64 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 51.8 mtpt -94.05 124.7 38.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.794 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.6 mt -72.23 129.84 39.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.11 120.19 30.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.409 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 61.0 t -130.82 108.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.285 0.565 . . . . 0.0 109.901 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -151.12 163.03 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.412 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.69 126.74 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.911 -176.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 15.1 t . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -19.71 65.76 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.968 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.21 -28.46 48.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.008 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.56 -32.37 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 145' ' ' THR . 24.0 mtm180 -72.47 -10.75 60.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.96 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -111.26 132.83 54.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.402 -174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.49 153.38 33.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.701 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -86.61 125.55 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.452 HG21 HD22 ' A' ' 200' ' ' LEU . 41.0 t -110.53 117.09 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 110.623 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 197' ' ' PHE . . . -105.8 169.62 16.18 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.887 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.6 t30 66.89 50.06 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.632 0.729 . . . . 0.0 110.524 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 pt -116.37 150.82 46.06 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.494 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.43 131.02 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.857 2.371 . . . . 0.0 111.62 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -64.14 131.7 48.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.882 0.372 . . . . 0.0 110.162 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.95 8.41 58.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.641 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.5 tt -67.63 147.14 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -101.69 148.79 24.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -46.19 -59.09 3.1 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.679 0.391 . . . . 0.0 111.499 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.7 -34.24 64.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.281 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -57.07 12.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.67 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 4.6 ttm -69.31 -37.69 77.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.413 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 15.1 ttt -57.73 -49.43 76.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.227 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.44 -36.42 83.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.066 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.606 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.0 m-85 -59.26 -53.41 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.408 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -61.98 -41.67 98.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.265 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.07 -40.81 95.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.995 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.606 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -62.01 -43.41 98.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.916 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 56.0 mm-40 -64.13 -36.05 82.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.191 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 11.4 mmt -59.62 -42.15 92.04 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.211 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.88 -44.31 81.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.673 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 60.9 mt -62.58 -47.6 83.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.956 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.14 -24.23 72.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.312 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.99 30.33 17.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.813 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' ' OE1' ' A' ' 210' ' ' GLN . 23.4 mt -87.72 -17.89 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.51 106.41 0.46 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 111.854 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.33 -4.44 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.592 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . -89.49 132.46 37.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.49 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.13 131.35 36.31 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.144 1.896 . . . . 0.0 110.426 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 76.98 -140.05 24.31 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.229 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -92.84 126.86 50.0 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.986 0.422 . . . . 0.0 110.373 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 -30.42 67.34 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.163 2.576 . . . . 0.0 112.991 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.12 131.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 203' ' ' ARG . 47.5 tp -90.29 -42.43 10.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.44 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.35 168.05 24.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.35 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.29 136.64 28.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.044 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -125.01 118.13 25.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.549 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.86 125.68 55.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.139 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.571 ' CD1' ' HA2' ' A' ' 154' ' ' GLY . 44.9 m-85 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.781 0.324 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.08 172.24 11.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.397 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.8 139.81 51.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.509 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -115.48 129.16 56.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.37 130.65 56.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.607 0.717 . . . . 0.0 111.133 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.58 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.6 m-85 -106.68 164.43 12.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.795 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.477 ' HA ' HD21 ' A' ' 187' ' ' LEU . 14.7 ptt180 -68.06 -28.18 67.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.095 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 38.6 m -152.38 153.56 33.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.07 -30.12 47.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.44 ' O ' HG21 ' A' ' 209' ' ' THR . 2.6 m-20 -57.23 -45.44 83.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 181' ' ' ALA . 2.2 mm-40 -72.31 -32.28 66.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.569 0.7 . . . . 0.0 109.638 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 55.7 m -68.22 -47.2 68.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.537 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 206' ' ' ASP . 12.2 t -64.85 -32.8 74.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.662 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.523 ' OE1' ' HB3' ' A' ' 178' ' ' LEU . 7.4 pt20 -75.52 -18.19 59.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.4 51.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.255 0.55 . . . . 0.0 109.816 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 9.9 mtt -66.41 -15.31 63.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.411 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -27.11 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.03 0.443 . . . . 0.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 217' ' ' ILE . 27.2 m-85 -83.93 17.22 2.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.462 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.64 117.44 13.21 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.976 -0.453 . . . . 0.0 110.985 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.97 12.67 61.73 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.904 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 214' ' ' PHE . 15.5 tt -100.58 151.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.916 0.389 . . . . 0.0 110.669 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.74 101.72 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.398 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.676 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 13.7 m-85 -104.81 122.46 45.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.73 20.25 8.99 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.688 0.395 . . . . 0.0 112.006 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 98.02 -12.02 63.97 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.202 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.1 pt20 -99.21 138.32 36.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.03 0.415 . . . . 0.0 109.941 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.5 t -92.37 130.01 38.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.986 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.62 118.99 38.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.313 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -109.89 122.77 48.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 118.82 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.799 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 177.215 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.834 0.349 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 19.8 m -71.34 146.34 48.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.782 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.0 p -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 110.305 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.531 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 61.2 t -97.64 100.66 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.124 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.485 HG12 ' HZ1' ' A' ' 260' ' ' LYS . 6.2 t -93.13 107.05 22.36 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.047 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.1 Cg_exo -58.38 149.18 75.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.336 2.69 . . . . 0.0 112.68 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.48 128.81 44.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.559 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 37.8 t -146.1 -178.72 6.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -78.92 -19.22 52.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 109.776 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -93.62 27.83 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.639 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 257' ' ' SER . 1.8 tmtm? -70.07 136.52 50.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.186 -176.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.452 ' N ' ' HD3' ' A' ' 260' ' ' LYS . 11.7 mt -121.96 149.19 43.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.947 0.403 . . . . 0.0 111.528 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -127.84 136.25 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.353 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.67 122.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.068 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.49 -179.55 15.88 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.31 1.17 90.38 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.431 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.0 mt -66.93 133.21 93.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.726 0.298 . . . . 0.0 111.617 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.78 143.42 99.62 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.935 2.424 . . . . 0.0 111.585 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -72.34 -5.67 37.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -102.03 0.67 35.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.7 133.86 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -105.2 -175.77 2.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.6 p-10 -51.83 -40.67 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.597 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 9.5 t70 -69.69 -39.19 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.675 0.274 . . . . 0.0 111.131 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.13 -37.53 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.195 0.522 . . . . 0.0 110.605 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.2 -30.97 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.81 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 27.2 mtmm -50.81 -41.85 57.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.531 0.205 . . . . 0.0 111.257 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -56.51 -35.58 68.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.504 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.33 -38.03 71.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.902 0.382 . . . . 0.0 110.552 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.2 mt -81.45 -31.31 33.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.281 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 38.1 p -72.78 -12.49 61.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 59.4 p -54.17 -41.51 68.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 111.531 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -87.59 -41.41 13.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 0.0 110.373 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -167.86 154.95 25.4 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.072 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.77 156.96 52.64 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.447 2.098 . . . . 0.0 112.643 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.57 136.19 45.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.495 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -75.37 -30.14 60.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.453 176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -154.92 126.3 7.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.226 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.86 113.16 8.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.38 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -117.37 120.55 38.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.543 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -102.05 129.28 48.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.3 105.29 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.342 0.591 . . . . 0.0 110.82 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.51 164.34 14.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.56 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -100.55 130.56 46.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 37.9 m -81.79 -9.75 59.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.165 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.9 -40.65 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.966 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 68.2 p -88.21 -28.07 21.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 83.79 8.4 84.46 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.61 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 45.4 mt -118.33 159.42 23.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 111.001 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.8 m -71.62 127.01 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.675 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.92 -9.4 58.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 111.529 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 91.09 26.39 21.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.974 171.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -148.81 144.4 26.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.096 0.448 . . . . 0.0 110.034 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.44 170.78 17.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.4 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.17 135.81 52.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.763 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 13.9 p -134.9 159.12 42.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.718 0.294 . . . . 0.0 110.716 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 254' ' ' VAL . 73.0 mm-40 -133.36 128.85 36.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.645 173.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.75 144.12 26.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.296 0.569 . . . . 0.0 110.366 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.48 -32.9 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.493 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -121.46 157.01 31.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.33 -21.66 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.092 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -71.27 -31.94 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.034 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.458 HG23 ' HA3' ' A' ' 283' ' ' GLY . 9.6 p -81.82 -23.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.509 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.3 m -54.73 -54.03 47.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.22 -23.26 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.278 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -34.3 53.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.812 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.26 -49.89 21.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.471 HG21 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -61.86 -21.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.644 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.2 60.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.243 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.79 -36.74 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.162 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 63.9 mt -75.75 -33.71 60.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.637 0.256 . . . . 0.0 111.296 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.79 112.48 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.75 11.36 56.86 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.453 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.1 ttm -68.65 119.81 13.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 0.0 110.125 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.46 86.57 7.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.61 114.74 28.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.667 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.11 -122.06 6.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.704 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.12 -13.75 15.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 0.0 111.085 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -122.28 173.29 7.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -103.3 128.91 50.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.324 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.15 129.57 37.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.4 tp -90.18 119.65 30.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.455 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.471 HG12 HG21 ' A' ' 317' ' ' ILE . 65.0 t -130.51 109.03 16.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.5 177.32 9.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -69.43 130.99 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.193 -177.053 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -35.07 79.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.164 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.4 -11.6 55.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.3 -29.05 20.66 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -79.85 7.9 7.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.882 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 53.7 ttp180 -127.84 130.07 47.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.05 153.03 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.314 0.578 . . . . 0.0 111.945 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 47.8 t80 -82.06 111.32 18.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.43 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.35 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.64 161.68 12.94 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.475 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 5.9 t30 70.7 49.44 0.39 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.744 0.783 . . . . 0.0 110.258 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 pt -104.14 151.04 38.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.13 132.28 7.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.977 2.452 . . . . 0.0 111.475 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -66.5 120.27 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.53 -1.18 18.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.16 143.78 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.0 m -100.58 157.82 16.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -52.53 -58.9 5.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.742 0.306 . . . . 0.0 110.653 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.68 -23.61 64.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.57 -58.47 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.791 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.402 ' O ' ' HD1' ' A' ' 169' ' ' PHE . 19.9 ptp -77.96 -24.53 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.946 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 20.0 ttt -61.62 -56.19 22.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.372 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.89 -31.47 72.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.069 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.614 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.1 m-85 -61.13 -54.26 46.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 165' ' ' MET . 44.8 m-85 -65.64 -42.89 90.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -55.99 -34.09 65.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -73.05 -49.84 26.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 81.2 mm-40 -56.26 -39.72 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.414 ' HB3' HG21 ' A' ' 179' ' ' THR . 0.0 OUTLIER -57.15 -42.06 80.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.097 0.475 . . . . 0.0 110.732 177.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -77.56 -27.48 51.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 76.7 mt -72.84 -36.8 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.61 -23.85 35.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.14 36.39 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.392 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.9 mt -94.88 -26.58 16.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.806 0.336 . . . . 0.0 110.535 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.34 112.32 1.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.105 -178.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.2 -37.62 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.226 0.536 . . . . 0.0 109.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.91 39.74 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.215 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.14 142.18 54.99 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.278 1.986 . . . . 0.0 111.629 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.01 -157.95 15.11 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.79 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -96.23 124.45 51.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.225 0.536 . . . . 0.0 110.946 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 40.8 Cg_endo -67.94 -29.56 34.25 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.984 2.456 . . . . 0.0 112.624 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.54 132.81 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.187 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 187' ' ' LEU . 2.4 mt -89.62 -49.52 6.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.424 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.47 157.69 32.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.758 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.421 HG23 HD23 ' A' ' 200' ' ' LEU . 6.7 t -124.23 128.92 74.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.613 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.55 118.97 35.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.6 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.39 126.92 56.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.593 179.675 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.59 156.74 33.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.005 0.431 . . . . 0.0 110.59 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -127.14 124.19 38.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.948 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.4 mt -103.71 115.37 30.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.281 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -96.85 127.14 42.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.514 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.508 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 33.8 m-85 -109.39 158.63 17.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.453 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.2 ptt180 -74.1 -18.4 60.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.874 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.0 m -148.49 144.98 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.091 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.81 -36.5 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.302 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 209' ' ' THR . 20.4 t70 -64.46 -40.26 95.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 110.067 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.54 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.0 mt-10 -72.23 -20.62 61.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.239 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 28.6 m -73.46 -50.44 21.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.235 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 206' ' ' ASP . 6.0 t -66.47 -29.2 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.713 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.54 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 1.8 pt20 -71.56 -20.88 61.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.632 0.253 . . . . 0.0 111.125 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.98 48.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.685 0.755 . . . . 0.0 109.539 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 19.7 mtt -71.24 -17.34 62.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.758 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.12 -21.82 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.146 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 217' ' ' ILE . 22.8 m-85 -83.28 9.36 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.993 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.54 117.49 6.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.54 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.88 83.86 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 214' ' ' PHE . 7.1 tt -88.19 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.21 98.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.639 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.7 p90 -116.69 139.06 50.97 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.158 173.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 65.22 24.39 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.66 82.63 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.523 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.4 pt20 -113.55 145.81 40.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.103 0.452 . . . . 0.0 110.073 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.4 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 32.2 t -103.36 115.31 30.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.919 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.8 137.32 52.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.157 0.503 . . . . 0.0 111.269 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -122.8 133.8 54.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.612 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.7 mp -132.61 146.08 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 . . . . . 0 C--N 1.321 -0.664 0 O-C-N 121.895 -0.503 . . . . 0.0 111.001 -178.11 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.002 0.429 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 66.3 m -104.23 150.69 24.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.23 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.7 p -86.16 8.1 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.8 112.94 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.357 0.598 . . . . 0.0 110.131 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.36 106.08 54.73 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.97 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.82 166.92 12.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.156 2.571 . . . . 0.0 112.34 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.22 83.6 4.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.252 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -79.62 154.44 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.789 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.8 -16.67 63.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.196 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -128.18 36.92 4.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.295 0.569 . . . . 0.0 110.111 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -74.08 150.43 40.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.008 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.414 ' HB2' ' SG ' ' A' ' 305' ' ' CYS . 12.6 mt -122.5 149.1 44.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.879 0.371 . . . . 0.0 111.62 -171.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.75 128.77 56.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.768 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.94 120.93 65.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.645 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.93 166.41 21.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.893 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.63 5.02 63.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.456 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.516 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.1 mt -68.49 125.61 91.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.978 0.418 . . . . 0.0 112.056 -172.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 143.32 94.51 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.839 2.359 . . . . 0.0 111.648 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 298' ' ' LEU . 10.0 t30 -59.68 -26.71 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.442 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -81.84 -0.12 42.02 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.726 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.2 mt -113.9 124.28 51.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -104.29 -174.5 2.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.8 p-10 -47.78 -44.26 28.31 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.499 0.499 . . . . 0.0 111.842 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 31.4 t70 -72.01 -36.93 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.735 0.303 . . . . 0.0 111.812 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.39 -42.89 67.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.12 -29.67 33.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' CD1' ' A' ' 288' ' ' PHE . 1.0 OUTLIER -54.45 -39.36 67.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.795 176.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.87 -36.02 81.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.073 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.07 -41.74 67.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.3 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.24 -40.13 71.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.2 p -70.19 -11.87 61.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.794 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 35.3 t -53.11 -40.41 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.12 -41.0 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.21 150.81 20.03 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.707 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -69.03 156.3 65.68 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.432 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.7 mt -107.17 134.75 49.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.31 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -28.95 33.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.235 0.54 . . . . 0.0 109.824 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.2 120.97 7.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 17.2 t80 -139.2 109.54 6.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.85 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.58 119.22 34.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.401 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.76 124.49 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.3 126.85 36.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.432 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -122.86 148.72 45.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.74 116.35 18.2 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.5 t -70.1 -10.02 57.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.905 0.383 . . . . 0.0 110.511 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -85.68 -53.47 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 46.6 p -83.28 -23.69 32.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.498 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 78.21 18.34 76.55 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.5 ' HB3' ' OD1' ' A' ' 268' ' ' ASN . 59.6 mt -114.95 157.6 23.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.115 0.483 . . . . 0.0 110.881 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 49.5 m -73.48 134.29 43.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 302' ' ' TYR . 18.3 mmtp -61.66 -34.27 75.42 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.344 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 99.82 21.7 13.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.8 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 300' ' ' LYS . 32.0 p90 -153.68 145.0 23.03 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.68 168.25 24.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.911 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.82 132.84 53.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.995 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 32.0 p -127.16 166.35 17.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.964 0.411 . . . . 0.0 111.054 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 127.03 15.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.263 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.21 149.23 25.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.78 -21.03 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.279 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -133.77 159.85 39.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.256 0.551 . . . . 0.0 110.895 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.71 -25.93 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.218 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.8 -34.36 71.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.633 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 283' ' ' GLY . 10.0 p -79.53 -18.14 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.792 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.408 HG21 HD23 ' A' ' 261' ' ' LEU . 55.5 m -55.48 -48.38 74.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.114 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.94 -37.87 67.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.137 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.403 . . . . 0.0 110.838 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.56 -56.92 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.34 -21.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.127 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.89 96.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.225 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.12 -36.28 4.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.015 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 84.4 mt -67.83 -35.71 79.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 111.304 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -64.44 109.29 1.89 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.433 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 99.95 11.53 42.85 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.359 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.8 ttm -59.0 115.24 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.739 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.71 89.17 6.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.687 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 tp -112.72 122.86 48.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 77.73 -125.45 7.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.83 -1.49 25.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.058 0.456 . . . . 0.0 110.097 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -111.14 169.92 8.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.822 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 47.2 mtpt -118.11 117.48 29.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.866 168.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.84 137.21 51.56 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.152 0.501 . . . . 0.0 111.412 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.14 121.78 31.8 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.25 110.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -145.5 146.25 31.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.3 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -62.1 125.76 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.634 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.764 -178.004 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -70.47 -18.59 62.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 110.243 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -90.13 -37.03 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.69 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.86 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.73 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -91.33 9.77 30.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.0 ttp180 -127.24 129.49 47.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.03 153.48 34.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.299 0.571 . . . . 0.0 111.786 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -82.86 115.66 21.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.057 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.8 123.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.749 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.98 172.42 15.15 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.97 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 2.7 t30 69.07 49.52 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.543 0.687 . . . . 0.0 109.713 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.6 pt -123.01 153.49 64.21 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.7 131.07 15.46 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.319 2.013 . . . . 0.0 111.366 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.55 124.76 21.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.01 16.6 40.71 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.087 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.24 148.45 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.929 0.395 . . . . 0.0 110.321 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 148.03 22.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -48.13 -58.52 4.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.088 -175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -55.68 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.279 . . . . 0.0 110.675 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.6 ptp -81.08 -26.16 36.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 18.4 ttt -61.56 -58.54 7.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -31.94 72.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.504 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -63.96 -57.71 8.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.022 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -57.63 -41.11 80.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.545 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -59.39 -27.85 66.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -85.54 -43.48 13.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.47 -41.13 89.03 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.5 ' HB3' HG21 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.1 -36.12 76.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.096 0.474 . . . . 0.0 110.882 177.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.52 -39.56 74.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.344 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.7 mt -65.22 -42.2 93.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.302 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.18 -12.96 78.14 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.607 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 33.17 46.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.676 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.47 -23.9 19.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.59 0.233 . . . . 0.0 110.902 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -59.09 107.97 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -83.43 -28.66 28.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 0.0 109.946 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -107.9 150.78 40.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.601 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.45 135.53 26.72 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.166 1.911 . . . . 0.0 111.578 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 109.34 -167.96 13.1 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.27 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -80.34 120.86 80.72 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 111.096 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.04 -31.24 46.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.945 2.43 . . . . 0.0 112.572 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.2 t -77.75 131.0 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 109.969 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.1 tp -99.33 -43.09 6.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.578 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.43 28.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.368 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.1 t -125.41 139.72 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.838 0.351 . . . . 0.0 110.827 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -124.6 121.55 35.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.959 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.03 122.82 67.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.15 167.16 21.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 73.8 m-85 -127.99 125.85 40.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.144 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 12.9 mt -106.95 122.16 45.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.713 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -100.96 129.72 46.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.43 . . . . 0.0 110.136 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.522 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 53.3 m-85 -108.21 151.52 25.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.952 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.62 -23.38 63.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.932 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -138.22 142.84 39.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.668 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.46 -29.84 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.528 ' O ' HG21 ' A' ' 209' ' ' THR . 14.4 t70 -63.37 -40.51 97.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.453 0.644 . . . . 0.0 109.779 175.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.591 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.6 mt-10 -77.66 -19.96 54.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.55 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.1 m -73.02 -48.26 37.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 110.216 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 206' ' ' ASP . 4.9 t -67.22 -30.55 70.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.471 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.591 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 2.5 pt20 -73.15 -20.55 60.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.052 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.97 -29.02 62.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.387 0.613 . . . . 0.0 109.515 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 12.2 mtt -68.64 -15.95 63.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.833 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.1 74.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 110.465 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 217' ' ' ILE . 32.5 m-85 -80.61 5.08 16.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.426 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.5 106.47 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.992 0.425 . . . . 0.0 111.072 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.07 14.43 57.66 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 214' ' ' PHE . 9.6 tt -103.61 159.62 4.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.876 0.338 . . . . 0.0 110.232 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mm -106.91 98.98 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.57 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.1 m-85 -109.12 136.59 48.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.14 173.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 58.62 28.79 17.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 111.393 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 75.73 5.44 79.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.319 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 14.1 pt20 -118.68 145.45 45.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.033 0.416 . . . . 0.0 110.254 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.408 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 42.6 t -94.93 127.63 41.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.032 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 123.03 40.4 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.95 134.44 54.83 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.87 123.51 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.614 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.4 m -85.18 147.72 26.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 32.9 p -94.08 24.4 4.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.304 0.573 . . . . 0.0 110.719 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.51 108.49 19.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.512 0.673 . . . . 0.0 110.163 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.37 102.28 32.32 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.845 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 170.05 21.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.084 2.523 . . . . 0.0 112.32 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.72 102.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.317 0.58 . . . . 0.0 109.758 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.6 t -118.42 148.74 42.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.598 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.21 55.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.64 ' CE1' ' HB ' ' A' ' 310' ' ' ILE . 23.0 m-70 -120.18 34.1 5.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.797 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.36 146.34 55.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.327 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 313' ' ' THR . 6.2 mt -132.93 139.44 47.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.987 0.422 . . . . 0.0 111.751 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.423 ' C ' HD12 ' A' ' 263' ' ' ILE . 23.2 t80 -119.78 133.47 55.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.019 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.8 mp -121.11 115.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -115.2 -171.97 16.97 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.34 -1.31 85.79 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.824 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.484 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 89.5 mt -70.74 125.99 92.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -173.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.71 142.44 83.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.667 2.245 . . . . 0.0 111.115 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -62.67 -17.89 61.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -86.03 -9.16 57.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.7 mt -102.85 130.06 49.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.156 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -104.38 -177.32 3.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.413 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.673 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.9 p-10 -48.6 -46.88 40.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.383 0.427 . . . . 0.0 111.744 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.14 -44.0 87.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.487 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.6 -38.34 59.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.48 -30.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 0.0 109.914 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 14.4 ttpp -50.45 -38.95 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.722 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.45 -35.05 79.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.591 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.41 -27.61 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.89 0.376 . . . . 0.0 110.228 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 77.1 mt -82.98 -38.8 22.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.116 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 33.3 p -68.41 -11.66 60.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.952 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 74.6 p -50.31 -48.08 55.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.9 -40.99 21.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.775 0.321 . . . . 0.0 110.723 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.75 151.4 20.81 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 280' ' ' THR . 25.3 Cg_endo -67.08 156.08 67.93 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 112.3 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.18 132.98 45.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.646 0.736 . . . . 0.0 111.244 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -78.89 -42.46 27.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.354 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -142.44 128.12 19.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.419 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 10.5 t80 -138.74 107.06 5.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 110.14 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -116.24 108.57 16.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.424 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -94.44 125.69 39.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.31 131.77 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.863 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -117.83 157.84 25.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.53 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 6.0 t70 -100.17 125.18 46.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.2 t -76.3 -14.28 60.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.796 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.28 -37.81 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 111.458 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 81.7 p -86.24 -28.08 24.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.201 0.524 . . . . 0.0 110.563 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.74 18.4 77.35 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 48.5 mt -130.18 179.53 5.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.456 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.439 ' HB3' HD23 ' A' ' 290' ' ' LEU . 69.2 m -74.77 147.36 41.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.63 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 302' ' ' TYR . 35.4 mmtt -73.32 -25.6 60.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.147 0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 97.14 22.54 17.06 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.068 -176.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 1.9 p90 -157.42 146.81 20.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 110.978 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.37 18.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.222 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -129.84 137.84 50.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 31.7 p -139.65 166.88 23.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 112.079 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -133.21 134.04 43.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.366 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -83.24 149.52 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.233 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.64 -36.61 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -115.62 149.08 38.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.252 174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.64 ' HB ' ' CE1' ' A' ' 259' ' ' HIS . 2.8 pp -84.66 -13.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.749 -171.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -78.99 -41.21 29.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.008 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.87 -17.0 21.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.423 HG22 HD12 ' A' ' 261' ' ' LEU . 31.3 m -50.83 -44.41 59.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.893 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.88 -39.51 50.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.433 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -61.29 -37.39 83.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 111.507 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.81 -52.36 31.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.54 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 332' ' ' VAL . 2.7 pp -64.8 -20.88 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.61 67.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.262 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.19 -37.01 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.79 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.97 -28.27 55.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.928 0.364 . . . . 0.0 111.86 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.6 t-20 -66.8 108.8 2.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 329' ' ' LYS . . . 104.65 12.68 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.827 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 35.0 ttm -68.52 113.62 6.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 103.55 4.25 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.467 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.44 111.01 15.23 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 86.61 -116.38 4.42 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.0 5.15 12.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.433 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -122.97 165.74 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.768 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.513 ' HD2' ' O ' ' A' ' 322' ' ' GLY . 24.7 mtmm -109.86 127.94 55.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.422 HD22 HD21 ' A' ' 266' ' ' LEU . 27.4 mt -75.93 137.98 40.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -173.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -89.14 115.42 26.65 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 67.5 t -124.19 107.0 17.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.322 0.582 . . . . 0.0 109.506 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -147.46 145.53 29.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.001 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -63.44 129.05 38.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.02 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.5 -173.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.421 ' OG1' ' HB1' ' A' ' 148' ' ' ALA . 8.9 t . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.649 0.738 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -66.72 -41.98 87.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.841 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -87.6 -4.53 58.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' OG1' ' A' ' 145' ' ' THR . . . -86.32 -32.04 21.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -87.95 -12.97 43.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.024 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 99.6 mtt180 -110.9 156.49 21.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.556 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.97 152.61 42.16 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 20.0 t80 -81.08 113.09 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.216 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -99.3 125.89 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.974 0.416 . . . . 0.0 111.283 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.17 176.19 22.48 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 65.84 52.29 1.28 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.647 0.737 . . . . 0.0 109.409 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 pt -119.2 150.92 50.11 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 11.5 Cg_endo -91.8 146.57 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.425 2.75 . . . . 0.0 112.17 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.13 111.47 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.868 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.76 15.56 36.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.161 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 148.53 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.187 0.518 . . . . 0.0 110.287 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.5 m -99.63 144.83 28.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.037 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 191' ' ' ILE . 1.5 mp0 -42.49 -54.51 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.865 0.728 . . . . 0.0 111.545 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.17 -37.37 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.803 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.85 -55.25 36.79 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.343 0.592 . . . . 0.0 111.088 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -78.24 -29.33 48.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.388 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.0 ttt -61.22 -54.54 42.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.695 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.52 -33.32 75.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.858 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.548 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.1 OUTLIER -63.13 -49.9 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -72.68 -40.04 66.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 72.8 m-20 -56.35 -34.79 66.94 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.552 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -68.1 -39.67 82.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.057 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 62.6 mm-40 -64.12 -38.65 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.425 ' HB3' HG21 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.27 -41.72 93.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 83.4 mtt180 -69.4 -36.01 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.438 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 97.9 mt -61.75 -50.43 72.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.64 65.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.667 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.03 30.97 24.41 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.304 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.82 -22.45 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.3 . . . . 0.0 110.22 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.425 HG21 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.23 108.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.097 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -88.19 -30.04 20.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.031 0.443 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.463 ' HB1' ' CZ ' ' A' ' 203' ' ' ARG . . . -108.56 149.03 38.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.968 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.48 145.03 95.55 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.291 1.994 . . . . 0.0 111.421 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.15 -149.95 19.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.463 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.51 123.91 42.75 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.817 0.341 . . . . 0.0 111.12 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.4 -37.82 22.15 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.201 2.601 . . . . 0.0 112.398 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.55 123.53 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.44 -46.72 8.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.305 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.74 40.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.41 HG22 HD23 ' A' ' 200' ' ' LEU . 3.5 t -127.82 140.12 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -119.15 117.81 29.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.014 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' A' ' 162' ' ' GLU . 3.8 mp -106.58 129.19 60.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.529 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.468 178.239 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 17.0 p90 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.55 155.96 49.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.131 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.5 125.35 50.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.878 0.371 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 20.2 mt -94.62 125.29 39.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.686 174.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -105.05 130.62 53.2 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.52 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 61.5 m-85 -109.79 157.48 19.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.463 ' CZ ' ' HB1' ' A' ' 181' ' ' ALA . 37.3 ptt180 -78.16 -18.98 54.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.787 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 54.7 m -147.91 139.56 23.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.797 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.66 -25.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.44 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -76.21 -23.76 54.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -84.23 -20.9 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.237 0.541 . . . . 0.0 109.673 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 67.6 m -69.83 -49.87 48.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.639 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.8 t -60.69 -36.79 79.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.43 -22.45 61.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.79 -28.49 60.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 109.87 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 23.8 mtp -72.76 -14.64 61.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.192 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -18.15 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.489 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.477 ' CG ' ' HE2' ' A' ' 219' ' ' PHE . 11.4 m-85 -84.56 5.19 28.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.57 107.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.466 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.51 13.54 59.68 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.017 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -94.56 154.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.151 0.476 . . . . 0.0 110.818 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.8 mm -97.73 100.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.132 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.66 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.9 m-85 -105.03 103.39 12.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.69 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 60.54 37.63 19.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.95 -13.57 63.47 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.155 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.8 pt20 -100.96 132.83 46.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.604 0.702 . . . . 0.0 110.344 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.0 t -98.7 90.41 4.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 pp -91.71 144.69 25.25 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.46 143.25 47.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.153 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.4 mp -130.65 115.41 31.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.9 tpt180 . . . . . 0 C--N 1.318 -0.788 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.2 m -81.39 147.88 29.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 67.2 p -93.27 4.08 54.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.553 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 4.3 p -109.12 106.64 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.861 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.03 110.12 39.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.992 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 8.1 Cg_exo -72.53 139.72 31.81 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.996 2.464 . . . . 0.0 110.953 172.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 260' ' ' LYS . 26.9 t70 -86.65 83.44 7.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.463 0.649 . . . . 0.0 110.479 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 33.1 t -89.55 -178.03 5.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.823 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.74 65.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.665 0.745 . . . . 0.0 110.023 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -102.46 31.63 3.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.377 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 257' ' ' SER . 2.3 tmtp? -67.75 133.34 49.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 305' ' ' CYS . 2.2 mt -122.17 149.24 43.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.483 . . . . 0.0 112.251 -172.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.403 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 45.2 t80 -119.62 132.12 55.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.796 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.474 HD12 ' SG ' ' A' ' 305' ' ' CYS . 2.5 mp -116.25 120.05 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.02 0.438 . . . . 0.0 110.298 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.39 -174.43 13.84 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 87.47 -6.72 82.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.008 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 301' ' ' GLY . 91.9 mt -68.86 127.62 93.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -172.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.01 140.17 59.12 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.173 1.915 . . . . 0.0 109.803 166.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -64.55 -15.08 60.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -169.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -83.61 -7.56 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.021 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.35 126.47 42.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.41 ' HA ' ' HG ' ' A' ' 299' ' ' SER . 34.3 p-10 -104.4 176.15 5.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.699 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 12.6 t70 -40.22 -43.49 1.69 Allowed 'General case' 0 CA--C 1.534 0.327 0 O-C-N 123.644 0.59 . . . . 0.0 111.882 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.43 -47.9 74.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.896 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -73.74 -39.64 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.94 -32.6 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.671 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.9 mtmm -56.26 -33.98 65.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.651 0.262 . . . . 0.0 111.176 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.48 -31.53 72.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.406 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.74 -34.92 60.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.131 0.491 . . . . 0.0 110.174 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.93 -32.23 27.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.274 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 17.0 p -69.38 -13.8 62.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.753 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.4 m -49.63 -46.43 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.467 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.26 -41.12 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.158 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.19 164.34 35.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.915 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -70.48 166.17 29.36 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.776 2.317 . . . . 0.0 111.85 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.2 mt -112.22 133.18 54.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.732 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.35 -38.09 74.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.272 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -152.27 131.96 13.16 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.686 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -138.57 117.89 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.266 0.555 . . . . 0.0 110.559 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -121.39 102.37 8.22 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.789 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.443 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 6.5 tt -86.82 133.6 33.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.329 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.92 133.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.541 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -122.16 165.29 16.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 295' ' ' ALA . 20.5 t70 -110.0 133.35 53.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.74 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.7 t -83.86 -11.12 57.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.92 0.391 . . . . 0.0 110.537 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.428 ' HB3' ' OD2' ' A' ' 293' ' ' ASP . . . -88.31 -43.46 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.735 0.302 . . . . 0.0 111.003 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 70.0 p -83.39 -30.66 27.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.17 0.51 . . . . 0.0 110.787 176.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.46 13.52 80.16 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 42.2 mt -123.61 -175.43 3.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.709 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' A' ' 271' ' ' ASN . 36.6 m -74.75 152.45 39.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.133 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.4 ' HE2' ' OH ' ' A' ' 302' ' ' TYR . 46.0 mtpt -87.38 -10.9 50.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.544 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.484 ' C ' ' HB2' ' A' ' 266' ' ' LEU . . . 92.66 26.84 16.1 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.67 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.4 ' OH ' ' HE2' ' A' ' 300' ' ' LYS . 1.6 p90 -164.42 149.43 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.029 0.443 . . . . 0.0 110.615 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -149.37 170.27 18.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.912 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.428 ' CD1' ' HE2' ' A' ' 260' ' ' LYS . 98.5 m-85 -123.19 127.97 49.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.484 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.474 ' SG ' HD12 ' A' ' 263' ' ' ILE . 12.4 p -122.42 162.48 21.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.101 0.476 . . . . 0.0 110.187 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 111.96 6.04 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -70.38 171.3 10.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.962 0.411 . . . . 0.0 110.995 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.83 -45.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.625 ' HB3' ' ND2' ' A' ' 311' ' ' ASN . 11.0 m-20 -85.6 142.15 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.96 -14.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.248 0.547 . . . . 0.0 110.498 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.625 ' ND2' ' HB3' ' A' ' 309' ' ' ASP . 9.1 p30 -86.89 -24.24 24.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.026 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 309' ' ' ASP . 8.9 p -83.78 -18.27 10.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.116 0.484 . . . . 0.0 109.802 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 21.9 m -53.8 -49.23 68.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.257 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.31 -24.82 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -70.79 -36.04 72.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.173 0.511 . . . . 0.0 110.971 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.5 -52.32 14.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.019 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.418 HG21 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -61.45 -21.21 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.162 0.506 . . . . 0.0 110.968 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.48 -39.08 74.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.259 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.62 -35.96 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.243 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.5 -34.25 58.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.406 ' OD1' HD12 ' A' ' 331' ' ' LEU . 64.8 t30 -69.91 117.79 11.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.478 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 96.06 10.75 55.88 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.036 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.449 ' O ' HD23 ' A' ' 330' ' ' LEU . 41.9 ttm -64.22 116.2 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 86.82 7.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.27 121.83 45.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.414 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.18 -117.63 4.52 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -116.37 -14.68 11.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 110.793 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.41 165.26 11.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -107.31 125.86 51.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.898 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.488 ' HA ' ' HA3' ' A' ' 265' ' ' GLY . 2.6 mm? -73.21 133.97 44.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.814 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.406 HD12 ' OD1' ' A' ' 321' ' ' ASN . 33.6 tp -97.62 122.81 41.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 174.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.418 HG12 HG21 ' A' ' 317' ' ' ILE . 99.6 t -131.22 108.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.95 160.08 40.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.8 141.49 36.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.782 0 CA-C-O 121.137 0.494 . . . . 0.0 109.98 179.233 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.89 -19.13 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 110.613 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.74 -33.68 27.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.452 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.83 -25.95 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.51 -6.59 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.362 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 30.8 mtm180 -110.45 158.08 18.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.233 0.539 . . . . 0.0 111.542 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.34 153.53 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.562 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 15.5 t80 -79.61 118.97 21.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.585 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.96 121.26 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -122.88 176.21 16.56 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.218 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.2 43.5 1.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.807 0.813 . . . . 0.0 109.866 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.8 pt -116.35 154.6 48.89 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.67 130.91 14.1 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.633 2.222 . . . . 0.0 111.378 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.82 117.64 9.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.657 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.29 6.49 29.41 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.514 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.71 147.93 11.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 110.2 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 m -93.48 144.89 24.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.546 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 189' ' ' VAL . 1.9 mp0 -49.54 -54.21 19.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 123.371 0.42 . . . . 0.0 111.397 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.26 -24.28 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.278 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 -58.39 5.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.704 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 ptp -72.06 -31.67 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.353 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.27 -54.83 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.309 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.62 -36.12 83.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.6 OUTLIER -56.95 -61.11 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.978 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -58.65 -42.37 88.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -59.79 -42.05 92.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 111.063 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.99 -43.93 77.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.988 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 23.1 mm-40 -64.34 -31.81 73.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.165 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.464 ' HB3' HG23 ' A' ' 179' ' ' THR . 11.9 mmt -57.07 -46.17 82.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -73.69 -30.17 62.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 81.0 mt -66.85 -48.39 68.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.359 . . . . 0.0 110.278 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.82 74.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.476 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.56 36.75 10.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.174 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.463 HD11 ' SD ' ' A' ' 173' ' ' MET . 17.3 mt -90.89 -27.37 18.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -60.16 108.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.809 -177.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -22.97 14.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.13 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.7 127.78 27.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.46 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.86 142.17 98.07 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.723 2.282 . . . . 0.0 112.572 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 107.17 -143.16 15.83 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.39 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -108.27 115.07 58.77 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-O 120.953 0.406 . . . . 0.0 110.801 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.32 -37.8 58.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.817 2.345 . . . . 0.0 112.114 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.43 119.31 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.0 tm? -97.46 -34.96 10.82 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 -170.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.12 157.96 38.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 162' ' ' GLU . 97.2 t -138.0 128.81 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.809 0.338 . . . . 0.0 110.677 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -119.38 125.25 48.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.06 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 162' ' ' GLU . 15.9 mm -90.94 130.69 39.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.527 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.53 161.65 37.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.821 0.343 . . . . 0.0 111.049 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.49 121.3 43.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.066 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 1.0 OUTLIER -94.47 118.96 32.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.926 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -102.64 126.8 49.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.363 0.601 . . . . 0.0 110.551 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.533 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 59.1 m-85 -106.52 157.29 17.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.443 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.494 ' HB3' ' HG ' ' A' ' 187' ' ' LEU . 17.9 ptt180 -79.18 -20.63 47.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.8 m -141.74 144.07 33.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.51 -26.63 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.007 0.432 . . . . 0.0 111.103 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 209' ' ' THR . 9.2 p-10 -75.58 -18.25 59.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.672 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.429 ' OE1' ' HG3' ' A' ' 203' ' ' ARG . 44.5 mt-10 -86.01 -26.43 25.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 45.0 m -68.31 -44.74 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.816 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.5 t -61.56 -37.01 82.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.171 -174.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -74.73 -18.22 60.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.55 -27.3 58.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.35 0.595 . . . . 0.0 109.955 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 9.8 mtt -68.36 -16.24 63.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.14 -24.85 64.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.497 ' O ' HG22 ' A' ' 217' ' ' ILE . 18.9 m-30 -75.33 -0.85 21.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.954 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.8 106.28 1.49 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.57 14.34 38.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.3 tt -106.84 153.94 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.28 99.56 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.141 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.75 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.1 m-85 -103.0 118.94 37.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.513 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 57.61 32.49 21.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.205 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.8 -13.34 64.64 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.593 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 24.7 pt20 -94.36 136.67 34.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.498 0.649 . . . . 0.0 110.438 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.0 t -90.35 124.73 35.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.638 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.48 121.98 42.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.798 0.333 . . . . 0.0 110.528 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -113.23 119.24 37.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.998 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.1 mp -121.75 130.78 74.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.115 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.049 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.5 m -69.34 139.38 54.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.173 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 p -87.92 1.71 53.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.347 0.594 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.74 108.08 22.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.748 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.26 107.51 59.18 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.822 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.15 160.49 49.41 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.811 2.341 . . . . 0.0 111.346 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.33 142.21 47.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.7 p -156.49 -177.07 6.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.026 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.38 0.69 55.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.243 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -131.52 16.03 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.4 125.99 30.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 0.8 OUTLIER -109.28 139.9 43.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -171.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.421 ' HD2' ' CE2' ' A' ' 304' ' ' PHE . 41.9 t80 -101.91 127.44 48.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.446 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.96 116.53 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.761 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -121.55 176.1 16.3 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.578 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.69 89.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.2 mt -68.87 129.69 92.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -174.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 139.88 91.09 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.688 2.259 . . . . 0.0 111.238 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.46 -18.66 62.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -98.03 8.2 45.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.57 122.92 48.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.219 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.78 -171.51 1.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.776 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 5.7 p-10 -48.81 -45.46 40.38 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.624 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.32 -47.64 78.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 111.619 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.19 -41.46 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.426 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.01 -31.68 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.441 0.639 . . . . 0.0 110.048 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.736 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 0.6 OUTLIER -55.11 -36.7 65.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.382 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.22 -26.34 68.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.663 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.68 -38.36 33.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.213 0.53 . . . . 0.0 109.711 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.74 -42.56 63.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.055 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 30.6 p -66.89 -11.38 55.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.016 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.1 t -59.72 -29.28 68.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.774 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.06 -40.61 6.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.026 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.48 160.48 32.75 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.054 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.31 168.43 23.43 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.151 2.567 . . . . 0.0 112.133 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.2 mt -117.74 134.1 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.469 0.652 . . . . 0.0 111.729 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.488 ' HB2' HG21 ' A' ' 308' ' ' VAL . 38.6 ttmt -70.51 -46.39 63.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.074 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -150.87 133.45 15.64 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.605 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 10.4 t80 -138.28 107.03 5.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.895 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.57 105.16 15.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.634 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.593 HD11 ' N ' ' A' ' 291' ' ' VAL . 0.6 OUTLIER -88.34 132.57 34.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.593 ' N ' HD11 ' A' ' 290' ' ' LEU . 27.8 t -98.57 119.07 46.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.161 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -114.41 167.3 10.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' A' ' 295' ' ' ALA . 13.6 t70 -96.27 118.49 32.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.3 t -72.12 -10.01 59.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.611 0.244 . . . . 0.0 110.847 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 293' ' ' ASP . . . -91.91 -49.45 6.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.264 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 76.0 p -82.4 -27.68 31.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 111.026 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.31 82.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.121 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 29.8 mt -108.49 170.01 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.4 m -82.44 138.92 34.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 110.53 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -63.86 -31.42 72.6 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.133 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 105.55 26.85 6.0 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 17.1 p90 -156.69 141.4 16.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 110.185 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.447 ' HB3' HD22 ' A' ' 290' ' ' LEU . . . -149.2 170.28 18.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.179 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 94.8 m-85 -131.45 130.29 42.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 30.7 p -130.26 175.68 8.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 111.465 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 129.32 11.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.403 ' OH ' HD13 ' A' ' 320' ' ' LEU . 8.4 m-85 -89.06 -0.16 57.2 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 286' ' ' LYS . 44.3 t 75.37 -63.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.555 0.693 . . . . 0.0 109.603 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 312' ' ' VAL . 15.1 t70 -75.51 135.48 40.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.131 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.26 -19.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 309' ' ' ASP . 1.7 m-80 -80.53 -45.51 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.782 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 309' ' ' ASP . 7.1 p -65.4 -18.47 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.205 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 23.5 m -53.8 -50.15 66.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.444 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.77 -35.87 62.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 0.0 110.627 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -67.27 -31.04 71.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 320' ' ' LEU . . . -75.48 -55.16 5.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.899 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.08 -21.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.762 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.32 79.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.049 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.66 -28.97 6.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 316' ' ' ALA . 78.8 mt -76.44 -36.82 57.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -175.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.05 110.05 2.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.51 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.95 11.47 56.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.277 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 43.6 ttm -60.94 117.19 5.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 110.521 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 94.45 6.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 120.01 40.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.589 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.69 -115.12 4.45 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.85 -3.91 12.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 110.559 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -111.94 156.14 22.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.771 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.79 125.64 49.61 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.26 141.88 41.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.123 0.487 . . . . 0.0 111.081 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.99 121.6 36.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.344 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 320' ' ' LEU . 59.2 t -130.8 111.41 20.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.016 0.436 . . . . 0.0 110.34 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -151.8 149.71 29.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.243 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -64.29 129.65 40.75 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.083 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.357 0.599 . . . . 0.0 110.408 -178.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.504 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 9.1 t . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -70.93 -24.59 62.48 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.229 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -79.75 -31.87 41.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.011 0.434 . . . . 0.0 110.021 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HB2' ' OG1' ' A' ' 145' ' ' THR . . . -72.57 -31.95 65.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.607 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 145' ' ' THR . 19.9 mtm180 -74.04 -13.2 60.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.82 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.7 ttp180 -110.98 137.35 48.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.979 0.419 . . . . 0.0 110.631 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.13 153.98 38.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.4 t80 -85.53 121.04 27.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.201 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.62 127.63 64.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 0.0 110.942 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -128.72 -178.22 15.26 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.331 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.567 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 3.5 t30 67.82 28.01 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.773 0.797 . . . . 0.0 109.706 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.5 pt -102.13 150.2 37.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.51 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.14 132.03 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.634 2.223 . . . . 0.0 111.388 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -65.92 123.89 21.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.73 -5.0 30.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.099 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.13 145.23 9.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.253 0.549 . . . . 0.0 110.883 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 m -101.02 148.69 24.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.144 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.413 ' HG3' HD12 ' A' ' 191' ' ' ILE . 1.7 mp0 -47.73 -55.16 10.16 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.454 0.471 . . . . 0.0 110.859 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -54.41 -38.38 66.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.226 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.26 -56.58 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.6 ttm -64.52 -36.82 85.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.259 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.2 ttt -62.49 -55.85 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.15 -36.94 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.316 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -55.49 25.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -60.45 -33.87 73.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.016 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.562 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 6.7 m-80 -59.99 -46.41 89.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.411 . . . . 0.0 110.489 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -65.7 -43.46 89.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.643 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -47.26 75.96 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.507 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -55.4 -44.71 76.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 111.085 177.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.5 mtm-85 -69.78 -33.41 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 83.2 mt -62.07 -35.78 79.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.948 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.99 -8.87 55.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.714 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.19 58.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.552 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.6 -21.82 18.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.19 . . . . 0.0 111.441 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -59.26 107.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.32 . . . . 0.0 110.83 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -90.03 -27.51 19.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.77 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.423 ' HB2' ' NH2' ' A' ' 203' ' ' ARG . . . -108.18 149.47 39.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.225 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.06 139.94 30.51 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.216 1.944 . . . . 0.0 111.417 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.34 -158.8 15.79 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.708 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 10.7 m120 -86.8 116.14 64.95 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.562 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 4.1 Cg_endo -52.3 -46.34 33.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.601 2.867 . . . . 0.0 112.289 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.57 136.85 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.4 tp -93.75 -51.22 5.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.929 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.75 142.33 25.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.6 t -110.9 131.83 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.965 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -118.68 126.73 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.413 HD12 ' HG3' ' A' ' 162' ' ' GLU . 3.3 mp -115.65 119.7 62.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.884 0.373 . . . . 0.0 110.398 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 0.0 111.468 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 C--O 1.233 0.218 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -137.6 167.25 22.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.978 0.418 . . . . 0.0 111.297 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -127.95 130.29 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 15.3 mt -110.67 117.83 34.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.335 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 37.7 tt0 -104.37 129.76 52.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.583 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 43.0 m-85 -104.98 159.64 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.134 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 38.3 ptt180 -77.34 -20.94 54.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.422 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 m -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.69 -29.1 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.228 0.537 . . . . 0.0 110.044 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 209' ' ' THR . 3.5 m-20 -67.92 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.792 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.16 -21.15 50.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.29 0.567 . . . . 0.0 109.922 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 86.4 m -72.45 -47.94 44.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 206' ' ' ASP . 7.5 t -62.27 -36.02 80.8 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.555 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -73.91 -25.09 59.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.198 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.58 75.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.272 0.558 . . . . 0.0 109.956 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 27.8 mtp -68.54 -14.74 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.171 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.26 67.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 110.633 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.495 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.4 m-85 -78.55 6.18 9.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.97 106.74 1.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.93 13.84 38.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.036 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.0 tt -103.65 155.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.107 0.454 . . . . 0.0 111.116 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.74 102.3 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.562 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.1 m-85 -106.39 117.48 34.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.957 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 57.32 31.73 20.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 0.0 111.443 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.47 -12.81 64.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.873 174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.8 pt20 -105.93 144.95 31.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.318 0.559 . . . . 0.0 110.501 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.567 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 23.3 t -102.46 128.89 48.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -101.76 120.66 40.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.559 ' HB3' ' HZ2' ' A' ' 225' ' ' LYS . 4.9 mmmp? -114.24 123.08 48.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 17.9 mt -130.8 118.79 43.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.01 -171.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.718 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.733 0.302 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.6 m -69.84 146.92 50.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.289 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.1 p -96.49 19.65 11.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.496 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 57.9 t -122.85 105.04 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.76 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.54 111.13 51.03 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 25.5 Cg_exo -63.72 153.58 74.45 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.807 2.338 . . . . 0.0 110.892 173.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -78.98 77.03 5.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.124 0.964 . . . . 0.0 110.8 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -91.22 158.28 16.69 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.63 48.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.088 0.471 . . . . 0.0 110.367 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -90.41 0.38 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.218 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -72.16 139.05 48.07 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.454 ' HB2' ' SG ' ' A' ' 305' ' ' CYS . 10.5 mt -112.42 149.27 32.79 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.798 -170.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -107.03 129.57 54.78 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.52 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -116.08 115.15 48.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.909 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.87 175.38 15.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.5 -1.2 83.85 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.442 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.46 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.2 mt -64.35 127.73 92.48 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.35 149.1 92.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.893 2.395 . . . . 0.0 111.757 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 -18.08 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.529 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -92.76 1.15 57.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.1 mt -112.13 119.73 39.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.032 0.444 . . . . 0.0 109.935 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -104.54 -178.5 3.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.566 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER -40.31 -48.66 2.69 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.77 0.668 . . . . 0.0 112.561 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -65.26 -45.58 83.96 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.05 -49.52 72.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.478 . . . . 0.0 110.652 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 83.0 t -63.94 -33.79 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.341 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 24.9 mtmm -53.19 -46.73 69.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.496 0.188 . . . . 0.0 111.078 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.54 -43.96 76.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.008 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.27 -43.89 89.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.81 -44.35 73.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 34.6 p -62.74 -12.21 22.56 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.7 m -55.61 -35.35 65.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.715 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -90.4 -41.96 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 110.693 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.91 167.79 39.37 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -77.95 155.8 30.35 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 66.5 mt -106.02 134.48 49.07 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.778 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -77.3 -31.87 54.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.76 127.19 10.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.484 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 29.3 t80 -138.48 114.48 10.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.487 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -120.95 107.49 12.74 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 10.0 tt -86.9 123.68 32.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.88 111.19 13.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.436 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.2 165.44 11.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.741 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.3 t70 -98.82 133.72 42.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.7 m -78.04 -15.4 58.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.335 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.94 -44.91 10.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.8 p -89.2 -25.92 21.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.188 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.99 13.98 82.65 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.526 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.9 162.65 16.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 111.303 -172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.3 m -71.87 123.15 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.146 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -63.75 -30.06 71.2 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 109.09 25.12 5.72 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.74 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 19.2 p90 -155.08 144.35 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.11 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.97 169.95 19.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.567 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 97.5 m-85 -126.37 131.14 51.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.868 176.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.484 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 21.8 p -129.03 158.95 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.618 0.247 . . . . 0.0 110.668 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.54 125.21 15.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -81.59 156.73 25.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.48 -51.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.683 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.04 153.94 17.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 110.326 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 311' ' ' ASN . 2.9 pp -85.14 -22.37 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.17 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.43 ' N ' HD11 ' A' ' 310' ' ' ILE . 8.0 p30 -79.76 -28.7 40.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.557 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -17.79 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.981 0.419 . . . . 0.0 110.448 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 m -55.91 -52.17 65.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.225 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.14 -19.32 51.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -77.48 -35.91 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.99 -52.53 16.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.731 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.438 HG23 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -60.69 -21.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.013 0.435 . . . . 0.0 111.091 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.12 83.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.46 -34.67 4.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.301 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.77 -33.55 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.679 0.276 . . . . 0.0 111.628 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -68.81 122.92 19.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.01 10.23 60.02 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.846 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.418 ' SD ' HD22 ' A' ' 325' ' ' LEU . 33.4 ttm -59.62 116.44 4.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.619 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.62 85.19 6.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.418 HD22 ' SD ' ' A' ' 323' ' ' MET . 0.2 OUTLIER -103.06 129.85 50.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.25 -118.51 8.02 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.142 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.98 1.82 12.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.927 0.394 . . . . 0.0 110.904 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -110.05 172.58 6.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -117.13 119.77 36.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.06 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.6 145.36 50.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.447 0.641 . . . . 0.0 112.029 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.1 tm? -91.4 120.18 32.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.801 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.438 HG12 HG23 ' A' ' 317' ' ' ILE . 41.3 t -129.24 108.93 17.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.558 . . . . 0.0 109.507 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -145.27 161.41 39.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.691 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -64.12 136.36 57.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.274 0.559 . . . . 0.0 109.994 178.344 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 13.5 tpt -140.44 110.31 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.5 t 61.49 47.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 122.075 0.941 . . . . 0.0 109.353 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.68 166.07 26.3 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.6 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 t 65.64 26.93 11.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.869 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.42 -41.57 89.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.763 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.6 ttm -60.4 -54.82 41.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.527 0.203 . . . . 0.0 110.898 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.3 t -74.02 -20.15 60.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.994 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -59.59 -54.32 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 110.068 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -87.9 -11.45 47.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.57 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 232' ' ' TYR . . . -83.72 -33.24 25.15 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.055 0.455 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -92.95 4.58 53.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 22.8 ttp180 -126.2 129.94 49.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 110.943 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -114.04 153.17 29.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.108 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 59.5 t80 -84.96 119.67 25.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.434 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.65 124.15 57.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.541 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.26 177.87 16.78 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.905 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 4.8 t30 66.02 30.97 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.784 0.802 . . . . 0.0 109.967 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.67 154.44 37.17 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.184 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.02 130.84 12.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.518 2.145 . . . . 0.0 111.259 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.33 108.79 2.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.107 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.52 3.31 7.92 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.585 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.36 145.6 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.082 0.467 . . . . 0.0 110.192 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.2 m -105.32 154.19 20.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.397 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.93 -58.65 4.13 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.477 0.486 . . . . 0.0 111.465 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.11 -35.86 67.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.892 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.89 -56.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.021 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 32.6 ttm -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.7 ttt -59.02 -56.89 16.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.086 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -37.44 81.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.49 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.632 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.4 m-85 -60.5 -51.8 67.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.63 -39.97 88.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -55.75 -42.46 75.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.072 0.463 . . . . 0.0 110.603 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.594 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.29 -45.96 78.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.22 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 68.5 mm-40 -59.25 -41.15 88.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.386 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.516 ' HB3' HG22 ' A' ' 179' ' ' THR . 0.0 OUTLIER -56.7 -42.66 79.5 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.875 0.369 . . . . 0.0 111.046 176.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -66.14 -41.66 90.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 58.7 mt -64.86 -49.94 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.293 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.62 0.09 86.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.906 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.3 37.84 91.09 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.771 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.5 mt -93.67 -31.17 14.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.581 0.229 . . . . 0.0 110.386 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.27 108.4 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.278 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -85.71 -29.25 24.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.028 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.0 148.95 38.44 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.619 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.13 157.06 61.66 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.246 1.964 . . . . 0.0 111.901 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.68 -147.55 18.64 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.593 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -102.29 119.52 56.14 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.861 0.363 . . . . 0.0 111.0 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -32.9 34.12 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.911 2.407 . . . . 0.0 112.227 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.73 128.8 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.92 -45.14 7.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.697 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.01 143.54 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.789 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.05 131.42 63.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.26 118.91 32.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.69 118.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -78.25 131.14 36.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.66 135.77 56.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.536 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.7 25.9 14.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.531 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.49 144.19 48.13 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.13 33.27 0.97 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.773 0.321 . . . . 0.0 110.776 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.01 163.05 39.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.68 170.82 15.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.417 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 74.6 m-85 -127.84 134.47 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.5 mt -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.25 131.3 48.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.202 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.558 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 45.8 m-85 -110.65 156.99 20.21 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.658 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -74.5 -19.65 60.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.19 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 m -141.89 135.75 29.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.04 -31.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -70.78 -31.35 68.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.372 . . . . 0.0 110.419 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.63 -20.15 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 109.95 173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.4 m -75.59 -48.67 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.945 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -63.77 -31.63 72.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.925 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 210' ' ' GLN . 2.6 pt20 -74.39 -18.1 60.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.595 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.07 -22.58 58.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 109.611 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.413 ' SD ' ' HD3' ' A' ' 228' ' ' ARG . 14.5 mtt -71.29 -17.65 62.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.589 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.53 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 217' ' ' ILE . 10.1 m-85 -81.57 4.12 22.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.577 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.07 106.64 2.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.843 0.354 . . . . 0.0 110.713 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.23 5.58 57.09 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.194 -0.526 . . . . 0.0 112.7 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 214' ' ' PHE . 11.3 tt -96.84 153.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.882 0.372 . . . . 0.0 110.648 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 36.4 mm -108.13 100.53 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.629 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.3 m-85 -102.07 108.73 20.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.731 0.3 . . . . 0.0 110.573 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.54 36.34 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.225 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.01 -13.57 66.86 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.916 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.0 pt20 -99.4 138.94 35.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.584 0.692 . . . . 0.0 110.267 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.554 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 21.6 t -96.5 126.03 41.41 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.95 132.33 51.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.53 125.57 48.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.6 mp -128.62 126.44 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 32.3 tpt180 -99.36 144.93 27.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.413 ' HD3' ' SD ' ' A' ' 212' ' ' MET . 17.2 tpp180 -89.08 110.41 37.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.398 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 9.9 Cg_exo -71.56 122.45 8.61 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.386 2.057 . . . . 0.0 110.909 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -94.3 27.17 3.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -94.29 -1.64 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.276 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 29.7 p90 -149.81 174.22 12.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.349 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -129.3 116.38 18.68 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.8 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.34 138.67 27.8 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.599 2.199 . . . . 0.0 111.565 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.88 125.83 40.74 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.829 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.56 137.35 68.73 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.717 2.278 . . . . 0.0 111.954 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.1 56.36 4.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -108.36 125.42 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 31.9 p -87.18 119.36 27.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.563 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.98 133.92 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.259 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -83.92 131.37 51.75 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.421 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -73.48 176.7 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 170.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.5 p -78.43 60.09 2.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.183 0.516 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.37 25.24 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.756 0.789 . . . . 0.0 110.543 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -132.22 160.97 34.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.653 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 249' ' ' VAL . 59.8 t -112.92 116.86 47.03 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.813 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.61 126.52 17.71 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.053 1.835 . . . . 0.0 111.497 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.31 2.04 24.75 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 250' ' ' VAL . 3.1 p -143.43 -172.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.565 ' H ' HG23 ' A' ' 249' ' ' VAL . 7.6 p -63.55 127.12 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.233 0.54 . . . . 0.0 110.241 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 28.3 m -83.15 149.45 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.7 p -92.9 19.55 7.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 111.318 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.77 113.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.221 0.534 . . . . 0.0 110.53 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 304' ' ' PHE . 21.4 t -107.98 108.19 61.07 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.54 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.89 152.12 82.32 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.923 2.415 . . . . 0.0 111.796 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.92 79.48 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.861 0.838 . . . . 0.0 109.945 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.0 p -87.05 -176.44 5.72 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.379 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -81.67 1.06 35.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -123.76 30.82 6.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.263 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -70.63 133.71 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.008 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.87 142.01 51.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -118.38 130.06 55.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.067 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.6 126.8 74.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -130.54 168.65 21.61 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.04 5.91 60.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.379 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.416 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 78.4 mt -71.48 132.73 85.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.921 0.391 . . . . 0.0 111.881 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.31 134.55 59.58 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.876 2.384 . . . . 0.0 111.858 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.08 -22.47 64.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.238 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -90.54 4.84 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.79 139.19 49.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.707 0.289 . . . . 0.0 110.351 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -105.65 -177.77 3.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.81 -41.96 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.326 0.391 . . . . 0.0 111.648 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.566 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 33.1 t70 -63.07 -47.97 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 0.0 111.353 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.506 ' HA ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -65.53 -40.81 93.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.727 179.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.41 -30.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.795 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 273' ' ' ASP . 6.9 mtmp? -53.26 -39.51 63.94 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.453 0.168 . . . . 0.0 111.293 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -52.75 -34.95 55.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.761 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.31 -40.48 62.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.88 -38.43 53.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.069 0.461 . . . . 0.0 111.042 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 25.2 p -65.92 -12.49 55.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.043 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.9 m -52.63 -34.21 50.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.166 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -100.58 -40.83 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.9 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.86 162.0 35.51 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.207 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -76.84 160.1 34.25 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.962 2.441 . . . . 0.0 112.28 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 136.58 49.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 306' ' ' GLU . 18.9 ptpt -80.18 -27.92 38.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.675 0.75 . . . . 0.0 109.008 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -153.86 124.58 7.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.188 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 17.1 t80 -139.13 112.72 8.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.019 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -118.73 115.91 25.47 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.415 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 290' ' ' LEU . 9.5 tt -95.07 123.47 38.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.9 t -82.25 106.03 12.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.751 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -95.31 159.41 15.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.347 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 8.7 t70 -94.87 133.47 38.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.0 m -72.36 -18.37 61.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.382 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.42 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 82.5 p -99.44 -28.31 13.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 74.84 15.68 80.76 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.58 157.65 39.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 111.298 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.5 m -65.08 123.06 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.442 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -68.4 -18.77 64.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.406 . . . . 0.0 110.646 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 106.45 26.4 5.94 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.76 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.24 148.02 21.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.503 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.54 170.12 19.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.81 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.484 ' O ' HG21 ' A' ' 254' ' ' VAL . 98.1 m-85 -125.83 136.55 53.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.66 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.5 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 19.6 p -133.97 166.68 22.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.878 0.37 . . . . 0.0 110.897 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 286' ' ' LYS . 10.6 tt0 -143.62 120.29 11.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -74.36 147.24 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.376 0.608 . . . . 0.0 110.886 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.49 -30.26 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.858 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -116.41 151.61 35.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.05 -21.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -41.46 60.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.46 -18.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.815 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 50.5 m -52.93 -56.82 13.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.338 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.99 -22.45 36.56 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.152 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.06 -34.68 64.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.962 0.411 . . . . 0.0 111.001 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.15 -50.9 17.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.472 HG21 HG13 ' A' ' 332' ' ' VAL . 2.6 pp -61.42 -21.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.084 0.468 . . . . 0.0 110.733 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.49 86.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.023 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.34 -33.84 5.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.169 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.67 -35.85 75.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.794 0.297 . . . . 0.0 111.579 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.26 109.59 3.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.453 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.3 3.71 29.22 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 46.3 ttm -61.64 115.32 3.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.724 0.297 . . . . 0.0 110.37 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 90.53 8.0 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.89 119.76 40.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.12 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.82 -110.76 3.61 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.868 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -106.55 -13.5 15.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -114.23 147.96 38.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -93.01 120.83 33.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 164.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.49 129.24 37.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.188 0.518 . . . . 0.0 110.879 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 23.5 tp -88.53 124.82 34.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.528 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.472 HG13 HG21 ' A' ' 317' ' ' ILE . 65.9 t -131.15 108.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.464 HE22 ' CG2' ' A' ' 337' ' ' VAL . 0.0 OUTLIER -143.17 143.65 31.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.47 -168.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -69.81 117.63 11.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.122 0.487 . . . . 0.0 110.61 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -76.44 -8.23 56.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 38.5 m -78.07 8.89 4.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.565 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.464 ' CG2' HE22 ' A' ' 333' ' ' GLN . 19.0 m -98.71 -0.65 10.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.761 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.33 80.17 1.22 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.505 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.02 2.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.799 0.333 . . . . 0.0 111.532 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 62.52 22.66 13.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.846 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -169.35 133.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.265 179.613 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.777 0.322 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.13 -61.14 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.117 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.38 65.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.421 0.629 . . . . 0.0 110.109 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.53 49.29 15.18 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.854 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.7 m -141.45 24.27 2.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.077 0.465 . . . . 0.0 110.43 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -69.65 -14.55 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.836 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.4 ttt -87.45 -55.25 3.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.902 0.382 . . . . 0.0 111.053 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 13.6 t -69.77 -9.93 56.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.259 -172.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.437 ' NE ' ' HG3' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -60.99 -22.71 64.76 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.23 -0.294 . . . . 0.0 111.57 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.437 ' HG3' ' NE ' ' A' ' 146' ' ' ARG . 82.1 mt-30 -87.3 -35.36 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.012 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.46 -31.85 67.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.902 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 145' ' ' THR . 34.0 mtm180 -80.62 2.23 26.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.686 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 34.4 ttp180 -122.02 130.54 53.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.304 0.573 . . . . 0.0 111.652 -172.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.48 154.24 32.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.077 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.8 t80 -81.45 124.4 29.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.607 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 200' ' ' LEU . 44.0 t -112.43 131.34 64.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 110.738 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.29 177.85 16.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.945 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.81 38.15 2.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.462 0.649 . . . . 0.0 110.359 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.3 pt -109.25 150.94 41.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.69 130.82 9.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.766 2.311 . . . . 0.0 111.641 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.48 118.89 10.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.39 -2.93 22.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.535 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.48 146.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 110.229 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 m -105.18 156.64 17.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 189' ' ' VAL . 24.8 mt-10 -47.51 -59.51 3.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.434 0.459 . . . . 0.0 111.715 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.88 -21.37 66.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.253 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.62 -53.12 30.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.299 0.571 . . . . 0.0 110.284 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.7 ttm -75.79 -33.96 60.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.102 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 14.5 ttt -59.55 -46.47 88.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.535 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.36 -44.51 88.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.449 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.511 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.1 m-85 -62.12 -55.66 26.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.707 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -58.71 -43.01 89.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.532 0.206 . . . . 0.0 111.368 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -59.82 -33.75 72.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.388 . . . . 0.0 111.18 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -79.16 -34.56 43.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.381 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 25.8 mm-40 -62.52 -37.76 87.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.868 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.423 ' HB3' HG22 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.5 -35.48 76.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 0.0 111.022 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.447 ' HD2' ' OG1' ' A' ' 179' ' ' THR . 28.2 mmm180 -78.41 -23.8 46.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.1 mt -76.73 -41.84 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.34 -5.55 75.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.636 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.43 36.05 83.16 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.859 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.94 -22.15 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.718 0.294 . . . . 0.0 110.772 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.447 ' OG1' ' HD2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -59.71 108.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.325 -178.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -87.88 -33.11 18.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.614 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -106.85 151.17 40.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.805 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 148.86 81.35 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.504 2.136 . . . . 0.0 111.938 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.09 -144.9 17.39 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.608 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.14 124.79 38.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.709 0.29 . . . . 0.0 111.118 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.497 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 41.2 Cg_endo -67.04 -29.51 40.15 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.153 2.569 . . . . 0.0 113.135 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.36 134.47 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.231 0.539 . . . . 0.0 110.86 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.406 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.5 mt -89.77 -49.37 6.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.134 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.14 171.26 19.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 0.2 OUTLIER -143.87 139.57 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.14 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -122.53 127.93 50.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.606 0.241 . . . . 0.0 110.786 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.68 127.56 63.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 48.0 m-80 -83.66 108.1 16.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.011 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -68.57 -23.54 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -97.99 5.85 48.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.625 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 192' ' ' ASN . 75.2 mmtt -131.1 -170.8 2.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.881 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -126.71 29.99 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.158 0.504 . . . . 0.0 110.404 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -144.41 164.75 29.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.434 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -132.36 170.96 14.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.055 0.455 . . . . 0.0 111.087 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.427 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . 73.0 m-85 -127.3 133.44 50.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.922 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -109.78 129.32 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.3 130.12 56.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 0.0 110.499 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.639 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.4 m-85 -108.53 165.57 11.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.124 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.4 ptt180 -80.75 -18.93 46.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.276 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.9 m -138.7 132.69 31.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.156 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.6 -28.11 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.15 -32.6 72.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.361 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -82.66 -20.89 35.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.205 0.526 . . . . 0.0 110.039 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 98.0 m -71.21 -51.32 25.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 173.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.7 t -60.0 -37.63 80.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.662 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.88 -19.65 61.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.4 -28.73 52.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 110.075 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.416 ' HE1' ' HA ' ' A' ' 228' ' ' ARG . 28.0 mtp -71.63 -14.38 62.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.079 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.2 -22.64 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.861 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 217' ' ' ILE . 17.8 m-85 -76.91 2.82 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.999 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.09 106.68 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.99 0.424 . . . . 0.0 110.735 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.44 37.36 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.725 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -108.33 153.36 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.868 0.366 . . . . 0.0 110.523 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.0 mm -105.95 101.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.71 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.3 m-85 -112.82 129.57 56.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.477 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 60.81 21.5 11.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 111.48 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 90.54 -11.63 70.92 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.959 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.5 pt20 -97.31 140.83 31.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.031 0.416 . . . . 0.0 110.277 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.7 t -93.97 118.41 31.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.23 128.92 38.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.26 122.82 40.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.885 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.5 mp -128.03 125.77 65.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.919 0.39 . . . . 0.0 110.027 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.507 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 28.6 tpt180 -99.63 148.13 24.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 234' ' ' PRO . 20.4 mtp180 -92.79 108.56 32.84 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.464 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 6.6 Cg_exo -74.03 126.85 10.88 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.647 2.232 . . . . 0.0 110.768 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.9 53.15 1.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.359 0.6 . . . . 0.0 111.916 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.65 -29.89 14.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 171.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -152.77 175.94 12.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -109.75 102.41 50.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.621 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 228' ' ' ARG . 28.7 Cg_endo -66.1 138.96 53.96 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.443 2.095 . . . . 0.0 112.33 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.5 155.42 78.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.316 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.52 78.01 2.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.018 2.478 . . . . 0.0 112.031 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.44 104.82 1.66 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.205 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -149.77 152.91 36.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.713 0.292 . . . . 0.0 110.507 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 18.3 m -115.02 46.52 1.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 69.41 120.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.953 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -85.03 125.27 70.93 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.194 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.7 -56.04 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.228 2.619 . . . . 0.0 112.842 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.2 m -158.13 91.49 1.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 34.6 m -78.64 174.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.3 t80 68.08 119.5 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.541 0.686 . . . . 0.0 112.318 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.56 119.23 68.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.698 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.69 131.98 48.94 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.654 2.236 . . . . 0.0 112.04 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.29 24.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.931 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.39 129.63 62.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.452 HG13 ' HD3' ' A' ' 276' ' ' LYS . 21.9 t -76.34 111.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.109 0.481 . . . . 0.0 110.662 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 14.7 m -76.49 146.92 38.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.641 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 18.78 9.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.44 121.93 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.5 t -109.58 104.86 56.31 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.545 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.82 169.6 8.51 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.485 2.79 . . . . 0.0 112.218 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.6 79.92 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.72 . . . . 0.0 110.03 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.6 t -91.8 151.85 20.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.328 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.98 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.345 0.593 . . . . 0.0 110.063 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -113.78 31.88 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.367 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.402 ' HG3' ' HB1' ' A' ' 335' ' ' ALA . 10.3 ptpp? -68.07 141.09 56.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 16.3 mt -122.68 143.37 49.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.98 0.419 . . . . 0.0 111.635 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -117.89 132.38 56.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.855 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 331' ' ' LEU . 2.5 mp -120.0 116.6 50.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.466 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -112.22 -176.89 19.96 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.1 69.75 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.147 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.477 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.1 mt -62.93 130.16 93.81 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.29 144.84 98.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.794 2.329 . . . . 0.0 111.285 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -67.16 -18.6 65.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -92.25 -8.8 44.27 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.773 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.82 128.3 43.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.9 -175.77 2.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.599 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.9 p-10 -50.67 -41.1 55.24 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.185 0.303 . . . . 0.0 111.082 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 19.2 t70 -70.79 -32.9 70.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.99 0.424 . . . . 0.0 111.495 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.67 -41.77 26.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.065 0.46 . . . . 0.0 110.441 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.83 -29.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 25.5 mtmm -50.69 -40.26 53.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.009 0.433 . . . . 0.0 110.845 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.94 -21.68 66.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.39 -32.01 19.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 110.264 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.4 -28.98 28.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.143 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.1 p -67.97 -12.2 60.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 16.8 m -50.57 -40.25 51.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.961 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.66 -39.12 10.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.15 155.69 27.21 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.994 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.16 155.94 56.06 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.04 1.827 . . . . 0.0 111.865 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 250' ' ' VAL . 78.7 mt -102.48 138.3 39.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.927 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.558 ' HZ2' ' HB2' ' A' ' 286' ' ' LYS . 0.1 OUTLIER -85.65 -24.4 27.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.44 0.638 . . . . 0.0 109.338 176.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.62 124.61 6.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.053 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 9.9 t80 -139.27 111.39 7.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.077 0.465 . . . . 0.0 110.246 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.95 108.34 17.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.536 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -99.24 133.96 42.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.5 t -94.13 109.78 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -90.09 164.5 14.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.212 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.543 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -104.34 127.49 52.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.886 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 t -76.65 -11.95 59.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.31 -31.37 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.629 0.252 . . . . 0.0 111.372 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 69.7 p -93.46 -27.69 16.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.028 0.442 . . . . 0.0 111.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.22 14.17 82.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.03 -172.97 2.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.254 -0.473 . . . . 0.0 109.764 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 61.4 m -81.94 147.18 29.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.174 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.26 -19.5 56.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.107 0.479 . . . . 0.0 110.381 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 96.68 27.38 9.74 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.753 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 14.4 p90 -154.13 144.08 21.88 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.275 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.06 19.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.337 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 92.9 m-85 -128.14 133.18 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.396 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 29.5 p -130.05 166.11 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.265 0.555 . . . . 0.0 111.251 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.66 125.79 21.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.715 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -80.86 154.88 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.09 -35.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.955 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.81 158.02 28.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.073 0.463 . . . . 0.0 110.263 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.89 -19.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.511 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 -30.11 57.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.55 -26.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.321 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.42 HG21 HD22 ' A' ' 261' ' ' LEU . 15.6 m -54.62 -53.48 54.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.481 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.34 -31.04 68.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.14 -36.5 72.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.83 -52.79 10.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.183 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.41 HG21 HG13 ' A' ' 332' ' ' VAL . 2.8 pp -59.61 -25.28 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.493 . . . . 0.0 110.705 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.18 -45.21 81.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.455 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.11 -27.36 7.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.612 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.12 -36.27 40.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.984 0.392 . . . . 0.0 111.703 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 2.3 t-20 -68.26 112.13 4.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.68 5.14 26.09 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.745 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 40.7 ttm -62.39 115.25 4.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 0.0 110.198 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -85.06 96.55 9.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 111.28 22.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.538 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.54 -109.47 2.8 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.341 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.82 6.4 11.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.925 0.393 . . . . 0.0 111.176 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -120.74 149.08 43.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.774 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 42.6 mtpt -98.66 119.61 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.39 134.06 45.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.443 0.64 . . . . 0.0 111.388 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -88.16 121.49 30.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 53.3 t -130.48 107.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.68 160.67 42.43 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.899 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.66 130.65 40.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 260' ' ' LYS . . . -80.51 -5.31 56.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.318 0.58 . . . . 0.0 110.122 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 2.8 p -87.03 -1.11 57.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.84 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.82 -47.35 70.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.099 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 171.86 154.65 10.16 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.672 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -133.25 67.88 1.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.128 0.49 . . . . 0.0 110.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -123.12 63.39 1.0 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 0.0 110.27 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -94.54 3.79 54.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.477 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 178.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.769 0.318 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 53.0 tpp -69.89 113.91 7.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.839 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.18 -24.54 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 0.0 109.971 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.1 32.84 3.96 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.657 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m -83.56 45.22 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.122 0.487 . . . . 0.0 110.685 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.553 ' O ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 mt-30 -100.62 119.56 38.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.259 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.71 -30.96 69.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.52 0.676 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 t -89.67 5.88 43.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.425 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -66.84 -31.03 71.38 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.014 -0.429 . . . . 0.0 111.081 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 232' ' ' TYR . 10.9 mm100 -87.51 -5.69 58.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.904 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.03 12.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.906 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 83.5 mtt180 -79.43 -6.12 56.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.95 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.567 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 18.4 mtm180 -110.37 150.91 28.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.14 0.495 . . . . 0.0 111.1 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.06 153.09 52.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.967 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 22.4 t80 -82.03 110.3 17.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.674 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 51.1 t -96.55 116.19 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.306 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.51 171.72 14.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.468 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 62.36 55.33 2.35 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.809 0.814 . . . . 0.0 109.451 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.0 pt -112.42 147.67 37.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.476 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.428 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 57.1 Cg_endo -80.26 130.79 8.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.711 2.274 . . . . 0.0 111.318 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.73 124.95 22.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.253 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.32 -0.67 53.87 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.134 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.428 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 16.1 tt -60.88 144.69 13.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 110.202 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 m -96.98 150.0 21.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.18 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' A' ' 189' ' ' VAL . 42.1 mt-10 -48.1 -59.87 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.16 -15.72 63.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.72 -58.32 4.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.0 ptp -76.17 -29.84 57.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.128 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.0 ttt -60.07 -54.93 40.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.37 -36.59 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.655 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.2 m-85 -60.0 -52.23 66.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.283 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -64.85 -38.82 92.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.206 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -59.69 -40.28 87.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.16 -49.69 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.93 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 70.0 mm-40 -60.47 -33.47 72.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.156 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.561 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 8.4 mmt -61.63 -41.87 98.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -72.15 -38.62 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.232 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 72.2 mt -63.68 -50.6 68.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.667 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.17 -10.13 86.45 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.571 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.16 40.08 56.78 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.479 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.561 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 22.0 mt -93.34 -24.33 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.485 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -58.38 114.72 2.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.956 0.407 . . . . 0.0 111.519 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.84 -34.3 15.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.107 0.479 . . . . 0.0 110.683 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 203' ' ' ARG . . . -107.65 150.44 40.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.544 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.71 132.57 40.8 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.051 1.834 . . . . 0.0 111.489 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.97 -162.12 12.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.545 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.77 124.18 73.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.511 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 49.4 Cg_endo -70.83 -31.96 14.93 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.882 2.388 . . . . 0.0 111.957 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.78 116.73 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 245' ' ' TYR . 44.8 tp -85.06 -45.12 12.4 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.381 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.01 165.44 32.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.196 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.439 ' HB ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -145.09 131.04 14.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.673 178.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.44 121.23 38.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 162' ' ' GLU . 4.5 mp -97.22 111.0 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -66.11 114.59 5.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.14 52.74 0.75 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.535 0.684 . . . . 0.0 110.818 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -124.96 10.04 8.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.823 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 83.0 tttt 53.63 65.46 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.287 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -157.14 -57.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.362 -0.535 . . . . 0.0 112.147 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.449 ' HE2' ' CE1' ' A' ' 199' ' ' PHE . 8.7 p90 -150.85 166.09 31.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.278 0.561 . . . . 0.0 112.254 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -131.83 164.67 25.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.258 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.449 ' CE1' ' HE2' ' A' ' 197' ' ' PHE . 25.7 m-85 -124.11 123.97 41.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.724 0.297 . . . . 0.0 110.732 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 66.2 mt -95.68 131.41 41.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.567 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 32.3 tt0 -107.03 141.7 37.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.855 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 65.0 m-85 -126.47 152.85 45.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.432 0.634 . . . . 0.0 111.581 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 39.3 ptt180 -78.05 -13.03 60.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.639 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 33.3 t -148.18 132.84 17.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.834 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.92 -24.24 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.608 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.29 -34.9 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -82.8 -21.82 34.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.095 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.6 m -65.67 -50.97 62.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.2 t -62.59 -36.86 84.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 111.687 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -76.06 -18.51 59.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.332 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.49 62.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.442 0.639 . . . . 0.0 109.631 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 31.0 mtp -68.89 -14.01 62.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.856 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.51 65.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 217' ' ' ILE . 13.1 m-85 -80.82 7.27 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.66 105.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.881 0.372 . . . . 0.0 111.387 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.71 59.58 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.196 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.7 tt -95.62 153.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 110.544 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.74 103.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.68 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 9.5 m-85 -102.88 111.96 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.734 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 59.61 30.97 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.321 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.71 -13.02 66.99 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.504 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 26.5 pt20 -94.89 137.82 33.46 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.778 0.789 . . . . 0.0 110.778 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.9 p -103.54 118.51 36.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.777 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.64 136.25 54.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 111.064 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -109.65 135.02 51.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.2 mp -121.44 105.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.258 0.552 . . . . 0.0 109.815 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -100.84 151.71 21.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.556 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 14.1 ptm180 -87.04 121.53 71.53 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 111.229 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 12.4 Cg_exo -70.65 166.24 29.35 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.775 2.317 . . . . 0.0 111.24 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.87 175.0 6.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.011 0.434 . . . . 0.0 110.554 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -82.18 56.78 3.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.192 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 147' ' ' GLN . 25.0 p90 46.71 -163.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.405 1.082 . . . . 0.0 113.415 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -158.18 130.6 4.28 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.23 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.58 148.8 26.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.119 2.546 . . . . 0.0 112.447 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.6 mt 68.61 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.16 0 O-C-N 123.87 0.731 . . . . 0.0 110.65 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.21 90.11 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.303 2.002 . . . . 0.0 111.992 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.91 70.48 2.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.094 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.1 ptp -152.44 158.27 42.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.812 0.339 . . . . 0.0 110.089 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 12.8 m -84.89 -33.63 22.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.645 0.736 . . . . 0.0 109.188 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -178.93 140.44 0.17 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.509 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 57.4 t30 -73.83 120.03 79.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 7.9 Cg_exo -71.25 132.94 21.86 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.81 2.34 . . . . 0.0 113.184 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.7 m 60.24 45.49 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.642 170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.1 m -70.65 153.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.112 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.593 ' HB2' ' O ' ' A' ' 187' ' ' LEU . 80.0 t80 -80.32 127.48 32.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.485 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.6 p -93.66 113.38 60.2 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.06 0.457 . . . . 0.0 110.359 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.98 150.69 82.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.37 2.047 . . . . 0.0 111.594 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.57 22.85 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.111 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.29 93.98 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.08 134.46 29.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.762 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 73.5 m -101.21 159.47 15.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.287 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 p -97.22 6.26 48.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.468 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 43.0 t -103.23 100.01 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.731 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.64 107.95 27.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.752 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 31.6 Cg_exo -60.24 169.59 4.89 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.424 2.749 . . . . 0.0 112.667 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.67 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 260' ' ' LYS . 26.7 t -69.24 155.77 39.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.949 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.7 -0.61 57.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.233 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -99.68 -6.36 27.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 257' ' ' SER . 23.7 pttp -72.43 154.94 40.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 334' ' ' ARG . 11.0 mt -128.99 150.58 50.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.235 -172.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -107.3 131.14 54.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.67 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.41 121.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.929 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.62 171.54 18.31 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.574 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.91 2.27 84.19 Favored Glycine 0 N--CA 1.454 -0.15 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.662 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.524 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.4 mt -66.41 136.98 95.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 17.0 Cg_exo -67.22 145.27 71.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.786 2.324 . . . . 0.0 111.386 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 3.0 m-20 -65.53 -20.98 66.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.633 -174.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -90.51 1.4 56.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.1 mt -113.53 122.27 46.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -93.01 -175.93 4.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.986 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 290' ' ' LEU . 3.9 p30 -47.54 -48.17 27.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.458 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 29.0 t70 -63.35 -46.99 84.02 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.2 -28.97 65.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.27 -38.38 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.439 0.638 . . . . 0.0 110.382 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 288' ' ' PHE . 15.7 ttpp -60.92 -30.67 70.33 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.68 -30.42 68.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.081 0.467 . . . . 0.0 110.689 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.86 -31.74 35.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.92 -34.99 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.547 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.8 p -71.19 -12.25 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.036 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.0 m -50.51 -43.2 55.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.077 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -86.17 -41.28 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.599 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.55 154.91 26.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.055 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -71.95 155.44 57.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.138 1.892 . . . . 0.0 112.252 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.26 140.64 37.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.692 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -84.75 -25.27 28.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -155.26 127.83 7.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.941 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.624 ' CD1' ' HB2' ' A' ' 276' ' ' LYS . 17.2 t80 -138.73 108.91 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -114.83 111.69 21.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 272' ' ' ASP . 9.7 tt -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.14 116.97 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -102.71 168.2 9.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.131 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.5 130.09 47.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 13.3 m -75.43 -12.71 60.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.573 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.42 12.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.4 p -89.07 -27.85 20.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.204 0.526 . . . . 0.0 111.185 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.15 9.17 86.44 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 56.1 mt -121.23 -179.47 4.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.652 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.8 m -80.34 146.95 31.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.143 0.497 . . . . 0.0 111.435 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.56 -24.85 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.778 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 107.75 27.0 5.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.327 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.86 139.0 18.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 117.465 0.632 . . . . 0.0 110.921 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -150.02 169.51 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.537 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.18 134.86 50.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.664 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 261' ' ' LEU . 23.0 p -127.79 165.18 20.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -147.98 129.35 14.8 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -84.94 163.74 18.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 0.0 111.547 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.79 -23.67 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.846 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.04 157.35 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.875 0.369 . . . . 0.0 110.082 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.37 -29.0 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.397 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.04 -27.0 62.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.543 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.403 HG21 ' HA3' ' A' ' 283' ' ' GLY . 14.9 p -84.17 -18.39 9.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.99 0.424 . . . . 0.0 110.713 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 37.0 m -61.98 -47.98 82.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.99 -24.66 43.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.78 -32.54 59.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.32 -53.44 12.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.114 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.446 HG22 HG13 ' A' ' 332' ' ' VAL . 2.8 pp -60.37 -21.69 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 110.878 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.03 -37.43 69.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.369 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.64 -36.78 3.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.32 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.25 -34.58 65.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -66.08 117.28 8.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.66 8.56 45.65 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 330' ' ' LEU . 48.0 ttm -64.35 116.0 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 110.317 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 86.09 7.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.16 112.62 25.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.23 -112.01 3.75 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.638 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.94 -14.1 10.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -113.32 168.42 9.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.51 124.87 50.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.674 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 323' ' ' MET . 13.9 mt -74.03 138.13 43.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.129 -173.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.9 124.18 35.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.698 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 317' ' ' ILE . 41.9 t -130.54 113.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.487 ' C ' ' H ' ' A' ' 335' ' ' ALA . 3.5 pt20 -137.69 168.14 20.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.447 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.542 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.3 mmm180 -74.56 34.61 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.951 0.5 . . . . 0.0 112.103 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 333' ' ' GLN . . . 57.7 -41.03 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.843 1.339 . . . . 0.0 113.419 -172.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 334' ' ' ARG . 15.0 t -90.52 -12.49 37.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.918 -169.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.14 -26.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.164 0.507 . . . . 0.0 110.298 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -81.09 47.25 3.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.858 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.86 -157.01 0.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 340' ' ' LYS . 3.2 mptp? -69.13 -38.07 78.64 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.992 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 65.84 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 0.0 111.459 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.923 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -105.26 99.7 9.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.926 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.5 p -136.09 150.01 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.216 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.98 -169.55 33.1 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -81.8 24.23 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.858 0.329 . . . . 0.0 111.277 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.66 42.92 28.9 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.286 0.565 . . . . 0.0 110.909 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 ttt -86.29 -54.23 4.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.883 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.0 t -76.76 -13.61 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.843 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -65.97 -17.96 65.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.147 -0.346 . . . . 0.0 111.331 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -87.31 -19.05 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.743 0.306 . . . . 0.0 110.788 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.99 -29.48 14.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 110.372 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.07 -6.16 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.855 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 40.0 ttp180 -114.28 130.11 56.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.034 0.445 . . . . 0.0 110.943 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.18 154.21 31.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.643 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 54.1 t80 -83.7 118.37 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.373 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.2 132.6 50.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.73 176.66 17.9 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.831 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 t30 68.28 30.58 5.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.443 0.639 . . . . 0.0 110.589 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.1 pt -92.65 150.24 39.38 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.82 134.1 17.71 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.502 2.134 . . . . 0.0 111.332 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -62.05 113.92 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.6 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 110.44 2.03 29.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.641 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.7 tt -57.66 146.23 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.211 0.529 . . . . 0.0 110.39 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.6 m -102.28 152.15 21.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -48.93 -58.6 4.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.515 0.509 . . . . 0.0 110.98 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.52 -37.16 72.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.885 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.28 -57.8 11.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.758 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 33.3 ttm -67.79 -39.54 84.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.502 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 15.6 ttt -60.01 -56.74 17.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.82 -38.39 85.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.053 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 1.4 m-85 -59.99 -57.81 11.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.972 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.451 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -60.36 -42.38 95.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 110.749 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.529 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.65 -44.12 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 21.8 mm-40 -62.74 -37.69 87.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.324 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 10.3 mmt -55.82 -42.92 76.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.921 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -75.79 -33.61 60.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.726 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 92.7 mt -62.81 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.47 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.86 -16.03 68.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.468 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.97 37.22 26.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.06 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.478 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 17.6 mt -90.33 -26.96 19.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 0.0 110.66 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.472 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -59.53 108.77 0.77 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 111.762 -176.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.78 -33.22 25.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.6 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.68 154.47 41.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.509 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.8 143.93 52.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.608 2.205 . . . . 0.0 111.544 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.02 -151.85 16.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.369 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -98.23 117.01 65.43 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.3 -35.43 84.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.427 2.084 . . . . 0.0 111.534 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -78.76 131.5 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.525 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 tp -98.9 -40.8 7.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.812 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.64 150.16 27.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.788 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 200' ' ' LEU . 7.3 t -126.26 125.75 68.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.627 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -118.3 112.14 19.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.444 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 191' ' ' ILE . 4.2 mp -104.62 104.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -85.63 114.14 22.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.717 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -81.64 49.58 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.964 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -108.42 -47.92 3.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.17 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -144.48 34.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.395 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.36 72.17 0.5 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.817 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.426 ' HE1' ' CE2' ' A' ' 199' ' ' PHE . 15.2 p90 -153.21 155.83 37.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.09 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 160.1 39.68 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.426 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 54.0 m-85 -117.76 122.59 43.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.614 174.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 14.2 mt -103.93 110.22 22.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.902 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -93.92 126.36 39.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.5 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 50.1 m-85 -103.03 165.11 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -84.65 -15.65 44.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.474 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 m -148.24 136.96 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.07 -30.32 49.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.114 0.483 . . . . 0.0 110.512 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 209' ' ' THR . 4.9 m-20 -64.29 -36.23 83.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.11 -21.14 40.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.378 0.608 . . . . 0.0 109.924 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 85.9 m -70.1 -48.61 56.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.151 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 206' ' ' ASP . 14.9 t -62.5 -36.1 81.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.966 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -74.62 -18.38 60.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.729 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.8 59.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.477 0.656 . . . . 0.0 109.552 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.507 ' SD ' ' HB3' ' A' ' 228' ' ' ARG . 10.4 mtt -67.75 -17.33 64.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.961 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.36 63.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.415 ' O ' HG23 ' A' ' 217' ' ' ILE . 11.8 m-30 -77.51 -2.86 37.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.624 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.96 106.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 0.0 110.513 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.21 4.33 59.85 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.569 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.46 HD11 ' CZ ' ' A' ' 219' ' ' PHE . 7.9 tt -92.31 156.74 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.05 99.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.284 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.723 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.4 m-85 -104.5 122.82 46.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.374 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 61.59 20.08 10.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 111.383 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 93.46 -11.15 72.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.082 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.723 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 19.9 pt20 -94.98 142.95 26.88 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.336 0.589 . . . . 0.0 110.288 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.1 p -103.51 124.39 48.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.557 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.5 mt -108.34 136.77 47.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -120.99 126.68 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.866 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.01 125.5 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 12.7 tpt180 -99.31 146.19 26.51 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.507 ' HB3' ' SD ' ' A' ' 212' ' ' MET . 0.0 OUTLIER -120.98 104.62 41.31 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.371 -174.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.94 124.12 9.41 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.614 2.209 . . . . 0.0 111.848 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -94.86 -41.51 9.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.777 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.61 28.47 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.178 0.513 . . . . 0.0 110.552 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 233' ' ' GLN . 26.2 p90 -67.19 136.49 55.1 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 232' ' ' TYR . 28.3 mm-40 -159.81 98.09 1.52 Allowed Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.574 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.99 127.87 17.67 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.97 2.446 . . . . 0.0 111.262 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.0 mt -142.8 134.56 13.08 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.716 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.56 154.49 31.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.438 2.092 . . . . 0.0 111.515 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 145.68 45.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.423 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -157.84 -40.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.3 p -147.98 59.56 1.11 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 111.334 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -108.24 155.61 20.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -148.81 149.97 31.8 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.653 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.62 -69.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.043 1.828 . . . . 0.0 112.243 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 65.6 m -152.24 56.46 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.238 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 244' ' ' VAL . 18.8 t -96.2 6.53 7.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 122.631 1.205 . . . . 0.0 109.4 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.556 ' O ' ' HD3' ' A' ' 247' ' ' PRO . 85.0 t80 -134.69 145.95 49.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.468 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.65 104.69 13.49 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 245' ' ' TYR . 73.2 Cg_endo -83.36 125.72 4.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.707 2.271 . . . . 0.0 111.134 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.18 0.8 54.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.608 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 250' ' ' VAL . 87.2 t 64.61 175.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 122.466 0.307 . . . . 0.0 110.711 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.505 ' N ' HG11 ' A' ' 249' ' ' VAL . 84.6 t -62.89 120.87 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 12.9 m -63.92 129.22 39.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.626 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.5 p -89.28 4.22 49.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.411 0.624 . . . . 0.0 110.626 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.497 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 3.5 p -107.52 104.45 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.836 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.62 109.63 39.88 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.73 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.8 Cg_exo -60.73 144.79 99.6 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.856 2.371 . . . . 0.0 111.066 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.53 90.62 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.723 0.773 . . . . 0.0 110.627 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.7 m -96.06 168.89 10.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.585 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.89 57.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.14 0.495 . . . . 0.0 110.701 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -111.47 27.79 9.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.868 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -55.45 144.86 24.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.709 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 14.8 mt -122.36 134.45 54.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -111.6 125.81 54.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.752 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.6 mp -113.32 114.09 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.64 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -120.5 -177.79 15.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.1 89.41 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.365 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.451 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 95.7 mt -69.01 130.67 91.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.963 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.17 139.43 85.67 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.764 2.309 . . . . 0.0 111.226 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.88 -1.2 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -103.12 -6.43 22.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.3 mt -96.84 128.61 43.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -104.56 -177.18 3.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 5.5 p-10 -48.71 -43.29 37.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -60.16 -44.4 95.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.616 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.7 -42.05 51.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.455 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.58 -28.63 43.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.687 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 50.2 mtmt -56.01 -33.77 65.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 110.997 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.81 -30.49 70.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.058 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.34 -40.82 29.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 0.0 110.285 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 48.0 mt -76.0 -30.42 58.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.358 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 7.4 p -67.5 -13.62 62.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.6 m -55.54 -30.42 60.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.856 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -103.79 -40.72 6.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.597 0.237 . . . . 0.0 111.435 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.2 163.06 35.79 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.369 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -72.03 162.32 42.18 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.304 2.67 . . . . 0.0 112.058 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.27 129.19 56.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.531 0.681 . . . . 0.0 111.34 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.415 ' HB2' HG12 ' A' ' 308' ' ' VAL . 15.5 tppt? -71.09 -46.4 61.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.765 175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -143.3 128.0 18.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.842 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 21.1 t80 -138.14 109.49 6.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.17 117.28 31.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.351 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.9 126.64 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.99 121.99 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.266 0.555 . . . . 0.0 110.667 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -115.02 145.66 42.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.546 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.539 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.6 t70 -89.84 140.57 29.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.9 t -85.67 -16.09 40.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.99 -40.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 0.0 110.977 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.9 p -85.56 -28.31 24.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 110.611 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.69 20.89 77.83 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.741 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.98 174.64 9.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.966 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 21.5 m -70.63 137.46 49.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.406 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -86.05 -1.08 57.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 84.4 27.13 37.09 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.557 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 43.2 p90 -158.62 144.77 16.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.9 0.381 . . . . 0.0 110.308 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.11 168.45 23.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.033 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.58 128.68 48.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.62 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 24.4 p -124.15 158.84 31.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 110.963 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.09 110.2 10.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.697 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.34 137.57 50.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.986 0.422 . . . . 0.0 110.006 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 286' ' ' LYS . 4.5 m -60.57 -27.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.658 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 312' ' ' VAL . 13.8 m-20 -113.22 136.26 52.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.35 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.1 -14.08 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 111.306 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -82.59 -19.62 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.822 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 309' ' ' ASP . 11.0 p -87.51 -18.49 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 109.879 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 45.4 m -51.25 -51.62 52.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.885 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.02 -18.78 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.636 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -83.86 -31.84 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.03 -53.99 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.636 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.47 HG23 HG13 ' A' ' 332' ' ' VAL . 2.9 pp -58.23 -25.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.121 0.486 . . . . 0.0 110.912 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -66.87 -42.9 84.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.172 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.98 -30.54 6.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.477 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.13 -35.87 59.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.872 0.336 . . . . 0.0 111.409 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 55.7 t30 -65.39 112.21 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 0.0 110.218 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 107.26 2.25 35.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.371 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.6 ttm -65.75 116.5 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.25 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.51 87.14 6.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 110.63 21.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.865 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.03 -122.79 6.28 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.891 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -99.29 -13.65 19.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.784 0.326 . . . . 0.0 111.501 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -126.03 166.76 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.164 0.507 . . . . 0.0 111.64 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 51.8 mtpt -94.05 124.7 38.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.794 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.6 mt -72.23 129.84 39.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.11 120.19 30.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.409 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 61.0 t -130.82 108.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.285 0.565 . . . . 0.0 109.901 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -151.12 163.03 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.412 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.621 ' O ' HG21 ' A' ' 337' ' ' VAL . 0.3 OUTLIER -70.69 126.74 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.054 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.49 65.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.911 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.7 m -62.53 -30.12 71.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.621 HG21 ' O ' ' A' ' 334' ' ' ARG . 7.6 m -75.86 -17.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 110.342 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -95.06 5.03 68.27 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.025 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -73.09 109.98 7.03 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -78.58 67.74 4.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -167.08 -61.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.639 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.805 -178.739 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.587 0.232 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -114.17 42.69 2.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.035 0.445 . . . . 0.0 110.636 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.7 t 67.37 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.69 -169.7 21.68 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.011 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.6 m -90.75 8.99 31.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.33 -17.44 64.76 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.68 0.276 . . . . 0.0 111.619 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 22.3 ttt -85.97 -50.88 6.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.76 0.314 . . . . 0.0 110.54 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 15.1 t -75.09 -17.22 60.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.652 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -19.71 65.76 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.968 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.21 -28.46 48.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.008 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.56 -32.37 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 145' ' ' THR . 24.0 mtm180 -72.47 -10.75 60.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.96 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -111.26 132.83 54.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.402 -174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.49 153.38 33.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.701 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -86.61 125.55 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.452 HG21 HD22 ' A' ' 200' ' ' LEU . 41.0 t -110.53 117.09 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 110.623 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 197' ' ' PHE . . . -105.8 169.62 16.18 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.887 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.6 t30 66.89 50.06 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.632 0.729 . . . . 0.0 110.524 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 pt -116.37 150.82 46.06 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.494 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.43 131.02 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.857 2.371 . . . . 0.0 111.62 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 195' ' ' LYS . 47.0 t80 -64.14 131.7 48.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.882 0.372 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.95 8.41 58.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.641 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.5 tt -67.63 147.14 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -101.69 148.79 24.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -46.19 -59.09 3.1 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.679 0.391 . . . . 0.0 111.499 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.7 -34.24 64.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.281 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -57.07 12.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.67 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 4.6 ttm -69.31 -37.69 77.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.413 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 15.1 ttt -57.73 -49.43 76.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.227 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.44 -36.42 83.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.066 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.606 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.0 m-85 -59.26 -53.41 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.408 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -61.98 -41.67 98.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.265 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.07 -40.81 95.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.995 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.606 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -62.01 -43.41 98.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.916 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 56.0 mm-40 -64.13 -36.05 82.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.191 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 11.4 mmt -59.62 -42.15 92.04 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.211 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.88 -44.31 81.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.673 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 60.9 mt -62.58 -47.6 83.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.956 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.14 -24.23 72.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.312 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.99 30.33 17.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.813 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' ' OE1' ' A' ' 210' ' ' GLN . 23.4 mt -87.72 -17.89 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.51 106.41 0.46 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 111.854 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.33 -4.44 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.592 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . -89.49 132.46 37.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.49 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.13 131.35 36.31 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.144 1.896 . . . . 0.0 110.426 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 76.98 -140.05 24.31 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.229 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -92.84 126.86 50.0 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.986 0.422 . . . . 0.0 110.373 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 -30.42 67.34 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.163 2.576 . . . . 0.0 112.991 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.12 131.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 203' ' ' ARG . 47.5 tp -90.29 -42.43 10.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.44 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.35 168.05 24.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.35 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.29 136.64 28.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.044 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -125.01 118.13 25.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.549 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.86 125.68 55.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.78 140.9 58.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -82.62 41.5 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.294 0.569 . . . . 0.0 110.921 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -147.22 161.31 41.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.785 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 24.0 pttm -80.48 45.49 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -168.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -118.07 -94.28 0.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.571 ' CD1' ' HA2' ' A' ' 154' ' ' GLY . 44.9 m-85 -139.1 171.55 14.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.781 0.324 . . . . 0.0 111.365 -168.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.08 172.24 11.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.397 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.8 139.81 51.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.509 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -115.48 129.16 56.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.37 130.65 56.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.607 0.717 . . . . 0.0 111.133 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.58 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.6 m-85 -106.68 164.43 12.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.795 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.477 ' HA ' HD21 ' A' ' 187' ' ' LEU . 14.7 ptt180 -68.06 -28.18 67.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.095 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 38.6 m -152.38 153.56 33.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.07 -30.12 47.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.44 ' O ' HG21 ' A' ' 209' ' ' THR . 2.6 m-20 -57.23 -45.44 83.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 181' ' ' ALA . 2.2 mm-40 -72.31 -32.28 66.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.569 0.7 . . . . 0.0 109.638 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 55.7 m -68.22 -47.2 68.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.537 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 206' ' ' ASP . 12.2 t -64.85 -32.8 74.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.662 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.523 ' OE1' ' HB3' ' A' ' 178' ' ' LEU . 7.4 pt20 -75.52 -18.19 59.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.4 51.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.255 0.55 . . . . 0.0 109.816 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.421 ' HE2' ' HG2' ' A' ' 228' ' ' ARG . 9.9 mtt -66.41 -15.31 63.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.411 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -27.11 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.03 0.443 . . . . 0.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 217' ' ' ILE . 27.2 m-85 -83.93 17.22 2.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.462 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.64 117.44 13.21 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.976 -0.453 . . . . 0.0 110.985 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.97 12.67 61.73 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.904 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 214' ' ' PHE . 15.5 tt -100.58 151.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.916 0.389 . . . . 0.0 110.669 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.74 101.72 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.398 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.676 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 13.7 m-85 -104.81 122.46 45.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.73 20.25 8.99 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.688 0.395 . . . . 0.0 112.006 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 98.02 -12.02 63.97 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.202 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.1 pt20 -99.21 138.32 36.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.03 0.415 . . . . 0.0 109.941 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.5 t -92.37 130.01 38.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.986 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.62 118.99 38.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.313 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -109.89 122.77 48.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.93 118.82 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.799 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -117.38 166.8 11.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.421 ' HG2' ' HE2' ' A' ' 212' ' ' MET . 70.7 mtm-85 -103.11 113.74 65.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.469 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 19.4 Cg_exo -66.62 121.35 8.58 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.414 2.076 . . . . 0.0 111.496 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 55.9 m80 68.15 174.06 0.28 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.053 0.454 . . . . 0.0 110.791 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -100.6 55.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.296 0.57 . . . . 0.0 111.428 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -86.3 176.44 7.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -143.73 138.88 15.63 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 121.026 0.441 . . . . 0.0 110.691 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.99 176.68 9.57 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.117 2.545 . . . . 0.0 112.028 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.89 153.16 54.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.513 ' HA ' ' OG ' ' A' ' 239' ' ' SER . 74.5 Cg_endo -75.3 26.62 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.466 2.111 . . . . 0.0 114.424 -170.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.97 -41.74 11.94 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 25.4 ttt -147.8 80.21 1.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 236' ' ' PRO . 48.9 m -96.55 118.91 34.05 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.604 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.06 -38.02 87.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.9 130.87 24.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.282 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.93 88.55 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.508 2.139 . . . . 0.0 111.601 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 55.3 p 51.02 -168.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.457 0.703 . . . . 0.0 110.807 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 m -130.73 168.26 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.421 . . . . 0.0 111.173 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -137.71 129.03 27.88 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.866 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.8 p -95.94 124.86 50.71 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.78 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 120.41 7.75 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.659 2.239 . . . . 0.0 111.834 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 249' ' ' VAL . . . 107.92 -18.87 33.68 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.206 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 39.6 t 66.87 137.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.104 0.478 . . . . 0.0 111.499 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.16 111.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 19.8 m -71.34 146.34 48.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.782 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.0 p -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 110.305 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.531 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 61.2 t -97.64 100.66 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.124 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.485 HG12 ' HZ1' ' A' ' 260' ' ' LYS . 6.2 t -93.13 107.05 22.36 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.047 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.1 Cg_exo -58.38 149.18 75.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.336 2.69 . . . . 0.0 112.68 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.48 128.81 44.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.559 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 37.8 t -146.1 -178.72 6.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -78.92 -19.22 52.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 109.776 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -93.62 27.83 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.639 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 257' ' ' SER . 1.8 tmtm? -70.07 136.52 50.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.186 -176.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.452 ' N ' ' HD3' ' A' ' 260' ' ' LYS . 11.7 mt -121.96 149.19 43.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.947 0.403 . . . . 0.0 111.528 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -127.84 136.25 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.353 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.67 122.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.068 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.49 -179.55 15.88 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.31 1.17 90.38 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.431 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.0 mt -66.93 133.21 93.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.726 0.298 . . . . 0.0 111.617 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.78 143.42 99.62 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.935 2.424 . . . . 0.0 111.585 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -72.34 -5.67 37.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -102.03 0.67 35.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.7 133.86 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -105.2 -175.77 2.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.6 p-10 -51.83 -40.67 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.597 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 9.5 t70 -69.69 -39.19 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.675 0.274 . . . . 0.0 111.131 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.13 -37.53 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.195 0.522 . . . . 0.0 110.605 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.2 -30.97 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.81 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 27.2 mtmm -50.81 -41.85 57.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.531 0.205 . . . . 0.0 111.257 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -56.51 -35.58 68.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.504 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.33 -38.03 71.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.902 0.382 . . . . 0.0 110.552 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.2 mt -81.45 -31.31 33.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.281 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 38.1 p -72.78 -12.49 61.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 59.4 p -54.17 -41.51 68.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 111.531 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -87.59 -41.41 13.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 0.0 110.373 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -167.86 154.95 25.4 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.072 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.77 156.96 52.64 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.447 2.098 . . . . 0.0 112.643 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.57 136.19 45.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.495 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -75.37 -30.14 60.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.453 176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -154.92 126.3 7.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.226 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.86 113.16 8.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.38 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -117.37 120.55 38.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.543 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -102.05 129.28 48.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.3 105.29 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.342 0.591 . . . . 0.0 110.82 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.51 164.34 14.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.56 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -100.55 130.56 46.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 37.9 m -81.79 -9.75 59.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.165 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.9 -40.65 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.966 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 68.2 p -88.21 -28.07 21.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 83.79 8.4 84.46 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.61 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 45.4 mt -118.33 159.42 23.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 111.001 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.8 m -71.62 127.01 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.675 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.92 -9.4 58.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 111.529 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 91.09 26.39 21.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.974 171.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -148.81 144.4 26.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.096 0.448 . . . . 0.0 110.034 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.44 170.78 17.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.4 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.17 135.81 52.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.763 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 13.9 p -134.9 159.12 42.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.718 0.294 . . . . 0.0 110.716 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 254' ' ' VAL . 73.0 mm-40 -133.36 128.85 36.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.645 173.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.75 144.12 26.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.296 0.569 . . . . 0.0 110.366 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.48 -32.9 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.493 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -121.46 157.01 31.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.33 -21.66 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.092 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -71.27 -31.94 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.034 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.458 HG23 ' HA3' ' A' ' 283' ' ' GLY . 9.6 p -81.82 -23.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.509 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.3 m -54.73 -54.03 47.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.22 -23.26 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.278 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -34.3 53.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.812 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.26 -49.89 21.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.471 HG21 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -61.86 -21.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.644 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.2 60.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.243 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.79 -36.74 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.162 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 63.9 mt -75.75 -33.71 60.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.637 0.256 . . . . 0.0 111.296 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.79 112.48 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.75 11.36 56.86 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.453 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.1 ttm -68.65 119.81 13.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 0.0 110.125 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.46 86.57 7.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.61 114.74 28.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.667 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.11 -122.06 6.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.704 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.12 -13.75 15.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 0.0 111.085 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -122.28 173.29 7.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -103.3 128.91 50.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.324 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.15 129.57 37.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.4 tp -90.18 119.65 30.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.455 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.471 HG12 HG21 ' A' ' 317' ' ' ILE . 65.0 t -130.51 109.03 16.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.5 177.32 9.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -69.43 130.99 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.69 -14.26 62.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.193 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 340' ' ' LYS . 31.0 m -74.4 -15.94 60.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.442 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.97 -50.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 111.224 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -92.84 96.31 2.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.025 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . 52.64 67.93 0.91 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.099 0.56 . . . . 0.0 112.269 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 336' ' ' SER . 26.3 tptp -92.04 70.48 5.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.274 0.559 . . . . 0.0 110.185 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.96 139.52 53.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.227 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.272 179.032 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 45.5 tpp 57.34 76.79 0.3 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.467 0.651 . . . . 0.0 110.765 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -104.07 132.45 50.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.012 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.62 -146.62 10.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.704 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -112.86 14.45 19.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 111.026 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.431 ' HB2' ' HG2' ' A' ' 240' ' ' GLU . 45.0 tt0 -65.61 -31.9 73.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.061 0.458 . . . . 0.0 110.635 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -61.86 -32.36 72.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -109.06 -20.13 13.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.523 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -35.07 79.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.164 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.4 -11.6 55.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.3 -29.05 20.66 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -79.85 7.9 7.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.882 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 53.7 ttp180 -127.84 130.07 47.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.05 153.03 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.314 0.578 . . . . 0.0 111.945 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 47.8 t80 -82.06 111.32 18.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.43 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.35 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.64 161.68 12.94 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.475 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 5.9 t30 70.7 49.44 0.39 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.744 0.783 . . . . 0.0 110.258 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 pt -104.14 151.04 38.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.13 132.28 7.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.977 2.452 . . . . 0.0 111.475 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -66.5 120.27 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.53 -1.18 18.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.16 143.78 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.0 m -100.58 157.82 16.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -52.53 -58.9 5.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.742 0.306 . . . . 0.0 110.653 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.68 -23.61 64.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.57 -58.47 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.791 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.402 ' O ' ' HD1' ' A' ' 169' ' ' PHE . 19.9 ptp -77.96 -24.53 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.946 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 20.0 ttt -61.62 -56.19 22.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.372 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.89 -31.47 72.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.069 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.614 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.1 m-85 -61.13 -54.26 46.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 165' ' ' MET . 44.8 m-85 -65.64 -42.89 90.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -55.99 -34.09 65.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -73.05 -49.84 26.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 81.2 mm-40 -56.26 -39.72 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.414 ' HB3' HG21 ' A' ' 179' ' ' THR . 0.0 OUTLIER -57.15 -42.06 80.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.097 0.475 . . . . 0.0 110.732 177.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -77.56 -27.48 51.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 76.7 mt -72.84 -36.8 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.61 -23.85 35.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.14 36.39 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.392 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.9 mt -94.88 -26.58 16.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.806 0.336 . . . . 0.0 110.535 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.34 112.32 1.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.105 -178.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.2 -37.62 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.226 0.536 . . . . 0.0 109.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.91 39.74 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.215 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.14 142.18 54.99 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.278 1.986 . . . . 0.0 111.629 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.01 -157.95 15.11 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.79 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -96.23 124.45 51.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.225 0.536 . . . . 0.0 110.946 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 40.8 Cg_endo -67.94 -29.56 34.25 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.984 2.456 . . . . 0.0 112.624 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.54 132.81 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.187 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 187' ' ' LEU . 2.4 mt -89.62 -49.52 6.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.424 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.47 157.69 32.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.758 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.421 HG23 HD23 ' A' ' 200' ' ' LEU . 6.7 t -124.23 128.92 74.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.613 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.55 118.97 35.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.6 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.39 126.92 56.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 195' ' ' LYS . 62.2 t30 -86.61 142.3 28.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.12 -40.54 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -76.31 -64.29 1.14 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.0 110.673 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.445 ' HB2' ' ND2' ' A' ' 192' ' ' ASN . 58.0 mttp -85.09 122.85 29.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.24 67.99 1.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 111.89 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.19 156.65 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.59 156.74 33.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.005 0.431 . . . . 0.0 110.59 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -127.14 124.19 38.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.948 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.4 mt -103.71 115.37 30.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.281 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -96.85 127.14 42.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.514 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.508 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 33.8 m-85 -109.39 158.63 17.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.453 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.2 ptt180 -74.1 -18.4 60.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.874 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.0 m -148.49 144.98 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.091 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.81 -36.5 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.302 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 209' ' ' THR . 20.4 t70 -64.46 -40.26 95.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 110.067 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.54 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.0 mt-10 -72.23 -20.62 61.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.239 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 28.6 m -73.46 -50.44 21.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.235 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 206' ' ' ASP . 6.0 t -66.47 -29.2 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.713 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.54 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 1.8 pt20 -71.56 -20.88 61.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.632 0.253 . . . . 0.0 111.125 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.98 48.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.685 0.755 . . . . 0.0 109.539 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 19.7 mtt -71.24 -17.34 62.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.758 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.12 -21.82 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.146 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 217' ' ' ILE . 22.8 m-85 -83.28 9.36 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.993 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.54 117.49 6.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.54 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.88 83.86 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 214' ' ' PHE . 7.1 tt -88.19 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.21 98.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.639 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.7 p90 -116.69 139.06 50.97 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.158 173.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 65.22 24.39 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.66 82.63 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.523 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.4 pt20 -113.55 145.81 40.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.103 0.452 . . . . 0.0 110.073 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.4 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 32.2 t -103.36 115.31 30.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.919 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.8 137.32 52.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.157 0.503 . . . . 0.0 111.269 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -122.8 133.8 54.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.612 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.7 mp -132.61 146.08 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -97.54 143.86 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.895 -0.503 . . . . 0.0 111.001 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.0 mtm-85 -65.24 149.4 97.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.509 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 90.1 Cg_endo -89.15 122.0 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.673 2.249 . . . . 0.0 112.988 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 25.3 t60 167.98 -54.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.97 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.78 57.03 0.66 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.41 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -70.18 168.97 14.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.81 114.13 14.06 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.185 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.08 134.87 66.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.471 2.78 . . . . 0.0 113.552 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 235' ' ' LEU . 2.4 mm? -104.19 148.08 35.35 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.429 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.01 62.38 5.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.485 2.123 . . . . 0.0 111.7 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -117.01 71.13 0.28 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.56 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 94.8 mmm 70.28 122.6 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.309 0.644 . . . . 0.0 112.237 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 48.0 m -83.79 130.12 34.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 143' ' ' GLN . 12.3 pt-20 -111.75 171.96 7.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.191 0.519 . . . . 0.0 111.49 -174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.487 ' O ' HG23 ' A' ' 244' ' ' VAL . 4.9 p-10 -174.63 158.26 2.4 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 47.1 Cg_endo -69.52 53.51 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 113.806 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t -159.54 8.23 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 241' ' ' ASN . 35.6 m -123.02 162.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.36 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 65.5 t80 59.24 99.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.966 0.791 . . . . 0.0 111.411 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.64 118.04 70.62 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.011 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.25 140.73 28.08 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.17 32.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.99 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.027 0.441 . . . . 0.0 109.921 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 p -104.1 147.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 66.3 m -104.23 150.69 24.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.23 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.7 p -86.16 8.1 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.8 112.94 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.357 0.598 . . . . 0.0 110.131 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.36 106.08 54.73 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.97 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.82 166.92 12.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.156 2.571 . . . . 0.0 112.34 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.22 83.6 4.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.252 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -79.62 154.44 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.789 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.8 -16.67 63.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.196 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -128.18 36.92 4.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.295 0.569 . . . . 0.0 110.111 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -74.08 150.43 40.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.008 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.414 ' HB2' ' SG ' ' A' ' 305' ' ' CYS . 12.6 mt -122.5 149.1 44.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.879 0.371 . . . . 0.0 111.62 -171.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.75 128.77 56.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.768 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.94 120.93 65.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.645 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.93 166.41 21.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.893 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.63 5.02 63.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.456 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.516 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.1 mt -68.49 125.61 91.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.978 0.418 . . . . 0.0 112.056 -172.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 143.32 94.51 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.839 2.359 . . . . 0.0 111.648 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 298' ' ' LEU . 10.0 t30 -59.68 -26.71 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.442 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -81.84 -0.12 42.02 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.726 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.2 mt -113.9 124.28 51.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -104.29 -174.5 2.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.8 p-10 -47.78 -44.26 28.31 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.499 0.499 . . . . 0.0 111.842 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 31.4 t70 -72.01 -36.93 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.735 0.303 . . . . 0.0 111.812 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.39 -42.89 67.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.12 -29.67 33.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' CD1' ' A' ' 288' ' ' PHE . 1.0 OUTLIER -54.45 -39.36 67.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.795 176.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.87 -36.02 81.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.073 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.07 -41.74 67.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.3 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.24 -40.13 71.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.2 p -70.19 -11.87 61.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.794 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 35.3 t -53.11 -40.41 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.12 -41.0 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.21 150.81 20.03 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.707 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -69.03 156.3 65.68 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.432 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.7 mt -107.17 134.75 49.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.31 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -28.95 33.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.235 0.54 . . . . 0.0 109.824 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.2 120.97 7.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 17.2 t80 -139.2 109.54 6.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.85 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.58 119.22 34.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.401 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.76 124.49 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.3 126.85 36.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.432 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -122.86 148.72 45.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.74 116.35 18.2 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.5 t -70.1 -10.02 57.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.905 0.383 . . . . 0.0 110.511 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -85.68 -53.47 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 46.6 p -83.28 -23.69 32.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.498 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 78.21 18.34 76.55 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.5 ' HB3' ' OD1' ' A' ' 268' ' ' ASN . 59.6 mt -114.95 157.6 23.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.115 0.483 . . . . 0.0 110.881 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 49.5 m -73.48 134.29 43.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 302' ' ' TYR . 18.3 mmtp -61.66 -34.27 75.42 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.344 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 99.82 21.7 13.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.8 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 300' ' ' LYS . 32.0 p90 -153.68 145.0 23.03 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.68 168.25 24.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.911 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.82 132.84 53.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.995 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 32.0 p -127.16 166.35 17.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.964 0.411 . . . . 0.0 111.054 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 127.03 15.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.263 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.21 149.23 25.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.78 -21.03 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.279 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -133.77 159.85 39.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.256 0.551 . . . . 0.0 110.895 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.71 -25.93 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.218 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.8 -34.36 71.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.633 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 283' ' ' GLY . 10.0 p -79.53 -18.14 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.792 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.408 HG21 HD23 ' A' ' 261' ' ' LEU . 55.5 m -55.48 -48.38 74.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.114 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.94 -37.87 67.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.137 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.403 . . . . 0.0 110.838 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.56 -56.92 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.34 -21.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.127 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.89 96.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.225 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.12 -36.28 4.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.015 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 84.4 mt -67.83 -35.71 79.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 111.304 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -64.44 109.29 1.89 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.433 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 99.95 11.53 42.85 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.359 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.8 ttm -59.0 115.24 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.739 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.71 89.17 6.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.687 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 tp -112.72 122.86 48.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 77.73 -125.45 7.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.83 -1.49 25.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.058 0.456 . . . . 0.0 110.097 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -111.14 169.92 8.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.822 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 47.2 mtpt -118.11 117.48 29.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.866 168.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.84 137.21 51.56 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.152 0.501 . . . . 0.0 111.412 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.14 121.78 31.8 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.25 110.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -145.5 146.25 31.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.3 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -62.1 125.76 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.634 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.83 -15.67 63.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.764 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 8.6 m -76.42 -9.53 58.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.302 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 69.9 t -70.63 -33.07 51.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 111.306 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 154.53 62.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.625 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -110.64 45.85 1.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.558 . . . . 0.0 110.329 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -69.61 -36.6 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -151.22 -49.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.536 -178.749 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.944 0.402 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -51.92 10.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.59 -40.17 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.626 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.68 60.74 6.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.215 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 144' ' ' MET . 16.8 m -57.0 114.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.446 0.298 . . . . 0.0 111.391 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 71.31 -12.32 0.62 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.662 0.785 . . . . 0.0 111.922 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.436 ' H ' ' C ' ' A' ' 142' ' ' SER . 36.0 tpp -88.01 -49.57 6.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.634 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.2 t -70.44 -20.77 62.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.639 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -70.47 -18.59 62.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 110.243 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -90.13 -37.03 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.69 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.86 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.73 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -91.33 9.77 30.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.0 ttp180 -127.24 129.49 47.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.03 153.48 34.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.299 0.571 . . . . 0.0 111.786 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -82.86 115.66 21.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.057 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.8 123.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.749 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.98 172.42 15.15 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.97 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 2.7 t30 69.07 49.52 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.543 0.687 . . . . 0.0 109.713 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.6 pt -123.01 153.49 64.21 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.7 131.07 15.46 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.319 2.013 . . . . 0.0 111.366 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.55 124.76 21.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.01 16.6 40.71 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.087 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.24 148.45 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.929 0.395 . . . . 0.0 110.321 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 148.03 22.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -48.13 -58.52 4.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.088 -175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -55.68 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.279 . . . . 0.0 110.675 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.6 ptp -81.08 -26.16 36.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 18.4 ttt -61.56 -58.54 7.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -31.94 72.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.504 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -63.96 -57.71 8.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.022 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -57.63 -41.11 80.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.545 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -59.39 -27.85 66.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -85.54 -43.48 13.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.47 -41.13 89.03 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.5 ' HB3' HG21 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.1 -36.12 76.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.096 0.474 . . . . 0.0 110.882 177.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.52 -39.56 74.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.344 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.7 mt -65.22 -42.2 93.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.302 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.18 -12.96 78.14 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.607 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 33.17 46.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.676 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.47 -23.9 19.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.59 0.233 . . . . 0.0 110.902 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -59.09 107.97 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -83.43 -28.66 28.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 0.0 109.946 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -107.9 150.78 40.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.601 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.45 135.53 26.72 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.166 1.911 . . . . 0.0 111.578 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 109.34 -167.96 13.1 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.27 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -80.34 120.86 80.72 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 111.096 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.04 -31.24 46.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.945 2.43 . . . . 0.0 112.572 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.2 t -77.75 131.0 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 109.969 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.1 tp -99.33 -43.09 6.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.578 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.43 28.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.368 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.1 t -125.41 139.72 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.838 0.351 . . . . 0.0 110.827 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -124.6 121.55 35.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.959 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.03 122.82 67.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -72.27 130.39 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -87.5 -10.58 51.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.923 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -104.87 -14.33 15.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.18 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.465 ' HZ3' ' HB2' ' A' ' 195' ' ' LYS . 1.2 tppm? -145.8 147.72 32.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -78.19 57.26 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -141.62 154.97 45.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 109.995 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.15 167.16 21.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 73.8 m-85 -127.99 125.85 40.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.144 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 12.9 mt -106.95 122.16 45.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.713 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -100.96 129.72 46.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.43 . . . . 0.0 110.136 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.522 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 53.3 m-85 -108.21 151.52 25.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.952 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.62 -23.38 63.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.932 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -138.22 142.84 39.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.668 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.46 -29.84 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.528 ' O ' HG21 ' A' ' 209' ' ' THR . 14.4 t70 -63.37 -40.51 97.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.453 0.644 . . . . 0.0 109.779 175.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.591 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.6 mt-10 -77.66 -19.96 54.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.55 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.1 m -73.02 -48.26 37.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 110.216 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 206' ' ' ASP . 4.9 t -67.22 -30.55 70.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.471 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.591 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 2.5 pt20 -73.15 -20.55 60.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.052 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.97 -29.02 62.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.387 0.613 . . . . 0.0 109.515 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 12.2 mtt -68.64 -15.95 63.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.833 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.1 74.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 110.465 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 217' ' ' ILE . 32.5 m-85 -80.61 5.08 16.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.426 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.5 106.47 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.992 0.425 . . . . 0.0 111.072 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.07 14.43 57.66 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 214' ' ' PHE . 9.6 tt -103.61 159.62 4.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.876 0.338 . . . . 0.0 110.232 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mm -106.91 98.98 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.57 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.1 m-85 -109.12 136.59 48.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.14 173.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 58.62 28.79 17.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 111.393 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 75.73 5.44 79.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.319 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 14.1 pt20 -118.68 145.45 45.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.033 0.416 . . . . 0.0 110.254 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.408 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 42.6 t -94.93 127.63 41.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.032 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 123.03 40.4 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.95 134.44 54.83 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.87 123.51 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -114.14 153.88 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.71 120.99 67.88 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.7 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.66 132.27 42.1 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.49 2.126 . . . . 0.0 111.674 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -91.23 21.13 4.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.771 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -80.33 -9.16 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.635 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -142.52 175.52 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.731 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -133.23 116.77 14.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.199 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.16 161.74 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.582 2.188 . . . . 0.0 111.999 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.6 145.81 37.19 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.43 69.21 5.11 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.772 2.315 . . . . 0.0 112.989 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.03 13.37 66.68 Favored Glycine 0 C--O 1.236 0.224 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.937 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 53.43 58.04 5.59 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.365 0.602 . . . . 0.0 110.475 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.9 m -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.063 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.65 38.14 18.74 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.573 0.546 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.96 143.9 48.11 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.2 174.36 10.05 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.839 2.36 . . . . 0.0 111.856 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.0 m -79.04 87.98 4.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.977 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 t -88.7 23.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.271 1.034 . . . . 0.0 109.643 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -126.01 141.75 51.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.361 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.8 t -92.41 110.15 42.87 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.693 0.282 . . . . 0.0 110.534 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 122.72 9.48 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.441 2.094 . . . . 0.0 111.611 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.37 -22.23 31.31 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.802 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.6 t 64.07 125.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.153 0.581 . . . . 0.0 112.04 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.18 111.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.4 m -85.18 147.72 26.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 32.9 p -94.08 24.4 4.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.304 0.573 . . . . 0.0 110.719 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.51 108.49 19.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.512 0.673 . . . . 0.0 110.163 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.37 102.28 32.32 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.845 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 170.05 21.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.084 2.523 . . . . 0.0 112.32 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.72 102.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.317 0.58 . . . . 0.0 109.758 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.6 t -118.42 148.74 42.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.598 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.21 55.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.64 ' CE1' ' HB ' ' A' ' 310' ' ' ILE . 23.0 m-70 -120.18 34.1 5.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.797 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.36 146.34 55.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.327 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 313' ' ' THR . 6.2 mt -132.93 139.44 47.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.987 0.422 . . . . 0.0 111.751 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.423 ' C ' HD12 ' A' ' 263' ' ' ILE . 23.2 t80 -119.78 133.47 55.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.019 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.8 mp -121.11 115.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -115.2 -171.97 16.97 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.34 -1.31 85.79 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.824 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.484 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 89.5 mt -70.74 125.99 92.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -173.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.71 142.44 83.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.667 2.245 . . . . 0.0 111.115 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -62.67 -17.89 61.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -86.03 -9.16 57.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.7 mt -102.85 130.06 49.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.156 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -104.38 -177.32 3.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.413 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.673 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.9 p-10 -48.6 -46.88 40.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.383 0.427 . . . . 0.0 111.744 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.14 -44.0 87.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.487 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.6 -38.34 59.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.48 -30.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 0.0 109.914 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 14.4 ttpp -50.45 -38.95 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.722 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.45 -35.05 79.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.591 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.41 -27.61 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.89 0.376 . . . . 0.0 110.228 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 77.1 mt -82.98 -38.8 22.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.116 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 33.3 p -68.41 -11.66 60.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.952 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 74.6 p -50.31 -48.08 55.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.9 -40.99 21.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.775 0.321 . . . . 0.0 110.723 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.75 151.4 20.81 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 280' ' ' THR . 25.3 Cg_endo -67.08 156.08 67.93 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 112.3 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.18 132.98 45.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.646 0.736 . . . . 0.0 111.244 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -78.89 -42.46 27.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.354 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -142.44 128.12 19.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.419 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 10.5 t80 -138.74 107.06 5.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 110.14 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -116.24 108.57 16.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.424 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -94.44 125.69 39.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.31 131.77 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.863 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -117.83 157.84 25.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.53 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 6.0 t70 -100.17 125.18 46.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.2 t -76.3 -14.28 60.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.796 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.28 -37.81 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 111.458 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 81.7 p -86.24 -28.08 24.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.201 0.524 . . . . 0.0 110.563 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.74 18.4 77.35 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 48.5 mt -130.18 179.53 5.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.456 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.439 ' HB3' HD23 ' A' ' 290' ' ' LEU . 69.2 m -74.77 147.36 41.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.63 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 302' ' ' TYR . 35.4 mmtt -73.32 -25.6 60.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.147 0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 97.14 22.54 17.06 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.068 -176.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 1.9 p90 -157.42 146.81 20.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 110.978 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.37 18.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.222 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -129.84 137.84 50.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 31.7 p -139.65 166.88 23.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 112.079 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -133.21 134.04 43.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.366 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -83.24 149.52 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.233 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.64 -36.61 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -115.62 149.08 38.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.252 174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.64 ' HB ' ' CE1' ' A' ' 259' ' ' HIS . 2.8 pp -84.66 -13.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.749 -171.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -78.99 -41.21 29.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.008 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.87 -17.0 21.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.423 HG22 HD12 ' A' ' 261' ' ' LEU . 31.3 m -50.83 -44.41 59.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.893 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.88 -39.51 50.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.433 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -61.29 -37.39 83.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 111.507 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.81 -52.36 31.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.54 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 332' ' ' VAL . 2.7 pp -64.8 -20.88 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.61 67.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.262 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.19 -37.01 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.79 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.97 -28.27 55.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.928 0.364 . . . . 0.0 111.86 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.6 t-20 -66.8 108.8 2.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 329' ' ' LYS . . . 104.65 12.68 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.827 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 35.0 ttm -68.52 113.62 6.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 103.55 4.25 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.467 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.44 111.01 15.23 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 86.61 -116.38 4.42 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.0 5.15 12.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.433 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -122.97 165.74 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.768 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.513 ' HD2' ' O ' ' A' ' 322' ' ' GLY . 24.7 mtmm -109.86 127.94 55.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.422 HD22 HD21 ' A' ' 266' ' ' LEU . 27.4 mt -75.93 137.98 40.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -173.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -89.14 115.42 26.65 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 67.5 t -124.19 107.0 17.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.322 0.582 . . . . 0.0 109.506 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -147.46 145.53 29.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.001 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.447 ' O ' HG21 ' A' ' 337' ' ' VAL . 55.1 mtp180 -63.44 129.05 38.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.02 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -73.06 5.8 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.5 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 1.9 p -67.32 -22.79 65.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 334' ' ' ARG . 20.6 m -83.11 -3.06 7.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.765 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -86.81 131.43 10.56 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.069 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -79.83 -20.82 45.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -88.31 143.48 26.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.106 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -106.95 -179.85 4.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.527 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.654 -0.688 . . . . 0.0 110.202 178.765 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -73.33 -44.53 58.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.983 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.4 t 62.82 92.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.188 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 -177.91 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.675 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.9 t -65.63 -53.11 45.97 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HG3' HG21 ' A' ' 145' ' ' THR . 7.4 tp-100 -178.5 145.44 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.351 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -60.45 -18.88 54.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.073 179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.421 ' OG1' ' HB1' ' A' ' 148' ' ' ALA . 8.9 t -119.47 18.64 12.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.649 0.738 . . . . 0.0 110.254 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -66.72 -41.98 87.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.841 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -87.6 -4.53 58.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' OG1' ' A' ' 145' ' ' THR . . . -86.32 -32.04 21.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -87.95 -12.97 43.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.024 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 99.6 mtt180 -110.9 156.49 21.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.556 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.97 152.61 42.16 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 20.0 t80 -81.08 113.09 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.216 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -99.3 125.89 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.974 0.416 . . . . 0.0 111.283 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.17 176.19 22.48 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 65.84 52.29 1.28 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.647 0.737 . . . . 0.0 109.409 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 pt -119.2 150.92 50.11 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 11.5 Cg_endo -91.8 146.57 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.425 2.75 . . . . 0.0 112.17 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.13 111.47 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.868 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.76 15.56 36.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.161 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 148.53 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.187 0.518 . . . . 0.0 110.287 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.5 m -99.63 144.83 28.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.037 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 191' ' ' ILE . 1.5 mp0 -42.49 -54.51 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.865 0.728 . . . . 0.0 111.545 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.17 -37.37 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.803 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.85 -55.25 36.79 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.343 0.592 . . . . 0.0 111.088 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -78.24 -29.33 48.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.388 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.0 ttt -61.22 -54.54 42.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.695 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.52 -33.32 75.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.858 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.548 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.1 OUTLIER -63.13 -49.9 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -72.68 -40.04 66.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 72.8 m-20 -56.35 -34.79 66.94 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.552 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -68.1 -39.67 82.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.057 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 62.6 mm-40 -64.12 -38.65 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.425 ' HB3' HG21 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.27 -41.72 93.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 83.4 mtt180 -69.4 -36.01 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.438 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 97.9 mt -61.75 -50.43 72.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.64 65.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.667 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.03 30.97 24.41 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.304 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.82 -22.45 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.3 . . . . 0.0 110.22 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.425 HG21 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.23 108.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.097 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -88.19 -30.04 20.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.031 0.443 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.463 ' HB1' ' CZ ' ' A' ' 203' ' ' ARG . . . -108.56 149.03 38.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.968 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.48 145.03 95.55 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.291 1.994 . . . . 0.0 111.421 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.15 -149.95 19.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.463 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.51 123.91 42.75 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.817 0.341 . . . . 0.0 111.12 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.4 -37.82 22.15 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.201 2.601 . . . . 0.0 112.398 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.55 123.53 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.44 -46.72 8.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.305 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.74 40.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.41 HG22 HD23 ' A' ' 200' ' ' LEU . 3.5 t -127.82 140.12 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -119.15 117.81 29.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.014 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' A' ' 162' ' ' GLU . 3.8 mp -106.58 129.19 60.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.529 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -76.69 151.7 36.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.468 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.4 -3.76 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.19 161.7 14.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.082 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.48 34.89 0.33 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.249 0.547 . . . . 0.0 110.864 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.38 -65.27 1.01 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.388 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -153.78 167.94 27.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.328 0.585 . . . . 0.0 112.143 -173.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.55 155.96 49.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.131 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.5 125.35 50.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.878 0.371 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 20.2 mt -94.62 125.29 39.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.686 174.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -105.05 130.62 53.2 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.52 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 61.5 m-85 -109.79 157.48 19.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.463 ' CZ ' ' HB1' ' A' ' 181' ' ' ALA . 37.3 ptt180 -78.16 -18.98 54.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.787 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 54.7 m -147.91 139.56 23.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.797 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.66 -25.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.44 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -76.21 -23.76 54.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -84.23 -20.9 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.237 0.541 . . . . 0.0 109.673 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 67.6 m -69.83 -49.87 48.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.639 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.8 t -60.69 -36.79 79.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.43 -22.45 61.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.79 -28.49 60.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 109.87 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 23.8 mtp -72.76 -14.64 61.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.192 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -18.15 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.489 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.477 ' CG ' ' HE2' ' A' ' 219' ' ' PHE . 11.4 m-85 -84.56 5.19 28.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.57 107.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.466 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.51 13.54 59.68 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.017 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -94.56 154.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.151 0.476 . . . . 0.0 110.818 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.8 mm -97.73 100.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.132 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.66 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.9 m-85 -105.03 103.39 12.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.69 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 60.54 37.63 19.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.95 -13.57 63.47 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.155 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.8 pt20 -100.96 132.83 46.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.604 0.702 . . . . 0.0 110.344 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.0 t -98.7 90.41 4.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 pp -91.71 144.69 25.25 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.46 143.25 47.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.153 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.4 mp -130.65 115.41 31.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.9 tpt180 -97.8 144.33 27.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -103.82 113.02 65.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.396 . . . . 0.0 111.158 -174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.17 148.9 89.29 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.524 2.149 . . . . 0.0 111.54 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -123.34 10.83 9.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -100.47 41.4 1.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.191 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -161.31 157.35 25.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.153 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -158.9 115.49 1.65 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 123.283 0.365 . . . . 0.0 110.531 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.435 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 58.7 Cg_endo -74.0 131.53 15.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.41 2.073 . . . . 0.0 111.346 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 235' ' ' LEU . 2.1 pp -147.53 151.58 39.92 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 111.466 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.79 -159.47 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.41 2.74 . . . . 0.0 111.854 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 128.63 -53.39 0.8 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.08 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.2 mtm -116.4 24.42 11.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.516 0.674 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 72.65 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.0 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.85 106.39 17.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.457 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -115.4 115.48 42.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.598 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.8 -74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.443 2.762 . . . . 0.0 113.802 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 18.6 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 110.477 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.1 m -75.03 171.12 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.345 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -140.8 131.38 25.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.66 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.31 117.81 25.15 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 121.084 0.469 . . . . 0.0 111.527 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.82 119.42 6.43 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 111.535 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.55 26.16 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.735 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 94.8 t 58.89 87.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.765 0.793 . . . . 0.0 112.2 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.16 127.03 61.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.039 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.2 m -81.39 147.88 29.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 67.2 p -93.27 4.08 54.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.553 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 4.3 p -109.12 106.64 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.861 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.03 110.12 39.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.992 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 8.1 Cg_exo -72.53 139.72 31.81 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.996 2.464 . . . . 0.0 110.953 172.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 260' ' ' LYS . 26.9 t70 -86.65 83.44 7.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.463 0.649 . . . . 0.0 110.479 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 33.1 t -89.55 -178.03 5.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.823 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.74 65.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.665 0.745 . . . . 0.0 110.023 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -102.46 31.63 3.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.377 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 257' ' ' SER . 2.3 tmtp? -67.75 133.34 49.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 305' ' ' CYS . 2.2 mt -122.17 149.24 43.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.483 . . . . 0.0 112.251 -172.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.403 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 45.2 t80 -119.62 132.12 55.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.796 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.474 HD12 ' SG ' ' A' ' 305' ' ' CYS . 2.5 mp -116.25 120.05 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.02 0.438 . . . . 0.0 110.298 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.39 -174.43 13.84 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 87.47 -6.72 82.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.008 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 301' ' ' GLY . 91.9 mt -68.86 127.62 93.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -172.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.01 140.17 59.12 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.173 1.915 . . . . 0.0 109.803 166.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -64.55 -15.08 60.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -169.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -83.61 -7.56 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.021 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.35 126.47 42.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.41 ' HA ' ' HG ' ' A' ' 299' ' ' SER . 34.3 p-10 -104.4 176.15 5.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.699 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 12.6 t70 -40.22 -43.49 1.69 Allowed 'General case' 0 CA--C 1.534 0.327 0 O-C-N 123.644 0.59 . . . . 0.0 111.882 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.43 -47.9 74.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.896 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -73.74 -39.64 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.94 -32.6 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.671 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.9 mtmm -56.26 -33.98 65.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.651 0.262 . . . . 0.0 111.176 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.48 -31.53 72.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.406 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.74 -34.92 60.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.131 0.491 . . . . 0.0 110.174 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.93 -32.23 27.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.274 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 17.0 p -69.38 -13.8 62.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.753 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.4 m -49.63 -46.43 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.467 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.26 -41.12 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.158 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.19 164.34 35.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.915 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -70.48 166.17 29.36 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.776 2.317 . . . . 0.0 111.85 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.2 mt -112.22 133.18 54.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.732 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.35 -38.09 74.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.272 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -152.27 131.96 13.16 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.686 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -138.57 117.89 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.266 0.555 . . . . 0.0 110.559 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -121.39 102.37 8.22 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.789 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.443 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 6.5 tt -86.82 133.6 33.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.329 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.92 133.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.541 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -122.16 165.29 16.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 295' ' ' ALA . 20.5 t70 -110.0 133.35 53.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.74 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.7 t -83.86 -11.12 57.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.92 0.391 . . . . 0.0 110.537 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.428 ' HB3' ' OD2' ' A' ' 293' ' ' ASP . . . -88.31 -43.46 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.735 0.302 . . . . 0.0 111.003 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 70.0 p -83.39 -30.66 27.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.17 0.51 . . . . 0.0 110.787 176.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.46 13.52 80.16 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 42.2 mt -123.61 -175.43 3.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.709 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' A' ' 271' ' ' ASN . 36.6 m -74.75 152.45 39.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.133 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.4 ' HE2' ' OH ' ' A' ' 302' ' ' TYR . 46.0 mtpt -87.38 -10.9 50.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.544 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.484 ' C ' ' HB2' ' A' ' 266' ' ' LEU . . . 92.66 26.84 16.1 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.67 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.4 ' OH ' ' HE2' ' A' ' 300' ' ' LYS . 1.6 p90 -164.42 149.43 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.029 0.443 . . . . 0.0 110.615 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -149.37 170.27 18.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.912 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.428 ' CD1' ' HE2' ' A' ' 260' ' ' LYS . 98.5 m-85 -123.19 127.97 49.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.484 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.474 ' SG ' HD12 ' A' ' 263' ' ' ILE . 12.4 p -122.42 162.48 21.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.101 0.476 . . . . 0.0 110.187 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 111.96 6.04 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -70.38 171.3 10.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.962 0.411 . . . . 0.0 110.995 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.83 -45.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.625 ' HB3' ' ND2' ' A' ' 311' ' ' ASN . 11.0 m-20 -85.6 142.15 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.96 -14.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.248 0.547 . . . . 0.0 110.498 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.625 ' ND2' ' HB3' ' A' ' 309' ' ' ASP . 9.1 p30 -86.89 -24.24 24.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.026 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 309' ' ' ASP . 8.9 p -83.78 -18.27 10.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.116 0.484 . . . . 0.0 109.802 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 21.9 m -53.8 -49.23 68.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.257 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.31 -24.82 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -70.79 -36.04 72.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.173 0.511 . . . . 0.0 110.971 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.5 -52.32 14.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.019 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.418 HG21 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -61.45 -21.21 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.162 0.506 . . . . 0.0 110.968 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.48 -39.08 74.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.259 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.62 -35.96 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.243 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.5 -34.25 58.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.406 ' OD1' HD12 ' A' ' 331' ' ' LEU . 64.8 t30 -69.91 117.79 11.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.478 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 96.06 10.75 55.88 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.036 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.449 ' O ' HD23 ' A' ' 330' ' ' LEU . 41.9 ttm -64.22 116.2 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 86.82 7.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.27 121.83 45.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.414 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.18 -117.63 4.52 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -116.37 -14.68 11.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 110.793 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.41 165.26 11.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -107.31 125.86 51.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.898 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.488 ' HA ' ' HA3' ' A' ' 265' ' ' GLY . 2.6 mm? -73.21 133.97 44.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.814 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.406 HD12 ' OD1' ' A' ' 321' ' ' ASN . 33.6 tp -97.62 122.81 41.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 174.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.418 HG12 HG21 ' A' ' 317' ' ' ILE . 99.6 t -131.22 108.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.95 160.08 40.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.8 141.49 36.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -72.04 -14.95 62.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.137 0.494 . . . . 0.0 109.98 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 12.9 t -97.6 46.76 1.02 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.087 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.19 25.46 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.376 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 146.35 162.45 9.82 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . 72.48 -50.39 0.7 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.644 0.778 . . . . 0.0 112.109 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -79.16 77.2 5.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -94.81 78.71 3.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.397 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.728 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 121.231 0.538 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 14.1 tpt -154.96 90.9 1.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.2 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.01 -44.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.591 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.47 -66.98 3.18 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.879 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -151.33 -177.79 6.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -74.61 53.19 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 33.8 ttm -88.62 -47.69 8.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t -72.1 -8.4 54.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.076 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.89 -19.13 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 110.613 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.74 -33.68 27.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.452 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.83 -25.95 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.51 -6.59 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.362 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 30.8 mtm180 -110.45 158.08 18.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.233 0.539 . . . . 0.0 111.542 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.34 153.53 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.562 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 15.5 t80 -79.61 118.97 21.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.585 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.96 121.26 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -122.88 176.21 16.56 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.218 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.2 43.5 1.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.807 0.813 . . . . 0.0 109.866 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.8 pt -116.35 154.6 48.89 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.67 130.91 14.1 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.633 2.222 . . . . 0.0 111.378 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.82 117.64 9.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.657 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.29 6.49 29.41 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.514 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.71 147.93 11.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 110.2 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 m -93.48 144.89 24.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.546 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 189' ' ' VAL . 1.9 mp0 -49.54 -54.21 19.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 123.371 0.42 . . . . 0.0 111.397 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.26 -24.28 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.278 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 -58.39 5.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.704 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 ptp -72.06 -31.67 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.353 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.27 -54.83 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.309 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.62 -36.12 83.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.6 OUTLIER -56.95 -61.11 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.978 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -58.65 -42.37 88.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -59.79 -42.05 92.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 111.063 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.99 -43.93 77.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.988 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 23.1 mm-40 -64.34 -31.81 73.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.165 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.464 ' HB3' HG23 ' A' ' 179' ' ' THR . 11.9 mmt -57.07 -46.17 82.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -73.69 -30.17 62.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 81.0 mt -66.85 -48.39 68.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.359 . . . . 0.0 110.278 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.82 74.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.476 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.56 36.75 10.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.174 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.463 HD11 ' SD ' ' A' ' 173' ' ' MET . 17.3 mt -90.89 -27.37 18.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -60.16 108.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.809 -177.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -22.97 14.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.13 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.7 127.78 27.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.46 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.86 142.17 98.07 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.723 2.282 . . . . 0.0 112.572 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 107.17 -143.16 15.83 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.39 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -108.27 115.07 58.77 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-O 120.953 0.406 . . . . 0.0 110.801 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.32 -37.8 58.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.817 2.345 . . . . 0.0 112.114 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.43 119.31 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.0 tm? -97.46 -34.96 10.82 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 -170.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.12 157.96 38.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 162' ' ' GLU . 97.2 t -138.0 128.81 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.809 0.338 . . . . 0.0 110.677 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -119.38 125.25 48.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.06 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 162' ' ' GLU . 15.9 mm -90.94 130.69 39.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.49 127.69 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -85.8 -12.31 51.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.726 0.298 . . . . 0.0 110.889 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -84.47 -62.47 1.55 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.31 170.41 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.993 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -82.49 52.41 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.102 0.477 . . . . 0.0 111.502 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.6 167.36 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.53 161.65 37.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.821 0.343 . . . . 0.0 111.049 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.49 121.3 43.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.066 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 1.0 OUTLIER -94.47 118.96 32.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.926 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -102.64 126.8 49.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.363 0.601 . . . . 0.0 110.551 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.533 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 59.1 m-85 -106.52 157.29 17.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.443 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.494 ' HB3' ' HG ' ' A' ' 187' ' ' LEU . 17.9 ptt180 -79.18 -20.63 47.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.8 m -141.74 144.07 33.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.51 -26.63 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.007 0.432 . . . . 0.0 111.103 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 209' ' ' THR . 9.2 p-10 -75.58 -18.25 59.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.672 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.429 ' OE1' ' HG3' ' A' ' 203' ' ' ARG . 44.5 mt-10 -86.01 -26.43 25.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 45.0 m -68.31 -44.74 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.816 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.5 t -61.56 -37.01 82.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.171 -174.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -74.73 -18.22 60.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.55 -27.3 58.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.35 0.595 . . . . 0.0 109.955 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.537 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 9.8 mtt -68.36 -16.24 63.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.14 -24.85 64.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.497 ' O ' HG22 ' A' ' 217' ' ' ILE . 18.9 m-30 -75.33 -0.85 21.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.954 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.8 106.28 1.49 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.57 14.34 38.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.3 tt -106.84 153.94 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.28 99.56 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.141 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.75 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.1 m-85 -103.0 118.94 37.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.513 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 57.61 32.49 21.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.205 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.8 -13.34 64.64 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.593 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 24.7 pt20 -94.36 136.67 34.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.498 0.649 . . . . 0.0 110.438 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.0 t -90.35 124.73 35.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.638 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.48 121.98 42.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.798 0.333 . . . . 0.0 110.528 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -113.23 119.24 37.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.998 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.1 mp -121.75 130.78 74.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.115 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -114.5 149.73 35.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.537 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 9.3 mpt_? -89.67 113.52 57.1 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.366 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.01 129.6 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.583 2.189 . . . . 0.0 111.813 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.24 36.42 3.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.8 -34.14 71.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.443 0.64 . . . . 0.0 109.543 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -83.05 159.81 22.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -129.5 112.93 17.96 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 23.1 Cg_exo -64.98 150.97 87.38 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.809 2.339 . . . . 0.0 111.667 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 234' ' ' PRO . 91.2 mt 70.84 132.21 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.841 0.713 . . . . 0.0 111.402 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 151.51 49.85 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.48 77.25 1.75 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.355 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.441 ' C ' ' H ' ' A' ' 240' ' ' GLU . 96.1 mmm -79.71 172.78 13.32 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 61.1 m 71.67 -10.3 0.85 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.677 0.611 . . . . 0.0 111.651 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 238' ' ' MET . 33.9 mt-10 -86.94 -48.0 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -99.05 136.58 20.51 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.941 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.35 143.63 97.99 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.466 2.111 . . . . 0.0 111.33 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -72.25 81.52 1.01 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.743 0.782 . . . . 0.0 109.363 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 m -116.77 174.86 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.792 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -86.36 132.95 33.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.443 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.83 103.55 49.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.12 119.24 6.22 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.502 2.134 . . . . 0.0 111.744 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 97.26 -3.49 61.81 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 89.2 t 41.94 82.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.708 0.766 . . . . 0.0 112.036 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.86 120.89 34.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.465 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.5 m -69.34 139.38 54.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.173 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 p -87.92 1.71 53.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.347 0.594 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.74 108.08 22.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.748 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.26 107.51 59.18 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.822 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.15 160.49 49.41 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.811 2.341 . . . . 0.0 111.346 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.33 142.21 47.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.7 p -156.49 -177.07 6.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.026 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.38 0.69 55.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.243 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -131.52 16.03 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.4 125.99 30.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 0.8 OUTLIER -109.28 139.9 43.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -171.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.421 ' HD2' ' CE2' ' A' ' 304' ' ' PHE . 41.9 t80 -101.91 127.44 48.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.446 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.96 116.53 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.761 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -121.55 176.1 16.3 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.578 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.69 89.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.2 mt -68.87 129.69 92.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -174.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 139.88 91.09 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.688 2.259 . . . . 0.0 111.238 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.46 -18.66 62.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -98.03 8.2 45.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.57 122.92 48.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.219 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.78 -171.51 1.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.776 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 5.7 p-10 -48.81 -45.46 40.38 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.624 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.32 -47.64 78.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 111.619 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.19 -41.46 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.426 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.01 -31.68 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.441 0.639 . . . . 0.0 110.048 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.736 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 0.6 OUTLIER -55.11 -36.7 65.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.382 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.22 -26.34 68.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.663 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.68 -38.36 33.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.213 0.53 . . . . 0.0 109.711 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.74 -42.56 63.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.055 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 30.6 p -66.89 -11.38 55.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.016 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.1 t -59.72 -29.28 68.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.774 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.06 -40.61 6.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.026 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.48 160.48 32.75 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.054 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.31 168.43 23.43 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.151 2.567 . . . . 0.0 112.133 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.2 mt -117.74 134.1 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.469 0.652 . . . . 0.0 111.729 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.488 ' HB2' HG21 ' A' ' 308' ' ' VAL . 38.6 ttmt -70.51 -46.39 63.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.074 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -150.87 133.45 15.64 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.605 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 10.4 t80 -138.28 107.03 5.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.895 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.57 105.16 15.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.634 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.593 HD11 ' N ' ' A' ' 291' ' ' VAL . 0.6 OUTLIER -88.34 132.57 34.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.593 ' N ' HD11 ' A' ' 290' ' ' LEU . 27.8 t -98.57 119.07 46.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.161 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 240' ' ' GLU . 46.4 mtpt -114.41 167.3 10.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' A' ' 295' ' ' ALA . 13.6 t70 -96.27 118.49 32.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.3 t -72.12 -10.01 59.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.611 0.244 . . . . 0.0 110.847 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 293' ' ' ASP . . . -91.91 -49.45 6.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.264 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 76.0 p -82.4 -27.68 31.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 111.026 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.31 82.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.121 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 29.8 mt -108.49 170.01 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.4 m -82.44 138.92 34.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 110.53 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -63.86 -31.42 72.6 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.133 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 105.55 26.85 6.0 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 17.1 p90 -156.69 141.4 16.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 110.185 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.447 ' HB3' HD22 ' A' ' 290' ' ' LEU . . . -149.2 170.28 18.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.179 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 94.8 m-85 -131.45 130.29 42.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 30.7 p -130.26 175.68 8.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 111.465 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 129.32 11.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.403 ' OH ' HD13 ' A' ' 320' ' ' LEU . 8.4 m-85 -89.06 -0.16 57.2 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 286' ' ' LYS . 44.3 t 75.37 -63.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.555 0.693 . . . . 0.0 109.603 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 312' ' ' VAL . 15.1 t70 -75.51 135.48 40.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.131 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.26 -19.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 309' ' ' ASP . 1.7 m-80 -80.53 -45.51 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.782 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 309' ' ' ASP . 7.1 p -65.4 -18.47 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.205 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 23.5 m -53.8 -50.15 66.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.444 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.77 -35.87 62.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 0.0 110.627 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -67.27 -31.04 71.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 320' ' ' LEU . . . -75.48 -55.16 5.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.899 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.08 -21.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.762 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.32 79.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.049 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.66 -28.97 6.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 316' ' ' ALA . 78.8 mt -76.44 -36.82 57.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -175.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.05 110.05 2.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.51 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.95 11.47 56.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.277 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 43.6 ttm -60.94 117.19 5.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 110.521 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 94.45 6.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 120.01 40.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.589 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.69 -115.12 4.45 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.85 -3.91 12.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 110.559 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -111.94 156.14 22.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.771 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.79 125.64 49.61 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.26 141.88 41.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.123 0.487 . . . . 0.0 111.081 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.99 121.6 36.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.344 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 320' ' ' LEU . 59.2 t -130.8 111.41 20.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.016 0.436 . . . . 0.0 110.34 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -151.8 149.71 29.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.243 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 337' ' ' VAL . 0.0 OUTLIER -64.29 129.65 40.75 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.083 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -70.29 -8.15 48.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.357 0.599 . . . . 0.0 110.408 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.405 ' HA ' ' ND2' ' A' ' 341' ' ' ASN . 6.0 m -67.43 -13.27 61.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.455 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 334' ' ' ARG . 32.3 m -81.09 -6.19 9.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.99 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -88.51 -178.94 46.64 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.336 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 341' ' ' ASN . . . -86.18 167.11 15.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.48 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 72.01 -36.46 0.36 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.423 0.689 . . . . 0.0 111.754 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 339' ' ' ALA . 6.8 t30 -67.55 -58.42 4.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.162 0.506 . . . . 0.0 110.348 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.316 -178.197 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 69.24 125.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.856 0.722 . . . . 0.0 111.556 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t 69.2 -75.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.287 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -88.01 64.3 3.64 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.192 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.1 p -154.81 110.62 3.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.808 0.337 . . . . 0.0 110.535 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.03 4.38 8.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.9 ptp -61.72 -30.33 70.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.504 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 9.1 t -120.5 21.67 11.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.819 -171.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -70.93 -24.59 62.48 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.229 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.549 ' OE1' ' HB2' ' A' ' 231' ' ' ASP . 66.6 mt-30 -79.75 -31.87 41.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.011 0.434 . . . . 0.0 110.021 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HB2' ' OG1' ' A' ' 145' ' ' THR . . . -72.57 -31.95 65.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.607 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 145' ' ' THR . 19.9 mtm180 -74.04 -13.2 60.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.82 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.7 ttp180 -110.98 137.35 48.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.979 0.419 . . . . 0.0 110.631 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.13 153.98 38.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.4 t80 -85.53 121.04 27.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.201 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.62 127.63 64.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 0.0 110.942 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -128.72 -178.22 15.26 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.331 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.567 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 3.5 t30 67.82 28.01 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.773 0.797 . . . . 0.0 109.706 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.5 pt -102.13 150.2 37.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.51 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.14 132.03 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.634 2.223 . . . . 0.0 111.388 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -65.92 123.89 21.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.73 -5.0 30.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.099 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.13 145.23 9.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.253 0.549 . . . . 0.0 110.883 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 m -101.02 148.69 24.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.144 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.413 ' HG3' HD12 ' A' ' 191' ' ' ILE . 1.7 mp0 -47.73 -55.16 10.16 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.454 0.471 . . . . 0.0 110.859 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -54.41 -38.38 66.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.226 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.26 -56.58 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.6 ttm -64.52 -36.82 85.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.259 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.2 ttt -62.49 -55.85 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.15 -36.94 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.316 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -55.49 25.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -60.45 -33.87 73.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.016 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.562 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 6.7 m-80 -59.99 -46.41 89.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.411 . . . . 0.0 110.489 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -65.7 -43.46 89.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.643 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -47.26 75.96 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.507 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -55.4 -44.71 76.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 111.085 177.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.5 mtm-85 -69.78 -33.41 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 83.2 mt -62.07 -35.78 79.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.948 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.99 -8.87 55.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.714 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.19 58.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.552 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.6 -21.82 18.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.19 . . . . 0.0 111.441 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.56 ' O ' HG21 ' A' ' 246' ' ' VAL . 0.2 OUTLIER -59.26 107.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.32 . . . . 0.0 110.83 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.417 ' HB2' HG21 ' A' ' 244' ' ' VAL . 6.4 pt20 -90.03 -27.51 19.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.77 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.423 ' HB2' ' NH2' ' A' ' 203' ' ' ARG . . . -108.18 149.47 39.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.225 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.06 139.94 30.51 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.216 1.944 . . . . 0.0 111.417 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.34 -158.8 15.79 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.708 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 10.7 m120 -86.8 116.14 64.95 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.562 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 4.1 Cg_endo -52.3 -46.34 33.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.601 2.867 . . . . 0.0 112.289 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.57 136.85 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.4 tp -93.75 -51.22 5.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.929 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.75 142.33 25.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.6 t -110.9 131.83 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.965 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -118.68 126.73 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.413 HD12 ' HG3' ' A' ' 162' ' ' GLU . 3.3 mp -115.65 119.7 62.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.884 0.373 . . . . 0.0 110.398 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -85.54 144.05 28.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 0.0 111.468 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -107.4 3.23 25.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.794 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.31 -45.34 19.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.844 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.12 154.73 45.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.549 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -81.41 52.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.69 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.15 171.01 15.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.975 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -137.6 167.25 22.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.978 0.418 . . . . 0.0 111.297 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -127.95 130.29 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 15.3 mt -110.67 117.83 34.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.335 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 37.7 tt0 -104.37 129.76 52.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.583 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 43.0 m-85 -104.98 159.64 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.134 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 38.3 ptt180 -77.34 -20.94 54.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.422 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 m -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.69 -29.1 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.228 0.537 . . . . 0.0 110.044 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 209' ' ' THR . 3.5 m-20 -67.92 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.792 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.16 -21.15 50.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.29 0.567 . . . . 0.0 109.922 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 86.4 m -72.45 -47.94 44.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 206' ' ' ASP . 7.5 t -62.27 -36.02 80.8 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.555 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -73.91 -25.09 59.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.198 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.58 75.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.272 0.558 . . . . 0.0 109.956 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.417 ' HE3' ' HB2' ' A' ' 228' ' ' ARG . 27.8 mtp -68.54 -14.74 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.171 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.26 67.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 110.633 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.495 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.4 m-85 -78.55 6.18 9.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.97 106.74 1.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.93 13.84 38.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.036 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.0 tt -103.65 155.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.107 0.454 . . . . 0.0 111.116 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.74 102.3 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.562 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.1 m-85 -106.39 117.48 34.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.957 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 57.32 31.73 20.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 0.0 111.443 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.47 -12.81 64.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.873 174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.8 pt20 -105.93 144.95 31.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.318 0.559 . . . . 0.0 110.501 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.567 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 23.3 t -102.46 128.89 48.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -101.76 120.66 40.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.559 ' HB3' ' HZ2' ' A' ' 225' ' ' LYS . 4.9 mmmp? -114.24 123.08 48.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 17.9 mt -130.8 118.79 43.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.01 -171.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.58 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 25.0 tpt180 -105.99 154.18 20.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.718 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.417 ' HB2' ' HE3' ' A' ' 212' ' ' MET . 8.7 tpm_? -102.45 98.68 11.23 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.079 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 20.4 Cg_exo -66.42 122.85 10.39 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.309 2.006 . . . . 0.0 110.571 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -114.36 57.55 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.271 0.558 . . . . 0.0 110.145 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.549 ' HB2' ' OE1' ' A' ' 147' ' ' GLN . 11.4 m-20 -93.49 33.24 1.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.595 0.712 . . . . 0.0 109.6 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 234' ' ' PRO . 43.3 p90 -160.68 170.98 19.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.944 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.549 ' HA ' HE21 ' A' ' 233' ' ' GLN . 0.1 OUTLIER -117.6 109.28 41.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.447 ' HG3' ' CE2' ' A' ' 232' ' ' TYR . 16.9 Cg_exo -65.24 150.21 87.72 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.031 2.487 . . . . 0.0 112.066 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.67 131.26 29.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.25 71.9 4.3 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.379 2.053 . . . . 0.0 112.129 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.31 -17.24 76.72 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.098 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 69.2 mtm 68.87 -75.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.257 0.623 . . . . 0.0 110.983 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 43.1 t -128.67 105.8 8.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.879 0.371 . . . . 0.0 110.267 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -98.29 -8.91 26.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.493 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -144.79 109.8 4.78 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.395 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.32 -51.12 0.28 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.226 2.618 . . . . 0.0 112.558 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.9 t -172.97 133.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 180' ' ' GLN . 17.2 m -131.48 161.38 41.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.201 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -76.62 103.56 6.67 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 179' ' ' THR . 2.7 p -75.49 119.03 75.16 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.926 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 179' ' ' THR . 37.1 Cg_endo -67.85 142.62 58.05 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.373 2.049 . . . . 0.0 111.405 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.93 11.53 13.92 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.99 136.75 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.57 121.88 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.6 m -69.84 146.92 50.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.289 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.1 p -96.49 19.65 11.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.496 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 57.9 t -122.85 105.04 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.76 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.54 111.13 51.03 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 25.5 Cg_exo -63.72 153.58 74.45 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.807 2.338 . . . . 0.0 110.892 173.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -78.98 77.03 5.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.124 0.964 . . . . 0.0 110.8 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -91.22 158.28 16.69 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.63 48.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.088 0.471 . . . . 0.0 110.367 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -90.41 0.38 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.218 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -72.16 139.05 48.07 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.454 ' HB2' ' SG ' ' A' ' 305' ' ' CYS . 10.5 mt -112.42 149.27 32.79 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.798 -170.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -107.03 129.57 54.78 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.52 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -116.08 115.15 48.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.909 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.87 175.38 15.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.5 -1.2 83.85 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.442 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.46 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.2 mt -64.35 127.73 92.48 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.35 149.1 92.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.893 2.395 . . . . 0.0 111.757 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 -18.08 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.529 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -92.76 1.15 57.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.1 mt -112.13 119.73 39.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.032 0.444 . . . . 0.0 109.935 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -104.54 -178.5 3.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.566 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER -40.31 -48.66 2.69 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.77 0.668 . . . . 0.0 112.561 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -65.26 -45.58 83.96 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.05 -49.52 72.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.478 . . . . 0.0 110.652 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 83.0 t -63.94 -33.79 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.341 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 24.9 mtmm -53.19 -46.73 69.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.496 0.188 . . . . 0.0 111.078 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.54 -43.96 76.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.008 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.27 -43.89 89.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.81 -44.35 73.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 34.6 p -62.74 -12.21 22.56 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.7 m -55.61 -35.35 65.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.715 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -90.4 -41.96 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 110.693 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.91 167.79 39.37 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -77.95 155.8 30.35 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 66.5 mt -106.02 134.48 49.07 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.778 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -77.3 -31.87 54.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.76 127.19 10.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.484 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 29.3 t80 -138.48 114.48 10.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.487 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -120.95 107.49 12.74 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 10.0 tt -86.9 123.68 32.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.88 111.19 13.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.436 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.2 165.44 11.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.741 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.3 t70 -98.82 133.72 42.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.7 m -78.04 -15.4 58.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.335 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.94 -44.91 10.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.8 p -89.2 -25.92 21.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.188 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.99 13.98 82.65 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.526 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.9 162.65 16.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 111.303 -172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.3 m -71.87 123.15 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.146 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -63.75 -30.06 71.2 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 109.09 25.12 5.72 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.74 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 19.2 p90 -155.08 144.35 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.11 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.97 169.95 19.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.567 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 97.5 m-85 -126.37 131.14 51.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.868 176.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.484 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 21.8 p -129.03 158.95 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.618 0.247 . . . . 0.0 110.668 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.54 125.21 15.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -81.59 156.73 25.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.48 -51.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.683 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.04 153.94 17.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 110.326 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 311' ' ' ASN . 2.9 pp -85.14 -22.37 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.17 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.43 ' N ' HD11 ' A' ' 310' ' ' ILE . 8.0 p30 -79.76 -28.7 40.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.557 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -17.79 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.981 0.419 . . . . 0.0 110.448 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 m -55.91 -52.17 65.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.225 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.14 -19.32 51.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -77.48 -35.91 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.99 -52.53 16.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.731 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.438 HG23 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -60.69 -21.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.013 0.435 . . . . 0.0 111.091 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.12 83.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.46 -34.67 4.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.301 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.77 -33.55 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.679 0.276 . . . . 0.0 111.628 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -68.81 122.92 19.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.01 10.23 60.02 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.846 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.418 ' SD ' HD22 ' A' ' 325' ' ' LEU . 33.4 ttm -59.62 116.44 4.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.619 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.62 85.19 6.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.418 HD22 ' SD ' ' A' ' 323' ' ' MET . 0.2 OUTLIER -103.06 129.85 50.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.25 -118.51 8.02 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.142 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.98 1.82 12.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.927 0.394 . . . . 0.0 110.904 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -110.05 172.58 6.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -117.13 119.77 36.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.06 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.6 145.36 50.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.447 0.641 . . . . 0.0 112.029 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.1 tm? -91.4 120.18 32.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.801 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.438 HG12 HG23 ' A' ' 317' ' ' ILE . 41.3 t -129.24 108.93 17.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.558 . . . . 0.0 109.507 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -145.27 161.41 39.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.691 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -64.12 136.36 57.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -70.54 -14.43 62.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.274 0.559 . . . . 0.0 109.994 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.1 p -88.15 -7.45 56.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.69 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 19.4 m 37.52 40.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.182 1.393 . . . . 0.0 113.412 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -176.31 171.15 44.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.52 18.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.028 0.414 . . . . 0.0 111.036 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 69.62 -54.97 0.59 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.837 0.711 . . . . 0.0 110.517 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -152.14 -52.58 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.348 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.023 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . 8.3 t . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 120.764 0.316 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -59.59 -54.32 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 110.068 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -87.9 -11.45 47.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.57 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 145' ' ' THR . . . -83.72 -33.24 25.15 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.055 0.455 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 96.7 mtt180 -92.95 4.58 53.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 22.8 ttp180 -126.2 129.94 49.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 110.943 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -114.04 153.17 29.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.108 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 59.5 t80 -84.96 119.67 25.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.434 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.65 124.15 57.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.541 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.26 177.87 16.78 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.905 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 223' ' ' SER . 4.9 t-20 66.02 30.97 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.784 0.802 . . . . 0.0 109.967 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.67 154.44 37.17 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.184 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.02 130.84 12.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.518 2.145 . . . . 0.0 111.259 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.33 108.79 2.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.107 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.52 3.31 7.92 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.585 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.36 145.6 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.082 0.467 . . . . 0.0 110.192 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.2 m -105.32 154.19 20.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.397 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.93 -58.65 4.13 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.477 0.486 . . . . 0.0 111.465 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.11 -35.86 67.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.892 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.89 -56.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.021 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 32.6 ttm -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.7 ttt -59.02 -56.89 16.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.086 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -37.44 81.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.49 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.642 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.4 m-85 -60.5 -51.8 67.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.63 -39.97 88.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -55.75 -42.46 75.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.072 0.463 . . . . 0.0 110.603 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.29 -45.96 78.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.22 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 68.5 mm-40 -59.25 -41.15 88.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.386 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.604 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -56.7 -42.66 79.5 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.875 0.369 . . . . 0.0 111.046 176.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -66.14 -41.66 90.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 58.7 mt -64.86 -49.94 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.293 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.62 0.09 86.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.906 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.3 37.84 91.09 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.771 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HB3' ' NE2' ' A' ' 210' ' ' GLN . 66.5 mt -93.67 -31.17 14.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.581 0.229 . . . . 0.0 110.386 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.27 108.4 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.278 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -85.71 -29.25 24.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.028 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.0 148.95 38.44 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.619 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.13 157.06 61.66 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.246 1.964 . . . . 0.0 111.901 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.68 -147.55 18.64 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.593 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -102.29 119.52 56.14 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.861 0.363 . . . . 0.0 111.0 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -32.9 34.12 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.911 2.407 . . . . 0.0 112.227 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.73 128.8 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.92 -45.14 7.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.697 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.01 143.54 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.789 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.05 131.42 63.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.26 118.91 32.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.69 118.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.212 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.4 p90 . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.68 170.82 15.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 74.6 m-85 -127.84 134.47 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.5 mt -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.25 131.3 48.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.202 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.582 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 45.8 m-85 -110.65 156.99 20.21 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.658 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -74.5 -19.65 60.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.19 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 m -141.89 135.75 29.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.04 -31.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -70.78 -31.35 68.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.372 . . . . 0.0 110.419 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.411 ' HA ' ' NE2' ' A' ' 210' ' ' GLN . 53.2 mt-10 -78.63 -20.15 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 109.95 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.4 m -75.59 -48.67 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.945 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -63.77 -31.63 72.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.925 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.444 ' NE2' ' HB3' ' A' ' 178' ' ' LEU . 11.2 pt20 -74.39 -18.1 60.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.595 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.07 -22.58 58.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 109.611 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 226' ' ' ILE . 14.5 mtt -71.29 -17.65 62.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.589 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.53 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.492 ' O ' HG22 ' A' ' 217' ' ' ILE . 10.1 m-85 -81.57 4.12 22.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.577 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.07 106.64 2.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.843 0.354 . . . . 0.0 110.713 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.23 5.58 57.09 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.194 -0.526 . . . . 0.0 112.7 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 214' ' ' PHE . 11.3 tt -96.84 153.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.882 0.372 . . . . 0.0 110.648 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 36.4 mm -108.13 100.53 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.3 m-85 -102.07 108.73 20.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.731 0.3 . . . . 0.0 110.573 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.54 36.34 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.225 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.01 -13.57 66.86 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.916 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.0 pt20 -99.4 138.94 35.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.584 0.692 . . . . 0.0 110.267 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.407 ' HB3' ' OD1' ' A' ' 155' ' ' ASN . 21.6 t -96.5 126.03 41.41 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.95 132.33 51.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.53 125.57 48.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.6 mp -128.62 126.44 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 32.3 tpt180 . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.415 HG11 ' HE2' ' A' ' 276' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.233 0.54 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 28.3 m -83.15 149.45 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.7 p -92.9 19.55 7.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 111.318 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.77 113.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.221 0.534 . . . . 0.0 110.53 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 304' ' ' PHE . 21.4 t -107.98 108.19 61.07 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.54 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.89 152.12 82.32 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.923 2.415 . . . . 0.0 111.796 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.92 79.48 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.861 0.838 . . . . 0.0 109.945 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.0 p -87.05 -176.44 5.72 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.379 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -81.67 1.06 35.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -123.76 30.82 6.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.263 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -70.63 133.71 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.008 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.87 142.01 51.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.466 ' HE1' HD23 ' A' ' 331' ' ' LEU . 55.1 t80 -118.38 130.06 55.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.067 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.408 ' CG2' HD21 ' A' ' 266' ' ' LEU . 2.3 mp -117.6 126.8 74.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -130.54 168.65 21.61 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.04 5.91 60.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.379 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 275' ' ' VAL . 78.4 mt -71.48 132.73 85.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.921 0.391 . . . . 0.0 111.881 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 34.2 Cg_exo -59.31 134.55 59.58 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.876 2.384 . . . . 0.0 111.858 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.08 -22.47 64.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.238 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -90.54 4.84 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.79 139.19 49.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.707 0.289 . . . . 0.0 110.351 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -105.65 -177.77 3.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.81 -41.96 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.326 0.391 . . . . 0.0 111.648 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.59 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 33.1 t70 -63.07 -47.97 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 0.0 111.353 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -65.53 -40.81 93.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.727 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 266' ' ' LEU . 77.5 t -68.41 -30.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.795 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 273' ' ' ASP . 6.9 mtmp? -53.26 -39.51 63.94 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.453 0.168 . . . . 0.0 111.293 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -52.75 -34.95 55.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.761 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.31 -40.48 62.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.88 -38.43 53.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.069 0.461 . . . . 0.0 111.042 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 25.2 p -65.92 -12.49 55.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.043 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.9 m -52.63 -34.21 50.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.166 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -100.58 -40.83 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.9 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.86 162.0 35.51 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.207 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -76.84 160.1 34.25 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.962 2.441 . . . . 0.0 112.28 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 305' ' ' CYS . 77.5 mt -110.44 136.58 49.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 306' ' ' GLU . 18.9 ptpt -80.18 -27.92 38.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.675 0.75 . . . . 0.0 109.008 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -153.86 124.58 7.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.188 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 17.1 t80 -139.13 112.72 8.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.019 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -118.73 115.91 25.47 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.415 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.07 123.47 38.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.9 t -82.25 106.03 12.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.751 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -95.31 159.41 15.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.347 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.473 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 8.7 t70 -94.87 133.47 38.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.0 m -72.36 -18.37 61.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.382 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.42 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 82.5 p -99.44 -28.31 13.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 74.84 15.68 80.76 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.58 157.65 39.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 111.298 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.5 m -65.08 123.06 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.442 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -68.4 -18.77 64.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.406 . . . . 0.0 110.646 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 106.45 26.4 5.94 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.76 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.24 148.02 21.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.503 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.54 170.12 19.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.81 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.491 ' O ' HG21 ' A' ' 254' ' ' VAL . 98.1 m-85 -125.83 136.55 53.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.66 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 19.6 p -133.97 166.68 22.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.878 0.37 . . . . 0.0 110.897 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 286' ' ' LYS . 10.6 tt0 -143.62 120.29 11.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -74.36 147.24 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.376 0.608 . . . . 0.0 110.886 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.49 -30.26 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.858 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -116.41 151.61 35.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 310' ' ' ILE . 2.9 pp -84.05 -21.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.65 -41.46 60.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.46 -18.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.815 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 50.5 m -52.93 -56.82 13.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.338 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.99 -22.45 36.56 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.152 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -74.06 -34.68 64.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.962 0.411 . . . . 0.0 111.001 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.15 -50.9 17.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 HG12 ' A' ' 332' ' ' VAL . 2.6 pp -61.42 -21.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.084 0.468 . . . . 0.0 110.733 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.49 86.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.023 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.34 -33.84 5.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.169 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.67 -35.85 75.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.794 0.297 . . . . 0.0 111.579 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -68.26 109.59 3.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.453 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.3 3.71 29.22 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 46.3 ttm -61.64 115.32 3.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.724 0.297 . . . . 0.0 110.37 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.0 OUTLIER -85.54 90.53 8.0 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.89 119.76 40.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.12 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.82 -110.76 3.61 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.868 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -106.55 -13.5 15.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -114.23 147.96 38.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 47.1 mtpt -93.01 120.83 33.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 164.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.49 129.24 37.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.188 0.518 . . . . 0.0 110.879 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 262' ' ' PHE . 23.5 tp -88.53 124.82 34.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 317' ' ' ILE . 65.9 t -131.15 108.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.17 143.65 31.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.47 -168.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -69.81 117.63 11.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.122 0.487 . . . . 0.0 110.61 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.915 -175.788 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 13.6 t . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NE ' ' HG3' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -60.99 -22.71 64.76 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.23 -0.294 . . . . 0.0 111.57 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HG3' ' NE ' ' A' ' 146' ' ' ARG . 82.1 mt-30 -87.3 -35.36 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.012 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.46 -31.85 67.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.902 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 145' ' ' THR . 34.0 mtm180 -80.62 2.23 26.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.686 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 34.4 ttp180 -122.02 130.54 53.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.304 0.573 . . . . 0.0 111.652 -172.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 212' ' ' MET . 3.9 pp -118.48 154.24 32.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.077 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.8 t80 -81.45 124.4 29.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.607 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG21 HD23 ' A' ' 200' ' ' LEU . 44.0 t -112.43 131.34 64.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 110.738 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.29 177.85 16.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.945 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.81 38.15 2.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.462 0.649 . . . . 0.0 110.359 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.3 pt -109.25 150.94 41.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.69 130.82 9.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.766 2.311 . . . . 0.0 111.641 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.48 118.89 10.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.39 -2.93 22.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.535 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.48 146.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 110.229 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 m -105.18 156.64 17.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 189' ' ' VAL . 24.8 mt-10 -47.51 -59.51 3.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.434 0.459 . . . . 0.0 111.715 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.88 -21.37 66.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.253 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.62 -53.12 30.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.299 0.571 . . . . 0.0 110.284 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.7 ttm -75.79 -33.96 60.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.102 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 14.5 ttt -59.55 -46.47 88.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.535 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.36 -44.51 88.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.449 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.1 m-85 -62.12 -55.66 26.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.707 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -58.71 -43.01 89.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.532 0.206 . . . . 0.0 111.368 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -59.82 -33.75 72.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.388 . . . . 0.0 111.18 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -79.16 -34.56 43.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.381 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 25.8 mm-40 -62.52 -37.76 87.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.868 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.5 -35.48 76.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 0.0 111.022 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.464 ' HD2' ' OG1' ' A' ' 179' ' ' THR . 28.2 mmm180 -78.41 -23.8 46.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.1 mt -76.73 -41.84 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.34 -5.55 75.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.636 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.43 36.05 83.16 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.859 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.94 -22.15 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.718 0.294 . . . . 0.0 110.772 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.71 108.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.325 -178.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -87.88 -33.11 18.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.614 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -106.85 151.17 40.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.805 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 148.86 81.35 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.504 2.136 . . . . 0.0 111.938 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.09 -144.9 17.39 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.608 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.14 124.79 38.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.709 0.29 . . . . 0.0 111.118 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.516 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 41.2 Cg_endo -67.04 -29.51 40.15 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.153 2.569 . . . . 0.0 113.135 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.36 134.47 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.231 0.539 . . . . 0.0 110.86 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.5 mt -89.77 -49.37 6.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.134 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.14 171.26 19.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 0.2 OUTLIER -143.87 139.57 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.14 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -122.53 127.93 50.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.606 0.241 . . . . 0.0 110.786 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.68 127.56 63.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.011 -178.79 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -132.36 170.96 14.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.055 0.455 . . . . 0.0 111.087 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.44 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . 73.0 m-85 -127.3 133.44 50.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.922 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -109.78 129.32 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.3 130.12 56.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 0.0 110.499 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.646 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.4 m-85 -108.53 165.57 11.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.124 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.4 ptt180 -80.75 -18.93 46.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.276 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.9 m -138.7 132.69 31.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.156 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.6 -28.11 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.15 -32.6 72.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.361 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.409 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 53.2 mt-10 -82.66 -20.89 35.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.205 0.526 . . . . 0.0 110.039 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 98.0 m -71.21 -51.32 25.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 173.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.7 t -60.0 -37.63 80.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.662 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.409 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 14.0 pt20 -71.88 -19.65 61.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.4 -28.73 52.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 110.075 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.406 ' HG2' HD22 ' A' ' 151' ' ' LEU . 28.0 mtp -71.63 -14.38 62.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.079 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.2 -22.64 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.861 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.8 m-85 -76.91 2.82 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.999 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.09 106.68 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.99 0.424 . . . . 0.0 110.735 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.44 37.36 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.725 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -108.33 153.36 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.868 0.366 . . . . 0.0 110.523 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.0 mm -105.95 101.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.728 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.3 m-85 -112.82 129.57 56.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.477 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 60.81 21.5 11.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 111.48 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 90.54 -11.63 70.92 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.959 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.728 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.5 pt20 -97.31 140.83 31.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.031 0.416 . . . . 0.0 110.277 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.7 t -93.97 118.41 31.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.23 128.92 38.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.26 122.82 40.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.885 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.5 mp -128.03 125.77 65.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.919 0.39 . . . . 0.0 110.027 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 . . . . . 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.739 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.522 HG11 ' HD3' ' A' ' 276' ' ' LYS . 21.9 t . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 14.7 m -76.49 146.92 38.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.641 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 18.78 9.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.44 121.93 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.5 t -109.58 104.86 56.31 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.545 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.82 169.6 8.51 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.485 2.79 . . . . 0.0 112.218 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.6 79.92 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.72 . . . . 0.0 110.03 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.6 t -91.8 151.85 20.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.328 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.98 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.345 0.593 . . . . 0.0 110.063 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -113.78 31.88 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.367 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -68.07 141.09 56.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 16.3 mt -122.68 143.37 49.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.98 0.419 . . . . 0.0 111.635 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 331' ' ' LEU . 22.7 t80 -117.89 132.38 56.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.855 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 331' ' ' LEU . 2.5 mp -120.0 116.6 50.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.466 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -112.22 -176.89 19.96 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.1 69.75 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.147 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.497 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.1 mt -62.93 130.16 93.81 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.29 144.84 98.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.794 2.329 . . . . 0.0 111.285 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -67.16 -18.6 65.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -92.25 -8.8 44.27 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.773 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.82 128.3 43.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.9 -175.77 2.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.9 p-10 -50.67 -41.1 55.24 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.185 0.303 . . . . 0.0 111.082 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 19.2 t70 -70.79 -32.9 70.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.99 0.424 . . . . 0.0 111.495 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -79.67 -41.77 26.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.065 0.46 . . . . 0.0 110.441 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.83 -29.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 25.5 mtmm -50.69 -40.26 53.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.009 0.433 . . . . 0.0 110.845 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.94 -21.68 66.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.39 -32.01 19.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 110.264 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.4 -28.98 28.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.143 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.1 p -67.97 -12.2 60.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 16.8 m -50.57 -40.25 51.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.961 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.66 -39.12 10.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.15 155.69 27.21 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.994 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.0 Cg_endo -72.16 155.94 56.06 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.04 1.827 . . . . 0.0 111.865 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 250' ' ' VAL . 78.7 mt -102.48 138.3 39.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.927 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 308' ' ' VAL . 0.1 OUTLIER -85.65 -24.4 27.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.44 0.638 . . . . 0.0 109.338 176.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.62 124.61 6.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.053 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 9.9 t80 -139.27 111.39 7.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.077 0.465 . . . . 0.0 110.246 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.95 108.34 17.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.536 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -99.24 133.96 42.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.5 t -94.13 109.78 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 58.8 mtpt -90.09 164.5 14.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.212 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.558 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -104.34 127.49 52.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.886 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 t -76.65 -11.95 59.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.31 -31.37 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.629 0.252 . . . . 0.0 111.372 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 69.7 p -93.46 -27.69 16.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.028 0.442 . . . . 0.0 111.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.22 14.17 82.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.03 -172.97 2.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.254 -0.473 . . . . 0.0 109.764 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 61.4 m -81.94 147.18 29.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.174 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.26 -19.5 56.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.107 0.479 . . . . 0.0 110.381 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 96.68 27.38 9.74 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.753 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 14.4 p90 -154.13 144.08 21.88 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.275 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.06 19.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.337 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 92.9 m-85 -128.14 133.18 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.396 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 29.5 p -130.05 166.11 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.265 0.555 . . . . 0.0 111.251 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.66 125.79 21.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.715 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -80.86 154.88 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 286' ' ' LYS . 46.5 t -68.09 -35.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.955 -175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.81 158.02 28.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.073 0.463 . . . . 0.0 110.263 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.89 -19.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.511 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 -30.11 57.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.55 -26.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.321 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.464 HG23 HD21 ' A' ' 261' ' ' LEU . 15.6 m -54.62 -53.48 54.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.481 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.34 -31.04 68.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.14 -36.5 72.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.83 -52.79 10.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.183 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.461 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -59.61 -25.28 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.493 . . . . 0.0 110.705 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.18 -45.21 81.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.455 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.11 -27.36 7.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.612 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.12 -36.27 40.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.984 0.392 . . . . 0.0 111.703 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.7 t30 -68.26 112.13 4.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.68 5.14 26.09 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.745 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 40.7 ttm -62.39 115.25 4.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 0.0 110.198 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.48 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 8.7 tm0? -85.06 96.55 9.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 111.28 22.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.538 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.54 -109.47 2.8 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.341 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.82 6.4 11.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.925 0.393 . . . . 0.0 111.176 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -120.74 149.08 43.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.774 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.48 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 42.6 mtpt -98.66 119.61 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.39 134.06 45.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.443 0.64 . . . . 0.0 111.388 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -88.16 121.49 30.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 53.3 t -130.48 107.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -147.68 160.67 42.43 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.899 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.66 130.65 40.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 121.318 0.58 . . . . 0.0 110.122 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.368 0.604 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' HD2' ' HG2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -66.84 -31.03 71.38 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.014 -0.429 . . . . 0.0 111.081 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' HG2' ' HD2' ' A' ' 146' ' ' ARG . 10.9 mm100 -87.51 -5.69 58.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.904 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.03 12.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.906 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 83.5 mtt180 -79.43 -6.12 56.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.95 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 18.4 mtm180 -110.37 150.91 28.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.14 0.495 . . . . 0.0 111.1 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 226' ' ' ILE . 2.5 pp -135.06 153.09 52.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.967 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -82.03 110.3 17.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.674 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 51.1 t -96.55 116.19 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.306 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.51 171.72 14.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.468 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 225' ' ' LYS . 8.4 t-20 62.36 55.33 2.35 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.809 0.814 . . . . 0.0 109.451 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.0 pt -112.42 147.67 37.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.476 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 57.1 Cg_endo -80.26 130.79 8.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.711 2.274 . . . . 0.0 111.318 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.73 124.95 22.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.253 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.32 -0.67 53.87 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.134 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.437 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 16.1 tt -60.88 144.69 13.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 110.202 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 m -96.98 150.0 21.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.18 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.488 ' HB3' HG13 ' A' ' 189' ' ' VAL . 42.1 mt-10 -48.1 -59.87 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 166' ' ' MET . 8.4 pt-20 -66.16 -15.72 63.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.72 -58.32 4.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.0 ptp -76.17 -29.84 57.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.128 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.44 ' HB2' HG11 ' A' ' 189' ' ' VAL . 21.0 ttt -60.07 -54.93 40.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.37 -36.59 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.2 m-85 -60.0 -52.23 66.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.283 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -64.85 -38.82 92.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.206 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -59.69 -40.28 87.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.16 -49.69 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.93 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 70.0 mm-40 -60.47 -33.47 72.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.156 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 8.4 mmt -61.63 -41.87 98.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -72.15 -38.62 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.232 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 72.2 mt -63.68 -50.6 68.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.667 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.17 -10.13 86.45 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.571 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.16 40.08 56.78 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.479 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 22.0 mt -93.34 -24.33 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -58.38 114.72 2.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.956 0.407 . . . . 0.0 111.519 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.84 -34.3 15.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.107 0.479 . . . . 0.0 110.683 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -107.65 150.44 40.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.544 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.71 132.57 40.8 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.051 1.834 . . . . 0.0 111.489 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.97 -162.12 12.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.545 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.77 124.18 73.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.497 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 49.4 Cg_endo -70.83 -31.96 14.93 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.882 2.388 . . . . 0.0 111.957 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.78 116.73 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.8 tp -85.06 -45.12 12.4 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.381 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.01 165.44 32.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.196 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 162' ' ' GLU . 0.6 OUTLIER -145.09 131.04 14.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.673 178.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.44 121.23 38.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 162' ' ' GLU . 4.5 mp -97.22 111.0 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.45 ' HE2' ' CE1' ' A' ' 199' ' ' PHE . 8.7 p90 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.278 0.561 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -131.83 164.67 25.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.258 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 25.7 m-85 -124.11 123.97 41.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.724 0.297 . . . . 0.0 110.732 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 189' ' ' VAL . 66.2 mt -95.68 131.41 41.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 32.3 tt0 -107.03 141.7 37.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.855 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.407 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 65.0 m-85 -126.47 152.85 45.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.432 0.634 . . . . 0.0 111.581 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 39.3 ptt180 -78.05 -13.03 60.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.639 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 33.3 t -148.18 132.84 17.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.834 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.92 -24.24 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.608 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.29 -34.9 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.457 ' HA ' ' NE2' ' A' ' 210' ' ' GLN . 61.9 mt-10 -82.8 -21.82 34.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.095 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.6 m -65.67 -50.97 62.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.2 t -62.59 -36.86 84.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 111.687 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 178' ' ' LEU . 10.1 pt20 -76.06 -18.51 59.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.332 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.49 62.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.442 0.639 . . . . 0.0 109.631 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.544 ' HA ' HG21 ' A' ' 226' ' ' ILE . 31.0 mtp -68.89 -14.01 62.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.856 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.51 65.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.512 ' O ' HG22 ' A' ' 217' ' ' ILE . 13.1 m-85 -80.82 7.27 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.66 105.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.881 0.372 . . . . 0.0 111.387 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.71 59.58 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.196 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.7 tt -95.62 153.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 110.544 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.74 103.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 9.5 m-85 -102.88 111.96 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.734 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 59.61 30.97 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.321 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.71 -13.02 66.99 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.504 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 26.5 pt20 -94.89 137.82 33.46 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.778 0.789 . . . . 0.0 110.778 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.9 p -103.54 118.51 36.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.777 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.64 136.25 54.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 111.064 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 155' ' ' ASN . 47.5 mtmt -109.65 135.02 51.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.66 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 212' ' ' MET . 4.2 mp -121.44 105.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.258 0.552 . . . . 0.0 109.815 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.556 -178.626 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 276' ' ' LYS . 12.6 p . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.532 0.682 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 73.5 m -101.21 159.47 15.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.287 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 p -97.22 6.26 48.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.466 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 43.0 t -103.23 100.01 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.731 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.64 107.95 27.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.752 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 31.6 Cg_exo -60.24 169.59 4.89 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.424 2.749 . . . . 0.0 112.667 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.67 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' LYS . 26.7 t -69.24 155.77 39.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.949 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.7 -0.61 57.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.233 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -99.68 -6.36 27.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 257' ' ' SER . 23.7 pttp -72.43 154.94 40.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 334' ' ' ARG . 11.0 mt -128.99 150.58 50.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.235 -172.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -107.3 131.14 54.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.67 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.41 121.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.929 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.62 171.54 18.31 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.574 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.91 2.27 84.19 Favored Glycine 0 N--CA 1.454 -0.15 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.662 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.547 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.4 mt -66.41 136.98 95.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 17.0 Cg_exo -67.22 145.27 71.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.786 2.324 . . . . 0.0 111.386 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 3.0 m-20 -65.53 -20.98 66.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.633 -174.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -90.51 1.4 56.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.1 mt -113.53 122.27 46.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -93.01 -175.93 4.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.986 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 290' ' ' LEU . 3.9 p30 -47.54 -48.17 27.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 29.0 t70 -63.35 -46.99 84.02 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -70.2 -28.97 65.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.27 -38.38 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.439 0.638 . . . . 0.0 110.382 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.642 ' HB2' ' CD1' ' A' ' 288' ' ' PHE . 15.7 ttpp -60.92 -30.67 70.33 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.68 -30.42 68.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.081 0.467 . . . . 0.0 110.689 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.86 -31.74 35.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.92 -34.99 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.547 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.8 p -71.19 -12.25 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.036 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.0 m -50.51 -43.2 55.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.077 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -86.17 -41.28 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.599 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.55 154.91 26.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.055 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 280' ' ' THR . 30.7 Cg_endo -71.95 155.44 57.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.138 1.892 . . . . 0.0 112.252 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 276' ' ' LYS . 81.8 mt -104.26 140.64 37.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.692 -176.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -84.75 -25.27 28.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -155.26 127.83 7.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.941 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 276' ' ' LYS . 17.2 t80 -138.73 108.91 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -114.83 111.69 21.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 272' ' ' ASP . 9.7 tt -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.14 116.97 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -102.71 168.2 9.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.131 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.5 130.09 47.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 13.3 m -75.43 -12.71 60.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.573 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.42 12.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.4 p -89.07 -27.85 20.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.204 0.526 . . . . 0.0 111.185 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.15 9.17 86.44 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 56.1 mt -121.23 -179.47 4.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.652 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.8 m -80.34 146.95 31.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.143 0.497 . . . . 0.0 111.435 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.56 -24.85 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.778 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 107.75 27.0 5.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.327 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.86 139.0 18.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 117.465 0.632 . . . . 0.0 110.921 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -150.02 169.51 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.537 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.18 134.86 50.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.664 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 261' ' ' LEU . 23.0 p -127.79 165.18 20.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -147.98 129.35 14.8 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -84.94 163.74 18.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 0.0 111.547 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.79 -23.67 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.846 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.04 157.35 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.875 0.369 . . . . 0.0 110.082 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.37 -29.0 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.397 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.04 -27.0 62.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.543 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.461 HG21 ' HA3' ' A' ' 283' ' ' GLY . 14.9 p -84.17 -18.39 9.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.99 0.424 . . . . 0.0 110.713 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 37.0 m -61.98 -47.98 82.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.99 -24.66 43.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.78 -32.54 59.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.32 -53.44 12.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.114 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -60.37 -21.69 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 110.878 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.03 -37.43 69.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.369 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.64 -36.78 3.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.32 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.25 -34.58 65.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -66.08 117.28 8.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.66 8.56 45.65 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' A' ' 330' ' ' LEU . 48.0 ttm -64.35 116.0 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 110.317 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 86.09 7.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.16 112.62 25.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.23 -112.01 3.75 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.638 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.94 -14.1 10.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -113.32 168.42 9.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.51 124.87 50.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.674 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 323' ' ' MET . 13.9 mt -74.03 138.13 43.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.129 -173.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.9 124.18 35.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.698 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 317' ' ' ILE . 41.9 t -130.54 113.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 335' ' ' ALA . 22.6 pt20 -137.69 168.14 20.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.447 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.605 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 mmm180 -74.56 34.61 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.951 0.5 . . . . 0.0 112.103 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 333' ' ' GLN . . . . . . . . 0 C--N 1.316 -0.886 0 O-C-N 124.843 1.339 . . . . 0.0 113.419 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -65.97 -17.96 65.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.147 -0.346 . . . . 0.0 111.331 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -87.31 -19.05 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.743 0.306 . . . . 0.0 110.788 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.99 -29.48 14.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 110.372 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.07 -6.16 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.855 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 40.0 ttp180 -114.28 130.11 56.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.034 0.445 . . . . 0.0 110.943 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.18 154.21 31.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.643 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 54.1 t80 -83.7 118.37 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.373 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG21 HD12 ' A' ' 200' ' ' LEU . 23.1 t -104.2 132.6 50.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.73 176.66 17.9 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.831 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 68.28 30.58 5.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.443 0.639 . . . . 0.0 110.589 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.1 pt -92.65 150.24 39.38 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.82 134.1 17.71 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.502 2.134 . . . . 0.0 111.332 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -62.05 113.92 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.6 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 110.44 2.03 29.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.641 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.454 HD13 ' HE2' ' A' ' 165' ' ' MET . 18.7 tt -57.66 146.23 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.211 0.529 . . . . 0.0 110.39 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.6 m -102.28 152.15 21.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.411 ' HA ' HD11 ' A' ' 191' ' ' ILE . 38.1 mt-10 -48.93 -58.6 4.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.515 0.509 . . . . 0.0 110.98 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.52 -37.16 72.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.885 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.28 -57.8 11.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.758 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.454 ' HE2' HD13 ' A' ' 160' ' ' ILE . 33.3 ttm -67.79 -39.54 84.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.502 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 189' ' ' VAL . 15.6 ttt -60.01 -56.74 17.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.675 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.82 -38.39 85.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.053 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 1.4 m-85 -59.99 -57.81 11.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.972 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.451 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -60.36 -42.38 95.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 110.749 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.65 -44.12 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 8.2 mm100 -62.74 -37.69 87.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.324 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 179' ' ' THR . 10.3 mmt -55.82 -42.92 76.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.921 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -75.79 -33.61 60.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.726 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 92.7 mt -62.81 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.47 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.86 -16.03 68.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.468 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.97 37.22 26.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.06 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.494 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 17.6 mt -90.33 -26.96 19.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 0.0 110.66 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -59.53 108.77 0.77 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 111.762 -176.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.78 -33.22 25.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.6 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -108.68 154.47 41.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.509 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 14.2 Cg_exo -69.8 143.93 52.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.608 2.205 . . . . 0.0 111.544 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.02 -151.85 16.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.369 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 93.6 m-20 -98.23 117.01 65.43 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_endo -61.3 -35.43 84.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.427 2.084 . . . . 0.0 111.534 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -78.76 131.5 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.525 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 tp -98.9 -40.8 7.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.812 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.64 150.16 27.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.788 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.481 HG22 HD23 ' A' ' 200' ' ' LEU . 7.3 t -126.26 125.75 68.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.627 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -118.3 112.14 19.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.444 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 191' ' ' ILE . 4.2 mp -104.62 104.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.717 -179.329 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.428 ' HE1' ' CE2' ' A' ' 199' ' ' PHE . 15.2 p90 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 120.834 0.35 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 160.1 39.68 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.428 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 54.0 m-85 -117.76 122.59 43.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.614 174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 14.2 mt -103.93 110.22 22.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.902 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -93.92 126.36 39.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.519 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 50.1 m-85 -103.03 165.11 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -84.65 -15.65 44.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.474 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 m -148.24 136.96 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.07 -30.32 49.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.114 0.483 . . . . 0.0 110.512 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 209' ' ' THR . 4.9 m-20 -64.29 -36.23 83.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.11 -21.14 40.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.378 0.608 . . . . 0.0 109.924 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 85.9 m -70.1 -48.61 56.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.151 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 206' ' ' ASP . 14.9 t -62.5 -36.1 81.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.966 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.62 -18.38 60.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.729 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.8 59.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.477 0.656 . . . . 0.0 109.552 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 10.4 mtt -67.75 -17.33 64.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.961 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.36 63.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 217' ' ' ILE . 11.8 m-30 -77.51 -2.86 37.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.624 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.96 106.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 0.0 110.513 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.21 4.33 59.85 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.569 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.467 HD13 ' CZ ' ' A' ' 219' ' ' PHE . 7.9 tt -92.31 156.74 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.05 99.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.284 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.731 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.4 m-85 -104.5 122.82 46.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.374 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 61.59 20.08 10.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 111.383 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 93.46 -11.15 72.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.082 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.731 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 19.9 pt20 -94.98 142.95 26.88 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.336 0.589 . . . . 0.0 110.288 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.1 p -103.51 124.39 48.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.557 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.5 mt -108.34 136.77 47.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -120.99 126.68 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.866 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.01 125.5 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 12.7 tpt180 . . . . . 0 C--N 1.32 -0.678 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 12.9 m -63.92 129.22 39.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.626 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.5 p -89.28 4.22 49.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.411 0.624 . . . . 0.0 110.626 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 3.5 p -107.52 104.45 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.836 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.62 109.63 39.88 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.73 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.8 Cg_exo -60.73 144.79 99.6 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.856 2.371 . . . . 0.0 111.066 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.53 90.62 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.723 0.773 . . . . 0.0 110.627 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.7 m -96.06 168.89 10.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.585 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.89 57.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.14 0.495 . . . . 0.0 110.701 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -111.47 27.79 9.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.868 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -55.45 144.86 24.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.709 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 313' ' ' THR . 14.8 mt -122.36 134.45 54.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -111.6 125.81 54.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.752 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.6 mp -113.32 114.09 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.64 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -120.5 -177.79 15.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.1 89.41 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.365 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.474 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 95.7 mt -69.01 130.67 91.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.963 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.17 139.43 85.67 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.764 2.309 . . . . 0.0 111.226 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.88 -1.2 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -103.12 -6.43 22.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.3 mt -96.84 128.61 43.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -104.56 -177.18 3.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 5.5 p-10 -48.71 -43.29 37.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -60.16 -44.4 95.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.616 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.7 -42.05 51.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.455 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.58 -28.63 43.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.687 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 50.2 mtmt -56.01 -33.77 65.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 110.997 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.81 -30.49 70.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.058 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.34 -40.82 29.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 0.0 110.285 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 48.0 mt -76.0 -30.42 58.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.358 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 7.4 p -67.5 -13.62 62.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.6 m -55.54 -30.42 60.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.856 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -103.79 -40.72 6.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.597 0.237 . . . . 0.0 111.435 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.2 163.06 35.79 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.369 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -72.03 162.32 42.18 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.304 2.67 . . . . 0.0 112.058 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' A' ' 305' ' ' CYS . 85.1 mt -112.27 129.19 56.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.531 0.681 . . . . 0.0 111.34 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.437 ' HB2' HG12 ' A' ' 308' ' ' VAL . 15.5 tppt? -71.09 -46.4 61.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.765 175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -143.3 128.0 18.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.842 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 21.1 t80 -138.14 109.49 6.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.17 117.28 31.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.351 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.9 126.64 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.453 HG12 ' HD3' ' A' ' 300' ' ' LYS . 21.7 t -81.99 121.99 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.266 0.555 . . . . 0.0 110.667 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -115.02 145.66 42.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.546 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.555 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.6 t70 -89.84 140.57 29.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.9 t -85.67 -16.09 40.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.99 -40.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 0.0 110.977 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.9 p -85.56 -28.31 24.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 110.611 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.69 20.89 77.83 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.741 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.98 174.64 9.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.966 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 21.5 m -70.63 137.46 49.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.406 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.453 ' HD3' HG12 ' A' ' 291' ' ' VAL . 24.4 mtpp -86.05 -1.08 57.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.474 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 84.4 27.13 37.09 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.557 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 43.2 p90 -158.62 144.77 16.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.9 0.381 . . . . 0.0 110.308 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.11 168.45 23.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.033 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.58 128.68 48.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.62 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 24.4 p -124.15 158.84 31.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 110.963 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.09 110.2 10.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.697 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.34 137.57 50.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.986 0.422 . . . . 0.0 110.006 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 286' ' ' LYS . 4.5 m -60.57 -27.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.658 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 312' ' ' VAL . 13.8 m-20 -113.22 136.26 52.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.35 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.1 -14.08 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 111.306 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.59 -19.62 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.822 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 309' ' ' ASP . 11.0 p -87.51 -18.49 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 109.879 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.411 HG23 HD21 ' A' ' 261' ' ' LEU . 45.4 m -51.25 -51.62 52.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.885 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.02 -18.78 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.636 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -83.86 -31.84 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.03 -53.99 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.636 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.564 HG22 HG12 ' A' ' 332' ' ' VAL . 2.9 pp -58.23 -25.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.121 0.486 . . . . 0.0 110.912 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -66.87 -42.9 84.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.172 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.98 -30.54 6.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.477 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.13 -35.87 59.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.872 0.336 . . . . 0.0 111.409 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 55.7 t30 -65.39 112.21 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 0.0 110.218 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 107.26 2.25 35.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.371 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.6 ttm -65.75 116.5 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.25 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -81.51 87.14 6.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 110.63 21.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.865 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.03 -122.79 6.28 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.891 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -99.29 -13.65 19.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.784 0.326 . . . . 0.0 111.501 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -126.03 166.76 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.164 0.507 . . . . 0.0 111.64 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 51.8 mtpt -94.05 124.7 38.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.794 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.6 mt -72.23 129.84 39.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.11 120.19 30.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.409 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.564 HG12 HG22 ' A' ' 317' ' ' ILE . 61.0 t -130.82 108.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.285 0.565 . . . . 0.0 109.901 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -151.12 163.03 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.412 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.69 126.74 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.911 -176.807 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 15.1 t . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -19.71 65.76 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.968 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.21 -28.46 48.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.008 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.56 -32.37 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 145' ' ' THR . 24.0 mtm180 -72.47 -10.75 60.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.96 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 28.4 ttp180 -111.26 132.83 54.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.402 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 226' ' ' ILE . 3.9 pp -117.49 153.38 33.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.701 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -86.61 125.55 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.514 HG21 HD23 ' A' ' 200' ' ' LEU . 41.0 t -110.53 117.09 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 110.623 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.588 ' HA2' ' CD1' ' A' ' 197' ' ' PHE . . . -105.8 169.62 16.18 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.887 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.6 t30 66.89 50.06 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.632 0.729 . . . . 0.0 110.524 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 pt -116.37 150.82 46.06 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.494 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.43 131.02 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.857 2.371 . . . . 0.0 111.62 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -64.14 131.7 48.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.882 0.372 . . . . 0.0 110.162 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.95 8.41 58.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.641 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.5 tt -67.63 147.14 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -101.69 148.79 24.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -46.19 -59.09 3.1 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.679 0.391 . . . . 0.0 111.499 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.7 -34.24 64.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.281 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -57.07 12.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.67 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 4.6 ttm -69.31 -37.69 77.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.413 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.433 ' HG3' HG11 ' A' ' 186' ' ' VAL . 15.1 ttt -57.73 -49.43 76.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.227 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.44 -36.42 83.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.066 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.608 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.0 m-85 -59.26 -53.41 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.408 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -61.98 -41.67 98.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.265 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.07 -40.81 95.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.995 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -62.01 -43.41 98.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.916 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 56.0 mm-40 -64.13 -36.05 82.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.191 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 11.4 mmt -59.62 -42.15 92.04 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.211 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.88 -44.31 81.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.673 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 60.9 mt -62.58 -47.6 83.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.956 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.14 -24.23 72.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.312 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.99 30.33 17.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.813 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.537 ' HB3' ' OE1' ' A' ' 210' ' ' GLN . 23.4 mt -87.72 -17.89 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.51 106.41 0.46 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 111.854 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.33 -4.44 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.592 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.417 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . -89.49 132.46 37.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.49 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.13 131.35 36.31 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.144 1.896 . . . . 0.0 110.426 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 76.98 -140.05 24.31 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.229 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -92.84 126.86 50.0 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.986 0.422 . . . . 0.0 110.373 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 -30.42 67.34 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.163 2.576 . . . . 0.0 112.991 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 166' ' ' MET . 91.1 t -73.12 131.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 203' ' ' ARG . 47.5 tp -90.29 -42.43 10.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.44 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.35 168.05 24.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.35 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.29 136.64 28.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.044 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -125.01 118.13 25.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.549 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.86 125.68 55.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.139 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.588 ' CD1' ' HA2' ' A' ' 154' ' ' GLY . 44.9 m-85 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.781 0.324 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.08 172.24 11.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.397 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.8 139.81 51.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.509 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.514 HD23 HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -115.48 129.16 56.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.37 130.65 56.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.607 0.717 . . . . 0.0 111.133 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.592 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.6 m-85 -106.68 164.43 12.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.795 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 187' ' ' LEU . 14.7 ptt180 -68.06 -28.18 67.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.095 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 38.6 m -152.38 153.56 33.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.07 -30.12 47.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 209' ' ' THR . 2.6 m-20 -57.23 -45.44 83.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 202' ' ' PHE . 2.2 mm-40 -72.31 -32.28 66.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.569 0.7 . . . . 0.0 109.638 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 55.7 m -68.22 -47.2 68.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.537 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.2 t -64.85 -32.8 74.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.662 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.537 ' OE1' ' HB3' ' A' ' 178' ' ' LEU . 7.4 pt20 -75.52 -18.19 59.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.4 51.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.255 0.55 . . . . 0.0 109.816 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 226' ' ' ILE . 9.9 mtt -66.41 -15.31 63.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.411 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -27.11 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.03 0.443 . . . . 0.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 217' ' ' ILE . 27.2 m-85 -83.93 17.22 2.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.462 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.64 117.44 13.21 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.976 -0.453 . . . . 0.0 110.985 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.97 12.67 61.73 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.904 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 214' ' ' PHE . 15.5 tt -100.58 151.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.916 0.389 . . . . 0.0 110.669 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.74 101.72 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.398 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.69 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 13.7 m-85 -104.81 122.46 45.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.73 20.25 8.99 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.688 0.395 . . . . 0.0 112.006 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 98.02 -12.02 63.97 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.202 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.1 pt20 -99.21 138.32 36.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.03 0.415 . . . . 0.0 109.941 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.5 t -92.37 130.01 38.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.986 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.62 118.99 38.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.313 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -109.89 122.77 48.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.459 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.1 mp -119.93 118.82 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.799 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 177.215 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.834 0.349 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.8 m -71.34 146.34 48.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.782 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.0 p -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 110.305 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 61.2 t -97.64 100.66 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.124 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.596 HG12 ' HZ1' ' A' ' 260' ' ' LYS . 6.2 t -93.13 107.05 22.36 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.047 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.1 Cg_exo -58.38 149.18 75.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.336 2.69 . . . . 0.0 112.68 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.48 128.81 44.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.559 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 37.8 t -146.1 -178.72 6.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -78.92 -19.22 52.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 109.776 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -93.62 27.83 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.639 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HZ1' HG12 ' A' ' 254' ' ' VAL . 1.8 tmtm? -70.07 136.52 50.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.186 -176.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' N ' ' HD3' ' A' ' 260' ' ' LYS . 11.7 mt -121.96 149.19 43.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.947 0.403 . . . . 0.0 111.528 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -127.84 136.25 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.353 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 332' ' ' VAL . 2.1 mp -117.67 122.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.068 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.49 -179.55 15.88 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.31 1.17 90.38 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.457 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.0 mt -66.93 133.21 93.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.726 0.298 . . . . 0.0 111.617 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.78 143.42 99.62 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.935 2.424 . . . . 0.0 111.585 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -72.34 -5.67 37.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -102.03 0.67 35.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.7 133.86 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -105.2 -175.77 2.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.6 p-10 -51.83 -40.67 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.597 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.52 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 9.5 t70 -69.69 -39.19 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.675 0.274 . . . . 0.0 111.131 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.13 -37.53 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.195 0.522 . . . . 0.0 110.605 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.2 -30.97 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.81 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 27.2 mtmm -50.81 -41.85 57.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.531 0.205 . . . . 0.0 111.257 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -56.51 -35.58 68.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.504 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.33 -38.03 71.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.902 0.382 . . . . 0.0 110.552 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.2 mt -81.45 -31.31 33.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.281 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 38.1 p -72.78 -12.49 61.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 59.4 p -54.17 -41.51 68.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 111.531 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -87.59 -41.41 13.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 0.0 110.373 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -167.86 154.95 25.4 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.072 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 280' ' ' THR . 31.7 Cg_endo -72.77 156.96 52.64 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.447 2.098 . . . . 0.0 112.643 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.57 136.19 45.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.495 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -75.37 -30.14 60.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.453 176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.92 126.3 7.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.226 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.86 113.16 8.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.38 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -117.37 120.55 38.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.543 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -102.05 129.28 48.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.3 105.29 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.342 0.591 . . . . 0.0 110.82 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.51 164.34 14.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.56 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.47 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -100.55 130.56 46.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 37.9 m -81.79 -9.75 59.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.165 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.9 -40.65 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.966 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 68.2 p -88.21 -28.07 21.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 83.79 8.4 84.46 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.61 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 45.4 mt -118.33 159.42 23.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 111.001 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.8 m -71.62 127.01 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.675 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.92 -9.4 58.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 111.529 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 91.09 26.39 21.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.974 171.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -148.81 144.4 26.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.096 0.448 . . . . 0.0 110.034 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.44 170.78 17.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.4 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.17 135.81 52.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.763 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 13.9 p -134.9 159.12 42.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.718 0.294 . . . . 0.0 110.716 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 254' ' ' VAL . 73.0 mm-40 -133.36 128.85 36.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.645 173.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.75 144.12 26.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.296 0.569 . . . . 0.0 110.366 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.48 -32.9 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.493 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -121.46 157.01 31.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.33 -21.66 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.092 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -71.27 -31.94 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.034 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 283' ' ' GLY . 9.6 p -81.82 -23.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.509 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.3 m -54.73 -54.03 47.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.22 -23.26 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.278 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -34.3 53.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.812 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.26 -49.89 21.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.504 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -61.86 -21.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.644 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.2 60.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.243 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.79 -36.74 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.162 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 332' ' ' VAL . 63.9 mt -75.75 -33.71 60.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.637 0.256 . . . . 0.0 111.296 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.79 112.48 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.75 11.36 56.86 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.453 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.1 ttm -68.65 119.81 13.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 0.0 110.125 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.46 86.57 7.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.61 114.74 28.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.667 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.11 -122.06 6.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.704 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.12 -13.75 15.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 0.0 111.085 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -122.28 173.29 7.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -103.3 128.91 50.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.324 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.452 HD22 HD23 ' A' ' 266' ' ' LEU . 15.6 mt -75.15 129.57 37.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.4 tp -90.18 119.65 30.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.455 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 263' ' ' ILE . 65.0 t -130.51 109.03 16.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -146.5 177.32 9.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -69.43 130.99 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.193 -177.053 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -35.07 79.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.164 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.4 -11.6 55.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.3 -29.05 20.66 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -79.85 7.9 7.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.882 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 53.7 ttp180 -127.84 130.07 47.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.05 153.03 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.314 0.578 . . . . 0.0 111.945 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 47.8 t80 -82.06 111.32 18.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.43 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.35 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.64 161.68 12.94 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.475 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.7 49.44 0.39 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.744 0.783 . . . . 0.0 110.258 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 pt -104.14 151.04 38.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.13 132.28 7.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.977 2.452 . . . . 0.0 111.475 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -66.5 120.27 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.53 -1.18 18.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.16 143.78 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.0 m -100.58 157.82 16.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -52.53 -58.9 5.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.742 0.306 . . . . 0.0 110.653 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.68 -23.61 64.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.57 -58.47 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.791 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.401 ' O ' ' HD1' ' A' ' 169' ' ' PHE . 19.9 ptp -77.96 -24.53 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.946 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.446 ' HB2' HG21 ' A' ' 189' ' ' VAL . 20.0 ttt -61.62 -56.19 22.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.372 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.89 -31.47 72.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.069 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.622 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.1 m-85 -61.13 -54.26 46.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' MET . 44.8 m-85 -65.64 -42.89 90.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -55.99 -34.09 65.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -73.05 -49.84 26.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 81.2 mm-40 -56.26 -39.72 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.434 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -57.15 -42.06 80.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.097 0.475 . . . . 0.0 110.732 177.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -77.56 -27.48 51.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 76.7 mt -72.84 -36.8 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.61 -23.85 35.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.14 36.39 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.392 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.9 mt -94.88 -26.58 16.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.806 0.336 . . . . 0.0 110.535 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.34 112.32 1.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.105 -178.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -80.2 -37.62 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.226 0.536 . . . . 0.0 109.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.91 39.74 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.215 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.14 142.18 54.99 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.278 1.986 . . . . 0.0 111.629 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.01 -157.95 15.11 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.79 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -96.23 124.45 51.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.225 0.536 . . . . 0.0 110.946 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.468 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 40.8 Cg_endo -67.94 -29.56 34.25 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.984 2.456 . . . . 0.0 112.624 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.54 132.81 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.187 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.4 mt -89.62 -49.52 6.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.424 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.47 157.69 32.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.758 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.517 HG22 HD23 ' A' ' 200' ' ' LEU . 6.7 t -124.23 128.92 74.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.613 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.55 118.97 35.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.6 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.39 126.92 56.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.593 179.675 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.59 156.74 33.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.005 0.431 . . . . 0.0 110.59 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -127.14 124.19 38.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.948 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.4 mt -103.71 115.37 30.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.281 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -96.85 127.14 42.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.514 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 33.8 m-85 -109.39 158.63 17.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.2 ptt180 -74.1 -18.4 60.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.874 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.0 m -148.49 144.98 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.091 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.81 -36.5 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.302 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 209' ' ' THR . 20.4 t70 -64.46 -40.26 95.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 110.067 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.557 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.0 mt-10 -72.23 -20.62 61.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.239 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 28.6 m -73.46 -50.44 21.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.235 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 206' ' ' ASP . 6.0 t -66.47 -29.2 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.713 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.557 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 1.8 pt20 -71.56 -20.88 61.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.632 0.253 . . . . 0.0 111.125 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.98 48.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.685 0.755 . . . . 0.0 109.539 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.429 ' HG2' HG21 ' A' ' 226' ' ' ILE . 19.7 mtt -71.24 -17.34 62.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.12 -21.82 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.146 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 217' ' ' ILE . 22.8 m-85 -83.28 9.36 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.993 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.54 117.49 6.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.54 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.88 83.86 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 214' ' ' PHE . 7.1 tt -88.19 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.21 98.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.655 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.7 p90 -116.69 139.06 50.97 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.158 173.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 65.22 24.39 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.66 82.63 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.523 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.4 pt20 -113.55 145.81 40.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.103 0.452 . . . . 0.0 110.073 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.2 t -103.36 115.31 30.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.919 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.8 137.32 52.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.157 0.503 . . . . 0.0 111.269 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -122.8 133.8 54.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.612 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.7 mp -132.61 146.08 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 227' ' ' ARG . 20.6 mmt180 . . . . . 0 C--N 1.321 -0.664 0 O-C-N 121.895 -0.503 . . . . 0.0 111.001 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.002 0.429 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 66.3 m -104.23 150.69 24.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.23 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.7 p -86.16 8.1 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.8 112.94 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.357 0.598 . . . . 0.0 110.131 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.36 106.08 54.73 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.97 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.82 166.92 12.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.156 2.571 . . . . 0.0 112.34 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.22 83.6 4.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.252 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -79.62 154.44 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.789 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.8 -16.67 63.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.196 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -128.18 36.92 4.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.295 0.569 . . . . 0.0 110.111 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -74.08 150.43 40.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.008 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 313' ' ' THR . 12.6 mt -122.5 149.1 44.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.879 0.371 . . . . 0.0 111.62 -171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.75 128.77 56.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.768 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 332' ' ' VAL . 2.5 mp -114.94 120.93 65.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.645 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.93 166.41 21.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.893 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.63 5.02 63.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.456 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.538 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.1 mt -68.49 125.61 91.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.978 0.418 . . . . 0.0 112.056 -172.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 143.32 94.51 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.839 2.359 . . . . 0.0 111.648 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 298' ' ' LEU . 10.0 t30 -59.68 -26.71 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.442 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -81.84 -0.12 42.02 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.726 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.2 mt -113.9 124.28 51.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -104.29 -174.5 2.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.8 p-10 -47.78 -44.26 28.31 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.499 0.499 . . . . 0.0 111.842 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 31.4 t70 -72.01 -36.93 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.735 0.303 . . . . 0.0 111.812 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.39 -42.89 67.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 266' ' ' LEU . 97.7 t -72.12 -29.67 33.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' CD1' ' A' ' 288' ' ' PHE . 1.0 OUTLIER -54.45 -39.36 67.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.795 176.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.87 -36.02 81.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.073 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.07 -41.74 67.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.3 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 320' ' ' LEU . 61.9 mt -71.24 -40.13 71.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.181 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.2 p -70.19 -11.87 61.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.794 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 35.3 t -53.11 -40.41 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.12 -41.0 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.21 150.81 20.03 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.707 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.484 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.6 Cg_endo -69.03 156.3 65.68 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.432 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 305' ' ' CYS . 76.7 mt -107.17 134.75 49.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.31 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -28.95 33.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.235 0.54 . . . . 0.0 109.824 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.2 120.97 7.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 17.2 t80 -139.2 109.54 6.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.85 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.58 119.22 34.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.401 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 8.4 tt -98.76 124.49 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.3 126.85 36.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.432 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -122.86 148.72 45.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.403 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 25.1 t0 -77.74 116.35 18.2 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.5 t -70.1 -10.02 57.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.905 0.383 . . . . 0.0 110.511 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.403 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -85.68 -53.47 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 46.6 p -83.28 -23.69 32.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.498 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 78.21 18.34 76.55 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.512 ' HB3' ' OD1' ' A' ' 268' ' ' ASN . 59.6 mt -114.95 157.6 23.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.115 0.483 . . . . 0.0 110.881 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 290' ' ' LEU . 49.5 m -73.48 134.29 43.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 302' ' ' TYR . 18.3 mmtp -61.66 -34.27 75.42 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.344 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 99.82 21.7 13.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.8 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 300' ' ' LYS . 32.0 p90 -153.68 145.0 23.03 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.68 168.25 24.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.911 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.82 132.84 53.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.995 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 32.0 p -127.16 166.35 17.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.964 0.411 . . . . 0.0 111.054 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 127.03 15.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.263 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.21 149.23 25.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.78 -21.03 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.279 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -133.77 159.85 39.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.256 0.551 . . . . 0.0 110.895 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.71 -25.93 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.218 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.8 -34.36 71.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.633 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.505 HG21 ' HA3' ' A' ' 283' ' ' GLY . 10.0 p -79.53 -18.14 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.792 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.465 HG23 HD21 ' A' ' 261' ' ' LEU . 55.5 m -55.48 -48.38 74.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.114 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.94 -37.87 67.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.137 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.403 . . . . 0.0 110.838 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.56 -56.92 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.34 -21.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.127 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.89 96.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.225 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.12 -36.28 4.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.015 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.402 HD13 HD22 ' A' ' 279' ' ' LEU . 84.4 mt -67.83 -35.71 79.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 111.304 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -64.44 109.29 1.89 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.433 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.439 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 99.95 11.53 42.85 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.359 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.8 ttm -59.0 115.24 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.739 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.71 89.17 6.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.687 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 tp -112.72 122.86 48.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 77.73 -125.45 7.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.83 -1.49 25.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.058 0.456 . . . . 0.0 110.097 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -111.14 169.92 8.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.822 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 47.2 mtpt -118.11 117.48 29.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.866 168.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.84 137.21 51.56 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.152 0.501 . . . . 0.0 111.412 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.14 121.78 31.8 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 263' ' ' ILE . 60.0 t -131.25 110.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.5 146.25 31.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.3 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -62.1 125.76 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.634 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.764 -178.004 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -70.47 -18.59 62.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 110.243 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.13 -37.03 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.69 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.86 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.73 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -91.33 9.77 30.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.0 ttp180 -127.24 129.49 47.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.03 153.48 34.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.299 0.571 . . . . 0.0 111.786 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -82.86 115.66 21.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.057 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.8 123.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.749 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.98 172.42 15.15 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.97 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 2.7 t30 69.07 49.52 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.543 0.687 . . . . 0.0 109.713 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.6 pt -123.01 153.49 64.21 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.7 131.07 15.46 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.319 2.013 . . . . 0.0 111.366 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.55 124.76 21.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.01 16.6 40.71 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.087 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.24 148.45 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.929 0.395 . . . . 0.0 110.321 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 148.03 22.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -48.13 -58.52 4.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.088 -175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -55.68 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.279 . . . . 0.0 110.675 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.6 ptp -81.08 -26.16 36.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.438 ' HB2' HG21 ' A' ' 189' ' ' VAL . 18.4 ttt -61.56 -58.54 7.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -31.94 72.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.504 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -63.96 -57.71 8.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.022 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -57.63 -41.11 80.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.545 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -59.39 -27.85 66.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -85.54 -43.48 13.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.47 -41.13 89.03 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.567 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.1 -36.12 76.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.096 0.474 . . . . 0.0 110.882 177.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.52 -39.56 74.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.344 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.7 mt -65.22 -42.2 93.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.302 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.18 -12.96 78.14 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.607 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 33.17 46.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.676 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.47 -23.9 19.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.59 0.233 . . . . 0.0 110.902 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -59.09 107.97 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -83.43 -28.66 28.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 0.0 109.946 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -107.9 150.78 40.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.601 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.45 135.53 26.72 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.166 1.911 . . . . 0.0 111.578 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 109.34 -167.96 13.1 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.27 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -80.34 120.86 80.72 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 111.096 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.04 -31.24 46.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.945 2.43 . . . . 0.0 112.572 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.2 t -77.75 131.0 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 109.969 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.1 tp -99.33 -43.09 6.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.578 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.43 28.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.368 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.456 HG22 HD23 ' A' ' 200' ' ' LEU . 5.1 t -125.41 139.72 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.838 0.351 . . . . 0.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -124.6 121.55 35.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.959 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.03 122.82 67.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.436 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.15 167.16 21.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.454 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 73.8 m-85 -127.99 125.85 40.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.144 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 12.9 mt -106.95 122.16 45.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.713 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -100.96 129.72 46.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.43 . . . . 0.0 110.136 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.542 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 53.3 m-85 -108.21 151.52 25.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.952 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.62 -23.38 63.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.932 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -138.22 142.84 39.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.668 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.46 -29.84 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.523 ' O ' HG22 ' A' ' 209' ' ' THR . 14.4 t70 -63.37 -40.51 97.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.453 0.644 . . . . 0.0 109.779 175.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.612 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.6 mt-10 -77.66 -19.96 54.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.55 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.1 m -73.02 -48.26 37.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 110.216 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 206' ' ' ASP . 4.9 t -67.22 -30.55 70.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.471 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.612 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 2.5 pt20 -73.15 -20.55 60.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.052 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.97 -29.02 62.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.387 0.613 . . . . 0.0 109.515 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 226' ' ' ILE . 12.2 mtt -68.64 -15.95 63.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.833 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.1 74.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 110.465 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 217' ' ' ILE . 32.5 m-85 -80.61 5.08 16.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.426 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.5 106.47 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.992 0.425 . . . . 0.0 111.072 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.07 14.43 57.66 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 214' ' ' PHE . 9.6 tt -103.61 159.62 4.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.876 0.338 . . . . 0.0 110.232 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mm -106.91 98.98 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.1 m-85 -109.12 136.59 48.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.14 173.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 58.62 28.79 17.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 111.393 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 75.73 5.44 79.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.319 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 14.1 pt20 -118.68 145.45 45.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.033 0.416 . . . . 0.0 110.254 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 42.6 t -94.93 127.63 41.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.032 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 123.03 40.4 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.95 134.44 54.83 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.5 mp -124.87 123.51 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 -173.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.614 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.4 m -85.18 147.72 26.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 32.9 p -94.08 24.4 4.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.304 0.573 . . . . 0.0 110.719 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.51 108.49 19.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.512 0.673 . . . . 0.0 110.163 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 306' ' ' GLU . 24.5 t -104.37 102.28 32.32 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.845 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 170.05 21.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.084 2.523 . . . . 0.0 112.32 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.72 102.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.317 0.58 . . . . 0.0 109.758 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.6 t -118.42 148.74 42.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.598 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.21 55.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.448 ' CD2' ' HB ' ' A' ' 310' ' ' ILE . 30.1 m80 -120.18 34.1 5.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.797 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.36 146.34 55.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.327 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.44 HD11 HG23 ' A' ' 313' ' ' THR . 6.2 mt -132.93 139.44 47.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.987 0.422 . . . . 0.0 111.751 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.429 ' C ' HD12 ' A' ' 263' ' ' ILE . 23.2 t80 -119.78 133.47 55.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.019 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.8 mp -121.11 115.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -115.2 -171.97 16.97 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.34 -1.31 85.79 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.824 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 330' ' ' LEU . 89.5 mt -70.74 125.99 92.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -173.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 25.6 Cg_exo -63.71 142.44 83.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.667 2.245 . . . . 0.0 111.115 172.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -62.67 -17.89 61.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -86.03 -9.16 57.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.7 mt -102.85 130.06 49.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.156 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -104.38 -177.32 3.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.413 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.686 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.9 p-10 -48.6 -46.88 40.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.383 0.427 . . . . 0.0 111.744 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.14 -44.0 87.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.487 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.6 -38.34 59.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.48 -30.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 0.0 109.914 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 14.4 ttpp -50.45 -38.95 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.722 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.45 -35.05 79.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.591 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.41 -27.61 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.89 0.376 . . . . 0.0 110.228 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 77.1 mt -82.98 -38.8 22.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.116 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 33.3 p -68.41 -11.66 60.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.952 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 74.6 p -50.31 -48.08 55.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.9 -40.99 21.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.775 0.321 . . . . 0.0 110.723 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.75 151.4 20.81 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 280' ' ' THR . 25.3 Cg_endo -67.08 156.08 67.93 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 112.3 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.18 132.98 45.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.646 0.736 . . . . 0.0 111.244 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -78.89 -42.46 27.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.354 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -142.44 128.12 19.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.419 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 10.5 t80 -138.74 107.06 5.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 110.14 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -116.24 108.57 16.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.424 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -94.44 125.69 39.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.31 131.77 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.863 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -117.83 157.84 25.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.544 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 6.0 t70 -100.17 125.18 46.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.2 t -76.3 -14.28 60.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.796 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.28 -37.81 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 111.458 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 81.7 p -86.24 -28.08 24.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.201 0.524 . . . . 0.0 110.563 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.74 18.4 77.35 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 48.5 mt -130.18 179.53 5.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.456 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 290' ' ' LEU . 69.2 m -74.77 147.36 41.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.63 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 302' ' ' TYR . 35.4 mmtt -73.32 -25.6 60.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.147 0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 97.14 22.54 17.06 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.068 -176.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 1.9 p90 -157.42 146.81 20.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 110.978 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.37 18.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.222 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -129.84 137.84 50.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 31.7 p -139.65 166.88 23.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 112.079 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 254' ' ' VAL . 31.1 mt-10 -133.21 134.04 43.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.366 168.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -83.24 149.52 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.233 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.64 -36.61 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -115.62 149.08 38.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.252 174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.448 ' HB ' ' CD2' ' A' ' 259' ' ' HIS . 2.8 pp -84.66 -13.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.749 -171.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -78.99 -41.21 29.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.008 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.87 -17.0 21.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.44 HG23 HD11 ' A' ' 261' ' ' LEU . 31.3 m -50.83 -44.41 59.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.893 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.88 -39.51 50.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.433 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -61.29 -37.39 83.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 111.507 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.81 -52.36 31.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.54 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.486 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -64.8 -20.88 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.61 67.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.262 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.19 -37.01 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.79 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.97 -28.27 55.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.928 0.364 . . . . 0.0 111.86 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.6 t-20 -66.8 108.8 2.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 329' ' ' LYS . . . 104.65 12.68 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.827 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 35.0 ttm -68.52 113.62 6.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 103.55 4.25 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.467 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.44 111.01 15.23 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 86.61 -116.38 4.42 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.0 5.15 12.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.433 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -122.97 165.74 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.768 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 322' ' ' GLY . 24.7 mtmm -109.86 127.94 55.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 266' ' ' LEU . 27.4 mt -75.93 137.98 40.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -173.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -89.14 115.42 26.65 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 67.5 t -124.19 107.0 17.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.322 0.582 . . . . 0.0 109.506 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -147.46 145.53 29.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.001 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -63.44 129.05 38.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.02 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.5 -173.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 148' ' ' ALA . 8.9 t . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.649 0.738 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -66.72 -41.98 87.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.841 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -87.6 -4.53 58.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.423 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -86.32 -32.04 21.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -87.95 -12.97 43.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.024 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 99.6 mtt180 -110.9 156.49 21.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.556 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.97 152.61 42.16 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 20.0 t80 -81.08 113.09 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.216 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -99.3 125.89 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.974 0.416 . . . . 0.0 111.283 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.17 176.19 22.48 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 65.84 52.29 1.28 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.647 0.737 . . . . 0.0 109.409 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 pt -119.2 150.92 50.11 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 11.5 Cg_endo -91.8 146.57 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.425 2.75 . . . . 0.0 112.17 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.13 111.47 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.868 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.76 15.56 36.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.161 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 148.53 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.187 0.518 . . . . 0.0 110.287 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.5 m -99.63 144.83 28.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.037 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 162' ' ' GLU . 1.5 mp0 -42.49 -54.51 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.865 0.728 . . . . 0.0 111.545 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.17 -37.37 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.803 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.85 -55.25 36.79 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.343 0.592 . . . . 0.0 111.088 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -78.24 -29.33 48.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.388 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.0 ttt -61.22 -54.54 42.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.695 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.52 -33.32 75.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.858 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.558 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.1 OUTLIER -63.13 -49.9 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 29.6 m-85 -72.68 -40.04 66.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 72.8 m-20 -56.35 -34.79 66.94 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -68.1 -39.67 82.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.057 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 62.6 mm-40 -64.12 -38.65 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.469 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.27 -41.72 93.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 83.4 mtt180 -69.4 -36.01 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.438 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 97.9 mt -61.75 -50.43 72.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.64 65.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.667 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.03 30.97 24.41 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.304 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.82 -22.45 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.3 . . . . 0.0 110.22 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.23 108.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.097 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -88.19 -30.04 20.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.031 0.443 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -108.56 149.03 38.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.968 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.48 145.03 95.55 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.291 1.994 . . . . 0.0 111.421 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.15 -149.95 19.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.463 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.51 123.91 42.75 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.817 0.341 . . . . 0.0 111.12 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.4 -37.82 22.15 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.201 2.601 . . . . 0.0 112.398 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.55 123.53 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.44 -46.72 8.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.305 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.74 40.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.515 HG22 HD23 ' A' ' 200' ' ' LEU . 3.5 t -127.82 140.12 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -119.15 117.81 29.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.014 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.456 ' CD1' ' HG3' ' A' ' 162' ' ' GLU . 3.8 mp -106.58 129.19 60.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.529 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.468 178.239 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 17.0 p90 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.55 155.96 49.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.131 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.5 125.35 50.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.878 0.371 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 189' ' ' VAL . 20.2 mt -94.62 125.29 39.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.686 174.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -105.05 130.62 53.2 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.531 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 61.5 m-85 -109.79 157.48 19.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 181' ' ' ALA . 37.3 ptt180 -78.16 -18.98 54.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.787 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 54.7 m -147.91 139.56 23.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.797 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.66 -25.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.44 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -76.21 -23.76 54.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -84.23 -20.9 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.237 0.541 . . . . 0.0 109.673 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 67.6 m -69.83 -49.87 48.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.639 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.8 t -60.69 -36.79 79.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.43 -22.45 61.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.79 -28.49 60.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 109.87 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 23.8 mtp -72.76 -14.64 61.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.192 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -18.15 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.489 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.476 ' CG ' ' HE2' ' A' ' 219' ' ' PHE . 11.4 m-85 -84.56 5.19 28.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.57 107.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.466 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.51 13.54 59.68 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.017 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -94.56 154.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.151 0.476 . . . . 0.0 110.818 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.8 mm -97.73 100.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.132 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.672 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.9 m-85 -105.03 103.39 12.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.69 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 60.54 37.63 19.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.95 -13.57 63.47 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.155 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.8 pt20 -100.96 132.83 46.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.604 0.702 . . . . 0.0 110.344 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.0 t -98.7 90.41 4.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 224' ' ' LEU . 1.3 pp -91.71 144.69 25.25 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.46 143.25 47.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.153 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.4 mp -130.65 115.41 31.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.9 tpt180 . . . . . 0 C--N 1.318 -0.788 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.2 m -81.39 147.88 29.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 67.2 p -93.27 4.08 54.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.554 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 4.3 p -109.12 106.64 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.861 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.03 110.12 39.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.992 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 8.1 Cg_exo -72.53 139.72 31.81 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.996 2.464 . . . . 0.0 110.953 172.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.49 ' HA ' ' HG3' ' A' ' 260' ' ' LYS . 26.9 t70 -86.65 83.44 7.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.463 0.649 . . . . 0.0 110.479 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 33.1 t -89.55 -178.03 5.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.823 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.74 65.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.665 0.745 . . . . 0.0 110.023 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -102.46 31.63 3.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.377 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 256' ' ' ASP . 2.3 tmtp? -67.75 133.34 49.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.17 149.24 43.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.483 . . . . 0.0 112.251 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.403 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 45.2 t80 -119.62 132.12 55.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.796 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 305' ' ' CYS . 2.5 mp -116.25 120.05 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.02 0.438 . . . . 0.0 110.298 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.39 -174.43 13.84 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 87.47 -6.72 82.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.008 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.495 ' HB2' ' C ' ' A' ' 301' ' ' GLY . 91.9 mt -68.86 127.62 93.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -172.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.01 140.17 59.12 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.173 1.915 . . . . 0.0 109.803 166.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -64.55 -15.08 60.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -169.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -83.61 -7.56 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.021 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.35 126.47 42.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -104.4 176.15 5.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.699 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 12.6 t70 -40.22 -43.49 1.69 Allowed 'General case' 0 CA--C 1.534 0.327 0 O-C-N 123.644 0.59 . . . . 0.0 111.882 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.43 -47.9 74.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.896 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -73.74 -39.64 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.94 -32.6 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.671 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.9 mtmm -56.26 -33.98 65.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.651 0.262 . . . . 0.0 111.176 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.48 -31.53 72.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.406 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.74 -34.92 60.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.131 0.491 . . . . 0.0 110.174 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.93 -32.23 27.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.274 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 17.0 p -69.38 -13.8 62.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.753 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.4 m -49.63 -46.43 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.467 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.26 -41.12 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.158 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.19 164.34 35.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.915 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -70.48 166.17 29.36 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.776 2.317 . . . . 0.0 111.85 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.2 mt -112.22 133.18 54.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.732 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.35 -38.09 74.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.272 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -152.27 131.96 13.16 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.686 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -138.57 117.89 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.266 0.555 . . . . 0.0 110.559 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -121.39 102.37 8.22 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.789 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 6.5 tt -86.82 133.6 33.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.329 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.92 133.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.541 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -122.16 165.29 16.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 295' ' ' ALA . 20.5 t70 -110.0 133.35 53.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.74 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.7 t -83.86 -11.12 57.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.92 0.391 . . . . 0.0 110.537 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.483 ' HB3' ' OD2' ' A' ' 293' ' ' ASP . . . -88.31 -43.46 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.735 0.302 . . . . 0.0 111.003 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 70.0 p -83.39 -30.66 27.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.17 0.51 . . . . 0.0 110.787 176.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.46 13.52 80.16 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 42.2 mt -123.61 -175.43 3.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.709 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 290' ' ' LEU . 36.6 m -74.75 152.45 39.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.133 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.38 -10.9 50.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.544 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.495 ' C ' ' HB2' ' A' ' 266' ' ' LEU . . . 92.66 26.84 16.1 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.67 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -164.42 149.43 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.029 0.443 . . . . 0.0 110.615 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -149.37 170.27 18.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.912 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.435 ' CD1' ' HE2' ' A' ' 260' ' ' LYS . 98.5 m-85 -123.19 127.97 49.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.484 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 263' ' ' ILE . 12.4 p -122.42 162.48 21.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.101 0.476 . . . . 0.0 110.187 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 111.96 6.04 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -70.38 171.3 10.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.962 0.411 . . . . 0.0 110.995 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.83 -45.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.567 ' HB2' HG12 ' A' ' 312' ' ' VAL . 11.0 m-20 -85.6 142.15 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.96 -14.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.248 0.547 . . . . 0.0 110.498 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 309' ' ' ASP . 3.7 p-10 -86.89 -24.24 24.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.026 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' A' ' 309' ' ' ASP . 8.9 p -83.78 -18.27 10.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.116 0.484 . . . . 0.0 109.802 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 21.9 m -53.8 -49.23 68.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.257 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.31 -24.82 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -70.79 -36.04 72.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.173 0.511 . . . . 0.0 110.971 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.5 -52.32 14.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.019 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.463 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -61.45 -21.21 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.162 0.506 . . . . 0.0 110.968 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.48 -39.08 74.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.259 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.62 -35.96 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.243 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.5 -34.25 58.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.416 ' OD1' HD12 ' A' ' 331' ' ' LEU . 64.8 t30 -69.91 117.79 11.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.478 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 96.06 10.75 55.88 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.036 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' MET . . . . . 0.461 ' O ' HD23 ' A' ' 330' ' ' LEU . 41.9 ttm -64.22 116.2 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 86.82 7.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.27 121.83 45.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.414 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.18 -117.63 4.52 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -116.37 -14.68 11.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 110.793 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.41 165.26 11.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -107.31 125.86 51.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.898 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 265' ' ' GLY . 2.6 mm? -73.21 133.97 44.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.814 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.416 HD12 ' OD1' ' A' ' 321' ' ' ASN . 33.6 tp -97.62 122.81 41.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 174.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.463 HG12 HG22 ' A' ' 317' ' ' ILE . 99.6 t -131.22 108.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -139.95 160.08 40.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.8 141.49 36.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.782 0 CA-C-O 121.137 0.494 . . . . 0.0 109.98 179.233 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.89 -19.13 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 110.613 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -82.74 -33.68 27.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.452 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.83 -25.95 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.51 -6.59 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.362 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 30.8 mtm180 -110.45 158.08 18.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.233 0.539 . . . . 0.0 111.542 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.34 153.53 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.562 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 15.5 t80 -79.61 118.97 21.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.585 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 200' ' ' LEU . 49.3 t -105.96 121.26 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -122.88 176.21 16.56 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.218 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.2 43.5 1.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.807 0.813 . . . . 0.0 109.866 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.8 pt -116.35 154.6 48.89 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.67 130.91 14.1 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.633 2.222 . . . . 0.0 111.378 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.82 117.64 9.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.657 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.29 6.49 29.41 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.514 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.71 147.93 11.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 110.2 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 m -93.48 144.89 24.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.546 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 189' ' ' VAL . 1.9 mp0 -49.54 -54.21 19.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 123.371 0.42 . . . . 0.0 111.397 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.26 -24.28 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.278 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 -58.39 5.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.704 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 ptp -72.06 -31.67 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.353 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.27 -54.83 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.309 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.62 -36.12 83.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.657 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.6 OUTLIER -56.95 -61.11 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.978 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -58.65 -42.37 88.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -59.79 -42.05 92.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 111.063 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.99 -43.93 77.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.988 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 9.3 mm100 -64.34 -31.81 73.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.165 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.505 ' HB3' HG23 ' A' ' 179' ' ' THR . 11.9 mmt -57.07 -46.17 82.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 174' ' ' ARG . 52.3 mtm180 -73.69 -30.17 62.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 81.0 mt -66.85 -48.39 68.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.359 . . . . 0.0 110.278 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.82 74.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.476 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.56 36.75 10.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.174 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.479 HD12 ' SD ' ' A' ' 173' ' ' MET . 17.3 mt -90.89 -27.37 18.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -60.16 108.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.809 -177.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -22.97 14.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.13 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.7 127.78 27.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.46 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.86 142.17 98.07 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.723 2.282 . . . . 0.0 112.572 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 107.17 -143.16 15.83 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.39 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 18.4 p-10 -108.27 115.07 58.77 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-O 120.953 0.406 . . . . 0.0 110.801 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 19.3 Cg_endo -62.32 -37.8 58.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.817 2.345 . . . . 0.0 112.114 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.43 119.31 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.0 tm? -97.46 -34.96 10.82 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 -170.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.12 157.96 38.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 162' ' ' GLU . 97.2 t -138.0 128.81 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.809 0.338 . . . . 0.0 110.677 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -119.38 125.25 48.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.06 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 162' ' ' GLU . 15.9 mm -90.94 130.69 39.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.527 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.53 161.65 37.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.821 0.343 . . . . 0.0 111.049 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.49 121.3 43.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.066 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 1.0 OUTLIER -94.47 118.96 32.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.926 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 38.0 tt0 -102.64 126.8 49.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.363 0.601 . . . . 0.0 110.551 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.549 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 59.1 m-85 -106.52 157.29 17.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.443 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.54 ' HB3' ' HG ' ' A' ' 187' ' ' LEU . 17.9 ptt180 -79.18 -20.63 47.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.8 m -141.74 144.07 33.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.51 -26.63 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.007 0.432 . . . . 0.0 111.103 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 209' ' ' THR . 9.2 p-10 -75.58 -18.25 59.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.672 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 203' ' ' ARG . 44.5 mt-10 -86.01 -26.43 25.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 45.0 m -68.31 -44.74 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.816 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.5 t -61.56 -37.01 82.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.171 -174.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.73 -18.22 60.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.55 -27.3 58.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.35 0.595 . . . . 0.0 109.955 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 9.8 mtt -68.36 -16.24 63.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.14 -24.85 64.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 217' ' ' ILE . 18.9 m-30 -75.33 -0.85 21.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.954 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.8 106.28 1.49 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.57 14.34 38.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.3 tt -106.84 153.94 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.28 99.56 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.141 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.754 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.1 m-85 -103.0 118.94 37.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.513 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 57.61 32.49 21.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.205 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.8 -13.34 64.64 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.593 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 24.7 pt20 -94.36 136.67 34.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.498 0.649 . . . . 0.0 110.438 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.0 t -90.35 124.73 35.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.638 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.48 121.98 42.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.798 0.333 . . . . 0.0 110.528 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -113.23 119.24 37.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.998 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.1 mp -121.75 130.78 74.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.115 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.049 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 13.5 m -69.34 139.38 54.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.173 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 p -87.92 1.71 53.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.347 0.594 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.74 108.08 22.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.748 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.26 107.51 59.18 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.822 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.15 160.49 49.41 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.811 2.341 . . . . 0.0 111.346 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.33 142.21 47.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.7 p -156.49 -177.07 6.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.026 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.38 0.69 55.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.243 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -131.52 16.03 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.4 125.99 30.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 0.8 OUTLIER -109.28 139.9 43.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -171.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.421 ' HD2' ' CE2' ' A' ' 304' ' ' PHE . 41.9 t80 -101.91 127.44 48.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.446 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.96 116.53 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.761 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -121.55 176.1 16.3 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.578 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.69 89.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.565 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.2 mt -68.87 129.69 92.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -174.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 139.88 91.09 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.688 2.259 . . . . 0.0 111.238 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.46 -18.66 62.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -98.03 8.2 45.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.57 122.92 48.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.219 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.78 -171.51 1.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.776 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 5.7 p-10 -48.81 -45.46 40.38 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.624 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.32 -47.64 78.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 111.619 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.19 -41.46 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.426 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.01 -31.68 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.441 0.639 . . . . 0.0 110.048 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 0.6 OUTLIER -55.11 -36.7 65.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.382 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.22 -26.34 68.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.663 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.68 -38.36 33.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.213 0.53 . . . . 0.0 109.711 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.74 -42.56 63.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.055 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 30.6 p -66.89 -11.38 55.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.016 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.1 t -59.72 -29.28 68.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.774 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.06 -40.61 6.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.026 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.48 160.48 32.75 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.054 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.31 168.43 23.43 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.151 2.567 . . . . 0.0 112.133 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 305' ' ' CYS . 89.2 mt -117.74 134.1 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.469 0.652 . . . . 0.0 111.729 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 308' ' ' VAL . 38.6 ttmt -70.51 -46.39 63.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.074 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -150.87 133.45 15.64 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.605 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 10.4 t80 -138.28 107.03 5.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.895 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -103.57 105.16 15.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.634 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 303' ' ' ALA . 0.6 OUTLIER -88.34 132.57 34.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 290' ' ' LEU . 27.8 t -98.57 119.07 46.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.161 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -114.41 167.3 10.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 13.6 t70 -96.27 118.49 32.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.3 t -72.12 -10.01 59.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.611 0.244 . . . . 0.0 110.847 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -91.91 -49.45 6.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.264 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 76.0 p -82.4 -27.68 31.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 111.026 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.31 82.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.121 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 29.8 mt -108.49 170.01 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.4 m -82.44 138.92 34.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 110.53 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -63.86 -31.42 72.6 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.133 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 105.55 26.85 6.0 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 17.1 p90 -156.69 141.4 16.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 110.185 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 290' ' ' LEU . . . -149.2 170.28 18.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.179 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 94.8 m-85 -131.45 130.29 42.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 30.7 p -130.26 175.68 8.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 111.465 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 129.32 11.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 308' ' ' VAL . 8.4 m-85 -89.06 -0.16 57.2 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 286' ' ' LYS . 44.3 t 75.37 -63.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.555 0.693 . . . . 0.0 109.603 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.548 ' HB3' HG12 ' A' ' 312' ' ' VAL . 15.1 t70 -75.51 135.48 40.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.131 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.26 -19.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -80.53 -45.51 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.782 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 309' ' ' ASP . 7.1 p -65.4 -18.47 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.205 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 23.5 m -53.8 -50.15 66.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.444 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.77 -35.87 62.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 0.0 110.627 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.27 -31.04 71.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 320' ' ' LEU . . . -75.48 -55.16 5.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.899 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.418 HG22 HG12 ' A' ' 332' ' ' VAL . 2.3 pp -61.08 -21.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.762 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.32 79.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.049 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.66 -28.97 6.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 316' ' ' ALA . 78.8 mt -76.44 -36.82 57.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -175.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.05 110.05 2.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.51 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.95 11.47 56.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.277 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 43.6 ttm -60.94 117.19 5.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 110.521 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 94.45 6.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 120.01 40.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.589 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.69 -115.12 4.45 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.85 -3.91 12.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 110.559 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -111.94 156.14 22.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.771 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.79 125.64 49.61 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.26 141.88 41.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.123 0.487 . . . . 0.0 111.081 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.99 121.6 36.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.344 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 320' ' ' LEU . 59.2 t -130.8 111.41 20.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.016 0.436 . . . . 0.0 110.34 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -151.8 149.71 29.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.243 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -64.29 129.65 40.75 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.083 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.357 0.599 . . . . 0.0 110.408 -178.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 9.1 t . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -70.93 -24.59 62.48 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.229 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -79.75 -31.87 41.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.011 0.434 . . . . 0.0 110.021 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -72.57 -31.95 65.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.607 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 145' ' ' THR . 19.9 mtm180 -74.04 -13.2 60.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.82 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.7 ttp180 -110.98 137.35 48.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.979 0.419 . . . . 0.0 110.631 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.13 153.98 38.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.4 t80 -85.53 121.04 27.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.201 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.466 HG21 HD12 ' A' ' 200' ' ' LEU . 21.2 t -108.62 127.63 64.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 0.0 110.942 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -128.72 -178.22 15.26 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.331 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 223' ' ' SER . 4.0 t-20 67.82 28.01 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.773 0.797 . . . . 0.0 109.706 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.5 pt -102.13 150.2 37.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.51 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.14 132.03 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.634 2.223 . . . . 0.0 111.388 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -65.92 123.89 21.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.73 -5.0 30.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.099 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.13 145.23 9.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.253 0.549 . . . . 0.0 110.883 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 m -101.02 148.69 24.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.144 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.435 ' HG3' HD13 ' A' ' 191' ' ' ILE . 1.7 mp0 -47.73 -55.16 10.16 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.454 0.471 . . . . 0.0 110.859 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -54.41 -38.38 66.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.226 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.26 -56.58 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.6 ttm -64.52 -36.82 85.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.259 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.2 ttt -62.49 -55.85 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.15 -36.94 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.316 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -55.49 25.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -60.45 -33.87 73.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.016 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.569 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 6.7 m-80 -59.99 -46.41 89.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.411 . . . . 0.0 110.489 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.664 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -65.7 -43.46 89.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.643 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -47.26 75.96 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.556 ' HE1' ' HB2' ' A' ' 211' ' ' ALA . 0.0 OUTLIER -55.4 -44.71 76.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 111.085 177.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.5 mtm-85 -69.78 -33.41 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 83.2 mt -62.07 -35.78 79.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.948 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.99 -8.87 55.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.714 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.19 58.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.552 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.6 -21.82 18.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.19 . . . . 0.0 111.441 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -59.26 107.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.32 . . . . 0.0 110.83 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -90.03 -27.51 19.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.77 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.18 149.47 39.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.225 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.06 139.94 30.51 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.216 1.944 . . . . 0.0 111.417 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.34 -158.8 15.79 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.708 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 10.7 m120 -86.8 116.14 64.95 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 4.1 Cg_endo -52.3 -46.34 33.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.601 2.867 . . . . 0.0 112.289 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 200' ' ' LEU . 7.8 p -80.57 136.85 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.4 tp -93.75 -51.22 5.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.929 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.75 142.33 25.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.6 t -110.9 131.83 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.965 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -118.68 126.73 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.435 HD13 ' HG3' ' A' ' 162' ' ' GLU . 3.3 mp -115.65 119.7 62.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.884 0.373 . . . . 0.0 110.398 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 0.0 111.468 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 C--O 1.233 0.218 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -137.6 167.25 22.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.978 0.418 . . . . 0.0 111.297 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -127.95 130.29 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 186' ' ' VAL . 15.3 mt -110.67 117.83 34.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.335 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 37.7 tt0 -104.37 129.76 52.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.593 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 43.0 m-85 -104.98 159.64 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.134 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 38.3 ptt180 -77.34 -20.94 54.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.422 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 m -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.69 -29.1 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.228 0.537 . . . . 0.0 110.044 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 209' ' ' THR . 3.5 m-20 -67.92 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.792 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.16 -21.15 50.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.29 0.567 . . . . 0.0 109.922 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 86.4 m -72.45 -47.94 44.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 206' ' ' ASP . 7.5 t -62.27 -36.02 80.8 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.555 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -73.91 -25.09 59.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.198 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HB2' ' HE1' ' A' ' 173' ' ' MET . . . -68.81 -34.58 75.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.272 0.558 . . . . 0.0 109.956 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.411 ' HE2' ' HB3' ' A' ' 212' ' ' MET . 27.8 mtp -68.54 -14.74 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.171 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.26 67.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 110.633 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.4 m-85 -78.55 6.18 9.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.97 106.74 1.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.93 13.84 38.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.036 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.0 tt -103.65 155.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.107 0.454 . . . . 0.0 111.116 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.74 102.3 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.1 m-85 -106.39 117.48 34.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.957 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 57.32 31.73 20.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 0.0 111.443 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.47 -12.81 64.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.873 174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.8 pt20 -105.93 144.95 31.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.318 0.559 . . . . 0.0 110.501 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.435 ' HB3' ' OD1' ' A' ' 155' ' ' ASN . 23.3 t -102.46 128.89 48.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -101.76 120.66 40.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 4.9 mmmp? -114.24 123.08 48.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 17.9 mt -130.8 118.79 43.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.01 -171.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.407 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.0 tpt180 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.718 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.733 0.302 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 32.6 m -69.84 146.92 50.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.289 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.1 p -96.49 19.65 11.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 57.9 t -122.85 105.04 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.76 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.54 111.13 51.03 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 25.5 Cg_exo -63.72 153.58 74.45 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.807 2.338 . . . . 0.0 110.892 173.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -78.98 77.03 5.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.124 0.964 . . . . 0.0 110.8 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -91.22 158.28 16.69 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.63 48.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.088 0.471 . . . . 0.0 110.367 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -90.41 0.38 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.218 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.413 ' HG3' ' HB3' ' A' ' 335' ' ' ALA . 19.2 pttm -72.16 139.05 48.07 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.476 HD12 ' SG ' ' A' ' 305' ' ' CYS . 10.5 mt -112.42 149.27 32.79 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.798 -170.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -107.03 129.57 54.78 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.52 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -116.08 115.15 48.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.909 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.87 175.38 15.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.5 -1.2 83.85 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.442 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.483 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.2 mt -64.35 127.73 92.48 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 27.9 Cg_exo -63.35 149.1 92.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.893 2.395 . . . . 0.0 111.757 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 -18.08 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.529 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -92.76 1.15 57.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.1 mt -112.13 119.73 39.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.032 0.444 . . . . 0.0 109.935 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -104.54 -178.5 3.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.566 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER -40.31 -48.66 2.69 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.77 0.668 . . . . 0.0 112.561 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -65.26 -45.58 83.96 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.05 -49.52 72.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.478 . . . . 0.0 110.652 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 83.0 t -63.94 -33.79 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.341 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 24.9 mtmm -53.19 -46.73 69.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.496 0.188 . . . . 0.0 111.078 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.54 -43.96 76.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.008 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.27 -43.89 89.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.81 -44.35 73.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 34.6 p -62.74 -12.21 22.56 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.7 m -55.61 -35.35 65.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.715 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -90.4 -41.96 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 110.693 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.91 167.79 39.37 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.412 ' HG3' ' HA ' ' A' ' 175' ' ' LEU . 4.1 Cg_endo -77.95 155.8 30.35 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 66.5 mt -106.02 134.48 49.07 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.778 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -77.3 -31.87 54.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -151.76 127.19 10.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.53 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 29.3 t80 -138.48 114.48 10.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.487 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -120.95 107.49 12.74 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 10.0 tt -86.9 123.68 32.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.88 111.19 13.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.436 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.2 165.44 11.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.741 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.3 t70 -98.82 133.72 42.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.7 m -78.04 -15.4 58.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.335 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.94 -44.91 10.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.8 p -89.2 -25.92 21.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.188 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.99 13.98 82.65 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.526 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.9 162.65 16.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 111.303 -172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.3 m -71.87 123.15 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.146 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -63.75 -30.06 71.2 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 109.09 25.12 5.72 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.74 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 19.2 p90 -155.08 144.35 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.11 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -148.97 169.95 19.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.567 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 97.5 m-85 -126.37 131.14 51.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.868 176.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.51 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 21.8 p -129.03 158.95 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.618 0.247 . . . . 0.0 110.668 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 260' ' ' LYS . 0.3 OUTLIER -142.54 125.21 15.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -81.59 156.73 25.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.48 -51.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.683 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.04 153.94 17.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 110.326 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 311' ' ' ASN . 2.9 pp -85.14 -22.37 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.17 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . 0.437 ' N ' HD12 ' A' ' 310' ' ' ILE . 8.0 p30 -79.76 -28.7 40.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.557 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -17.79 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.981 0.419 . . . . 0.0 110.448 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 m -55.91 -52.17 65.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.225 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.14 -19.32 51.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -77.48 -35.91 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.99 -52.53 16.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.731 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -60.69 -21.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.013 0.435 . . . . 0.0 111.091 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.12 83.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.46 -34.67 4.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.301 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.77 -33.55 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.679 0.276 . . . . 0.0 111.628 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -68.81 122.92 19.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.01 10.23 60.02 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.846 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' MET . . . . . 0.445 ' SD ' HD23 ' A' ' 325' ' ' LEU . 33.4 ttm -59.62 116.44 4.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.619 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.62 85.19 6.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' SD ' ' A' ' 323' ' ' MET . 0.2 OUTLIER -103.06 129.85 50.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.25 -118.51 8.02 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.142 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.98 1.82 12.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.927 0.394 . . . . 0.0 110.904 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -110.05 172.58 6.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -117.13 119.77 36.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.06 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.6 145.36 50.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.447 0.641 . . . . 0.0 112.029 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 331' ' ' LEU . 3.1 tm? -91.4 120.18 32.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.801 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 317' ' ' ILE . 41.3 t -129.24 108.93 17.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.558 . . . . 0.0 109.507 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -145.27 161.41 39.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.691 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -64.12 136.36 57.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.413 ' HB3' ' HG3' ' A' ' 260' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.274 0.559 . . . . 0.0 109.994 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 13.5 tpt -140.44 110.31 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.5 t 61.49 47.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 122.075 0.941 . . . . 0.0 109.353 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.68 166.07 26.3 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.6 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 t 65.64 26.93 11.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.869 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -66.42 -41.57 89.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.763 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.6 ttm -60.4 -54.82 41.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.527 0.203 . . . . 0.0 110.898 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . 8.3 t -74.02 -20.15 60.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.994 -175.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -59.59 -54.32 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 110.068 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -87.9 -11.45 47.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.57 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 145' ' ' THR . . . -83.72 -33.24 25.15 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.055 0.455 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 96.7 mtt180 -92.95 4.58 53.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 22.8 ttp180 -126.2 129.94 49.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 110.943 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.405 ' HB3' ' HE3' ' A' ' 212' ' ' MET . 3.8 pp -114.04 153.17 29.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.108 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 59.5 t80 -84.96 119.67 25.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.434 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.65 124.15 57.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.541 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.26 177.87 16.78 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.905 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 223' ' ' SER . 4.9 t-20 66.02 30.97 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.784 0.802 . . . . 0.0 109.967 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.67 154.44 37.17 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.184 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.02 130.84 12.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.518 2.145 . . . . 0.0 111.259 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.33 108.79 2.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.107 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.52 3.31 7.92 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.585 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.36 145.6 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.082 0.467 . . . . 0.0 110.192 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.2 m -105.32 154.19 20.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.397 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.93 -58.65 4.13 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.477 0.486 . . . . 0.0 111.465 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.11 -35.86 67.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.892 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.89 -56.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.021 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 32.6 ttm -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.7 ttt -59.02 -56.89 16.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.086 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -37.44 81.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.49 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.642 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.4 m-85 -60.5 -51.8 67.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.63 -39.97 88.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -55.75 -42.46 75.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.072 0.463 . . . . 0.0 110.603 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.29 -45.96 78.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.22 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 68.5 mm-40 -59.25 -41.15 88.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.386 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.604 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -56.7 -42.66 79.5 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.875 0.369 . . . . 0.0 111.046 176.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -66.14 -41.66 90.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 58.7 mt -64.86 -49.94 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.293 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.62 0.09 86.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.906 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.3 37.84 91.09 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.771 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HB3' ' NE2' ' A' ' 210' ' ' GLN . 66.5 mt -93.67 -31.17 14.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.581 0.229 . . . . 0.0 110.386 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.27 108.4 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.278 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -85.71 -29.25 24.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.028 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.0 148.95 38.44 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.619 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.13 157.06 61.66 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.246 1.964 . . . . 0.0 111.901 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.68 -147.55 18.64 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.593 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -102.29 119.52 56.14 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.861 0.363 . . . . 0.0 111.0 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -32.9 34.12 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.911 2.407 . . . . 0.0 112.227 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.73 128.8 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.92 -45.14 7.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.697 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.01 143.54 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.789 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.05 131.42 63.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.26 118.91 32.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.69 118.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -78.25 131.14 36.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.66 135.77 56.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.536 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.7 25.9 14.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.531 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.49 144.19 48.13 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -91.13 33.27 0.97 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.773 0.321 . . . . 0.0 110.776 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.01 163.05 39.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.68 170.82 15.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 74.6 m-85 -127.84 134.47 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.5 mt -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.25 131.3 48.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.202 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.582 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 45.8 m-85 -110.65 156.99 20.21 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.658 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -74.5 -19.65 60.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.19 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 m -141.89 135.75 29.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.04 -31.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -70.78 -31.35 68.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.372 . . . . 0.0 110.419 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.411 ' HA ' ' NE2' ' A' ' 210' ' ' GLN . 53.2 mt-10 -78.63 -20.15 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 109.95 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.4 m -75.59 -48.67 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.945 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -63.77 -31.63 72.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.925 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.444 ' NE2' ' HB3' ' A' ' 178' ' ' LEU . 11.2 pt20 -74.39 -18.1 60.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.595 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.07 -22.58 58.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 109.611 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 226' ' ' ILE . 14.5 mtt -71.29 -17.65 62.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.589 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.53 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.492 ' O ' HG22 ' A' ' 217' ' ' ILE . 10.1 m-85 -81.57 4.12 22.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.577 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.07 106.64 2.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.843 0.354 . . . . 0.0 110.713 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.23 5.58 57.09 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.194 -0.526 . . . . 0.0 112.7 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 214' ' ' PHE . 11.3 tt -96.84 153.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.882 0.372 . . . . 0.0 110.648 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 36.4 mm -108.13 100.53 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.3 m-85 -102.07 108.73 20.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.731 0.3 . . . . 0.0 110.573 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.54 36.34 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.225 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.01 -13.57 66.86 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.916 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.0 pt20 -99.4 138.94 35.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.584 0.692 . . . . 0.0 110.267 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.407 ' HB3' ' OD1' ' A' ' 155' ' ' ASN . 21.6 t -96.5 126.03 41.41 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.95 132.33 51.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.53 125.57 48.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.6 mp -128.62 126.44 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.421 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 32.3 tpt180 -99.36 144.93 27.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.419 ' HD3' ' SD ' ' A' ' 212' ' ' MET . 17.2 tpp180 -89.08 110.41 37.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.398 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 9.9 Cg_exo -71.56 122.45 8.61 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.386 2.057 . . . . 0.0 110.909 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -94.3 27.17 3.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -94.29 -1.64 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.276 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 29.7 p90 -149.81 174.22 12.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.349 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -129.3 116.38 18.68 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.8 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.34 138.67 27.8 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.599 2.199 . . . . 0.0 111.565 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.88 125.83 40.74 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.829 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.56 137.35 68.73 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.717 2.278 . . . . 0.0 111.954 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.1 56.36 4.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -108.36 125.42 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 31.9 p -87.18 119.36 27.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.563 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.98 133.92 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.259 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -83.92 131.37 51.75 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.421 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -73.48 176.7 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 170.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.5 p -78.43 60.09 2.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.183 0.516 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.37 25.24 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.756 0.789 . . . . 0.0 110.543 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.404 ' HB3' ' OG1' ' A' ' 252' ' ' THR . 41.4 p90 -132.22 160.97 34.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.653 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 249' ' ' VAL . 59.8 t -112.92 116.86 47.03 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.813 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.61 126.52 17.71 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.053 1.835 . . . . 0.0 111.497 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.31 2.04 24.75 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 250' ' ' VAL . 3.1 p -143.43 -172.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.615 ' H ' HG22 ' A' ' 249' ' ' VAL . 7.6 p -63.55 127.12 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.233 0.54 . . . . 0.0 110.241 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 28.3 m -83.15 149.45 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 245' ' ' TYR . 11.7 p -92.9 19.55 7.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 111.318 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.77 113.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.221 0.534 . . . . 0.0 110.53 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 304' ' ' PHE . 21.4 t -107.98 108.19 61.07 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.54 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.89 152.12 82.32 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.923 2.415 . . . . 0.0 111.796 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.92 79.48 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.861 0.838 . . . . 0.0 109.945 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.0 p -87.05 -176.44 5.72 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.379 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -81.67 1.06 35.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -123.76 30.82 6.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.263 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -70.63 133.71 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.008 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.87 142.01 51.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.466 ' HE1' HD23 ' A' ' 331' ' ' LEU . 55.1 t80 -118.38 130.06 55.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.067 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.408 ' CG2' HD21 ' A' ' 266' ' ' LEU . 2.3 mp -117.6 126.8 74.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -130.54 168.65 21.61 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.04 5.91 60.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.379 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 275' ' ' VAL . 78.4 mt -71.48 132.73 85.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.921 0.391 . . . . 0.0 111.881 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 34.2 Cg_exo -59.31 134.55 59.58 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.876 2.384 . . . . 0.0 111.858 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.08 -22.47 64.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.238 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -90.54 4.84 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.79 139.19 49.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.707 0.289 . . . . 0.0 110.351 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -105.65 -177.77 3.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.81 -41.96 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.326 0.391 . . . . 0.0 111.648 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.59 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 33.1 t70 -63.07 -47.97 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 0.0 111.353 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -65.53 -40.81 93.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.727 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 266' ' ' LEU . 77.5 t -68.41 -30.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.795 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 273' ' ' ASP . 6.9 mtmp? -53.26 -39.51 63.94 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.453 0.168 . . . . 0.0 111.293 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -52.75 -34.95 55.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.761 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.31 -40.48 62.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.88 -38.43 53.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.069 0.461 . . . . 0.0 111.042 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 25.2 p -65.92 -12.49 55.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.043 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.9 m -52.63 -34.21 50.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.166 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -100.58 -40.83 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.9 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.86 162.0 35.51 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.207 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -76.84 160.1 34.25 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.962 2.441 . . . . 0.0 112.28 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 305' ' ' CYS . 77.5 mt -110.44 136.58 49.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 306' ' ' GLU . 18.9 ptpt -80.18 -27.92 38.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.675 0.75 . . . . 0.0 109.008 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -153.86 124.58 7.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.188 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 17.1 t80 -139.13 112.72 8.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.019 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -118.73 115.91 25.47 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.415 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.07 123.47 38.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.9 t -82.25 106.03 12.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.751 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -95.31 159.41 15.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.347 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.473 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 8.7 t70 -94.87 133.47 38.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.0 m -72.36 -18.37 61.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.382 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.42 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 82.5 p -99.44 -28.31 13.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 74.84 15.68 80.76 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.58 157.65 39.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 111.298 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.5 m -65.08 123.06 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.442 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -68.4 -18.77 64.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.406 . . . . 0.0 110.646 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 106.45 26.4 5.94 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.76 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.24 148.02 21.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.503 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.54 170.12 19.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.81 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.491 ' O ' HG21 ' A' ' 254' ' ' VAL . 98.1 m-85 -125.83 136.55 53.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.66 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 19.6 p -133.97 166.68 22.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.878 0.37 . . . . 0.0 110.897 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 286' ' ' LYS . 10.6 tt0 -143.62 120.29 11.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -74.36 147.24 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.376 0.608 . . . . 0.0 110.886 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.49 -30.26 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.858 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -116.41 151.61 35.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 310' ' ' ILE . 2.9 pp -84.05 -21.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.65 -41.46 60.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.46 -18.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.815 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 50.5 m -52.93 -56.82 13.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.338 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.99 -22.45 36.56 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.152 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -74.06 -34.68 64.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.962 0.411 . . . . 0.0 111.001 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.15 -50.9 17.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 HG12 ' A' ' 332' ' ' VAL . 2.6 pp -61.42 -21.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.084 0.468 . . . . 0.0 110.733 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.49 86.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.023 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.34 -33.84 5.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.169 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.67 -35.85 75.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.794 0.297 . . . . 0.0 111.579 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -68.26 109.59 3.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.453 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.3 3.71 29.22 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 46.3 ttm -61.64 115.32 3.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.724 0.297 . . . . 0.0 110.37 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.0 OUTLIER -85.54 90.53 8.0 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.89 119.76 40.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.12 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.82 -110.76 3.61 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.868 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -106.55 -13.5 15.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -114.23 147.96 38.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 47.1 mtpt -93.01 120.83 33.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 164.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.49 129.24 37.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.188 0.518 . . . . 0.0 110.879 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 262' ' ' PHE . 23.5 tp -88.53 124.82 34.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 317' ' ' ILE . 65.9 t -131.15 108.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 334' ' ' ARG . 0.0 OUTLIER -143.17 143.65 31.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.47 -168.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.42 ' H ' ' NE2' ' A' ' 333' ' ' GLN . 61.6 mtm180 -69.81 117.63 11.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.122 0.487 . . . . 0.0 110.61 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -76.44 -8.23 56.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 38.5 m -78.07 8.89 4.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.565 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 19.0 m -98.71 -0.65 10.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.761 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.33 80.17 1.22 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.505 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.02 2.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.799 0.333 . . . . 0.0 111.532 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 62.52 22.66 13.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.846 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -169.35 133.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.265 179.613 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.777 0.322 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.13 -61.14 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.117 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.38 65.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.421 0.629 . . . . 0.0 110.109 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.53 49.29 15.18 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.854 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.7 m -141.45 24.27 2.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.077 0.465 . . . . 0.0 110.43 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -69.65 -14.55 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.836 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.4 ttt -87.45 -55.25 3.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.902 0.382 . . . . 0.0 111.053 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 13.6 t -69.77 -9.93 56.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.259 -172.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NE ' ' HG3' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -60.99 -22.71 64.76 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.23 -0.294 . . . . 0.0 111.57 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HG3' ' NE ' ' A' ' 146' ' ' ARG . 82.1 mt-30 -87.3 -35.36 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.012 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.46 -31.85 67.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.902 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 145' ' ' THR . 34.0 mtm180 -80.62 2.23 26.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.686 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 34.4 ttp180 -122.02 130.54 53.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.304 0.573 . . . . 0.0 111.652 -172.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 212' ' ' MET . 3.9 pp -118.48 154.24 32.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.077 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.8 t80 -81.45 124.4 29.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.607 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG21 HD23 ' A' ' 200' ' ' LEU . 44.0 t -112.43 131.34 64.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 110.738 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.29 177.85 16.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.945 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.81 38.15 2.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.462 0.649 . . . . 0.0 110.359 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.3 pt -109.25 150.94 41.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.69 130.82 9.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.766 2.311 . . . . 0.0 111.641 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.48 118.89 10.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.39 -2.93 22.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.535 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.48 146.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 110.229 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 m -105.18 156.64 17.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 189' ' ' VAL . 24.8 mt-10 -47.51 -59.51 3.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.434 0.459 . . . . 0.0 111.715 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.88 -21.37 66.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.253 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.62 -53.12 30.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.299 0.571 . . . . 0.0 110.284 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.7 ttm -75.79 -33.96 60.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.102 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 14.5 ttt -59.55 -46.47 88.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.535 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.36 -44.51 88.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.449 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.1 m-85 -62.12 -55.66 26.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.707 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -58.71 -43.01 89.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.532 0.206 . . . . 0.0 111.368 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -59.82 -33.75 72.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.388 . . . . 0.0 111.18 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -79.16 -34.56 43.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.381 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 25.8 mm-40 -62.52 -37.76 87.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.868 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.5 -35.48 76.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 0.0 111.022 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.464 ' HD2' ' OG1' ' A' ' 179' ' ' THR . 28.2 mmm180 -78.41 -23.8 46.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.1 mt -76.73 -41.84 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.34 -5.55 75.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.636 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.43 36.05 83.16 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.859 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.94 -22.15 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.718 0.294 . . . . 0.0 110.772 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.71 108.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.325 -178.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -87.88 -33.11 18.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.614 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -106.85 151.17 40.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.805 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 148.86 81.35 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.504 2.136 . . . . 0.0 111.938 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.09 -144.9 17.39 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.608 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.14 124.79 38.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.709 0.29 . . . . 0.0 111.118 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.516 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 41.2 Cg_endo -67.04 -29.51 40.15 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.153 2.569 . . . . 0.0 113.135 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.36 134.47 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.231 0.539 . . . . 0.0 110.86 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.5 mt -89.77 -49.37 6.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.134 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.14 171.26 19.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 0.2 OUTLIER -143.87 139.57 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.14 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -122.53 127.93 50.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.606 0.241 . . . . 0.0 110.786 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.68 127.56 63.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 48.0 m-80 -83.66 108.1 16.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.011 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -68.57 -23.54 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -97.99 5.85 48.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.625 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 192' ' ' ASN . 75.2 mmtt -131.1 -170.8 2.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.881 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -126.71 29.99 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.158 0.504 . . . . 0.0 110.404 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -144.41 164.75 29.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.434 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -132.36 170.96 14.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.055 0.455 . . . . 0.0 111.087 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.44 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . 73.0 m-85 -127.3 133.44 50.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.922 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -109.78 129.32 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.3 130.12 56.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 0.0 110.499 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.646 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.4 m-85 -108.53 165.57 11.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.124 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.4 ptt180 -80.75 -18.93 46.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.276 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.9 m -138.7 132.69 31.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.156 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.6 -28.11 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.15 -32.6 72.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.361 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.409 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 53.2 mt-10 -82.66 -20.89 35.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.205 0.526 . . . . 0.0 110.039 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 98.0 m -71.21 -51.32 25.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 173.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.7 t -60.0 -37.63 80.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.662 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.409 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 14.0 pt20 -71.88 -19.65 61.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.4 -28.73 52.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 110.075 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.406 ' HG2' HD22 ' A' ' 151' ' ' LEU . 28.0 mtp -71.63 -14.38 62.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.079 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.2 -22.64 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.861 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.8 m-85 -76.91 2.82 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.999 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.09 106.68 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.99 0.424 . . . . 0.0 110.735 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.44 37.36 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.725 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -108.33 153.36 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.868 0.366 . . . . 0.0 110.523 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.0 mm -105.95 101.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.728 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.3 m-85 -112.82 129.57 56.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.477 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 60.81 21.5 11.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 111.48 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 90.54 -11.63 70.92 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.959 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.728 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.5 pt20 -97.31 140.83 31.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.031 0.416 . . . . 0.0 110.277 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.7 t -93.97 118.41 31.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.23 128.92 38.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.26 122.82 40.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.885 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.5 mp -128.03 125.77 65.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.919 0.39 . . . . 0.0 110.027 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 28.6 tpt180 -99.63 148.13 24.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 234' ' ' PRO . 20.4 mtp180 -92.79 108.56 32.84 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.464 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 6.6 Cg_exo -74.03 126.85 10.88 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.647 2.232 . . . . 0.0 110.768 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.9 53.15 1.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.359 0.6 . . . . 0.0 111.916 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.65 -29.89 14.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 171.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -152.77 175.94 12.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -109.75 102.41 50.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.621 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 228' ' ' ARG . 28.7 Cg_endo -66.1 138.96 53.96 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.443 2.095 . . . . 0.0 112.33 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.5 155.42 78.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.316 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.52 78.01 2.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.018 2.478 . . . . 0.0 112.031 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.44 104.82 1.66 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.205 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -149.77 152.91 36.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.713 0.292 . . . . 0.0 110.507 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 18.3 m -115.02 46.52 1.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 69.41 120.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.953 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 83.2 m-20 -85.03 125.27 70.93 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.194 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 25.2 Cg_exo -62.7 -56.04 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.228 2.619 . . . . 0.0 112.842 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.2 m -158.13 91.49 1.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 34.6 m -78.64 174.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.3 t80 68.08 119.5 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.541 0.686 . . . . 0.0 112.318 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.56 119.23 68.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.698 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.69 131.98 48.94 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.654 2.236 . . . . 0.0 112.04 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.29 24.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.931 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.39 129.63 62.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.522 HG11 ' HD3' ' A' ' 276' ' ' LYS . 21.9 t -76.34 111.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.109 0.481 . . . . 0.0 110.662 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 14.7 m -76.49 146.92 38.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.641 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 18.78 9.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.44 121.93 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.5 t -109.58 104.86 56.31 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.545 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.82 169.6 8.51 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.485 2.79 . . . . 0.0 112.218 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.6 79.92 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.72 . . . . 0.0 110.03 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.6 t -91.8 151.85 20.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.328 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.98 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.345 0.593 . . . . 0.0 110.063 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -113.78 31.88 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.367 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -68.07 141.09 56.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 16.3 mt -122.68 143.37 49.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.98 0.419 . . . . 0.0 111.635 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 331' ' ' LEU . 22.7 t80 -117.89 132.38 56.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.855 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 331' ' ' LEU . 2.5 mp -120.0 116.6 50.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.466 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -112.22 -176.89 19.96 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.1 69.75 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.147 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.497 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.1 mt -62.93 130.16 93.81 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.29 144.84 98.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.794 2.329 . . . . 0.0 111.285 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -67.16 -18.6 65.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -92.25 -8.8 44.27 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.773 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.82 128.3 43.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.9 -175.77 2.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.9 p-10 -50.67 -41.1 55.24 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.185 0.303 . . . . 0.0 111.082 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 19.2 t70 -70.79 -32.9 70.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.99 0.424 . . . . 0.0 111.495 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -79.67 -41.77 26.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.065 0.46 . . . . 0.0 110.441 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.83 -29.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 25.5 mtmm -50.69 -40.26 53.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.009 0.433 . . . . 0.0 110.845 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.94 -21.68 66.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.39 -32.01 19.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 110.264 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.4 -28.98 28.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.143 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.1 p -67.97 -12.2 60.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 16.8 m -50.57 -40.25 51.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.961 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.66 -39.12 10.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.15 155.69 27.21 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.994 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.0 Cg_endo -72.16 155.94 56.06 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.04 1.827 . . . . 0.0 111.865 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 250' ' ' VAL . 78.7 mt -102.48 138.3 39.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.927 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 308' ' ' VAL . 0.1 OUTLIER -85.65 -24.4 27.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.44 0.638 . . . . 0.0 109.338 176.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.62 124.61 6.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.053 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 9.9 t80 -139.27 111.39 7.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.077 0.465 . . . . 0.0 110.246 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.95 108.34 17.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.536 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -99.24 133.96 42.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.5 t -94.13 109.78 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 58.8 mtpt -90.09 164.5 14.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.212 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.558 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -104.34 127.49 52.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.886 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 t -76.65 -11.95 59.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.31 -31.37 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.629 0.252 . . . . 0.0 111.372 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 69.7 p -93.46 -27.69 16.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.028 0.442 . . . . 0.0 111.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.22 14.17 82.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.03 -172.97 2.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.254 -0.473 . . . . 0.0 109.764 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 61.4 m -81.94 147.18 29.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.174 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.26 -19.5 56.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.107 0.479 . . . . 0.0 110.381 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 96.68 27.38 9.74 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.753 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 14.4 p90 -154.13 144.08 21.88 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.275 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.06 19.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.337 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 92.9 m-85 -128.14 133.18 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.396 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 29.5 p -130.05 166.11 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.265 0.555 . . . . 0.0 111.251 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.66 125.79 21.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.715 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -80.86 154.88 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 286' ' ' LYS . 46.5 t -68.09 -35.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.955 -175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.81 158.02 28.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.073 0.463 . . . . 0.0 110.263 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.89 -19.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.511 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 -30.11 57.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.55 -26.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.321 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.464 HG23 HD21 ' A' ' 261' ' ' LEU . 15.6 m -54.62 -53.48 54.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.481 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.34 -31.04 68.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.14 -36.5 72.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.83 -52.79 10.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.183 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.461 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -59.61 -25.28 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.493 . . . . 0.0 110.705 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.18 -45.21 81.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.455 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.11 -27.36 7.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.612 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.12 -36.27 40.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.984 0.392 . . . . 0.0 111.703 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.7 t30 -68.26 112.13 4.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.68 5.14 26.09 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.745 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 40.7 ttm -62.39 115.25 4.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 0.0 110.198 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.48 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 8.7 tm0? -85.06 96.55 9.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 111.28 22.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.538 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.54 -109.47 2.8 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.341 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.82 6.4 11.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.925 0.393 . . . . 0.0 111.176 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -120.74 149.08 43.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.774 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.48 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 42.6 mtpt -98.66 119.61 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.39 134.06 45.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.443 0.64 . . . . 0.0 111.388 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -88.16 121.49 30.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 53.3 t -130.48 107.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -147.68 160.67 42.43 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.899 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.66 130.65 40.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -80.51 -5.31 56.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.318 0.58 . . . . 0.0 110.122 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 2.8 p -87.03 -1.11 57.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.84 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.82 -47.35 70.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.099 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 171.86 154.65 10.16 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.672 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -133.25 67.88 1.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.128 0.49 . . . . 0.0 110.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -123.12 63.39 1.0 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 0.0 110.27 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -94.54 3.79 54.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.477 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 178.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.769 0.318 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 53.0 tpp -69.89 113.91 7.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.839 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.18 -24.54 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 0.0 109.971 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.1 32.84 3.96 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.657 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m -83.56 45.22 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.122 0.487 . . . . 0.0 110.685 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 mt-30 -100.62 119.56 38.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.259 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.71 -30.96 69.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.52 0.676 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 t -89.67 5.88 43.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.425 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -66.84 -31.03 71.38 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.014 -0.429 . . . . 0.0 111.081 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.61 ' HB2' ' HB3' ' A' ' 232' ' ' TYR . 10.9 mm100 -87.51 -5.69 58.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.904 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.03 12.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.906 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 83.5 mtt180 -79.43 -6.12 56.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.95 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 18.4 mtm180 -110.37 150.91 28.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.14 0.495 . . . . 0.0 111.1 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 226' ' ' ILE . 2.5 pp -135.06 153.09 52.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.967 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -82.03 110.3 17.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.674 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 51.1 t -96.55 116.19 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.306 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.51 171.72 14.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.468 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 225' ' ' LYS . 8.4 t-20 62.36 55.33 2.35 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.809 0.814 . . . . 0.0 109.451 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.0 pt -112.42 147.67 37.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.476 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 57.1 Cg_endo -80.26 130.79 8.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.711 2.274 . . . . 0.0 111.318 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.73 124.95 22.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.253 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.32 -0.67 53.87 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.134 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.437 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 16.1 tt -60.88 144.69 13.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 110.202 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 m -96.98 150.0 21.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.18 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.488 ' HB3' HG13 ' A' ' 189' ' ' VAL . 42.1 mt-10 -48.1 -59.87 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 166' ' ' MET . 8.4 pt-20 -66.16 -15.72 63.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.72 -58.32 4.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.0 ptp -76.17 -29.84 57.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.128 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.44 ' HB2' HG11 ' A' ' 189' ' ' VAL . 21.0 ttt -60.07 -54.93 40.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.37 -36.59 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.2 m-85 -60.0 -52.23 66.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.283 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -64.85 -38.82 92.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.206 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -59.69 -40.28 87.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.16 -49.69 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.93 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 70.0 mm-40 -60.47 -33.47 72.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.156 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 8.4 mmt -61.63 -41.87 98.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -72.15 -38.62 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.232 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 72.2 mt -63.68 -50.6 68.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.667 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.17 -10.13 86.45 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.571 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.16 40.08 56.78 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.479 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 22.0 mt -93.34 -24.33 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -58.38 114.72 2.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.956 0.407 . . . . 0.0 111.519 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.84 -34.3 15.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.107 0.479 . . . . 0.0 110.683 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -107.65 150.44 40.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.544 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.71 132.57 40.8 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.051 1.834 . . . . 0.0 111.489 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.97 -162.12 12.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.545 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.77 124.18 73.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.497 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 49.4 Cg_endo -70.83 -31.96 14.93 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.882 2.388 . . . . 0.0 111.957 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.78 116.73 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 245' ' ' TYR . 44.8 tp -85.06 -45.12 12.4 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.381 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.01 165.44 32.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.196 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 162' ' ' GLU . 0.6 OUTLIER -145.09 131.04 14.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.673 178.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.44 121.23 38.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 162' ' ' GLU . 4.5 mp -97.22 111.0 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -66.11 114.59 5.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -76.14 52.74 0.75 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.535 0.684 . . . . 0.0 110.818 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -124.96 10.04 8.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.823 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 83.0 tttt 53.63 65.46 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.287 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -157.14 -57.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.362 -0.535 . . . . 0.0 112.147 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.45 ' HE2' ' CE1' ' A' ' 199' ' ' PHE . 8.7 p90 -150.85 166.09 31.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.278 0.561 . . . . 0.0 112.254 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -131.83 164.67 25.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.258 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 25.7 m-85 -124.11 123.97 41.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.724 0.297 . . . . 0.0 110.732 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 189' ' ' VAL . 66.2 mt -95.68 131.41 41.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 32.3 tt0 -107.03 141.7 37.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.855 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.407 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 65.0 m-85 -126.47 152.85 45.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.432 0.634 . . . . 0.0 111.581 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 39.3 ptt180 -78.05 -13.03 60.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.639 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 33.3 t -148.18 132.84 17.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.834 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.92 -24.24 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.608 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.29 -34.9 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.457 ' HA ' ' NE2' ' A' ' 210' ' ' GLN . 61.9 mt-10 -82.8 -21.82 34.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.095 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.6 m -65.67 -50.97 62.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.2 t -62.59 -36.86 84.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 111.687 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 178' ' ' LEU . 10.1 pt20 -76.06 -18.51 59.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.332 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.49 62.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.442 0.639 . . . . 0.0 109.631 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.544 ' HA ' HG21 ' A' ' 226' ' ' ILE . 31.0 mtp -68.89 -14.01 62.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.856 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.51 65.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.512 ' O ' HG22 ' A' ' 217' ' ' ILE . 13.1 m-85 -80.82 7.27 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.66 105.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.881 0.372 . . . . 0.0 111.387 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.71 59.58 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.196 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.7 tt -95.62 153.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 110.544 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.74 103.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 9.5 m-85 -102.88 111.96 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.734 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 59.61 30.97 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.321 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.71 -13.02 66.99 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.504 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 26.5 pt20 -94.89 137.82 33.46 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.778 0.789 . . . . 0.0 110.778 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.9 p -103.54 118.51 36.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.777 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.64 136.25 54.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 111.064 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 155' ' ' ASN . 47.5 mtmt -109.65 135.02 51.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.66 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 212' ' ' MET . 4.2 mp -121.44 105.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.258 0.552 . . . . 0.0 109.815 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -100.84 151.71 21.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.556 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.457 ' HA ' ' HE1' ' A' ' 212' ' ' MET . 14.1 ptm180 -87.04 121.53 71.53 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 111.229 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 12.4 Cg_exo -70.65 166.24 29.35 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.775 2.317 . . . . 0.0 111.24 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.87 175.0 6.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.011 0.434 . . . . 0.0 110.554 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -82.18 56.78 3.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.192 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' A' ' 147' ' ' GLN . 25.0 p90 46.71 -163.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.405 1.082 . . . . 0.0 113.415 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -158.18 130.6 4.28 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.23 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.58 148.8 26.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.119 2.546 . . . . 0.0 112.447 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.6 mt 68.61 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.16 0 O-C-N 123.87 0.731 . . . . 0.0 110.65 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.21 90.11 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.303 2.002 . . . . 0.0 111.992 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.91 70.48 2.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.094 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.1 ptp -152.44 158.27 42.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.812 0.339 . . . . 0.0 110.089 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 12.8 m -84.89 -33.63 22.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.645 0.736 . . . . 0.0 109.188 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -178.93 140.44 0.17 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.509 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 57.4 t30 -73.83 120.03 79.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 7.9 Cg_exo -71.25 132.94 21.86 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.81 2.34 . . . . 0.0 113.184 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.7 m 60.24 45.49 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.642 170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.1 m -70.65 153.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.112 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 187' ' ' LEU . 80.0 t80 -80.32 127.48 32.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.485 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.6 p -93.66 113.38 60.2 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.06 0.457 . . . . 0.0 110.359 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.98 150.69 82.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.37 2.047 . . . . 0.0 111.594 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.57 22.85 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.111 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.29 93.98 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 276' ' ' LYS . 12.6 p -90.08 134.46 29.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.762 -170.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 73.5 m -101.21 159.47 15.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.287 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 p -97.22 6.26 48.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.466 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 43.0 t -103.23 100.01 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.731 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.64 107.95 27.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.752 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 31.6 Cg_exo -60.24 169.59 4.89 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.424 2.749 . . . . 0.0 112.667 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.67 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' LYS . 26.7 t -69.24 155.77 39.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.949 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.7 -0.61 57.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.233 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -99.68 -6.36 27.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 257' ' ' SER . 23.7 pttp -72.43 154.94 40.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 334' ' ' ARG . 11.0 mt -128.99 150.58 50.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.235 -172.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -107.3 131.14 54.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.67 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.41 121.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.929 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.62 171.54 18.31 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.574 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.91 2.27 84.19 Favored Glycine 0 N--CA 1.454 -0.15 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.662 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.547 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.4 mt -66.41 136.98 95.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 17.0 Cg_exo -67.22 145.27 71.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.786 2.324 . . . . 0.0 111.386 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 3.0 m-20 -65.53 -20.98 66.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.633 -174.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -90.51 1.4 56.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.1 mt -113.53 122.27 46.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -93.01 -175.93 4.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.986 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 290' ' ' LEU . 3.9 p30 -47.54 -48.17 27.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 29.0 t70 -63.35 -46.99 84.02 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -70.2 -28.97 65.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.27 -38.38 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.439 0.638 . . . . 0.0 110.382 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.642 ' HB2' ' CD1' ' A' ' 288' ' ' PHE . 15.7 ttpp -60.92 -30.67 70.33 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.68 -30.42 68.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.081 0.467 . . . . 0.0 110.689 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.86 -31.74 35.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.92 -34.99 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.547 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.8 p -71.19 -12.25 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.036 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.0 m -50.51 -43.2 55.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.077 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -86.17 -41.28 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.599 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.55 154.91 26.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.055 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 280' ' ' THR . 30.7 Cg_endo -71.95 155.44 57.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.138 1.892 . . . . 0.0 112.252 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 276' ' ' LYS . 81.8 mt -104.26 140.64 37.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.692 -176.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -84.75 -25.27 28.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -155.26 127.83 7.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.941 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 276' ' ' LYS . 17.2 t80 -138.73 108.91 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -114.83 111.69 21.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 272' ' ' ASP . 9.7 tt -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.14 116.97 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -102.71 168.2 9.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.131 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.5 130.09 47.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 13.3 m -75.43 -12.71 60.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.573 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.42 12.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.4 p -89.07 -27.85 20.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.204 0.526 . . . . 0.0 111.185 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.15 9.17 86.44 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 56.1 mt -121.23 -179.47 4.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.652 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.8 m -80.34 146.95 31.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.143 0.497 . . . . 0.0 111.435 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.56 -24.85 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.778 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 107.75 27.0 5.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.327 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.86 139.0 18.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 117.465 0.632 . . . . 0.0 110.921 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -150.02 169.51 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.537 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.18 134.86 50.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.664 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 261' ' ' LEU . 23.0 p -127.79 165.18 20.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -147.98 129.35 14.8 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -84.94 163.74 18.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 0.0 111.547 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.79 -23.67 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.846 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.04 157.35 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.875 0.369 . . . . 0.0 110.082 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.37 -29.0 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.397 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.04 -27.0 62.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.543 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.461 HG21 ' HA3' ' A' ' 283' ' ' GLY . 14.9 p -84.17 -18.39 9.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.99 0.424 . . . . 0.0 110.713 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 37.0 m -61.98 -47.98 82.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.99 -24.66 43.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.78 -32.54 59.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.32 -53.44 12.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.114 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -60.37 -21.69 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 110.878 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.03 -37.43 69.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.369 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.64 -36.78 3.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.32 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.25 -34.58 65.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -66.08 117.28 8.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.66 8.56 45.65 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' A' ' 330' ' ' LEU . 48.0 ttm -64.35 116.0 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 110.317 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 86.09 7.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.16 112.62 25.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.23 -112.01 3.75 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.638 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.94 -14.1 10.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -113.32 168.42 9.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.51 124.87 50.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.674 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 323' ' ' MET . 13.9 mt -74.03 138.13 43.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.129 -173.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.9 124.18 35.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.698 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 317' ' ' ILE . 41.9 t -130.54 113.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 335' ' ' ALA . 22.6 pt20 -137.69 168.14 20.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.447 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.605 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 mmm180 -74.56 34.61 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.951 0.5 . . . . 0.0 112.103 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 333' ' ' GLN . . . 57.7 -41.03 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.843 1.339 . . . . 0.0 113.419 -172.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 334' ' ' ARG . 15.0 t -90.52 -12.49 37.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.918 -169.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.14 -26.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.164 0.507 . . . . 0.0 110.298 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -81.09 47.25 3.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.858 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.86 -157.01 0.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 340' ' ' LYS . 3.2 mptp? -69.13 -38.07 78.64 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.992 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 65.84 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 0.0 111.459 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.923 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -105.26 99.7 9.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.926 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.5 p -136.09 150.01 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.216 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.98 -169.55 33.1 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -81.8 24.23 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.858 0.329 . . . . 0.0 111.277 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.66 42.92 28.9 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.286 0.565 . . . . 0.0 110.909 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 ttt -86.29 -54.23 4.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.883 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.0 t -76.76 -13.61 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.843 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -65.97 -17.96 65.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.147 -0.346 . . . . 0.0 111.331 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -87.31 -19.05 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.743 0.306 . . . . 0.0 110.788 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.99 -29.48 14.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 110.372 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.07 -6.16 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.855 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 40.0 ttp180 -114.28 130.11 56.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.034 0.445 . . . . 0.0 110.943 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.18 154.21 31.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.643 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 54.1 t80 -83.7 118.37 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.373 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG21 HD12 ' A' ' 200' ' ' LEU . 23.1 t -104.2 132.6 50.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.73 176.66 17.9 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.831 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 68.28 30.58 5.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.443 0.639 . . . . 0.0 110.589 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.1 pt -92.65 150.24 39.38 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.82 134.1 17.71 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.502 2.134 . . . . 0.0 111.332 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -62.05 113.92 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.6 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 110.44 2.03 29.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.641 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.454 HD13 ' HE2' ' A' ' 165' ' ' MET . 18.7 tt -57.66 146.23 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.211 0.529 . . . . 0.0 110.39 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.6 m -102.28 152.15 21.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.411 ' HA ' HD11 ' A' ' 191' ' ' ILE . 38.1 mt-10 -48.93 -58.6 4.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.515 0.509 . . . . 0.0 110.98 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.52 -37.16 72.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.885 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.28 -57.8 11.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.758 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.454 ' HE2' HD13 ' A' ' 160' ' ' ILE . 33.3 ttm -67.79 -39.54 84.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.502 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 189' ' ' VAL . 15.6 ttt -60.01 -56.74 17.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.675 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.82 -38.39 85.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.053 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 1.4 m-85 -59.99 -57.81 11.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.972 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.451 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -60.36 -42.38 95.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 110.749 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.65 -44.12 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 8.2 mm100 -62.74 -37.69 87.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.324 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 179' ' ' THR . 10.3 mmt -55.82 -42.92 76.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.921 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -75.79 -33.61 60.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.726 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 92.7 mt -62.81 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.47 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.86 -16.03 68.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.468 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.97 37.22 26.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.06 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.494 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 17.6 mt -90.33 -26.96 19.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 0.0 110.66 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -59.53 108.77 0.77 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 111.762 -176.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.78 -33.22 25.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.6 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -108.68 154.47 41.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.509 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 14.2 Cg_exo -69.8 143.93 52.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.608 2.205 . . . . 0.0 111.544 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.02 -151.85 16.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.369 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 93.6 m-20 -98.23 117.01 65.43 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_endo -61.3 -35.43 84.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.427 2.084 . . . . 0.0 111.534 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -78.76 131.5 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.525 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 tp -98.9 -40.8 7.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.812 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.64 150.16 27.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.788 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.481 HG22 HD23 ' A' ' 200' ' ' LEU . 7.3 t -126.26 125.75 68.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.627 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -118.3 112.14 19.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.444 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 191' ' ' ILE . 4.2 mp -104.62 104.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -85.63 114.14 22.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.717 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -81.64 49.58 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.964 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -108.42 -47.92 3.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.17 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -144.48 34.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.395 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.36 72.17 0.5 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.817 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.428 ' HE1' ' CE2' ' A' ' 199' ' ' PHE . 15.2 p90 -153.21 155.83 37.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.09 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 160.1 39.68 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.428 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 54.0 m-85 -117.76 122.59 43.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.614 174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 14.2 mt -103.93 110.22 22.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.902 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -93.92 126.36 39.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.519 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 50.1 m-85 -103.03 165.11 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -84.65 -15.65 44.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.474 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 m -148.24 136.96 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.07 -30.32 49.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.114 0.483 . . . . 0.0 110.512 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 209' ' ' THR . 4.9 m-20 -64.29 -36.23 83.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.11 -21.14 40.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.378 0.608 . . . . 0.0 109.924 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 85.9 m -70.1 -48.61 56.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.151 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 206' ' ' ASP . 14.9 t -62.5 -36.1 81.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.966 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.62 -18.38 60.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.729 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.8 59.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.477 0.656 . . . . 0.0 109.552 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 228' ' ' ARG . 10.4 mtt -67.75 -17.33 64.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.961 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.36 63.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 217' ' ' ILE . 11.8 m-30 -77.51 -2.86 37.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.624 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.96 106.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 0.0 110.513 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.21 4.33 59.85 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.569 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.467 HD13 ' CZ ' ' A' ' 219' ' ' PHE . 7.9 tt -92.31 156.74 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.05 99.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.284 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.731 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.4 m-85 -104.5 122.82 46.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.374 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 61.59 20.08 10.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 111.383 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 93.46 -11.15 72.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.082 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.731 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 19.9 pt20 -94.98 142.95 26.88 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.336 0.589 . . . . 0.0 110.288 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.1 p -103.51 124.39 48.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.557 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.5 mt -108.34 136.77 47.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -120.99 126.68 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.866 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.01 125.5 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 12.7 tpt180 -99.31 146.19 26.51 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.524 ' HB3' ' SD ' ' A' ' 212' ' ' MET . 0.0 OUTLIER -120.98 104.62 41.31 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.371 -174.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.94 124.12 9.41 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.614 2.209 . . . . 0.0 111.848 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -94.86 -41.51 9.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.777 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.61 28.47 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.178 0.513 . . . . 0.0 110.552 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 233' ' ' GLN . 26.2 p90 -67.19 136.49 55.1 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 232' ' ' TYR . 28.3 mm-40 -159.81 98.09 1.52 Allowed Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.574 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.99 127.87 17.67 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.97 2.446 . . . . 0.0 111.262 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.0 mt -142.8 134.56 13.08 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.716 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.56 154.49 31.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.438 2.092 . . . . 0.0 111.515 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 145.68 45.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.423 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -157.84 -40.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.3 p -147.98 59.56 1.11 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 111.334 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -108.24 155.61 20.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -148.81 149.97 31.8 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.653 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.62 -69.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.043 1.828 . . . . 0.0 112.243 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 65.6 m -152.24 56.46 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.238 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 244' ' ' VAL . 18.8 t -96.2 6.53 7.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 122.631 1.205 . . . . 0.0 109.4 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.569 ' O ' ' HD3' ' A' ' 247' ' ' PRO . 85.0 t80 -134.69 145.95 49.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.468 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.65 104.69 13.49 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 245' ' ' TYR . 73.2 Cg_endo -83.36 125.72 4.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.707 2.271 . . . . 0.0 111.134 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.18 0.8 54.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.608 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 250' ' ' VAL . 87.2 t 64.61 175.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 122.466 0.307 . . . . 0.0 110.711 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.501 ' N ' HG12 ' A' ' 249' ' ' VAL . 84.6 t -62.89 120.87 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 12.9 m -63.92 129.22 39.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.626 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.5 p -89.28 4.22 49.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.411 0.624 . . . . 0.0 110.626 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 3.5 p -107.52 104.45 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.836 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.62 109.63 39.88 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.73 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.8 Cg_exo -60.73 144.79 99.6 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.856 2.371 . . . . 0.0 111.066 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.53 90.62 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.723 0.773 . . . . 0.0 110.627 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.7 m -96.06 168.89 10.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.585 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.89 57.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.14 0.495 . . . . 0.0 110.701 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -111.47 27.79 9.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.868 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -55.45 144.86 24.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.709 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 313' ' ' THR . 14.8 mt -122.36 134.45 54.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -111.6 125.81 54.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.752 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.6 mp -113.32 114.09 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.64 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -120.5 -177.79 15.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.1 89.41 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.365 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.474 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 95.7 mt -69.01 130.67 91.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.963 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.17 139.43 85.67 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.764 2.309 . . . . 0.0 111.226 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.88 -1.2 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -103.12 -6.43 22.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.3 mt -96.84 128.61 43.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -104.56 -177.18 3.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 5.5 p-10 -48.71 -43.29 37.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -60.16 -44.4 95.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.616 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.7 -42.05 51.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.455 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.58 -28.63 43.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.687 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 50.2 mtmt -56.01 -33.77 65.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 110.997 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.81 -30.49 70.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.058 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.34 -40.82 29.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 0.0 110.285 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 48.0 mt -76.0 -30.42 58.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.358 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 7.4 p -67.5 -13.62 62.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.6 m -55.54 -30.42 60.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.856 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -103.79 -40.72 6.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.597 0.237 . . . . 0.0 111.435 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.2 163.06 35.79 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.369 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -72.03 162.32 42.18 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.304 2.67 . . . . 0.0 112.058 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' A' ' 305' ' ' CYS . 85.1 mt -112.27 129.19 56.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.531 0.681 . . . . 0.0 111.34 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.437 ' HB2' HG12 ' A' ' 308' ' ' VAL . 15.5 tppt? -71.09 -46.4 61.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.765 175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -143.3 128.0 18.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.842 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 21.1 t80 -138.14 109.49 6.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.17 117.28 31.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.351 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.9 126.64 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.453 HG12 ' HD3' ' A' ' 300' ' ' LYS . 21.7 t -81.99 121.99 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.266 0.555 . . . . 0.0 110.667 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -115.02 145.66 42.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.546 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.555 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.6 t70 -89.84 140.57 29.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.9 t -85.67 -16.09 40.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.99 -40.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 0.0 110.977 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.9 p -85.56 -28.31 24.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 110.611 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.69 20.89 77.83 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.741 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.98 174.64 9.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.966 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 21.5 m -70.63 137.46 49.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.406 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.453 ' HD3' HG12 ' A' ' 291' ' ' VAL . 24.4 mtpp -86.05 -1.08 57.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.474 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 84.4 27.13 37.09 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.557 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 43.2 p90 -158.62 144.77 16.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.9 0.381 . . . . 0.0 110.308 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.11 168.45 23.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.033 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.58 128.68 48.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.62 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 24.4 p -124.15 158.84 31.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 110.963 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.09 110.2 10.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.697 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.34 137.57 50.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.986 0.422 . . . . 0.0 110.006 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 286' ' ' LYS . 4.5 m -60.57 -27.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.658 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 312' ' ' VAL . 13.8 m-20 -113.22 136.26 52.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.35 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.1 -14.08 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 111.306 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.59 -19.62 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.822 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 309' ' ' ASP . 11.0 p -87.51 -18.49 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 109.879 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.411 HG23 HD21 ' A' ' 261' ' ' LEU . 45.4 m -51.25 -51.62 52.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.885 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.02 -18.78 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.636 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -83.86 -31.84 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.03 -53.99 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.636 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.564 HG22 HG12 ' A' ' 332' ' ' VAL . 2.9 pp -58.23 -25.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.121 0.486 . . . . 0.0 110.912 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -66.87 -42.9 84.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.172 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.98 -30.54 6.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.477 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.13 -35.87 59.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.872 0.336 . . . . 0.0 111.409 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 55.7 t30 -65.39 112.21 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 0.0 110.218 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 107.26 2.25 35.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.371 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.6 ttm -65.75 116.5 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.25 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -81.51 87.14 6.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 110.63 21.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.865 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.03 -122.79 6.28 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.891 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -99.29 -13.65 19.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.784 0.326 . . . . 0.0 111.501 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -126.03 166.76 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.164 0.507 . . . . 0.0 111.64 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 51.8 mtpt -94.05 124.7 38.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.794 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.6 mt -72.23 129.84 39.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.11 120.19 30.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.409 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.564 HG12 HG22 ' A' ' 317' ' ' ILE . 61.0 t -130.82 108.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.285 0.565 . . . . 0.0 109.901 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -151.12 163.03 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.412 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 337' ' ' VAL . 0.3 OUTLIER -70.69 126.74 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.054 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.49 65.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.911 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.7 m -62.53 -30.12 71.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 334' ' ' ARG . 7.6 m -75.86 -17.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 110.342 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -95.06 5.03 68.27 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.025 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -73.09 109.98 7.03 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -78.58 67.74 4.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -167.08 -61.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.639 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.805 -178.739 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.587 0.232 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -114.17 42.69 2.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.035 0.445 . . . . 0.0 110.636 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 324' ' ' GLN . 28.7 t 67.37 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.69 -169.7 21.68 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.011 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.6 m -90.75 8.99 31.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.33 -17.44 64.76 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.68 0.276 . . . . 0.0 111.619 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 22.3 ttt -85.97 -50.88 6.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.76 0.314 . . . . 0.0 110.54 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 15.1 t -75.09 -17.22 60.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.652 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -19.71 65.76 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.968 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.21 -28.46 48.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.008 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.56 -32.37 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 145' ' ' THR . 24.0 mtm180 -72.47 -10.75 60.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.96 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 28.4 ttp180 -111.26 132.83 54.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.402 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 226' ' ' ILE . 3.9 pp -117.49 153.38 33.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.701 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -86.61 125.55 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.514 HG21 HD23 ' A' ' 200' ' ' LEU . 41.0 t -110.53 117.09 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 110.623 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.588 ' HA2' ' CD1' ' A' ' 197' ' ' PHE . . . -105.8 169.62 16.18 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.887 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.6 t30 66.89 50.06 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.632 0.729 . . . . 0.0 110.524 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 pt -116.37 150.82 46.06 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.494 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.43 131.02 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.857 2.371 . . . . 0.0 111.62 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 195' ' ' LYS . 47.0 t80 -64.14 131.7 48.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.882 0.372 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.95 8.41 58.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.641 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.5 tt -67.63 147.14 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -101.69 148.79 24.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -46.19 -59.09 3.1 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.679 0.391 . . . . 0.0 111.499 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.7 -34.24 64.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.281 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -57.07 12.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.67 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 4.6 ttm -69.31 -37.69 77.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.413 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.433 ' HG3' HG11 ' A' ' 186' ' ' VAL . 15.1 ttt -57.73 -49.43 76.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.227 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.44 -36.42 83.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.066 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.608 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.0 m-85 -59.26 -53.41 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.408 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -61.98 -41.67 98.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.265 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.07 -40.81 95.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.995 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -62.01 -43.41 98.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.916 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 56.0 mm-40 -64.13 -36.05 82.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.191 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 11.4 mmt -59.62 -42.15 92.04 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.211 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.88 -44.31 81.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.673 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 60.9 mt -62.58 -47.6 83.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.956 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.14 -24.23 72.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.312 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.99 30.33 17.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.813 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.537 ' HB3' ' OE1' ' A' ' 210' ' ' GLN . 23.4 mt -87.72 -17.89 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.51 106.41 0.46 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 111.854 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.33 -4.44 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.592 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.417 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . -89.49 132.46 37.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.49 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.13 131.35 36.31 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.144 1.896 . . . . 0.0 110.426 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 76.98 -140.05 24.31 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.229 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -92.84 126.86 50.0 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.986 0.422 . . . . 0.0 110.373 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 -30.42 67.34 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.163 2.576 . . . . 0.0 112.991 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 166' ' ' MET . 91.1 t -73.12 131.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 203' ' ' ARG . 47.5 tp -90.29 -42.43 10.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.44 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.35 168.05 24.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.35 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.29 136.64 28.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.044 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -125.01 118.13 25.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.549 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.86 125.68 55.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.403 ' HB3' ' OD1' ' A' ' 194' ' ' ASP . 93.8 m-20 -64.78 140.9 58.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -82.62 41.5 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.294 0.569 . . . . 0.0 110.921 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.403 ' OD1' ' HB3' ' A' ' 192' ' ' ASN . 5.8 p-10 -147.22 161.31 41.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.785 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.527 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 24.0 pttm -80.48 45.49 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -168.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -118.07 -94.28 0.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.588 ' CD1' ' HA2' ' A' ' 154' ' ' GLY . 44.9 m-85 -139.1 171.55 14.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.781 0.324 . . . . 0.0 111.365 -168.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.08 172.24 11.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.397 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.8 139.81 51.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.509 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.514 HD23 HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -115.48 129.16 56.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.37 130.65 56.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.607 0.717 . . . . 0.0 111.133 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.592 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.6 m-85 -106.68 164.43 12.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.795 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 187' ' ' LEU . 14.7 ptt180 -68.06 -28.18 67.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.095 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 38.6 m -152.38 153.56 33.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.07 -30.12 47.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 209' ' ' THR . 2.6 m-20 -57.23 -45.44 83.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 202' ' ' PHE . 2.2 mm-40 -72.31 -32.28 66.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.569 0.7 . . . . 0.0 109.638 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 55.7 m -68.22 -47.2 68.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.537 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.2 t -64.85 -32.8 74.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.662 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.537 ' OE1' ' HB3' ' A' ' 178' ' ' LEU . 7.4 pt20 -75.52 -18.19 59.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.4 51.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.255 0.55 . . . . 0.0 109.816 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 226' ' ' ILE . 9.9 mtt -66.41 -15.31 63.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.411 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -27.11 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.03 0.443 . . . . 0.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 217' ' ' ILE . 27.2 m-85 -83.93 17.22 2.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.462 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.64 117.44 13.21 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.976 -0.453 . . . . 0.0 110.985 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.97 12.67 61.73 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.904 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 214' ' ' PHE . 15.5 tt -100.58 151.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.916 0.389 . . . . 0.0 110.669 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.74 101.72 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.398 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.69 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 13.7 m-85 -104.81 122.46 45.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.73 20.25 8.99 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.688 0.395 . . . . 0.0 112.006 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 98.02 -12.02 63.97 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.202 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.1 pt20 -99.21 138.32 36.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.03 0.415 . . . . 0.0 109.941 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.5 t -92.37 130.01 38.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.986 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.62 118.99 38.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.313 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -109.89 122.77 48.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.459 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.1 mp -119.93 118.82 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.799 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -117.38 166.8 11.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 70.7 mtm-85 -103.11 113.74 65.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.469 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 19.4 Cg_exo -66.62 121.35 8.58 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.414 2.076 . . . . 0.0 111.496 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 55.9 m80 68.15 174.06 0.28 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.053 0.454 . . . . 0.0 110.791 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -100.6 55.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.296 0.57 . . . . 0.0 111.428 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -86.3 176.44 7.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -143.73 138.88 15.63 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 121.026 0.441 . . . . 0.0 110.691 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.99 176.68 9.57 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.117 2.545 . . . . 0.0 112.028 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.89 153.16 54.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.512 ' HA ' ' OG ' ' A' ' 239' ' ' SER . 74.5 Cg_endo -75.3 26.62 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.466 2.111 . . . . 0.0 114.424 -170.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.97 -41.74 11.94 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 25.4 ttt -147.8 80.21 1.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 236' ' ' PRO . 48.9 m -96.55 118.91 34.05 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.604 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.06 -38.02 87.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.9 130.87 24.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.282 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.93 88.55 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.508 2.139 . . . . 0.0 111.601 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 55.3 p 51.02 -168.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.457 0.703 . . . . 0.0 110.807 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 m -130.73 168.26 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.421 . . . . 0.0 111.173 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -137.71 129.03 27.88 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.866 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.8 p -95.94 124.86 50.71 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.78 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 120.41 7.75 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.659 2.239 . . . . 0.0 111.834 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 249' ' ' VAL . . . 107.92 -18.87 33.68 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.206 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 39.6 t 66.87 137.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.104 0.478 . . . . 0.0 111.499 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.16 111.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.8 m -71.34 146.34 48.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.782 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.0 p -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 110.305 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 61.2 t -97.64 100.66 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.124 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.596 HG12 ' HZ1' ' A' ' 260' ' ' LYS . 6.2 t -93.13 107.05 22.36 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.047 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.1 Cg_exo -58.38 149.18 75.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.336 2.69 . . . . 0.0 112.68 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.48 128.81 44.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.559 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 37.8 t -146.1 -178.72 6.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -78.92 -19.22 52.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 109.776 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -93.62 27.83 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.639 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HZ1' HG12 ' A' ' 254' ' ' VAL . 1.8 tmtm? -70.07 136.52 50.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.186 -176.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' N ' ' HD3' ' A' ' 260' ' ' LYS . 11.7 mt -121.96 149.19 43.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.947 0.403 . . . . 0.0 111.528 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -127.84 136.25 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.353 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 332' ' ' VAL . 2.1 mp -117.67 122.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.068 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.49 -179.55 15.88 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.31 1.17 90.38 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.457 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.0 mt -66.93 133.21 93.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.726 0.298 . . . . 0.0 111.617 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.78 143.42 99.62 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.935 2.424 . . . . 0.0 111.585 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -72.34 -5.67 37.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -102.03 0.67 35.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.7 133.86 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -105.2 -175.77 2.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.6 p-10 -51.83 -40.67 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.597 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.52 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 9.5 t70 -69.69 -39.19 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.675 0.274 . . . . 0.0 111.131 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.13 -37.53 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.195 0.522 . . . . 0.0 110.605 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.2 -30.97 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.81 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 27.2 mtmm -50.81 -41.85 57.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.531 0.205 . . . . 0.0 111.257 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -56.51 -35.58 68.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.504 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.33 -38.03 71.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.902 0.382 . . . . 0.0 110.552 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.2 mt -81.45 -31.31 33.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.281 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 38.1 p -72.78 -12.49 61.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 59.4 p -54.17 -41.51 68.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 111.531 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -87.59 -41.41 13.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 0.0 110.373 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -167.86 154.95 25.4 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.072 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 280' ' ' THR . 31.7 Cg_endo -72.77 156.96 52.64 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.447 2.098 . . . . 0.0 112.643 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.57 136.19 45.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.495 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -75.37 -30.14 60.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.453 176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.92 126.3 7.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.226 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.86 113.16 8.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.38 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -117.37 120.55 38.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.543 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -102.05 129.28 48.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.3 105.29 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.342 0.591 . . . . 0.0 110.82 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.51 164.34 14.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.56 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.47 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -100.55 130.56 46.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 37.9 m -81.79 -9.75 59.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.165 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.9 -40.65 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.966 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 68.2 p -88.21 -28.07 21.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 83.79 8.4 84.46 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.61 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 45.4 mt -118.33 159.42 23.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 111.001 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.8 m -71.62 127.01 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.675 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.92 -9.4 58.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 111.529 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 91.09 26.39 21.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.974 171.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -148.81 144.4 26.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.096 0.448 . . . . 0.0 110.034 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.44 170.78 17.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.4 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.17 135.81 52.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.763 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 13.9 p -134.9 159.12 42.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.718 0.294 . . . . 0.0 110.716 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 254' ' ' VAL . 73.0 mm-40 -133.36 128.85 36.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.645 173.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.75 144.12 26.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.296 0.569 . . . . 0.0 110.366 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.48 -32.9 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.493 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -121.46 157.01 31.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.33 -21.66 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.092 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -71.27 -31.94 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.034 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 283' ' ' GLY . 9.6 p -81.82 -23.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.509 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.3 m -54.73 -54.03 47.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.22 -23.26 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.278 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -34.3 53.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.812 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.26 -49.89 21.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.504 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -61.86 -21.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.644 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.2 60.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.243 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.79 -36.74 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.162 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 332' ' ' VAL . 63.9 mt -75.75 -33.71 60.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.637 0.256 . . . . 0.0 111.296 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.79 112.48 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.75 11.36 56.86 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.453 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.1 ttm -68.65 119.81 13.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 0.0 110.125 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.486 ' HB2' HG21 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -84.46 86.57 7.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.61 114.74 28.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.667 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.11 -122.06 6.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.704 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.12 -13.75 15.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 0.0 111.085 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -122.28 173.29 7.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -103.3 128.91 50.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.324 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.452 HD22 HD23 ' A' ' 266' ' ' LEU . 15.6 mt -75.15 129.57 37.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.4 tp -90.18 119.65 30.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.455 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 263' ' ' ILE . 65.0 t -130.51 109.03 16.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -146.5 177.32 9.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -69.43 130.99 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.69 -14.26 62.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.193 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 340' ' ' LYS . 31.0 m -74.4 -15.94 60.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.442 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.97 -50.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 111.224 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -92.84 96.31 2.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.025 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . 52.64 67.93 0.91 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.099 0.56 . . . . 0.0 112.269 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 336' ' ' SER . 26.3 tptp -92.04 70.48 5.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.274 0.559 . . . . 0.0 110.185 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.96 139.52 53.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.227 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.272 179.032 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 45.5 tpp 57.34 76.79 0.3 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.467 0.651 . . . . 0.0 110.765 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -104.07 132.45 50.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.012 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.62 -146.62 10.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.704 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -112.86 14.45 19.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 111.026 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 240' ' ' GLU . 45.0 tt0 -65.61 -31.9 73.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.061 0.458 . . . . 0.0 110.635 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -61.86 -32.36 72.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -109.06 -20.13 13.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.523 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -35.07 79.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.164 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.4 -11.6 55.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.3 -29.05 20.66 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -79.85 7.9 7.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.882 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 53.7 ttp180 -127.84 130.07 47.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.05 153.03 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.314 0.578 . . . . 0.0 111.945 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 47.8 t80 -82.06 111.32 18.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.43 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.35 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.64 161.68 12.94 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.475 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.7 49.44 0.39 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.744 0.783 . . . . 0.0 110.258 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 pt -104.14 151.04 38.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.13 132.28 7.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.977 2.452 . . . . 0.0 111.475 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -66.5 120.27 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.53 -1.18 18.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.16 143.78 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.0 m -100.58 157.82 16.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -52.53 -58.9 5.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.742 0.306 . . . . 0.0 110.653 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.68 -23.61 64.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.57 -58.47 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.791 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.401 ' O ' ' HD1' ' A' ' 169' ' ' PHE . 19.9 ptp -77.96 -24.53 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.946 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.446 ' HB2' HG21 ' A' ' 189' ' ' VAL . 20.0 ttt -61.62 -56.19 22.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.372 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.89 -31.47 72.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.069 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.622 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.1 m-85 -61.13 -54.26 46.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' MET . 44.8 m-85 -65.64 -42.89 90.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -55.99 -34.09 65.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -73.05 -49.84 26.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 81.2 mm-40 -56.26 -39.72 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.434 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -57.15 -42.06 80.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.097 0.475 . . . . 0.0 110.732 177.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -77.56 -27.48 51.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 76.7 mt -72.84 -36.8 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.61 -23.85 35.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.14 36.39 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.392 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.9 mt -94.88 -26.58 16.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.806 0.336 . . . . 0.0 110.535 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.34 112.32 1.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.105 -178.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -80.2 -37.62 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.226 0.536 . . . . 0.0 109.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.91 39.74 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.215 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.14 142.18 54.99 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.278 1.986 . . . . 0.0 111.629 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.01 -157.95 15.11 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.79 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -96.23 124.45 51.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.225 0.536 . . . . 0.0 110.946 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.468 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 40.8 Cg_endo -67.94 -29.56 34.25 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.984 2.456 . . . . 0.0 112.624 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.54 132.81 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.187 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.4 mt -89.62 -49.52 6.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.424 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.47 157.69 32.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.758 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.517 HG22 HD23 ' A' ' 200' ' ' LEU . 6.7 t -124.23 128.92 74.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.613 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.55 118.97 35.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.6 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.39 126.92 56.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 195' ' ' LYS . 62.2 t30 -86.61 142.3 28.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.12 -40.54 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -76.31 -64.29 1.14 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.0 110.673 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.497 ' HB2' HD22 ' A' ' 192' ' ' ASN . 58.0 mttp -85.09 122.85 29.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.24 67.99 1.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 111.89 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.19 156.65 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.59 156.74 33.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.005 0.431 . . . . 0.0 110.59 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -127.14 124.19 38.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.948 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.4 mt -103.71 115.37 30.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.281 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -96.85 127.14 42.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.514 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 33.8 m-85 -109.39 158.63 17.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.2 ptt180 -74.1 -18.4 60.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.874 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.0 m -148.49 144.98 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.091 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.81 -36.5 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.302 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 209' ' ' THR . 20.4 t70 -64.46 -40.26 95.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 110.067 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.557 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.0 mt-10 -72.23 -20.62 61.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.239 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 28.6 m -73.46 -50.44 21.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.235 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 206' ' ' ASP . 6.0 t -66.47 -29.2 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.713 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.557 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 1.8 pt20 -71.56 -20.88 61.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.632 0.253 . . . . 0.0 111.125 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.98 48.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.685 0.755 . . . . 0.0 109.539 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.429 ' HG2' HG21 ' A' ' 226' ' ' ILE . 19.7 mtt -71.24 -17.34 62.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.12 -21.82 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.146 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 217' ' ' ILE . 22.8 m-85 -83.28 9.36 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.993 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.54 117.49 6.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.54 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.88 83.86 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 214' ' ' PHE . 7.1 tt -88.19 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.21 98.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.655 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.7 p90 -116.69 139.06 50.97 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.158 173.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 65.22 24.39 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.66 82.63 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.523 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.4 pt20 -113.55 145.81 40.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.103 0.452 . . . . 0.0 110.073 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.2 t -103.36 115.31 30.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.919 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.8 137.32 52.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.157 0.503 . . . . 0.0 111.269 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -122.8 133.8 54.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.612 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.7 mp -132.61 146.08 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 227' ' ' ARG . 20.6 mmt180 -97.54 143.86 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.895 -0.503 . . . . 0.0 111.001 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.0 mtm-85 -65.24 149.4 97.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.509 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 90.1 Cg_endo -89.15 122.0 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.673 2.249 . . . . 0.0 112.988 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 25.3 t60 167.98 -54.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.97 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.78 57.03 0.66 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.41 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -70.18 168.97 14.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 23.2 tm0? -132.81 114.13 14.06 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.185 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 49.3 Cg_exo -56.08 134.87 66.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.471 2.78 . . . . 0.0 113.552 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 235' ' ' LEU . 2.4 mm? -104.19 148.08 35.35 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.429 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.01 62.38 5.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.485 2.123 . . . . 0.0 111.7 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -117.01 71.13 0.28 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.56 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 94.8 mmm 70.28 122.6 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.309 0.644 . . . . 0.0 112.237 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 48.0 m -83.79 130.12 34.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 143' ' ' GLN . 12.3 pt-20 -111.75 171.96 7.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.191 0.519 . . . . 0.0 111.49 -174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 244' ' ' VAL . 5.9 p30 -174.63 158.26 2.4 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 47.1 Cg_endo -69.52 53.51 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 113.806 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t -159.54 8.23 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 241' ' ' ASN . 35.6 m -123.02 162.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.36 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 65.5 t80 59.24 99.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.966 0.791 . . . . 0.0 111.411 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.64 118.04 70.62 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.011 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.25 140.73 28.08 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.17 32.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.99 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.027 0.441 . . . . 0.0 109.921 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 p -104.1 147.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 66.3 m -104.23 150.69 24.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.23 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.7 p -86.16 8.1 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.8 112.94 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.357 0.598 . . . . 0.0 110.131 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.36 106.08 54.73 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.97 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.82 166.92 12.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.156 2.571 . . . . 0.0 112.34 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.22 83.6 4.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.252 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -79.62 154.44 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.789 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.8 -16.67 63.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.196 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -128.18 36.92 4.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.295 0.569 . . . . 0.0 110.111 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -74.08 150.43 40.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.008 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 313' ' ' THR . 12.6 mt -122.5 149.1 44.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.879 0.371 . . . . 0.0 111.62 -171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.75 128.77 56.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.768 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 332' ' ' VAL . 2.5 mp -114.94 120.93 65.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.645 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.93 166.41 21.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.893 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.63 5.02 63.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.456 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.538 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.1 mt -68.49 125.61 91.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.978 0.418 . . . . 0.0 112.056 -172.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 143.32 94.51 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.839 2.359 . . . . 0.0 111.648 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 298' ' ' LEU . 10.0 t30 -59.68 -26.71 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.442 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -81.84 -0.12 42.02 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.726 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.2 mt -113.9 124.28 51.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -104.29 -174.5 2.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.8 p-10 -47.78 -44.26 28.31 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.499 0.499 . . . . 0.0 111.842 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 31.4 t70 -72.01 -36.93 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.735 0.303 . . . . 0.0 111.812 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.39 -42.89 67.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 266' ' ' LEU . 97.7 t -72.12 -29.67 33.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' CD1' ' A' ' 288' ' ' PHE . 1.0 OUTLIER -54.45 -39.36 67.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.795 176.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.87 -36.02 81.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.073 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.07 -41.74 67.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.3 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 320' ' ' LEU . 61.9 mt -71.24 -40.13 71.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.181 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.2 p -70.19 -11.87 61.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.794 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 35.3 t -53.11 -40.41 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.12 -41.0 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.21 150.81 20.03 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.707 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.484 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.6 Cg_endo -69.03 156.3 65.68 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.432 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 305' ' ' CYS . 76.7 mt -107.17 134.75 49.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.31 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -28.95 33.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.235 0.54 . . . . 0.0 109.824 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.2 120.97 7.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 17.2 t80 -139.2 109.54 6.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.85 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.58 119.22 34.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.401 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 8.4 tt -98.76 124.49 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.3 126.85 36.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.432 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -122.86 148.72 45.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.403 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 25.1 t0 -77.74 116.35 18.2 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.5 t -70.1 -10.02 57.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.905 0.383 . . . . 0.0 110.511 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.403 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -85.68 -53.47 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 46.6 p -83.28 -23.69 32.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.498 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 78.21 18.34 76.55 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.512 ' HB3' ' OD1' ' A' ' 268' ' ' ASN . 59.6 mt -114.95 157.6 23.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.115 0.483 . . . . 0.0 110.881 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 290' ' ' LEU . 49.5 m -73.48 134.29 43.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 302' ' ' TYR . 18.3 mmtp -61.66 -34.27 75.42 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.344 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 99.82 21.7 13.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.8 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 300' ' ' LYS . 32.0 p90 -153.68 145.0 23.03 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.68 168.25 24.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.911 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.82 132.84 53.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.995 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 32.0 p -127.16 166.35 17.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.964 0.411 . . . . 0.0 111.054 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 127.03 15.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.263 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.21 149.23 25.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.78 -21.03 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.279 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -133.77 159.85 39.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.256 0.551 . . . . 0.0 110.895 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.71 -25.93 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.218 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.8 -34.36 71.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.633 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.505 HG21 ' HA3' ' A' ' 283' ' ' GLY . 10.0 p -79.53 -18.14 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.792 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.465 HG23 HD21 ' A' ' 261' ' ' LEU . 55.5 m -55.48 -48.38 74.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.114 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.94 -37.87 67.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.137 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.403 . . . . 0.0 110.838 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.56 -56.92 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.34 -21.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.127 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.89 96.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.225 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.12 -36.28 4.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.015 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.402 HD13 HD22 ' A' ' 279' ' ' LEU . 84.4 mt -67.83 -35.71 79.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 111.304 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -64.44 109.29 1.89 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.433 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.439 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 99.95 11.53 42.85 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.359 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.8 ttm -59.0 115.24 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.739 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.71 89.17 6.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.687 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 tp -112.72 122.86 48.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 77.73 -125.45 7.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.83 -1.49 25.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.058 0.456 . . . . 0.0 110.097 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -111.14 169.92 8.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.822 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 47.2 mtpt -118.11 117.48 29.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.866 168.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.84 137.21 51.56 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.152 0.501 . . . . 0.0 111.412 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.14 121.78 31.8 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 263' ' ' ILE . 60.0 t -131.25 110.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.5 146.25 31.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.3 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -62.1 125.76 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.634 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.83 -15.67 63.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.764 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 8.6 m -76.42 -9.53 58.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.302 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 69.9 t -70.63 -33.07 51.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 111.306 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 154.53 62.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.625 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -110.64 45.85 1.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.558 . . . . 0.0 110.329 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -69.61 -36.6 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -151.22 -49.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.536 -178.749 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.944 0.402 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -51.92 10.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.59 -40.17 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.626 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.68 60.74 6.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.215 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.8 m -57.0 114.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.446 0.298 . . . . 0.0 111.391 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 71.31 -12.32 0.62 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.662 0.785 . . . . 0.0 111.922 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.0 tpp -88.01 -49.57 6.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.634 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.2 t -70.44 -20.77 62.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.639 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.403 ' HD2' HE21 ' A' ' 147' ' ' GLN . 1.9 ppt_? -70.47 -18.59 62.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 110.243 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.403 HE21 ' HD2' ' A' ' 146' ' ' ARG . 24.3 mm-40 -90.13 -37.03 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.69 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.86 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.73 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -91.33 9.77 30.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.0 ttp180 -127.24 129.49 47.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.03 153.48 34.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.299 0.571 . . . . 0.0 111.786 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -82.86 115.66 21.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.057 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.8 123.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.749 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.98 172.42 15.15 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.97 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 2.7 t30 69.07 49.52 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.543 0.687 . . . . 0.0 109.713 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.6 pt -123.01 153.49 64.21 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.7 131.07 15.46 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.319 2.013 . . . . 0.0 111.366 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.55 124.76 21.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.01 16.6 40.71 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.087 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.24 148.45 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.929 0.395 . . . . 0.0 110.321 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 148.03 22.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -48.13 -58.52 4.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.088 -175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -55.68 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.279 . . . . 0.0 110.675 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.6 ptp -81.08 -26.16 36.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.438 ' HB2' HG21 ' A' ' 189' ' ' VAL . 18.4 ttt -61.56 -58.54 7.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -31.94 72.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.504 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -63.96 -57.71 8.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.022 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -57.63 -41.11 80.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.545 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -59.39 -27.85 66.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -85.54 -43.48 13.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.47 -41.13 89.03 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.567 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.1 -36.12 76.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.096 0.474 . . . . 0.0 110.882 177.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.52 -39.56 74.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.344 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.7 mt -65.22 -42.2 93.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.302 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.18 -12.96 78.14 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.607 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 33.17 46.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.676 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.47 -23.9 19.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.59 0.233 . . . . 0.0 110.902 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -59.09 107.97 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -83.43 -28.66 28.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 0.0 109.946 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -107.9 150.78 40.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.601 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.45 135.53 26.72 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.166 1.911 . . . . 0.0 111.578 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 109.34 -167.96 13.1 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.27 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -80.34 120.86 80.72 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 111.096 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.04 -31.24 46.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.945 2.43 . . . . 0.0 112.572 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.2 t -77.75 131.0 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 109.969 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.1 tp -99.33 -43.09 6.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.578 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.43 28.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.368 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.456 HG22 HD23 ' A' ' 200' ' ' LEU . 5.1 t -125.41 139.72 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.838 0.351 . . . . 0.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -124.6 121.55 35.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.959 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.03 122.82 67.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -72.27 130.39 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -87.5 -10.58 51.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.923 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -104.87 -14.33 15.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.18 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -145.8 147.72 32.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -78.19 57.26 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -141.62 154.97 45.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 109.995 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.15 167.16 21.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.454 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 73.8 m-85 -127.99 125.85 40.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.144 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 12.9 mt -106.95 122.16 45.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.713 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -100.96 129.72 46.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.43 . . . . 0.0 110.136 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.542 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 53.3 m-85 -108.21 151.52 25.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.952 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.62 -23.38 63.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.932 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -138.22 142.84 39.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.668 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.46 -29.84 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.523 ' O ' HG22 ' A' ' 209' ' ' THR . 14.4 t70 -63.37 -40.51 97.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.453 0.644 . . . . 0.0 109.779 175.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.612 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.6 mt-10 -77.66 -19.96 54.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.55 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.1 m -73.02 -48.26 37.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 110.216 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 206' ' ' ASP . 4.9 t -67.22 -30.55 70.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.471 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.612 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 2.5 pt20 -73.15 -20.55 60.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.052 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.97 -29.02 62.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.387 0.613 . . . . 0.0 109.515 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 226' ' ' ILE . 12.2 mtt -68.64 -15.95 63.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.833 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.1 74.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 110.465 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 217' ' ' ILE . 32.5 m-85 -80.61 5.08 16.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.426 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.5 106.47 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.992 0.425 . . . . 0.0 111.072 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.07 14.43 57.66 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 214' ' ' PHE . 9.6 tt -103.61 159.62 4.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.876 0.338 . . . . 0.0 110.232 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mm -106.91 98.98 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.1 m-85 -109.12 136.59 48.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.14 173.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 58.62 28.79 17.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 111.393 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 75.73 5.44 79.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.319 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 14.1 pt20 -118.68 145.45 45.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.033 0.416 . . . . 0.0 110.254 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 42.6 t -94.93 127.63 41.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.032 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 123.03 40.4 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.95 134.44 54.83 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.5 mp -124.87 123.51 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 -173.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -114.14 153.88 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.71 120.99 67.88 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.7 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.66 132.27 42.1 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.49 2.126 . . . . 0.0 111.674 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -91.23 21.13 4.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.771 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -80.33 -9.16 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.635 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -142.52 175.52 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.731 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -133.23 116.77 14.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.199 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.16 161.74 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.582 2.188 . . . . 0.0 111.999 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.6 145.81 37.19 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.43 69.21 5.11 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.772 2.315 . . . . 0.0 112.989 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.03 13.37 66.68 Favored Glycine 0 C--O 1.236 0.224 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.937 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 53.43 58.04 5.59 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.365 0.602 . . . . 0.0 110.475 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.9 m -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.063 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.65 38.14 18.74 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.573 0.546 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.96 143.9 48.11 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.2 174.36 10.05 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.839 2.36 . . . . 0.0 111.856 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.0 m -79.04 87.98 4.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.977 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 t -88.7 23.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.271 1.034 . . . . 0.0 109.643 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -126.01 141.75 51.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.361 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.8 t -92.41 110.15 42.87 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.693 0.282 . . . . 0.0 110.534 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 122.72 9.48 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.441 2.094 . . . . 0.0 111.611 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.37 -22.23 31.31 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.802 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.6 t 64.07 125.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.153 0.581 . . . . 0.0 112.04 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.18 111.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.4 m -85.18 147.72 26.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 32.9 p -94.08 24.4 4.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.304 0.573 . . . . 0.0 110.719 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.51 108.49 19.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.512 0.673 . . . . 0.0 110.163 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 306' ' ' GLU . 24.5 t -104.37 102.28 32.32 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.845 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 170.05 21.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.084 2.523 . . . . 0.0 112.32 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.72 102.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.317 0.58 . . . . 0.0 109.758 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.6 t -118.42 148.74 42.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.598 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.21 55.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.448 ' CD2' ' HB ' ' A' ' 310' ' ' ILE . 30.1 m80 -120.18 34.1 5.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.797 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.36 146.34 55.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.327 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.44 HD11 HG23 ' A' ' 313' ' ' THR . 6.2 mt -132.93 139.44 47.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.987 0.422 . . . . 0.0 111.751 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.429 ' C ' HD12 ' A' ' 263' ' ' ILE . 23.2 t80 -119.78 133.47 55.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.019 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.8 mp -121.11 115.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -115.2 -171.97 16.97 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.34 -1.31 85.79 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.824 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 330' ' ' LEU . 89.5 mt -70.74 125.99 92.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -173.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 25.6 Cg_exo -63.71 142.44 83.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.667 2.245 . . . . 0.0 111.115 172.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -62.67 -17.89 61.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -86.03 -9.16 57.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.7 mt -102.85 130.06 49.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.156 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -104.38 -177.32 3.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.413 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.686 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.9 p-10 -48.6 -46.88 40.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.383 0.427 . . . . 0.0 111.744 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.14 -44.0 87.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.487 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.6 -38.34 59.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.48 -30.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 0.0 109.914 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 14.4 ttpp -50.45 -38.95 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.722 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.45 -35.05 79.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.591 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.41 -27.61 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.89 0.376 . . . . 0.0 110.228 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 77.1 mt -82.98 -38.8 22.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.116 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 33.3 p -68.41 -11.66 60.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.952 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 74.6 p -50.31 -48.08 55.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.9 -40.99 21.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.775 0.321 . . . . 0.0 110.723 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.75 151.4 20.81 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 280' ' ' THR . 25.3 Cg_endo -67.08 156.08 67.93 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 112.3 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.18 132.98 45.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.646 0.736 . . . . 0.0 111.244 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -78.89 -42.46 27.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.354 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -142.44 128.12 19.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.419 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 10.5 t80 -138.74 107.06 5.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 110.14 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -116.24 108.57 16.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.424 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -94.44 125.69 39.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.31 131.77 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.863 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -117.83 157.84 25.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.544 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 6.0 t70 -100.17 125.18 46.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.2 t -76.3 -14.28 60.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.796 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.28 -37.81 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 111.458 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 81.7 p -86.24 -28.08 24.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.201 0.524 . . . . 0.0 110.563 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.74 18.4 77.35 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 48.5 mt -130.18 179.53 5.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.456 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 290' ' ' LEU . 69.2 m -74.77 147.36 41.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.63 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 302' ' ' TYR . 35.4 mmtt -73.32 -25.6 60.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.147 0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 97.14 22.54 17.06 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.068 -176.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 1.9 p90 -157.42 146.81 20.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 110.978 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.37 18.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.222 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -129.84 137.84 50.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 31.7 p -139.65 166.88 23.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 112.079 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 254' ' ' VAL . 31.1 mt-10 -133.21 134.04 43.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.366 168.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -83.24 149.52 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.233 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.64 -36.61 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -115.62 149.08 38.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.252 174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.448 ' HB ' ' CD2' ' A' ' 259' ' ' HIS . 2.8 pp -84.66 -13.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.749 -171.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -78.99 -41.21 29.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.008 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.87 -17.0 21.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.44 HG23 HD11 ' A' ' 261' ' ' LEU . 31.3 m -50.83 -44.41 59.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.893 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.88 -39.51 50.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.433 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -61.29 -37.39 83.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 111.507 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.81 -52.36 31.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.54 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.486 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -64.8 -20.88 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.61 67.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.262 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.19 -37.01 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.79 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.97 -28.27 55.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.928 0.364 . . . . 0.0 111.86 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.6 t-20 -66.8 108.8 2.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 329' ' ' LYS . . . 104.65 12.68 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.827 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 35.0 ttm -68.52 113.62 6.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 103.55 4.25 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.467 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.44 111.01 15.23 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 86.61 -116.38 4.42 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.0 5.15 12.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.433 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -122.97 165.74 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.768 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 322' ' ' GLY . 24.7 mtmm -109.86 127.94 55.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 266' ' ' LEU . 27.4 mt -75.93 137.98 40.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -173.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -89.14 115.42 26.65 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 67.5 t -124.19 107.0 17.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.322 0.582 . . . . 0.0 109.506 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -147.46 145.53 29.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.001 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.455 ' O ' HG22 ' A' ' 337' ' ' VAL . 55.1 mtp180 -63.44 129.05 38.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.02 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -73.06 5.8 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.5 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 1.9 p -67.32 -22.79 65.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 334' ' ' ARG . 20.6 m -83.11 -3.06 7.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.765 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -86.81 131.43 10.56 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.069 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -79.83 -20.82 45.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -88.31 143.48 26.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.106 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -106.95 -179.85 4.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.527 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.654 -0.688 . . . . 0.0 110.202 178.765 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -73.33 -44.53 58.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.983 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.4 t 62.82 92.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.188 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 -177.91 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.675 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.9 t -65.63 -53.11 45.97 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' HG3' HG22 ' A' ' 145' ' ' THR . 41.2 tp60 -178.5 145.44 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.351 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -60.45 -18.88 54.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.073 179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 143' ' ' GLN . 8.9 t -119.47 18.64 12.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.649 0.738 . . . . 0.0 110.254 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -66.72 -41.98 87.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.841 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -87.6 -4.53 58.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.423 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -86.32 -32.04 21.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -87.95 -12.97 43.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.024 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 99.6 mtt180 -110.9 156.49 21.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.556 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.97 152.61 42.16 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 20.0 t80 -81.08 113.09 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.216 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -99.3 125.89 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.974 0.416 . . . . 0.0 111.283 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.17 176.19 22.48 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 65.84 52.29 1.28 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.647 0.737 . . . . 0.0 109.409 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 pt -119.2 150.92 50.11 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 11.5 Cg_endo -91.8 146.57 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.425 2.75 . . . . 0.0 112.17 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 195' ' ' LYS . 86.6 t80 -66.13 111.47 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.76 15.56 36.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.161 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 148.53 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.187 0.518 . . . . 0.0 110.287 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.5 m -99.63 144.83 28.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.037 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 162' ' ' GLU . 1.5 mp0 -42.49 -54.51 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.865 0.728 . . . . 0.0 111.545 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.17 -37.37 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.803 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.85 -55.25 36.79 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.343 0.592 . . . . 0.0 111.088 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -78.24 -29.33 48.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.388 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.0 ttt -61.22 -54.54 42.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.695 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.52 -33.32 75.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.858 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.558 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.1 OUTLIER -63.13 -49.9 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 29.6 m-85 -72.68 -40.04 66.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 72.8 m-20 -56.35 -34.79 66.94 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -68.1 -39.67 82.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.057 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 62.6 mm-40 -64.12 -38.65 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.469 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.27 -41.72 93.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 83.4 mtt180 -69.4 -36.01 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.438 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 97.9 mt -61.75 -50.43 72.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.64 65.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.667 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.03 30.97 24.41 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.304 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.82 -22.45 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.3 . . . . 0.0 110.22 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.23 108.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.097 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -88.19 -30.04 20.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.031 0.443 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -108.56 149.03 38.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.968 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.48 145.03 95.55 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.291 1.994 . . . . 0.0 111.421 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.15 -149.95 19.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.463 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.51 123.91 42.75 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.817 0.341 . . . . 0.0 111.12 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.4 -37.82 22.15 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.201 2.601 . . . . 0.0 112.398 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.55 123.53 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.44 -46.72 8.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.305 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.74 40.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.515 HG22 HD23 ' A' ' 200' ' ' LEU . 3.5 t -127.82 140.12 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -119.15 117.81 29.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.014 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.456 ' CD1' ' HG3' ' A' ' 162' ' ' GLU . 3.8 mp -106.58 129.19 60.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.529 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -76.69 151.7 36.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.468 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.4 -3.76 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.19 161.7 14.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.082 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 158' ' ' PHE . 17.9 ptpt -80.48 34.89 0.33 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.249 0.547 . . . . 0.0 110.864 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.38 -65.27 1.01 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.388 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -153.78 167.94 27.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.328 0.585 . . . . 0.0 112.143 -173.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.55 155.96 49.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.131 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.5 125.35 50.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.878 0.371 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 189' ' ' VAL . 20.2 mt -94.62 125.29 39.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.686 174.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -105.05 130.62 53.2 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.531 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 61.5 m-85 -109.79 157.48 19.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 181' ' ' ALA . 37.3 ptt180 -78.16 -18.98 54.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.787 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 54.7 m -147.91 139.56 23.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.797 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.66 -25.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.44 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -76.21 -23.76 54.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -84.23 -20.9 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.237 0.541 . . . . 0.0 109.673 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 67.6 m -69.83 -49.87 48.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.639 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.8 t -60.69 -36.79 79.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.43 -22.45 61.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.79 -28.49 60.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 109.87 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 23.8 mtp -72.76 -14.64 61.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.192 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -18.15 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.489 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.476 ' CG ' ' HE2' ' A' ' 219' ' ' PHE . 11.4 m-85 -84.56 5.19 28.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.57 107.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.466 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.51 13.54 59.68 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.017 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -94.56 154.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.151 0.476 . . . . 0.0 110.818 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.8 mm -97.73 100.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.132 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.672 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.9 m-85 -105.03 103.39 12.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.69 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 60.54 37.63 19.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.95 -13.57 63.47 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.155 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.8 pt20 -100.96 132.83 46.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.604 0.702 . . . . 0.0 110.344 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.0 t -98.7 90.41 4.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 224' ' ' LEU . 1.3 pp -91.71 144.69 25.25 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.46 143.25 47.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.153 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.4 mp -130.65 115.41 31.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.9 tpt180 -97.8 144.33 27.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -103.82 113.02 65.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.396 . . . . 0.0 111.158 -174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.17 148.9 89.29 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.524 2.149 . . . . 0.0 111.54 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -123.34 10.83 9.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -100.47 41.4 1.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.191 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -161.31 157.35 25.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.153 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -158.9 115.49 1.65 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 123.283 0.365 . . . . 0.0 110.531 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 58.7 Cg_endo -74.0 131.53 15.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.41 2.073 . . . . 0.0 111.346 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 235' ' ' LEU . 2.1 pp -147.53 151.58 39.92 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 111.466 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.79 -159.47 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.41 2.74 . . . . 0.0 111.854 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 128.63 -53.39 0.8 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.08 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.2 mtm -116.4 24.42 11.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.516 0.674 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 72.65 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.0 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.85 106.39 17.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.457 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -115.4 115.48 42.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.598 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.8 -74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.443 2.762 . . . . 0.0 113.802 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 18.6 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 110.477 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.1 m -75.03 171.12 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.345 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -140.8 131.38 25.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.66 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.31 117.81 25.15 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 121.084 0.469 . . . . 0.0 111.527 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.82 119.42 6.43 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 111.535 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.55 26.16 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.735 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 94.8 t 58.89 87.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.765 0.793 . . . . 0.0 112.2 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.16 127.03 61.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.039 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.2 m -81.39 147.88 29.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 67.2 p -93.27 4.08 54.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.554 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 4.3 p -109.12 106.64 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.861 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.03 110.12 39.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.992 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 8.1 Cg_exo -72.53 139.72 31.81 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.996 2.464 . . . . 0.0 110.953 172.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.49 ' HA ' ' HG3' ' A' ' 260' ' ' LYS . 26.9 t70 -86.65 83.44 7.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.463 0.649 . . . . 0.0 110.479 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 33.1 t -89.55 -178.03 5.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.823 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.74 65.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.665 0.745 . . . . 0.0 110.023 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -102.46 31.63 3.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.377 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 256' ' ' ASP . 2.3 tmtp? -67.75 133.34 49.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.17 149.24 43.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.483 . . . . 0.0 112.251 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.403 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 45.2 t80 -119.62 132.12 55.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.796 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 305' ' ' CYS . 2.5 mp -116.25 120.05 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.02 0.438 . . . . 0.0 110.298 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.39 -174.43 13.84 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 87.47 -6.72 82.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.008 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.495 ' HB2' ' C ' ' A' ' 301' ' ' GLY . 91.9 mt -68.86 127.62 93.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -172.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.01 140.17 59.12 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.173 1.915 . . . . 0.0 109.803 166.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -64.55 -15.08 60.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -169.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -83.61 -7.56 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.021 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.35 126.47 42.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -104.4 176.15 5.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.699 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 12.6 t70 -40.22 -43.49 1.69 Allowed 'General case' 0 CA--C 1.534 0.327 0 O-C-N 123.644 0.59 . . . . 0.0 111.882 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.43 -47.9 74.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.896 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -73.74 -39.64 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.94 -32.6 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.671 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.9 mtmm -56.26 -33.98 65.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.651 0.262 . . . . 0.0 111.176 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.48 -31.53 72.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.406 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.74 -34.92 60.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.131 0.491 . . . . 0.0 110.174 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.93 -32.23 27.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.274 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 17.0 p -69.38 -13.8 62.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.753 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.4 m -49.63 -46.43 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.467 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.26 -41.12 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.158 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.19 164.34 35.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.915 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -70.48 166.17 29.36 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.776 2.317 . . . . 0.0 111.85 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.2 mt -112.22 133.18 54.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.732 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.35 -38.09 74.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.272 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -152.27 131.96 13.16 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.686 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -138.57 117.89 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.266 0.555 . . . . 0.0 110.559 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -121.39 102.37 8.22 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.789 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 6.5 tt -86.82 133.6 33.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.329 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.92 133.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.541 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -122.16 165.29 16.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 295' ' ' ALA . 20.5 t70 -110.0 133.35 53.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.74 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.7 t -83.86 -11.12 57.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.92 0.391 . . . . 0.0 110.537 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.483 ' HB3' ' OD2' ' A' ' 293' ' ' ASP . . . -88.31 -43.46 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.735 0.302 . . . . 0.0 111.003 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 70.0 p -83.39 -30.66 27.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.17 0.51 . . . . 0.0 110.787 176.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.46 13.52 80.16 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 42.2 mt -123.61 -175.43 3.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.709 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 290' ' ' LEU . 36.6 m -74.75 152.45 39.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.133 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.38 -10.9 50.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.544 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.495 ' C ' ' HB2' ' A' ' 266' ' ' LEU . . . 92.66 26.84 16.1 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.67 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -164.42 149.43 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.029 0.443 . . . . 0.0 110.615 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -149.37 170.27 18.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.912 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.435 ' CD1' ' HE2' ' A' ' 260' ' ' LYS . 98.5 m-85 -123.19 127.97 49.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.484 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 263' ' ' ILE . 12.4 p -122.42 162.48 21.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.101 0.476 . . . . 0.0 110.187 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 111.96 6.04 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -70.38 171.3 10.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.962 0.411 . . . . 0.0 110.995 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.83 -45.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.567 ' HB2' HG12 ' A' ' 312' ' ' VAL . 11.0 m-20 -85.6 142.15 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.96 -14.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.248 0.547 . . . . 0.0 110.498 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 309' ' ' ASP . 3.7 p-10 -86.89 -24.24 24.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.026 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' A' ' 309' ' ' ASP . 8.9 p -83.78 -18.27 10.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.116 0.484 . . . . 0.0 109.802 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 21.9 m -53.8 -49.23 68.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.257 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.31 -24.82 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -70.79 -36.04 72.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.173 0.511 . . . . 0.0 110.971 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.5 -52.32 14.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.019 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.463 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -61.45 -21.21 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.162 0.506 . . . . 0.0 110.968 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.48 -39.08 74.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.259 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.62 -35.96 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.243 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.5 -34.25 58.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.416 ' OD1' HD12 ' A' ' 331' ' ' LEU . 64.8 t30 -69.91 117.79 11.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.478 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 96.06 10.75 55.88 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.036 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' MET . . . . . 0.461 ' O ' HD23 ' A' ' 330' ' ' LEU . 41.9 ttm -64.22 116.2 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 86.82 7.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.27 121.83 45.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.414 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.18 -117.63 4.52 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -116.37 -14.68 11.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 110.793 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.41 165.26 11.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -107.31 125.86 51.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.898 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 265' ' ' GLY . 2.6 mm? -73.21 133.97 44.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.814 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.416 HD12 ' OD1' ' A' ' 321' ' ' ASN . 33.6 tp -97.62 122.81 41.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 174.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.463 HG12 HG22 ' A' ' 317' ' ' ILE . 99.6 t -131.22 108.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -139.95 160.08 40.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.8 141.49 36.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -72.04 -14.95 62.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.137 0.494 . . . . 0.0 109.98 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 12.9 t -97.6 46.76 1.02 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.087 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.19 25.46 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.376 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 146.35 162.45 9.82 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . 72.48 -50.39 0.7 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.644 0.778 . . . . 0.0 112.109 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -79.16 77.2 5.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -94.81 78.71 3.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.397 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.728 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 121.231 0.538 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 14.1 tpt -154.96 90.9 1.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.2 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.01 -44.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.591 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.47 -66.98 3.18 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.879 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -151.33 -177.79 6.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -74.61 53.19 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 33.8 ttm -88.62 -47.69 8.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t -72.1 -8.4 54.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.076 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.89 -19.13 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 110.613 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -82.74 -33.68 27.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.452 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.83 -25.95 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.51 -6.59 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.362 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 30.8 mtm180 -110.45 158.08 18.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.233 0.539 . . . . 0.0 111.542 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.34 153.53 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.562 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 15.5 t80 -79.61 118.97 21.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.585 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 200' ' ' LEU . 49.3 t -105.96 121.26 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -122.88 176.21 16.56 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.218 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.2 43.5 1.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.807 0.813 . . . . 0.0 109.866 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.8 pt -116.35 154.6 48.89 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.67 130.91 14.1 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.633 2.222 . . . . 0.0 111.378 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.82 117.64 9.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.657 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.29 6.49 29.41 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.514 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.71 147.93 11.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 110.2 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 m -93.48 144.89 24.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.546 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 189' ' ' VAL . 1.9 mp0 -49.54 -54.21 19.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 123.371 0.42 . . . . 0.0 111.397 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.26 -24.28 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.278 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 -58.39 5.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.704 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 ptp -72.06 -31.67 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.353 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.27 -54.83 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.309 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.62 -36.12 83.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.657 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.6 OUTLIER -56.95 -61.11 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.978 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -58.65 -42.37 88.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -59.79 -42.05 92.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 111.063 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.99 -43.93 77.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.988 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 9.3 mm100 -64.34 -31.81 73.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.165 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.505 ' HB3' HG23 ' A' ' 179' ' ' THR . 11.9 mmt -57.07 -46.17 82.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 174' ' ' ARG . 52.3 mtm180 -73.69 -30.17 62.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 81.0 mt -66.85 -48.39 68.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.359 . . . . 0.0 110.278 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.82 74.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.476 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.56 36.75 10.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.174 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.479 HD12 ' SD ' ' A' ' 173' ' ' MET . 17.3 mt -90.89 -27.37 18.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -60.16 108.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.809 -177.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -22.97 14.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.13 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.7 127.78 27.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.46 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.86 142.17 98.07 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.723 2.282 . . . . 0.0 112.572 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 107.17 -143.16 15.83 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.39 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 18.4 p-10 -108.27 115.07 58.77 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-O 120.953 0.406 . . . . 0.0 110.801 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 19.3 Cg_endo -62.32 -37.8 58.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.817 2.345 . . . . 0.0 112.114 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.43 119.31 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.0 tm? -97.46 -34.96 10.82 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 -170.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.12 157.96 38.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 162' ' ' GLU . 97.2 t -138.0 128.81 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.809 0.338 . . . . 0.0 110.677 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -119.38 125.25 48.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.06 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 162' ' ' GLU . 15.9 mm -90.94 130.69 39.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.49 127.69 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -85.8 -12.31 51.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.726 0.298 . . . . 0.0 110.889 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -84.47 -62.47 1.55 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.31 170.41 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.993 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -82.49 52.41 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.102 0.477 . . . . 0.0 111.502 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.6 167.36 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.53 161.65 37.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.821 0.343 . . . . 0.0 111.049 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.49 121.3 43.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.066 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 1.0 OUTLIER -94.47 118.96 32.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.926 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 38.0 tt0 -102.64 126.8 49.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.363 0.601 . . . . 0.0 110.551 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.549 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 59.1 m-85 -106.52 157.29 17.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.443 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.54 ' HB3' ' HG ' ' A' ' 187' ' ' LEU . 17.9 ptt180 -79.18 -20.63 47.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.8 m -141.74 144.07 33.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.51 -26.63 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.007 0.432 . . . . 0.0 111.103 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 209' ' ' THR . 9.2 p-10 -75.58 -18.25 59.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.672 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 203' ' ' ARG . 44.5 mt-10 -86.01 -26.43 25.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 45.0 m -68.31 -44.74 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.816 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.5 t -61.56 -37.01 82.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.171 -174.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.73 -18.22 60.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.55 -27.3 58.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.35 0.595 . . . . 0.0 109.955 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.546 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 9.8 mtt -68.36 -16.24 63.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.14 -24.85 64.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 217' ' ' ILE . 18.9 m-30 -75.33 -0.85 21.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.954 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.8 106.28 1.49 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.57 14.34 38.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.3 tt -106.84 153.94 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.28 99.56 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.141 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.754 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.1 m-85 -103.0 118.94 37.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.513 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 57.61 32.49 21.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.205 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.8 -13.34 64.64 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.593 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 24.7 pt20 -94.36 136.67 34.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.498 0.649 . . . . 0.0 110.438 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.0 t -90.35 124.73 35.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.638 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.48 121.98 42.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.798 0.333 . . . . 0.0 110.528 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -113.23 119.24 37.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.998 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.1 mp -121.75 130.78 74.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.115 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -114.5 149.73 35.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.546 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 9.3 mpt_? -89.67 113.52 57.1 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.366 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.01 129.6 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.583 2.189 . . . . 0.0 111.813 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.24 36.42 3.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.8 -34.14 71.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.443 0.64 . . . . 0.0 109.543 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -83.05 159.81 22.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.5 112.93 17.96 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 23.1 Cg_exo -64.98 150.97 87.38 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.809 2.339 . . . . 0.0 111.667 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 234' ' ' PRO . 91.2 mt 70.84 132.21 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.841 0.713 . . . . 0.0 111.402 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 151.51 49.85 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.48 77.25 1.75 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.355 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 96.1 mmm -79.71 172.78 13.32 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 61.1 m 71.67 -10.3 0.85 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.677 0.611 . . . . 0.0 111.651 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 292' ' ' LYS . 33.9 mt-10 -86.94 -48.0 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -99.05 136.58 20.51 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.941 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.35 143.63 97.99 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.466 2.111 . . . . 0.0 111.33 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -72.25 81.52 1.01 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.743 0.782 . . . . 0.0 109.363 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 m -116.77 174.86 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.792 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -86.36 132.95 33.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.443 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.83 103.55 49.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.12 119.24 6.22 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.502 2.134 . . . . 0.0 111.744 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 97.26 -3.49 61.81 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 89.2 t 41.94 82.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.708 0.766 . . . . 0.0 112.036 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.86 120.89 34.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.465 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 13.5 m -69.34 139.38 54.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.173 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 p -87.92 1.71 53.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.347 0.594 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.74 108.08 22.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.748 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.26 107.51 59.18 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.822 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.15 160.49 49.41 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.811 2.341 . . . . 0.0 111.346 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.33 142.21 47.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.7 p -156.49 -177.07 6.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.026 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.38 0.69 55.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.243 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -131.52 16.03 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.4 125.99 30.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 0.8 OUTLIER -109.28 139.9 43.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -171.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.421 ' HD2' ' CE2' ' A' ' 304' ' ' PHE . 41.9 t80 -101.91 127.44 48.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.446 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.96 116.53 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.761 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -121.55 176.1 16.3 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.578 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.69 89.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.565 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.2 mt -68.87 129.69 92.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -174.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 139.88 91.09 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.688 2.259 . . . . 0.0 111.238 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.46 -18.66 62.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -98.03 8.2 45.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.57 122.92 48.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.219 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.78 -171.51 1.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.776 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 5.7 p-10 -48.81 -45.46 40.38 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.624 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.32 -47.64 78.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 111.619 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.19 -41.46 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.426 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.01 -31.68 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.441 0.639 . . . . 0.0 110.048 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 0.6 OUTLIER -55.11 -36.7 65.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.382 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.22 -26.34 68.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.663 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.68 -38.36 33.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.213 0.53 . . . . 0.0 109.711 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.74 -42.56 63.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.055 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 30.6 p -66.89 -11.38 55.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.016 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.1 t -59.72 -29.28 68.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.774 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.06 -40.61 6.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.026 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.48 160.48 32.75 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.054 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.31 168.43 23.43 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.151 2.567 . . . . 0.0 112.133 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 305' ' ' CYS . 89.2 mt -117.74 134.1 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.469 0.652 . . . . 0.0 111.729 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 308' ' ' VAL . 38.6 ttmt -70.51 -46.39 63.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.074 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -150.87 133.45 15.64 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.605 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 10.4 t80 -138.28 107.03 5.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.895 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -103.57 105.16 15.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.634 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 303' ' ' ALA . 0.6 OUTLIER -88.34 132.57 34.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 290' ' ' LEU . 27.8 t -98.57 119.07 46.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.161 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.429 ' NZ ' ' HB3' ' A' ' 240' ' ' GLU . 46.4 mtpt -114.41 167.3 10.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 13.6 t70 -96.27 118.49 32.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.3 t -72.12 -10.01 59.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.611 0.244 . . . . 0.0 110.847 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -91.91 -49.45 6.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.264 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 76.0 p -82.4 -27.68 31.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 111.026 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.31 82.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.121 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 29.8 mt -108.49 170.01 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.4 m -82.44 138.92 34.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 110.53 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -63.86 -31.42 72.6 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.133 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 105.55 26.85 6.0 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 17.1 p90 -156.69 141.4 16.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 110.185 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 290' ' ' LEU . . . -149.2 170.28 18.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.179 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 94.8 m-85 -131.45 130.29 42.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 30.7 p -130.26 175.68 8.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 111.465 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 129.32 11.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 308' ' ' VAL . 8.4 m-85 -89.06 -0.16 57.2 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 286' ' ' LYS . 44.3 t 75.37 -63.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.555 0.693 . . . . 0.0 109.603 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.548 ' HB3' HG12 ' A' ' 312' ' ' VAL . 15.1 t70 -75.51 135.48 40.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.131 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.26 -19.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -80.53 -45.51 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.782 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 309' ' ' ASP . 7.1 p -65.4 -18.47 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.205 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 23.5 m -53.8 -50.15 66.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.444 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.77 -35.87 62.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 0.0 110.627 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.27 -31.04 71.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 320' ' ' LEU . . . -75.48 -55.16 5.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.899 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.418 HG22 HG12 ' A' ' 332' ' ' VAL . 2.3 pp -61.08 -21.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.762 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.32 79.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.049 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.66 -28.97 6.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 316' ' ' ALA . 78.8 mt -76.44 -36.82 57.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -175.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.05 110.05 2.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.51 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.95 11.47 56.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.277 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 43.6 ttm -60.94 117.19 5.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 110.521 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 94.45 6.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 120.01 40.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.589 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.69 -115.12 4.45 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.85 -3.91 12.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 110.559 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -111.94 156.14 22.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.771 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.79 125.64 49.61 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.26 141.88 41.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.123 0.487 . . . . 0.0 111.081 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.99 121.6 36.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.344 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 320' ' ' LEU . 59.2 t -130.8 111.41 20.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.016 0.436 . . . . 0.0 110.34 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -151.8 149.71 29.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.243 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.536 ' O ' HG22 ' A' ' 337' ' ' VAL . 0.0 OUTLIER -64.29 129.65 40.75 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.083 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -70.29 -8.15 48.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.357 0.599 . . . . 0.0 110.408 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 6.0 m -67.43 -13.27 61.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.455 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 334' ' ' ARG . 32.3 m -81.09 -6.19 9.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.99 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -88.51 -178.94 46.64 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.336 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 167.11 15.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.48 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 72.01 -36.46 0.36 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.423 0.689 . . . . 0.0 111.754 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -67.55 -58.42 4.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.162 0.506 . . . . 0.0 110.348 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.316 -178.197 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 69.24 125.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.856 0.722 . . . . 0.0 111.556 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t 69.2 -75.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.287 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -88.01 64.3 3.64 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.192 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.1 p -154.81 110.62 3.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.808 0.337 . . . . 0.0 110.535 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.03 4.38 8.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.9 ptp -61.72 -30.33 70.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 9.1 t -120.5 21.67 11.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.819 -171.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -70.93 -24.59 62.48 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.229 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' A' ' 231' ' ' ASP . 66.6 mt-30 -79.75 -31.87 41.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.011 0.434 . . . . 0.0 110.021 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -72.57 -31.95 65.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.607 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 145' ' ' THR . 19.9 mtm180 -74.04 -13.2 60.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.82 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.7 ttp180 -110.98 137.35 48.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.979 0.419 . . . . 0.0 110.631 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.13 153.98 38.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.4 t80 -85.53 121.04 27.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.201 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.466 HG21 HD12 ' A' ' 200' ' ' LEU . 21.2 t -108.62 127.63 64.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 0.0 110.942 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -128.72 -178.22 15.26 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.331 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 223' ' ' SER . 4.0 t-20 67.82 28.01 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.773 0.797 . . . . 0.0 109.706 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.5 pt -102.13 150.2 37.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.51 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.14 132.03 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.634 2.223 . . . . 0.0 111.388 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -65.92 123.89 21.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.73 -5.0 30.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.099 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.13 145.23 9.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.253 0.549 . . . . 0.0 110.883 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 m -101.02 148.69 24.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.144 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.435 ' HG3' HD13 ' A' ' 191' ' ' ILE . 1.7 mp0 -47.73 -55.16 10.16 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.454 0.471 . . . . 0.0 110.859 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -54.41 -38.38 66.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.226 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.26 -56.58 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.6 ttm -64.52 -36.82 85.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.259 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.2 ttt -62.49 -55.85 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.15 -36.94 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.316 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -55.49 25.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -60.45 -33.87 73.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.016 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.569 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 6.7 m-80 -59.99 -46.41 89.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.411 . . . . 0.0 110.489 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.664 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -65.7 -43.46 89.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.643 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -47.26 75.96 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.556 ' HE1' ' HB2' ' A' ' 211' ' ' ALA . 0.0 OUTLIER -55.4 -44.71 76.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 111.085 177.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.5 mtm-85 -69.78 -33.41 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 83.2 mt -62.07 -35.78 79.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.948 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.99 -8.87 55.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.714 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.19 58.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.552 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.6 -21.82 18.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.19 . . . . 0.0 111.441 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 246' ' ' VAL . 0.2 OUTLIER -59.26 107.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.32 . . . . 0.0 110.83 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.446 ' HB2' HG21 ' A' ' 244' ' ' VAL . 6.4 pt20 -90.03 -27.51 19.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.77 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.18 149.47 39.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.225 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.06 139.94 30.51 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.216 1.944 . . . . 0.0 111.417 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.34 -158.8 15.79 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.708 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 10.7 m120 -86.8 116.14 64.95 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 4.1 Cg_endo -52.3 -46.34 33.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.601 2.867 . . . . 0.0 112.289 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 200' ' ' LEU . 7.8 p -80.57 136.85 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.4 tp -93.75 -51.22 5.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.929 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.75 142.33 25.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.6 t -110.9 131.83 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.965 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -118.68 126.73 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.435 HD13 ' HG3' ' A' ' 162' ' ' GLU . 3.3 mp -115.65 119.7 62.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.884 0.373 . . . . 0.0 110.398 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -85.54 144.05 28.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 0.0 111.468 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -107.4 3.23 25.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.794 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.31 -45.34 19.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.844 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.12 154.73 45.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.549 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -81.41 52.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.69 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.15 171.01 15.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.975 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -137.6 167.25 22.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.978 0.418 . . . . 0.0 111.297 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -127.95 130.29 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 186' ' ' VAL . 15.3 mt -110.67 117.83 34.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.335 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 37.7 tt0 -104.37 129.76 52.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.593 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 43.0 m-85 -104.98 159.64 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.134 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 38.3 ptt180 -77.34 -20.94 54.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.422 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 m -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.69 -29.1 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.228 0.537 . . . . 0.0 110.044 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 209' ' ' THR . 3.5 m-20 -67.92 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.792 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.16 -21.15 50.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.29 0.567 . . . . 0.0 109.922 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 86.4 m -72.45 -47.94 44.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 206' ' ' ASP . 7.5 t -62.27 -36.02 80.8 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.555 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -73.91 -25.09 59.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.198 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HB2' ' HE1' ' A' ' 173' ' ' MET . . . -68.81 -34.58 75.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.272 0.558 . . . . 0.0 109.956 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.639 ' HE2' HG22 ' A' ' 226' ' ' ILE . 27.8 mtp -68.54 -14.74 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.171 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.26 67.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 110.633 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.4 m-85 -78.55 6.18 9.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.97 106.74 1.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.93 13.84 38.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.036 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.0 tt -103.65 155.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.107 0.454 . . . . 0.0 111.116 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.74 102.3 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.1 m-85 -106.39 117.48 34.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.957 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 57.32 31.73 20.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 0.0 111.443 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.47 -12.81 64.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.873 174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.8 pt20 -105.93 144.95 31.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.318 0.559 . . . . 0.0 110.501 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.435 ' HB3' ' OD1' ' A' ' 155' ' ' ASN . 23.3 t -102.46 128.89 48.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -101.76 120.66 40.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 4.9 mmmp? -114.24 123.08 48.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.639 HG22 ' HE2' ' A' ' 212' ' ' MET . 17.9 mt -130.8 118.79 43.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.01 -171.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.595 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 25.0 tpt180 -105.99 154.18 20.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.718 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -102.45 98.68 11.23 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.079 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 20.4 Cg_exo -66.42 122.85 10.39 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.309 2.006 . . . . 0.0 110.571 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -114.36 57.55 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.271 0.558 . . . . 0.0 110.145 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.569 ' HB2' ' OE1' ' A' ' 147' ' ' GLN . 11.4 m-20 -93.49 33.24 1.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.595 0.712 . . . . 0.0 109.6 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 234' ' ' PRO . 43.3 p90 -160.68 170.98 19.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.944 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -117.6 109.28 41.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 232' ' ' TYR . 16.9 Cg_exo -65.24 150.21 87.72 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.031 2.487 . . . . 0.0 112.066 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.67 131.26 29.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.25 71.9 4.3 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.379 2.053 . . . . 0.0 112.129 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.31 -17.24 76.72 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.098 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 69.2 mtm 68.87 -75.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.257 0.623 . . . . 0.0 110.983 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 43.1 t -128.67 105.8 8.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.879 0.371 . . . . 0.0 110.267 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -98.29 -8.91 26.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.493 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -144.79 109.8 4.78 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.395 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.32 -51.12 0.28 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.226 2.618 . . . . 0.0 112.558 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.9 t -172.97 133.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 180' ' ' GLN . 17.2 m -131.48 161.38 41.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.201 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -76.62 103.56 6.67 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 179' ' ' THR . 2.7 p -75.49 119.03 75.16 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.926 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 179' ' ' THR . 37.1 Cg_endo -67.85 142.62 58.05 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.373 2.049 . . . . 0.0 111.405 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.93 11.53 13.92 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.99 136.75 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.57 121.88 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 32.6 m -69.84 146.92 50.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.289 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.1 p -96.49 19.65 11.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 57.9 t -122.85 105.04 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.76 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.54 111.13 51.03 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 25.5 Cg_exo -63.72 153.58 74.45 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.807 2.338 . . . . 0.0 110.892 173.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -78.98 77.03 5.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.124 0.964 . . . . 0.0 110.8 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -91.22 158.28 16.69 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.63 48.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.088 0.471 . . . . 0.0 110.367 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -90.41 0.38 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.218 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.413 ' HG3' ' HB3' ' A' ' 335' ' ' ALA . 19.2 pttm -72.16 139.05 48.07 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.476 HD12 ' SG ' ' A' ' 305' ' ' CYS . 10.5 mt -112.42 149.27 32.79 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.798 -170.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -107.03 129.57 54.78 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.52 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -116.08 115.15 48.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.909 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.87 175.38 15.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.5 -1.2 83.85 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.442 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.483 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.2 mt -64.35 127.73 92.48 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 27.9 Cg_exo -63.35 149.1 92.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.893 2.395 . . . . 0.0 111.757 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 -18.08 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.529 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -92.76 1.15 57.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.1 mt -112.13 119.73 39.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.032 0.444 . . . . 0.0 109.935 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -104.54 -178.5 3.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.566 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER -40.31 -48.66 2.69 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.77 0.668 . . . . 0.0 112.561 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -65.26 -45.58 83.96 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.05 -49.52 72.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.478 . . . . 0.0 110.652 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 83.0 t -63.94 -33.79 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.341 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 24.9 mtmm -53.19 -46.73 69.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.496 0.188 . . . . 0.0 111.078 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.54 -43.96 76.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.008 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.27 -43.89 89.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.81 -44.35 73.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 34.6 p -62.74 -12.21 22.56 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.7 m -55.61 -35.35 65.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.715 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -90.4 -41.96 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 110.693 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.91 167.79 39.37 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.412 ' HG3' ' HA ' ' A' ' 175' ' ' LEU . 4.1 Cg_endo -77.95 155.8 30.35 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 66.5 mt -106.02 134.48 49.07 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.778 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -77.3 -31.87 54.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -151.76 127.19 10.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.53 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 29.3 t80 -138.48 114.48 10.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.487 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -120.95 107.49 12.74 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 10.0 tt -86.9 123.68 32.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.88 111.19 13.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.436 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.2 165.44 11.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.741 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.3 t70 -98.82 133.72 42.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.7 m -78.04 -15.4 58.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.335 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.94 -44.91 10.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.8 p -89.2 -25.92 21.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.188 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.99 13.98 82.65 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.526 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.9 162.65 16.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 111.303 -172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.3 m -71.87 123.15 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.146 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -63.75 -30.06 71.2 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 109.09 25.12 5.72 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.74 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 19.2 p90 -155.08 144.35 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.11 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -148.97 169.95 19.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.567 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 97.5 m-85 -126.37 131.14 51.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.868 176.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.51 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 21.8 p -129.03 158.95 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.618 0.247 . . . . 0.0 110.668 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 260' ' ' LYS . 0.3 OUTLIER -142.54 125.21 15.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -81.59 156.73 25.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.48 -51.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.683 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.04 153.94 17.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 110.326 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 311' ' ' ASN . 2.9 pp -85.14 -22.37 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.17 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . 0.437 ' N ' HD12 ' A' ' 310' ' ' ILE . 8.0 p30 -79.76 -28.7 40.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.557 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -17.79 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.981 0.419 . . . . 0.0 110.448 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 m -55.91 -52.17 65.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.225 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.14 -19.32 51.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -77.48 -35.91 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.99 -52.53 16.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.731 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -60.69 -21.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.013 0.435 . . . . 0.0 111.091 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.12 83.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.46 -34.67 4.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.301 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.77 -33.55 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.679 0.276 . . . . 0.0 111.628 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -68.81 122.92 19.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.01 10.23 60.02 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.846 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' MET . . . . . 0.445 ' SD ' HD23 ' A' ' 325' ' ' LEU . 33.4 ttm -59.62 116.44 4.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.619 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.62 85.19 6.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' SD ' ' A' ' 323' ' ' MET . 0.2 OUTLIER -103.06 129.85 50.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.25 -118.51 8.02 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.142 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.98 1.82 12.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.927 0.394 . . . . 0.0 110.904 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -110.05 172.58 6.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -117.13 119.77 36.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.06 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.6 145.36 50.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.447 0.641 . . . . 0.0 112.029 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 331' ' ' LEU . 3.1 tm? -91.4 120.18 32.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.801 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 317' ' ' ILE . 41.3 t -129.24 108.93 17.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.558 . . . . 0.0 109.507 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -145.27 161.41 39.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.691 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -64.12 136.36 57.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.413 ' HB3' ' HG3' ' A' ' 260' ' ' LYS . . . -70.54 -14.43 62.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.274 0.559 . . . . 0.0 109.994 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.1 p -88.15 -7.45 56.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.69 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 19.4 m 37.52 40.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.182 1.393 . . . . 0.0 113.412 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -176.31 171.15 44.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.52 18.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.028 0.414 . . . . 0.0 111.036 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 69.62 -54.97 0.59 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.837 0.711 . . . . 0.0 110.517 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -152.14 -52.58 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.348 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.023 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . 8.3 t . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 120.764 0.316 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -59.59 -54.32 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 110.068 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -87.9 -11.45 47.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.57 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 145' ' ' THR . . . -83.72 -33.24 25.15 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.055 0.455 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 96.7 mtt180 -92.95 4.58 53.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 22.8 ttp180 -126.2 129.94 49.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 110.943 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -114.04 153.17 29.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.108 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 59.5 t80 -84.96 119.67 25.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.434 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.65 124.15 57.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.541 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.26 177.87 16.78 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.905 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 4.8 t30 66.02 30.97 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.784 0.802 . . . . 0.0 109.967 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.67 154.44 37.17 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.184 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.02 130.84 12.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.518 2.145 . . . . 0.0 111.259 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.33 108.79 2.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.107 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.52 3.31 7.92 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.585 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.36 145.6 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.082 0.467 . . . . 0.0 110.192 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.2 m -105.32 154.19 20.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.397 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.93 -58.65 4.13 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.477 0.486 . . . . 0.0 111.465 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.11 -35.86 67.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.892 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.89 -56.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.021 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 32.6 ttm -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.7 ttt -59.02 -56.89 16.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.086 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -37.44 81.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.49 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.642 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.4 m-85 -60.5 -51.8 67.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.63 -39.97 88.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -55.75 -42.46 75.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.072 0.463 . . . . 0.0 110.603 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.29 -45.96 78.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.22 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 68.5 mm-40 -59.25 -41.15 88.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.386 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.604 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -56.7 -42.66 79.5 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.875 0.369 . . . . 0.0 111.046 176.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -66.14 -41.66 90.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 58.7 mt -64.86 -49.94 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.293 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.62 0.09 86.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.906 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.3 37.84 91.09 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.771 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.5 mt -93.67 -31.17 14.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.581 0.229 . . . . 0.0 110.386 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.27 108.4 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.278 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -85.71 -29.25 24.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.028 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.0 148.95 38.44 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.619 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.13 157.06 61.66 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.246 1.964 . . . . 0.0 111.901 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.68 -147.55 18.64 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.593 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -102.29 119.52 56.14 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.861 0.363 . . . . 0.0 111.0 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -32.9 34.12 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.911 2.407 . . . . 0.0 112.227 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.73 128.8 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.92 -45.14 7.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.697 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.01 143.54 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.789 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.05 131.42 63.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.26 118.91 32.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.69 118.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.4 p90 . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.68 170.82 15.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 74.6 m-85 -127.84 134.47 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.5 mt -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.25 131.3 48.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.202 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.582 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 45.8 m-85 -110.65 156.99 20.21 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.658 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -74.5 -19.65 60.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.19 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 m -141.89 135.75 29.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.04 -31.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -70.78 -31.35 68.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.372 . . . . 0.0 110.419 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.63 -20.15 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 109.95 173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.4 m -75.59 -48.67 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.945 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -63.77 -31.63 72.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.925 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 210' ' ' GLN . 2.6 pt20 -74.39 -18.1 60.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.595 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.07 -22.58 58.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 109.611 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 226' ' ' ILE . 14.5 mtt -71.29 -17.65 62.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.589 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.53 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.492 ' O ' HG22 ' A' ' 217' ' ' ILE . 10.1 m-85 -81.57 4.12 22.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.577 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.07 106.64 2.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.843 0.354 . . . . 0.0 110.713 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.23 5.58 57.09 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.194 -0.526 . . . . 0.0 112.7 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 214' ' ' PHE . 11.3 tt -96.84 153.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.882 0.372 . . . . 0.0 110.648 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 36.4 mm -108.13 100.53 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.3 m-85 -102.07 108.73 20.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.731 0.3 . . . . 0.0 110.573 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.54 36.34 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.225 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.01 -13.57 66.86 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.916 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.0 pt20 -99.4 138.94 35.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.584 0.692 . . . . 0.0 110.267 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.557 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 21.6 t -96.5 126.03 41.41 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.95 132.33 51.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.53 125.57 48.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.6 mp -128.62 126.44 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 32.3 tpt180 . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.415 HG11 ' HE2' ' A' ' 276' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.233 0.54 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 28.3 m -83.15 149.45 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.7 p -92.9 19.55 7.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 111.318 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.77 113.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.221 0.534 . . . . 0.0 110.53 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 304' ' ' PHE . 21.4 t -107.98 108.19 61.07 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.54 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.89 152.12 82.32 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.923 2.415 . . . . 0.0 111.796 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.92 79.48 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.861 0.838 . . . . 0.0 109.945 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.0 p -87.05 -176.44 5.72 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.379 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -81.67 1.06 35.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -123.76 30.82 6.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.263 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -70.63 133.71 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.008 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.87 142.01 51.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.466 ' HE1' HD23 ' A' ' 331' ' ' LEU . 55.1 t80 -118.38 130.06 55.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.067 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.408 ' CG2' HD21 ' A' ' 266' ' ' LEU . 2.3 mp -117.6 126.8 74.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -130.54 168.65 21.61 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.04 5.91 60.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.379 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 275' ' ' VAL . 78.4 mt -71.48 132.73 85.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.921 0.391 . . . . 0.0 111.881 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 34.2 Cg_exo -59.31 134.55 59.58 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.876 2.384 . . . . 0.0 111.858 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.08 -22.47 64.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.238 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -90.54 4.84 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.79 139.19 49.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.707 0.289 . . . . 0.0 110.351 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -105.65 -177.77 3.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.81 -41.96 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.326 0.391 . . . . 0.0 111.648 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.59 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 33.1 t70 -63.07 -47.97 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 0.0 111.353 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.54 ' HA ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -65.53 -40.81 93.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.727 179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 266' ' ' LEU . 77.5 t -68.41 -30.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.795 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 273' ' ' ASP . 6.9 mtmp? -53.26 -39.51 63.94 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.453 0.168 . . . . 0.0 111.293 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -52.75 -34.95 55.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.761 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.31 -40.48 62.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.88 -38.43 53.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.069 0.461 . . . . 0.0 111.042 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 25.2 p -65.92 -12.49 55.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.043 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.9 m -52.63 -34.21 50.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.166 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -100.58 -40.83 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.9 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.86 162.0 35.51 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.207 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -76.84 160.1 34.25 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.962 2.441 . . . . 0.0 112.28 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 305' ' ' CYS . 77.5 mt -110.44 136.58 49.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 306' ' ' GLU . 18.9 ptpt -80.18 -27.92 38.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.675 0.75 . . . . 0.0 109.008 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -153.86 124.58 7.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.188 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 17.1 t80 -139.13 112.72 8.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.019 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -118.73 115.91 25.47 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.415 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.07 123.47 38.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.9 t -82.25 106.03 12.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.751 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -95.31 159.41 15.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.347 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.473 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 8.7 t70 -94.87 133.47 38.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.0 m -72.36 -18.37 61.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.382 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.42 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 82.5 p -99.44 -28.31 13.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 74.84 15.68 80.76 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.58 157.65 39.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 111.298 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.5 m -65.08 123.06 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.442 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -68.4 -18.77 64.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.406 . . . . 0.0 110.646 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 106.45 26.4 5.94 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.76 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.24 148.02 21.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.503 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.54 170.12 19.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.81 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.491 ' O ' HG21 ' A' ' 254' ' ' VAL . 98.1 m-85 -125.83 136.55 53.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.66 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 19.6 p -133.97 166.68 22.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.878 0.37 . . . . 0.0 110.897 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 286' ' ' LYS . 10.6 tt0 -143.62 120.29 11.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -74.36 147.24 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.376 0.608 . . . . 0.0 110.886 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.49 -30.26 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.858 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -116.41 151.61 35.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 310' ' ' ILE . 2.9 pp -84.05 -21.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -41.46 60.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.46 -18.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.815 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 50.5 m -52.93 -56.82 13.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.338 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.99 -22.45 36.56 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.152 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.06 -34.68 64.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.962 0.411 . . . . 0.0 111.001 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.15 -50.9 17.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 HG12 ' A' ' 332' ' ' VAL . 2.6 pp -61.42 -21.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.084 0.468 . . . . 0.0 110.733 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.49 86.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.023 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.34 -33.84 5.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.169 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.67 -35.85 75.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.794 0.297 . . . . 0.0 111.579 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.26 109.59 3.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.453 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.3 3.71 29.22 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 46.3 ttm -61.64 115.32 3.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.724 0.297 . . . . 0.0 110.37 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.0 OUTLIER -85.54 90.53 8.0 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.89 119.76 40.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.12 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.82 -110.76 3.61 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.868 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -106.55 -13.5 15.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -114.23 147.96 38.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 47.1 mtpt -93.01 120.83 33.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 164.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.49 129.24 37.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.188 0.518 . . . . 0.0 110.879 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 262' ' ' PHE . 23.5 tp -88.53 124.82 34.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 317' ' ' ILE . 65.9 t -131.15 108.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.17 143.65 31.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.47 -168.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -69.81 117.63 11.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.122 0.487 . . . . 0.0 110.61 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.915 -175.788 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 13.6 t . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NE ' ' HG3' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -60.99 -22.71 64.76 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.23 -0.294 . . . . 0.0 111.57 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HG3' ' NE ' ' A' ' 146' ' ' ARG . 82.1 mt-30 -87.3 -35.36 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.012 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.46 -31.85 67.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.902 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 145' ' ' THR . 34.0 mtm180 -80.62 2.23 26.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.686 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 34.4 ttp180 -122.02 130.54 53.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.304 0.573 . . . . 0.0 111.652 -172.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 212' ' ' MET . 3.9 pp -118.48 154.24 32.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.077 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.8 t80 -81.45 124.4 29.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.607 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG21 HD23 ' A' ' 200' ' ' LEU . 44.0 t -112.43 131.34 64.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 110.738 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.29 177.85 16.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.945 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.81 38.15 2.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.462 0.649 . . . . 0.0 110.359 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.3 pt -109.25 150.94 41.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.69 130.82 9.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.766 2.311 . . . . 0.0 111.641 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.48 118.89 10.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.39 -2.93 22.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.535 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.48 146.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 110.229 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 m -105.18 156.64 17.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 189' ' ' VAL . 24.8 mt-10 -47.51 -59.51 3.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.434 0.459 . . . . 0.0 111.715 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.88 -21.37 66.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.253 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.62 -53.12 30.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.299 0.571 . . . . 0.0 110.284 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.7 ttm -75.79 -33.96 60.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.102 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 14.5 ttt -59.55 -46.47 88.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.535 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.36 -44.51 88.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.449 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.1 m-85 -62.12 -55.66 26.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.707 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -58.71 -43.01 89.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.532 0.206 . . . . 0.0 111.368 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -59.82 -33.75 72.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.388 . . . . 0.0 111.18 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -79.16 -34.56 43.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.381 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 25.8 mm-40 -62.52 -37.76 87.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.868 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.5 -35.48 76.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 0.0 111.022 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.464 ' HD2' ' OG1' ' A' ' 179' ' ' THR . 28.2 mmm180 -78.41 -23.8 46.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.1 mt -76.73 -41.84 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.34 -5.55 75.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.636 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.43 36.05 83.16 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.859 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.94 -22.15 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.718 0.294 . . . . 0.0 110.772 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.71 108.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.325 -178.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -87.88 -33.11 18.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.614 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -106.85 151.17 40.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.805 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 148.86 81.35 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.504 2.136 . . . . 0.0 111.938 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.09 -144.9 17.39 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.608 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.14 124.79 38.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.709 0.29 . . . . 0.0 111.118 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.516 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 41.2 Cg_endo -67.04 -29.51 40.15 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.153 2.569 . . . . 0.0 113.135 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.36 134.47 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.231 0.539 . . . . 0.0 110.86 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.5 mt -89.77 -49.37 6.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.134 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.14 171.26 19.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 0.2 OUTLIER -143.87 139.57 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.14 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -122.53 127.93 50.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.606 0.241 . . . . 0.0 110.786 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.68 127.56 63.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.011 -178.79 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -132.36 170.96 14.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.055 0.455 . . . . 0.0 111.087 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.44 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . 73.0 m-85 -127.3 133.44 50.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.922 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -109.78 129.32 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.3 130.12 56.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 0.0 110.499 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.646 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.4 m-85 -108.53 165.57 11.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.124 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.4 ptt180 -80.75 -18.93 46.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.276 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.9 m -138.7 132.69 31.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.156 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.6 -28.11 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.15 -32.6 72.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.361 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.409 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 53.2 mt-10 -82.66 -20.89 35.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.205 0.526 . . . . 0.0 110.039 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 98.0 m -71.21 -51.32 25.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 173.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.7 t -60.0 -37.63 80.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.662 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.409 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 3.2 pt20 -71.88 -19.65 61.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.4 -28.73 52.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 110.075 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.406 ' HG2' HD22 ' A' ' 151' ' ' LEU . 28.0 mtp -71.63 -14.38 62.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.079 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.2 -22.64 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.861 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.8 m-85 -76.91 2.82 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.999 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.09 106.68 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.99 0.424 . . . . 0.0 110.735 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.44 37.36 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.725 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -108.33 153.36 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.868 0.366 . . . . 0.0 110.523 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.0 mm -105.95 101.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.728 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.3 m-85 -112.82 129.57 56.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.477 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 60.81 21.5 11.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 111.48 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 90.54 -11.63 70.92 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.959 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.728 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.5 pt20 -97.31 140.83 31.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.031 0.416 . . . . 0.0 110.277 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.7 t -93.97 118.41 31.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.23 128.92 38.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.26 122.82 40.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.885 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.5 mp -128.03 125.77 65.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.919 0.39 . . . . 0.0 110.027 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 . . . . . 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.739 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.522 HG11 ' HD3' ' A' ' 276' ' ' LYS . 21.9 t . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 14.7 m -76.49 146.92 38.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.641 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 18.78 9.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.44 121.93 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.5 t -109.58 104.86 56.31 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.545 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.82 169.6 8.51 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.485 2.79 . . . . 0.0 112.218 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.6 79.92 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.72 . . . . 0.0 110.03 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.6 t -91.8 151.85 20.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.328 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.98 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.345 0.593 . . . . 0.0 110.063 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -113.78 31.88 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.367 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -68.07 141.09 56.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 16.3 mt -122.68 143.37 49.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.98 0.419 . . . . 0.0 111.635 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 331' ' ' LEU . 22.7 t80 -117.89 132.38 56.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.855 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 331' ' ' LEU . 2.5 mp -120.0 116.6 50.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.466 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -112.22 -176.89 19.96 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.1 69.75 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.147 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.497 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.1 mt -62.93 130.16 93.81 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.29 144.84 98.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.794 2.329 . . . . 0.0 111.285 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -67.16 -18.6 65.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -92.25 -8.8 44.27 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.773 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.82 128.3 43.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.9 -175.77 2.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.9 p-10 -50.67 -41.1 55.24 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.185 0.303 . . . . 0.0 111.082 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 19.2 t70 -70.79 -32.9 70.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.99 0.424 . . . . 0.0 111.495 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.67 -41.77 26.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.065 0.46 . . . . 0.0 110.441 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.83 -29.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 25.5 mtmm -50.69 -40.26 53.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.009 0.433 . . . . 0.0 110.845 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.94 -21.68 66.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.39 -32.01 19.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 110.264 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.4 -28.98 28.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.143 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.1 p -67.97 -12.2 60.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 16.8 m -50.57 -40.25 51.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.961 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.66 -39.12 10.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.15 155.69 27.21 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.994 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.0 Cg_endo -72.16 155.94 56.06 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.04 1.827 . . . . 0.0 111.865 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 250' ' ' VAL . 78.7 mt -102.48 138.3 39.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.927 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 308' ' ' VAL . 0.1 OUTLIER -85.65 -24.4 27.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.44 0.638 . . . . 0.0 109.338 176.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.62 124.61 6.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.053 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 9.9 t80 -139.27 111.39 7.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.077 0.465 . . . . 0.0 110.246 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.95 108.34 17.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.536 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -99.24 133.96 42.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.5 t -94.13 109.78 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 58.8 mtpt -90.09 164.5 14.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.212 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.558 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -104.34 127.49 52.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.886 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 t -76.65 -11.95 59.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.31 -31.37 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.629 0.252 . . . . 0.0 111.372 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 69.7 p -93.46 -27.69 16.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.028 0.442 . . . . 0.0 111.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.22 14.17 82.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.03 -172.97 2.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.254 -0.473 . . . . 0.0 109.764 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 61.4 m -81.94 147.18 29.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.174 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.26 -19.5 56.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.107 0.479 . . . . 0.0 110.381 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 96.68 27.38 9.74 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.753 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 14.4 p90 -154.13 144.08 21.88 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.275 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.06 19.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.337 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 92.9 m-85 -128.14 133.18 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.396 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 29.5 p -130.05 166.11 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.265 0.555 . . . . 0.0 111.251 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.66 125.79 21.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.715 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -80.86 154.88 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 286' ' ' LYS . 46.5 t -68.09 -35.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.955 -175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.81 158.02 28.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.073 0.463 . . . . 0.0 110.263 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.89 -19.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.511 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 -30.11 57.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.55 -26.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.321 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.464 HG23 HD21 ' A' ' 261' ' ' LEU . 15.6 m -54.62 -53.48 54.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.481 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.34 -31.04 68.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.14 -36.5 72.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.83 -52.79 10.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.183 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.461 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -59.61 -25.28 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.493 . . . . 0.0 110.705 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.18 -45.21 81.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.455 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.11 -27.36 7.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.612 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.12 -36.27 40.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.984 0.392 . . . . 0.0 111.703 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 2.3 t-20 -68.26 112.13 4.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.68 5.14 26.09 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.745 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 40.7 ttm -62.39 115.25 4.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 0.0 110.198 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.48 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -85.06 96.55 9.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 111.28 22.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.538 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.54 -109.47 2.8 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.341 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.82 6.4 11.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.925 0.393 . . . . 0.0 111.176 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -120.74 149.08 43.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.774 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.48 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 42.6 mtpt -98.66 119.61 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.39 134.06 45.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.443 0.64 . . . . 0.0 111.388 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -88.16 121.49 30.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 53.3 t -130.48 107.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.68 160.67 42.43 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.899 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.66 130.65 40.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 121.318 0.58 . . . . 0.0 110.122 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.368 0.604 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' HD2' ' HG2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -66.84 -31.03 71.38 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.014 -0.429 . . . . 0.0 111.081 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' HG2' ' HD2' ' A' ' 146' ' ' ARG . 10.9 mm100 -87.51 -5.69 58.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.904 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.03 12.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.906 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 83.5 mtt180 -79.43 -6.12 56.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.95 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 18.4 mtm180 -110.37 150.91 28.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.14 0.495 . . . . 0.0 111.1 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 226' ' ' ILE . 2.5 pp -135.06 153.09 52.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.967 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -82.03 110.3 17.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.674 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 51.1 t -96.55 116.19 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.306 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.51 171.72 14.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.468 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 225' ' ' LYS . 4.9 t30 62.36 55.33 2.35 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.809 0.814 . . . . 0.0 109.451 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.0 pt -112.42 147.67 37.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.476 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 57.1 Cg_endo -80.26 130.79 8.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.711 2.274 . . . . 0.0 111.318 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.73 124.95 22.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.253 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.32 -0.67 53.87 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.134 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.437 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 16.1 tt -60.88 144.69 13.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 110.202 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 m -96.98 150.0 21.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.18 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.488 ' HB3' HG13 ' A' ' 189' ' ' VAL . 42.1 mt-10 -48.1 -59.87 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 166' ' ' MET . 8.4 pt-20 -66.16 -15.72 63.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.72 -58.32 4.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.0 ptp -76.17 -29.84 57.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.128 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.44 ' HB2' HG11 ' A' ' 189' ' ' VAL . 21.0 ttt -60.07 -54.93 40.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.37 -36.59 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.2 m-85 -60.0 -52.23 66.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.283 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -64.85 -38.82 92.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.206 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -59.69 -40.28 87.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.16 -49.69 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.93 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 70.0 mm-40 -60.47 -33.47 72.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.156 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 8.4 mmt -61.63 -41.87 98.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -72.15 -38.62 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.232 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 72.2 mt -63.68 -50.6 68.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.667 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.17 -10.13 86.45 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.571 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.16 40.08 56.78 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.479 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 22.0 mt -93.34 -24.33 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -58.38 114.72 2.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.956 0.407 . . . . 0.0 111.519 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.84 -34.3 15.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.107 0.479 . . . . 0.0 110.683 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -107.65 150.44 40.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.544 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.71 132.57 40.8 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.051 1.834 . . . . 0.0 111.489 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.97 -162.12 12.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.545 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.77 124.18 73.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.497 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 49.4 Cg_endo -70.83 -31.96 14.93 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.882 2.388 . . . . 0.0 111.957 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.78 116.73 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.8 tp -85.06 -45.12 12.4 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.381 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.01 165.44 32.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.196 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 162' ' ' GLU . 0.6 OUTLIER -145.09 131.04 14.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.673 178.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.44 121.23 38.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 162' ' ' GLU . 4.5 mp -97.22 111.0 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.45 ' HE2' ' CE1' ' A' ' 199' ' ' PHE . 8.7 p90 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.278 0.561 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -131.83 164.67 25.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.258 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 25.7 m-85 -124.11 123.97 41.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.724 0.297 . . . . 0.0 110.732 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 189' ' ' VAL . 66.2 mt -95.68 131.41 41.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 32.3 tt0 -107.03 141.7 37.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.855 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.407 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 65.0 m-85 -126.47 152.85 45.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.432 0.634 . . . . 0.0 111.581 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 39.3 ptt180 -78.05 -13.03 60.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.639 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 33.3 t -148.18 132.84 17.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.834 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.92 -24.24 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.608 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.29 -34.9 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -82.8 -21.82 34.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.095 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.6 m -65.67 -50.97 62.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.2 t -62.59 -36.86 84.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 111.687 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -76.06 -18.51 59.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.332 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.49 62.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.442 0.639 . . . . 0.0 109.631 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.544 ' HA ' HG21 ' A' ' 226' ' ' ILE . 31.0 mtp -68.89 -14.01 62.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.856 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.51 65.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.512 ' O ' HG22 ' A' ' 217' ' ' ILE . 13.1 m-85 -80.82 7.27 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.66 105.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.881 0.372 . . . . 0.0 111.387 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.71 59.58 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.196 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.7 tt -95.62 153.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 110.544 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.74 103.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 9.5 m-85 -102.88 111.96 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.734 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 59.61 30.97 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.321 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.71 -13.02 66.99 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.504 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 26.5 pt20 -94.89 137.82 33.46 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.778 0.789 . . . . 0.0 110.778 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.9 p -103.54 118.51 36.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.777 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.64 136.25 54.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 111.064 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 155' ' ' ASN . 47.5 mtmt -109.65 135.02 51.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.66 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 212' ' ' MET . 4.2 mp -121.44 105.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.258 0.552 . . . . 0.0 109.815 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.556 -178.626 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 276' ' ' LYS . 12.6 p . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.532 0.682 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 73.5 m -101.21 159.47 15.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.287 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 p -97.22 6.26 48.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.466 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 43.0 t -103.23 100.01 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.731 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.64 107.95 27.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.752 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 31.6 Cg_exo -60.24 169.59 4.89 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.424 2.749 . . . . 0.0 112.667 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.67 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' LYS . 26.7 t -69.24 155.77 39.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.949 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.7 -0.61 57.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.233 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -99.68 -6.36 27.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 257' ' ' SER . 23.7 pttp -72.43 154.94 40.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 334' ' ' ARG . 11.0 mt -128.99 150.58 50.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.235 -172.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -107.3 131.14 54.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.67 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.41 121.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.929 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.62 171.54 18.31 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.574 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.91 2.27 84.19 Favored Glycine 0 N--CA 1.454 -0.15 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.662 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.547 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.4 mt -66.41 136.98 95.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 17.0 Cg_exo -67.22 145.27 71.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.786 2.324 . . . . 0.0 111.386 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 3.0 m-20 -65.53 -20.98 66.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.633 -174.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -90.51 1.4 56.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.1 mt -113.53 122.27 46.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -93.01 -175.93 4.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.986 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 290' ' ' LEU . 3.9 p30 -47.54 -48.17 27.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 29.0 t70 -63.35 -46.99 84.02 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.2 -28.97 65.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.27 -38.38 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.439 0.638 . . . . 0.0 110.382 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.642 ' HB2' ' CD1' ' A' ' 288' ' ' PHE . 15.7 ttpp -60.92 -30.67 70.33 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.68 -30.42 68.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.081 0.467 . . . . 0.0 110.689 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.86 -31.74 35.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.92 -34.99 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.547 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.8 p -71.19 -12.25 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.036 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.0 m -50.51 -43.2 55.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.077 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -86.17 -41.28 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.599 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.55 154.91 26.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.055 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 280' ' ' THR . 30.7 Cg_endo -71.95 155.44 57.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.138 1.892 . . . . 0.0 112.252 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 276' ' ' LYS . 81.8 mt -104.26 140.64 37.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.692 -176.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -84.75 -25.27 28.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -155.26 127.83 7.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.941 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 276' ' ' LYS . 17.2 t80 -138.73 108.91 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -114.83 111.69 21.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 272' ' ' ASP . 9.7 tt -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.14 116.97 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -102.71 168.2 9.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.131 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.5 130.09 47.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 13.3 m -75.43 -12.71 60.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.573 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.42 12.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.4 p -89.07 -27.85 20.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.204 0.526 . . . . 0.0 111.185 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.15 9.17 86.44 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 56.1 mt -121.23 -179.47 4.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.652 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.8 m -80.34 146.95 31.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.143 0.497 . . . . 0.0 111.435 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.56 -24.85 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.778 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 107.75 27.0 5.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.327 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.86 139.0 18.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 117.465 0.632 . . . . 0.0 110.921 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -150.02 169.51 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.537 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.18 134.86 50.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.664 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 261' ' ' LEU . 23.0 p -127.79 165.18 20.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -147.98 129.35 14.8 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -84.94 163.74 18.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 0.0 111.547 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.79 -23.67 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.846 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.04 157.35 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.875 0.369 . . . . 0.0 110.082 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.37 -29.0 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.397 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.04 -27.0 62.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.543 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.461 HG21 ' HA3' ' A' ' 283' ' ' GLY . 14.9 p -84.17 -18.39 9.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.99 0.424 . . . . 0.0 110.713 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 37.0 m -61.98 -47.98 82.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.99 -24.66 43.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.78 -32.54 59.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.32 -53.44 12.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.114 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -60.37 -21.69 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 110.878 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.03 -37.43 69.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.369 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.64 -36.78 3.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.32 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.25 -34.58 65.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -66.08 117.28 8.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.66 8.56 45.65 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' A' ' 330' ' ' LEU . 48.0 ttm -64.35 116.0 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 110.317 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 86.09 7.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.16 112.62 25.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.23 -112.01 3.75 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.638 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.94 -14.1 10.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -113.32 168.42 9.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.51 124.87 50.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.674 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 323' ' ' MET . 13.9 mt -74.03 138.13 43.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.129 -173.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.9 124.18 35.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.698 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 317' ' ' ILE . 41.9 t -130.54 113.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 335' ' ' ALA . 3.5 pt20 -137.69 168.14 20.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.447 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.605 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 mmm180 -74.56 34.61 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.951 0.5 . . . . 0.0 112.103 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 333' ' ' GLN . . . . . . . . 0 C--N 1.316 -0.886 0 O-C-N 124.843 1.339 . . . . 0.0 113.419 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -65.97 -17.96 65.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.147 -0.346 . . . . 0.0 111.331 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -87.31 -19.05 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.743 0.306 . . . . 0.0 110.788 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.99 -29.48 14.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 110.372 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.07 -6.16 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.855 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 40.0 ttp180 -114.28 130.11 56.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.034 0.445 . . . . 0.0 110.943 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.18 154.21 31.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.643 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 54.1 t80 -83.7 118.37 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.373 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG21 HD12 ' A' ' 200' ' ' LEU . 23.1 t -104.2 132.6 50.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.73 176.66 17.9 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.831 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 t30 68.28 30.58 5.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.443 0.639 . . . . 0.0 110.589 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.1 pt -92.65 150.24 39.38 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.82 134.1 17.71 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.502 2.134 . . . . 0.0 111.332 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -62.05 113.92 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.6 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 110.44 2.03 29.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.641 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.454 HD13 ' HE2' ' A' ' 165' ' ' MET . 18.7 tt -57.66 146.23 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.211 0.529 . . . . 0.0 110.39 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.6 m -102.28 152.15 21.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.411 ' HA ' HD11 ' A' ' 191' ' ' ILE . 38.1 mt-10 -48.93 -58.6 4.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.515 0.509 . . . . 0.0 110.98 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.52 -37.16 72.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.885 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.28 -57.8 11.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.758 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.454 ' HE2' HD13 ' A' ' 160' ' ' ILE . 33.3 ttm -67.79 -39.54 84.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.502 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 189' ' ' VAL . 15.6 ttt -60.01 -56.74 17.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.675 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.82 -38.39 85.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.053 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 1.4 m-85 -59.99 -57.81 11.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.972 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.451 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -60.36 -42.38 95.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 110.749 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.65 -44.12 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 21.8 mm-40 -62.74 -37.69 87.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.324 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 179' ' ' THR . 10.3 mmt -55.82 -42.92 76.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.921 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -75.79 -33.61 60.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.726 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 92.7 mt -62.81 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.47 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.86 -16.03 68.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.468 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.97 37.22 26.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.06 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.494 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 17.6 mt -90.33 -26.96 19.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 0.0 110.66 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -59.53 108.77 0.77 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 111.762 -176.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.78 -33.22 25.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.6 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -108.68 154.47 41.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.509 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 14.2 Cg_exo -69.8 143.93 52.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.608 2.205 . . . . 0.0 111.544 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.02 -151.85 16.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.369 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 93.6 m-20 -98.23 117.01 65.43 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_endo -61.3 -35.43 84.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.427 2.084 . . . . 0.0 111.534 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -78.76 131.5 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.525 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 tp -98.9 -40.8 7.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.812 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.64 150.16 27.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.788 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.481 HG22 HD23 ' A' ' 200' ' ' LEU . 7.3 t -126.26 125.75 68.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.627 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -118.3 112.14 19.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.444 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 191' ' ' ILE . 4.2 mp -104.62 104.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.717 -179.329 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.428 ' HE1' ' CE2' ' A' ' 199' ' ' PHE . 15.2 p90 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 120.834 0.35 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 160.1 39.68 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.428 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 54.0 m-85 -117.76 122.59 43.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.614 174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 14.2 mt -103.93 110.22 22.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.902 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -93.92 126.36 39.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.519 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 50.1 m-85 -103.03 165.11 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -84.65 -15.65 44.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.474 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 m -148.24 136.96 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.07 -30.32 49.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.114 0.483 . . . . 0.0 110.512 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 209' ' ' THR . 4.9 m-20 -64.29 -36.23 83.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.11 -21.14 40.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.378 0.608 . . . . 0.0 109.924 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 85.9 m -70.1 -48.61 56.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.151 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 206' ' ' ASP . 14.9 t -62.5 -36.1 81.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.966 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -74.62 -18.38 60.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.729 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.8 59.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.477 0.656 . . . . 0.0 109.552 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 10.4 mtt -67.75 -17.33 64.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.961 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.36 63.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 217' ' ' ILE . 11.8 m-30 -77.51 -2.86 37.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.624 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.96 106.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 0.0 110.513 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.21 4.33 59.85 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.569 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.467 HD13 ' CZ ' ' A' ' 219' ' ' PHE . 7.9 tt -92.31 156.74 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.05 99.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.284 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.731 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.4 m-85 -104.5 122.82 46.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.374 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 61.59 20.08 10.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 111.383 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 93.46 -11.15 72.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.082 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.731 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 19.9 pt20 -94.98 142.95 26.88 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.336 0.589 . . . . 0.0 110.288 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.1 p -103.51 124.39 48.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.557 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.5 mt -108.34 136.77 47.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -120.99 126.68 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.866 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.01 125.5 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 12.7 tpt180 . . . . . 0 C--N 1.32 -0.678 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 12.9 m -63.92 129.22 39.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.626 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.5 p -89.28 4.22 49.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.411 0.624 . . . . 0.0 110.626 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 3.5 p -107.52 104.45 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.836 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.62 109.63 39.88 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.73 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.8 Cg_exo -60.73 144.79 99.6 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.856 2.371 . . . . 0.0 111.066 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.53 90.62 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.723 0.773 . . . . 0.0 110.627 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.7 m -96.06 168.89 10.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.585 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.89 57.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.14 0.495 . . . . 0.0 110.701 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -111.47 27.79 9.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.868 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -55.45 144.86 24.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.709 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 313' ' ' THR . 14.8 mt -122.36 134.45 54.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -111.6 125.81 54.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.752 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.6 mp -113.32 114.09 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.64 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -120.5 -177.79 15.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.1 89.41 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.365 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.474 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 95.7 mt -69.01 130.67 91.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.963 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.17 139.43 85.67 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.764 2.309 . . . . 0.0 111.226 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.88 -1.2 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -103.12 -6.43 22.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.3 mt -96.84 128.61 43.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -104.56 -177.18 3.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 5.5 p-10 -48.71 -43.29 37.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -60.16 -44.4 95.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.616 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.7 -42.05 51.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.455 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.58 -28.63 43.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.687 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 50.2 mtmt -56.01 -33.77 65.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 110.997 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.81 -30.49 70.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.058 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.34 -40.82 29.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 0.0 110.285 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 48.0 mt -76.0 -30.42 58.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.358 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 7.4 p -67.5 -13.62 62.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.6 m -55.54 -30.42 60.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.856 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -103.79 -40.72 6.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.597 0.237 . . . . 0.0 111.435 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.2 163.06 35.79 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.369 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -72.03 162.32 42.18 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.304 2.67 . . . . 0.0 112.058 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' A' ' 305' ' ' CYS . 85.1 mt -112.27 129.19 56.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.531 0.681 . . . . 0.0 111.34 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.437 ' HB2' HG12 ' A' ' 308' ' ' VAL . 15.5 tppt? -71.09 -46.4 61.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.765 175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -143.3 128.0 18.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.842 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 21.1 t80 -138.14 109.49 6.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.17 117.28 31.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.351 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.9 126.64 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.453 HG12 ' HD3' ' A' ' 300' ' ' LYS . 21.7 t -81.99 121.99 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.266 0.555 . . . . 0.0 110.667 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -115.02 145.66 42.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.546 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.555 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.6 t70 -89.84 140.57 29.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.9 t -85.67 -16.09 40.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.99 -40.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 0.0 110.977 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.9 p -85.56 -28.31 24.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 110.611 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.69 20.89 77.83 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.741 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.98 174.64 9.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.966 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 21.5 m -70.63 137.46 49.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.406 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.453 ' HD3' HG12 ' A' ' 291' ' ' VAL . 24.4 mtpp -86.05 -1.08 57.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.474 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 84.4 27.13 37.09 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.557 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 43.2 p90 -158.62 144.77 16.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.9 0.381 . . . . 0.0 110.308 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.11 168.45 23.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.033 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.58 128.68 48.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.62 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 24.4 p -124.15 158.84 31.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 110.963 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.09 110.2 10.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.697 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.34 137.57 50.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.986 0.422 . . . . 0.0 110.006 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 286' ' ' LYS . 4.5 m -60.57 -27.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.658 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 312' ' ' VAL . 13.8 m-20 -113.22 136.26 52.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.35 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.1 -14.08 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 111.306 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 309' ' ' ASP . 7.8 p30 -82.59 -19.62 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.822 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 309' ' ' ASP . 11.0 p -87.51 -18.49 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 109.879 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.411 HG23 HD21 ' A' ' 261' ' ' LEU . 45.4 m -51.25 -51.62 52.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.885 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.02 -18.78 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.636 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -83.86 -31.84 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.03 -53.99 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.636 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.564 HG22 HG12 ' A' ' 332' ' ' VAL . 2.9 pp -58.23 -25.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.121 0.486 . . . . 0.0 110.912 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -66.87 -42.9 84.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.172 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.98 -30.54 6.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.477 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.13 -35.87 59.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.872 0.336 . . . . 0.0 111.409 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 55.7 t30 -65.39 112.21 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 0.0 110.218 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 107.26 2.25 35.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.371 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.6 ttm -65.75 116.5 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.25 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -81.51 87.14 6.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 110.63 21.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.865 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.03 -122.79 6.28 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.891 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -99.29 -13.65 19.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.784 0.326 . . . . 0.0 111.501 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -126.03 166.76 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.164 0.507 . . . . 0.0 111.64 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 51.8 mtpt -94.05 124.7 38.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.794 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.6 mt -72.23 129.84 39.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.11 120.19 30.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.409 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.564 HG12 HG22 ' A' ' 317' ' ' ILE . 61.0 t -130.82 108.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.285 0.565 . . . . 0.0 109.901 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -151.12 163.03 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.412 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.69 126.74 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.911 -176.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 15.1 t . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -19.71 65.76 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.968 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.21 -28.46 48.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.008 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.56 -32.37 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 145' ' ' THR . 24.0 mtm180 -72.47 -10.75 60.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.96 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 28.4 ttp180 -111.26 132.83 54.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.402 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 226' ' ' ILE . 3.9 pp -117.49 153.38 33.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.701 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -86.61 125.55 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.514 HG21 HD23 ' A' ' 200' ' ' LEU . 41.0 t -110.53 117.09 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 110.623 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.588 ' HA2' ' CD1' ' A' ' 197' ' ' PHE . . . -105.8 169.62 16.18 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.887 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.6 t30 66.89 50.06 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.632 0.729 . . . . 0.0 110.524 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 pt -116.37 150.82 46.06 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.494 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.43 131.02 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.857 2.371 . . . . 0.0 111.62 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -64.14 131.7 48.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.882 0.372 . . . . 0.0 110.162 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.95 8.41 58.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.641 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.5 tt -67.63 147.14 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -101.69 148.79 24.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -46.19 -59.09 3.1 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.679 0.391 . . . . 0.0 111.499 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.7 -34.24 64.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.281 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -57.07 12.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.67 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 4.6 ttm -69.31 -37.69 77.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.413 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.433 ' HG3' HG11 ' A' ' 186' ' ' VAL . 15.1 ttt -57.73 -49.43 76.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.227 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.44 -36.42 83.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.066 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.608 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.0 m-85 -59.26 -53.41 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.408 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -61.98 -41.67 98.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.265 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.07 -40.81 95.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.995 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -62.01 -43.41 98.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.916 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 56.0 mm-40 -64.13 -36.05 82.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.191 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 11.4 mmt -59.62 -42.15 92.04 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.211 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.88 -44.31 81.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.673 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 60.9 mt -62.58 -47.6 83.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.956 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.14 -24.23 72.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.312 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.99 30.33 17.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.813 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.537 ' HB3' ' OE1' ' A' ' 210' ' ' GLN . 23.4 mt -87.72 -17.89 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.51 106.41 0.46 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 111.854 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.33 -4.44 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.592 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.417 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . -89.49 132.46 37.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.49 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.13 131.35 36.31 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.144 1.896 . . . . 0.0 110.426 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 76.98 -140.05 24.31 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.229 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -92.84 126.86 50.0 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.986 0.422 . . . . 0.0 110.373 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 -30.42 67.34 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.163 2.576 . . . . 0.0 112.991 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 166' ' ' MET . 91.1 t -73.12 131.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 203' ' ' ARG . 47.5 tp -90.29 -42.43 10.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.44 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.35 168.05 24.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.35 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.29 136.64 28.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.044 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -125.01 118.13 25.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.549 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.86 125.68 55.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.139 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.588 ' CD1' ' HA2' ' A' ' 154' ' ' GLY . 44.9 m-85 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.781 0.324 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.08 172.24 11.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.397 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.8 139.81 51.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.509 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.514 HD23 HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -115.48 129.16 56.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.37 130.65 56.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.607 0.717 . . . . 0.0 111.133 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.592 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.6 m-85 -106.68 164.43 12.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.795 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 187' ' ' LEU . 14.7 ptt180 -68.06 -28.18 67.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.095 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 38.6 m -152.38 153.56 33.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.07 -30.12 47.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 209' ' ' THR . 2.6 m-20 -57.23 -45.44 83.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 202' ' ' PHE . 2.2 mm-40 -72.31 -32.28 66.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.569 0.7 . . . . 0.0 109.638 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 55.7 m -68.22 -47.2 68.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.537 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.2 t -64.85 -32.8 74.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.662 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.537 ' OE1' ' HB3' ' A' ' 178' ' ' LEU . 7.4 pt20 -75.52 -18.19 59.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.4 51.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.255 0.55 . . . . 0.0 109.816 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 226' ' ' ILE . 9.9 mtt -66.41 -15.31 63.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.411 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -27.11 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.03 0.443 . . . . 0.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 217' ' ' ILE . 27.2 m-85 -83.93 17.22 2.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.462 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.64 117.44 13.21 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.976 -0.453 . . . . 0.0 110.985 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.97 12.67 61.73 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.904 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 214' ' ' PHE . 15.5 tt -100.58 151.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.916 0.389 . . . . 0.0 110.669 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.74 101.72 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.398 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.69 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 13.7 m-85 -104.81 122.46 45.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.73 20.25 8.99 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.688 0.395 . . . . 0.0 112.006 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 98.02 -12.02 63.97 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.202 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.1 pt20 -99.21 138.32 36.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.03 0.415 . . . . 0.0 109.941 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.5 t -92.37 130.01 38.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.986 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.62 118.99 38.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.313 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -109.89 122.77 48.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.459 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.1 mp -119.93 118.82 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.799 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 177.215 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.834 0.349 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.8 m -71.34 146.34 48.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.782 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.0 p -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 110.305 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 61.2 t -97.64 100.66 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.124 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.596 HG12 ' HZ1' ' A' ' 260' ' ' LYS . 6.2 t -93.13 107.05 22.36 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.047 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.1 Cg_exo -58.38 149.18 75.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.336 2.69 . . . . 0.0 112.68 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.48 128.81 44.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.559 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 37.8 t -146.1 -178.72 6.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -78.92 -19.22 52.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 109.776 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -93.62 27.83 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.639 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HZ1' HG12 ' A' ' 254' ' ' VAL . 1.8 tmtm? -70.07 136.52 50.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.186 -176.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' N ' ' HD3' ' A' ' 260' ' ' LYS . 11.7 mt -121.96 149.19 43.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.947 0.403 . . . . 0.0 111.528 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -127.84 136.25 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.353 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 332' ' ' VAL . 2.1 mp -117.67 122.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.068 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.49 -179.55 15.88 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.31 1.17 90.38 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.457 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.0 mt -66.93 133.21 93.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.726 0.298 . . . . 0.0 111.617 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.78 143.42 99.62 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.935 2.424 . . . . 0.0 111.585 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -72.34 -5.67 37.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -102.03 0.67 35.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.7 133.86 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -105.2 -175.77 2.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.6 p-10 -51.83 -40.67 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.597 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.52 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 9.5 t70 -69.69 -39.19 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.675 0.274 . . . . 0.0 111.131 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.13 -37.53 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.195 0.522 . . . . 0.0 110.605 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.2 -30.97 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.81 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 27.2 mtmm -50.81 -41.85 57.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.531 0.205 . . . . 0.0 111.257 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -56.51 -35.58 68.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.504 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.33 -38.03 71.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.902 0.382 . . . . 0.0 110.552 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.2 mt -81.45 -31.31 33.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.281 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 38.1 p -72.78 -12.49 61.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 59.4 p -54.17 -41.51 68.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 111.531 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -87.59 -41.41 13.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 0.0 110.373 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -167.86 154.95 25.4 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.072 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 280' ' ' THR . 31.7 Cg_endo -72.77 156.96 52.64 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.447 2.098 . . . . 0.0 112.643 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.57 136.19 45.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.495 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -75.37 -30.14 60.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.453 176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.92 126.3 7.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.226 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.86 113.16 8.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.38 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -117.37 120.55 38.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.543 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -102.05 129.28 48.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.3 105.29 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.342 0.591 . . . . 0.0 110.82 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.51 164.34 14.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.56 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.47 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -100.55 130.56 46.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 37.9 m -81.79 -9.75 59.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.165 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.9 -40.65 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.966 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 68.2 p -88.21 -28.07 21.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 83.79 8.4 84.46 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.61 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 45.4 mt -118.33 159.42 23.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 111.001 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.8 m -71.62 127.01 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.675 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.92 -9.4 58.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 111.529 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 91.09 26.39 21.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.974 171.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -148.81 144.4 26.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.096 0.448 . . . . 0.0 110.034 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.44 170.78 17.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.4 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.17 135.81 52.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.763 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 13.9 p -134.9 159.12 42.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.718 0.294 . . . . 0.0 110.716 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 254' ' ' VAL . 73.0 mm-40 -133.36 128.85 36.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.645 173.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.75 144.12 26.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.296 0.569 . . . . 0.0 110.366 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.48 -32.9 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.493 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -121.46 157.01 31.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.33 -21.66 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.092 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -71.27 -31.94 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.034 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 283' ' ' GLY . 9.6 p -81.82 -23.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.509 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.3 m -54.73 -54.03 47.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.22 -23.26 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.278 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -34.3 53.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.812 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.26 -49.89 21.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.504 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -61.86 -21.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.644 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.2 60.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.243 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.79 -36.74 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.162 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 332' ' ' VAL . 63.9 mt -75.75 -33.71 60.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.637 0.256 . . . . 0.0 111.296 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.79 112.48 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.75 11.36 56.86 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.453 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.1 ttm -68.65 119.81 13.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 0.0 110.125 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.46 86.57 7.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.61 114.74 28.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.667 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.11 -122.06 6.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.704 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.12 -13.75 15.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 0.0 111.085 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -122.28 173.29 7.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -103.3 128.91 50.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.324 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.452 HD22 HD23 ' A' ' 266' ' ' LEU . 15.6 mt -75.15 129.57 37.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.4 tp -90.18 119.65 30.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.455 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 263' ' ' ILE . 65.0 t -130.51 109.03 16.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.5 177.32 9.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -69.43 130.99 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.193 -177.053 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -35.07 79.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.164 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.4 -11.6 55.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.3 -29.05 20.66 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -79.85 7.9 7.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.882 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 53.7 ttp180 -127.84 130.07 47.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.05 153.03 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.314 0.578 . . . . 0.0 111.945 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 47.8 t80 -82.06 111.32 18.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.43 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.35 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.64 161.68 12.94 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.475 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.7 49.44 0.39 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.744 0.783 . . . . 0.0 110.258 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 pt -104.14 151.04 38.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.13 132.28 7.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.977 2.452 . . . . 0.0 111.475 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -66.5 120.27 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.53 -1.18 18.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.16 143.78 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.0 m -100.58 157.82 16.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -52.53 -58.9 5.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.742 0.306 . . . . 0.0 110.653 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.68 -23.61 64.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.57 -58.47 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.791 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.401 ' O ' ' HD1' ' A' ' 169' ' ' PHE . 19.9 ptp -77.96 -24.53 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.946 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.446 ' HB2' HG21 ' A' ' 189' ' ' VAL . 20.0 ttt -61.62 -56.19 22.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.372 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.89 -31.47 72.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.069 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.622 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.1 m-85 -61.13 -54.26 46.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' MET . 44.8 m-85 -65.64 -42.89 90.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -55.99 -34.09 65.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -73.05 -49.84 26.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 81.2 mm-40 -56.26 -39.72 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.434 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -57.15 -42.06 80.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.097 0.475 . . . . 0.0 110.732 177.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -77.56 -27.48 51.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 76.7 mt -72.84 -36.8 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.61 -23.85 35.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.14 36.39 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.392 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.9 mt -94.88 -26.58 16.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.806 0.336 . . . . 0.0 110.535 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.34 112.32 1.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.105 -178.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.2 -37.62 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.226 0.536 . . . . 0.0 109.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.91 39.74 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.215 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.14 142.18 54.99 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.278 1.986 . . . . 0.0 111.629 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.01 -157.95 15.11 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.79 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -96.23 124.45 51.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.225 0.536 . . . . 0.0 110.946 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.468 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 40.8 Cg_endo -67.94 -29.56 34.25 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.984 2.456 . . . . 0.0 112.624 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.54 132.81 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.187 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.4 mt -89.62 -49.52 6.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.424 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.47 157.69 32.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.758 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.517 HG22 HD23 ' A' ' 200' ' ' LEU . 6.7 t -124.23 128.92 74.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.613 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.55 118.97 35.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.6 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.39 126.92 56.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.593 179.675 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.59 156.74 33.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.005 0.431 . . . . 0.0 110.59 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -127.14 124.19 38.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.948 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.4 mt -103.71 115.37 30.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.281 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -96.85 127.14 42.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.514 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 33.8 m-85 -109.39 158.63 17.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.2 ptt180 -74.1 -18.4 60.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.874 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.0 m -148.49 144.98 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.091 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.81 -36.5 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.302 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 209' ' ' THR . 20.4 t70 -64.46 -40.26 95.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 110.067 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.557 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.0 mt-10 -72.23 -20.62 61.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.239 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 28.6 m -73.46 -50.44 21.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.235 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 206' ' ' ASP . 6.0 t -66.47 -29.2 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.713 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.557 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 1.8 pt20 -71.56 -20.88 61.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.632 0.253 . . . . 0.0 111.125 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.98 48.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.685 0.755 . . . . 0.0 109.539 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.429 ' HG2' HG21 ' A' ' 226' ' ' ILE . 19.7 mtt -71.24 -17.34 62.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.12 -21.82 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.146 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 217' ' ' ILE . 22.8 m-85 -83.28 9.36 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.993 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.54 117.49 6.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.54 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.88 83.86 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 214' ' ' PHE . 7.1 tt -88.19 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.21 98.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.655 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.7 p90 -116.69 139.06 50.97 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.158 173.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 65.22 24.39 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.66 82.63 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.523 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.4 pt20 -113.55 145.81 40.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.103 0.452 . . . . 0.0 110.073 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.2 t -103.36 115.31 30.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.919 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.8 137.32 52.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.157 0.503 . . . . 0.0 111.269 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -122.8 133.8 54.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.612 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.7 mp -132.61 146.08 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 227' ' ' ARG . 20.6 mmt180 . . . . . 0 C--N 1.321 -0.664 0 O-C-N 121.895 -0.503 . . . . 0.0 111.001 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.002 0.429 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 66.3 m -104.23 150.69 24.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.23 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.7 p -86.16 8.1 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.8 112.94 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.357 0.598 . . . . 0.0 110.131 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.36 106.08 54.73 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.97 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.82 166.92 12.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.156 2.571 . . . . 0.0 112.34 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.22 83.6 4.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.252 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -79.62 154.44 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.789 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.8 -16.67 63.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.196 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -128.18 36.92 4.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.295 0.569 . . . . 0.0 110.111 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -74.08 150.43 40.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.008 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 313' ' ' THR . 12.6 mt -122.5 149.1 44.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.879 0.371 . . . . 0.0 111.62 -171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.75 128.77 56.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.768 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 332' ' ' VAL . 2.5 mp -114.94 120.93 65.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.645 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.93 166.41 21.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.893 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.63 5.02 63.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.456 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.538 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.1 mt -68.49 125.61 91.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.978 0.418 . . . . 0.0 112.056 -172.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 143.32 94.51 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.839 2.359 . . . . 0.0 111.648 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 298' ' ' LEU . 10.0 t30 -59.68 -26.71 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.442 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -81.84 -0.12 42.02 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.726 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.2 mt -113.9 124.28 51.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -104.29 -174.5 2.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.8 p-10 -47.78 -44.26 28.31 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.499 0.499 . . . . 0.0 111.842 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 31.4 t70 -72.01 -36.93 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.735 0.303 . . . . 0.0 111.812 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.39 -42.89 67.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 266' ' ' LEU . 97.7 t -72.12 -29.67 33.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' CD1' ' A' ' 288' ' ' PHE . 1.0 OUTLIER -54.45 -39.36 67.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.795 176.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.87 -36.02 81.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.073 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.07 -41.74 67.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.3 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 320' ' ' LEU . 61.9 mt -71.24 -40.13 71.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.181 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.2 p -70.19 -11.87 61.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.794 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 35.3 t -53.11 -40.41 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.12 -41.0 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.21 150.81 20.03 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.707 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.484 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.6 Cg_endo -69.03 156.3 65.68 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.432 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 305' ' ' CYS . 76.7 mt -107.17 134.75 49.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.31 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -28.95 33.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.235 0.54 . . . . 0.0 109.824 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.2 120.97 7.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 17.2 t80 -139.2 109.54 6.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.85 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.58 119.22 34.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.401 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 8.4 tt -98.76 124.49 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.3 126.85 36.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.432 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -122.86 148.72 45.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.403 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 25.1 t0 -77.74 116.35 18.2 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.5 t -70.1 -10.02 57.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.905 0.383 . . . . 0.0 110.511 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.403 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -85.68 -53.47 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 46.6 p -83.28 -23.69 32.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.498 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 78.21 18.34 76.55 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.512 ' HB3' ' OD1' ' A' ' 268' ' ' ASN . 59.6 mt -114.95 157.6 23.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.115 0.483 . . . . 0.0 110.881 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 290' ' ' LEU . 49.5 m -73.48 134.29 43.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 302' ' ' TYR . 18.3 mmtp -61.66 -34.27 75.42 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.344 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 99.82 21.7 13.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.8 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 300' ' ' LYS . 32.0 p90 -153.68 145.0 23.03 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.68 168.25 24.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.911 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.82 132.84 53.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.995 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 32.0 p -127.16 166.35 17.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.964 0.411 . . . . 0.0 111.054 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 127.03 15.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.263 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.21 149.23 25.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.78 -21.03 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.279 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -133.77 159.85 39.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.256 0.551 . . . . 0.0 110.895 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.71 -25.93 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.218 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.8 -34.36 71.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.633 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.505 HG21 ' HA3' ' A' ' 283' ' ' GLY . 10.0 p -79.53 -18.14 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.792 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.465 HG23 HD21 ' A' ' 261' ' ' LEU . 55.5 m -55.48 -48.38 74.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.114 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.94 -37.87 67.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.137 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.403 . . . . 0.0 110.838 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.56 -56.92 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.34 -21.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.127 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.89 96.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.225 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.12 -36.28 4.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.015 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.402 HD13 HD22 ' A' ' 279' ' ' LEU . 84.4 mt -67.83 -35.71 79.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 111.304 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -64.44 109.29 1.89 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.433 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.439 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 99.95 11.53 42.85 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.359 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.8 ttm -59.0 115.24 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.739 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.71 89.17 6.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.687 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 tp -112.72 122.86 48.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 77.73 -125.45 7.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.83 -1.49 25.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.058 0.456 . . . . 0.0 110.097 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -111.14 169.92 8.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.822 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 47.2 mtpt -118.11 117.48 29.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.866 168.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.84 137.21 51.56 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.152 0.501 . . . . 0.0 111.412 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.14 121.78 31.8 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 263' ' ' ILE . 60.0 t -131.25 110.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -145.5 146.25 31.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.3 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -62.1 125.76 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.634 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.764 -178.004 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.403 ' HD2' HE21 ' A' ' 147' ' ' GLN . 1.9 ppt_? -70.47 -18.59 62.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 110.243 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.403 HE21 ' HD2' ' A' ' 146' ' ' ARG . 24.3 mm-40 -90.13 -37.03 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.69 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.86 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.73 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -91.33 9.77 30.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.0 ttp180 -127.24 129.49 47.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.03 153.48 34.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.299 0.571 . . . . 0.0 111.786 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -82.86 115.66 21.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.057 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.8 123.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.749 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.98 172.42 15.15 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.97 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 2.7 t30 69.07 49.52 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.543 0.687 . . . . 0.0 109.713 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.6 pt -123.01 153.49 64.21 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.7 131.07 15.46 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.319 2.013 . . . . 0.0 111.366 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.55 124.76 21.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.01 16.6 40.71 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.087 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.24 148.45 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.929 0.395 . . . . 0.0 110.321 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 148.03 22.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -48.13 -58.52 4.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.088 -175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -55.68 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.279 . . . . 0.0 110.675 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.6 ptp -81.08 -26.16 36.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.438 ' HB2' HG21 ' A' ' 189' ' ' VAL . 18.4 ttt -61.56 -58.54 7.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -31.94 72.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.504 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -63.96 -57.71 8.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.022 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -57.63 -41.11 80.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.545 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -59.39 -27.85 66.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -85.54 -43.48 13.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.47 -41.13 89.03 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.567 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.1 -36.12 76.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.096 0.474 . . . . 0.0 110.882 177.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.52 -39.56 74.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.344 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.7 mt -65.22 -42.2 93.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.302 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.18 -12.96 78.14 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.607 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 33.17 46.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.676 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.47 -23.9 19.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.59 0.233 . . . . 0.0 110.902 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -59.09 107.97 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -83.43 -28.66 28.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 0.0 109.946 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -107.9 150.78 40.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.601 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.45 135.53 26.72 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.166 1.911 . . . . 0.0 111.578 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 109.34 -167.96 13.1 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.27 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -80.34 120.86 80.72 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 111.096 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.04 -31.24 46.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.945 2.43 . . . . 0.0 112.572 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.2 t -77.75 131.0 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 109.969 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.1 tp -99.33 -43.09 6.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.578 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.43 28.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.368 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.456 HG22 HD23 ' A' ' 200' ' ' LEU . 5.1 t -125.41 139.72 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.838 0.351 . . . . 0.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -124.6 121.55 35.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.959 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.03 122.82 67.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.15 167.16 21.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.454 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 73.8 m-85 -127.99 125.85 40.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.144 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 12.9 mt -106.95 122.16 45.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.713 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -100.96 129.72 46.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.43 . . . . 0.0 110.136 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.542 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 53.3 m-85 -108.21 151.52 25.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.952 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.62 -23.38 63.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.932 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -138.22 142.84 39.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.668 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.46 -29.84 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.523 ' O ' HG22 ' A' ' 209' ' ' THR . 14.4 t70 -63.37 -40.51 97.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.453 0.644 . . . . 0.0 109.779 175.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.612 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.6 mt-10 -77.66 -19.96 54.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.55 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.1 m -73.02 -48.26 37.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 110.216 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 206' ' ' ASP . 4.9 t -67.22 -30.55 70.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.471 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.612 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 2.5 pt20 -73.15 -20.55 60.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.052 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.97 -29.02 62.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.387 0.613 . . . . 0.0 109.515 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 226' ' ' ILE . 12.2 mtt -68.64 -15.95 63.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.833 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.1 74.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 110.465 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 217' ' ' ILE . 32.5 m-85 -80.61 5.08 16.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.426 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.5 106.47 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.992 0.425 . . . . 0.0 111.072 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.07 14.43 57.66 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 214' ' ' PHE . 9.6 tt -103.61 159.62 4.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.876 0.338 . . . . 0.0 110.232 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mm -106.91 98.98 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.1 m-85 -109.12 136.59 48.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.14 173.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 58.62 28.79 17.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 111.393 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 75.73 5.44 79.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.319 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 14.1 pt20 -118.68 145.45 45.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.033 0.416 . . . . 0.0 110.254 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 42.6 t -94.93 127.63 41.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.032 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 123.03 40.4 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.95 134.44 54.83 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.5 mp -124.87 123.51 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 -173.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.614 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.4 m -85.18 147.72 26.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 32.9 p -94.08 24.4 4.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.304 0.573 . . . . 0.0 110.719 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.51 108.49 19.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.512 0.673 . . . . 0.0 110.163 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 306' ' ' GLU . 24.5 t -104.37 102.28 32.32 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.845 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 170.05 21.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.084 2.523 . . . . 0.0 112.32 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.72 102.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.317 0.58 . . . . 0.0 109.758 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.6 t -118.42 148.74 42.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.598 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.21 55.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.647 ' CE1' ' HB ' ' A' ' 310' ' ' ILE . 23.0 m-70 -120.18 34.1 5.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.797 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.36 146.34 55.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.327 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.44 HD11 HG23 ' A' ' 313' ' ' THR . 6.2 mt -132.93 139.44 47.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.987 0.422 . . . . 0.0 111.751 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.429 ' C ' HD12 ' A' ' 263' ' ' ILE . 23.2 t80 -119.78 133.47 55.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.019 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.8 mp -121.11 115.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -115.2 -171.97 16.97 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.34 -1.31 85.79 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.824 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 330' ' ' LEU . 89.5 mt -70.74 125.99 92.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -173.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 25.6 Cg_exo -63.71 142.44 83.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.667 2.245 . . . . 0.0 111.115 172.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -62.67 -17.89 61.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -86.03 -9.16 57.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.7 mt -102.85 130.06 49.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.156 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -104.38 -177.32 3.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.413 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.686 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.9 p-10 -48.6 -46.88 40.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.383 0.427 . . . . 0.0 111.744 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.14 -44.0 87.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.487 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.6 -38.34 59.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.48 -30.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 0.0 109.914 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 14.4 ttpp -50.45 -38.95 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.722 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.45 -35.05 79.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.591 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.41 -27.61 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.89 0.376 . . . . 0.0 110.228 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 77.1 mt -82.98 -38.8 22.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.116 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 33.3 p -68.41 -11.66 60.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.952 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 74.6 p -50.31 -48.08 55.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.9 -40.99 21.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.775 0.321 . . . . 0.0 110.723 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.75 151.4 20.81 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 280' ' ' THR . 25.3 Cg_endo -67.08 156.08 67.93 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 112.3 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.18 132.98 45.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.646 0.736 . . . . 0.0 111.244 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -78.89 -42.46 27.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.354 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -142.44 128.12 19.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.419 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 10.5 t80 -138.74 107.06 5.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 110.14 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -116.24 108.57 16.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.424 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -94.44 125.69 39.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.31 131.77 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.863 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -117.83 157.84 25.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.544 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 6.0 t70 -100.17 125.18 46.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.2 t -76.3 -14.28 60.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.796 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.28 -37.81 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 111.458 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 81.7 p -86.24 -28.08 24.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.201 0.524 . . . . 0.0 110.563 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.74 18.4 77.35 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 48.5 mt -130.18 179.53 5.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.456 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 290' ' ' LEU . 69.2 m -74.77 147.36 41.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.63 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 302' ' ' TYR . 35.4 mmtt -73.32 -25.6 60.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.147 0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 97.14 22.54 17.06 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.068 -176.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 1.9 p90 -157.42 146.81 20.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 110.978 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.37 18.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.222 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -129.84 137.84 50.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 31.7 p -139.65 166.88 23.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 112.079 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 254' ' ' VAL . 31.1 mt-10 -133.21 134.04 43.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.366 168.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -83.24 149.52 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.233 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.64 -36.61 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -115.62 149.08 38.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.252 174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 259' ' ' HIS . 2.8 pp -84.66 -13.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.749 -171.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -78.99 -41.21 29.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.008 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.87 -17.0 21.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.44 HG23 HD11 ' A' ' 261' ' ' LEU . 31.3 m -50.83 -44.41 59.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.893 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.88 -39.51 50.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.433 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -61.29 -37.39 83.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 111.507 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.81 -52.36 31.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.54 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.486 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -64.8 -20.88 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.61 67.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.262 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.19 -37.01 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.79 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.97 -28.27 55.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.928 0.364 . . . . 0.0 111.86 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.6 t-20 -66.8 108.8 2.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 329' ' ' LYS . . . 104.65 12.68 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.827 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 35.0 ttm -68.52 113.62 6.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 103.55 4.25 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.467 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.44 111.01 15.23 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 86.61 -116.38 4.42 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.0 5.15 12.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.433 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -122.97 165.74 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.768 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 322' ' ' GLY . 24.7 mtmm -109.86 127.94 55.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 266' ' ' LEU . 27.4 mt -75.93 137.98 40.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -173.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -89.14 115.42 26.65 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 67.5 t -124.19 107.0 17.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.322 0.582 . . . . 0.0 109.506 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -147.46 145.53 29.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.001 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -63.44 129.05 38.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.02 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.5 -173.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 148' ' ' ALA . 8.9 t . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.649 0.738 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -66.72 -41.98 87.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.841 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -87.6 -4.53 58.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.423 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -86.32 -32.04 21.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -87.95 -12.97 43.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.024 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 99.6 mtt180 -110.9 156.49 21.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.556 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.97 152.61 42.16 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 20.0 t80 -81.08 113.09 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.216 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -99.3 125.89 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.974 0.416 . . . . 0.0 111.283 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.17 176.19 22.48 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 65.84 52.29 1.28 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.647 0.737 . . . . 0.0 109.409 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 pt -119.2 150.92 50.11 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 11.5 Cg_endo -91.8 146.57 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.425 2.75 . . . . 0.0 112.17 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.13 111.47 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.868 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.76 15.56 36.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.161 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 148.53 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.187 0.518 . . . . 0.0 110.287 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.5 m -99.63 144.83 28.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.037 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 162' ' ' GLU . 1.5 mp0 -42.49 -54.51 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.865 0.728 . . . . 0.0 111.545 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.17 -37.37 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.803 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.85 -55.25 36.79 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.343 0.592 . . . . 0.0 111.088 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -78.24 -29.33 48.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.388 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.0 ttt -61.22 -54.54 42.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.695 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.52 -33.32 75.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.858 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.558 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.1 OUTLIER -63.13 -49.9 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 29.6 m-85 -72.68 -40.04 66.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 72.8 m-20 -56.35 -34.79 66.94 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -68.1 -39.67 82.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.057 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 62.6 mm-40 -64.12 -38.65 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.469 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.27 -41.72 93.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 83.4 mtt180 -69.4 -36.01 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.438 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 97.9 mt -61.75 -50.43 72.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.64 65.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.667 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.03 30.97 24.41 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.304 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.82 -22.45 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.3 . . . . 0.0 110.22 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.23 108.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.097 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -88.19 -30.04 20.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.031 0.443 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -108.56 149.03 38.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.968 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.48 145.03 95.55 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.291 1.994 . . . . 0.0 111.421 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.15 -149.95 19.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.463 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.51 123.91 42.75 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.817 0.341 . . . . 0.0 111.12 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.4 -37.82 22.15 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.201 2.601 . . . . 0.0 112.398 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.55 123.53 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.44 -46.72 8.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.305 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.74 40.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.515 HG22 HD23 ' A' ' 200' ' ' LEU . 3.5 t -127.82 140.12 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -119.15 117.81 29.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.014 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.456 ' CD1' ' HG3' ' A' ' 162' ' ' GLU . 3.8 mp -106.58 129.19 60.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.529 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.468 178.239 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 17.0 p90 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.55 155.96 49.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.131 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.5 125.35 50.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.878 0.371 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 189' ' ' VAL . 20.2 mt -94.62 125.29 39.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.686 174.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -105.05 130.62 53.2 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.531 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 61.5 m-85 -109.79 157.48 19.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 181' ' ' ALA . 37.3 ptt180 -78.16 -18.98 54.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.787 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 54.7 m -147.91 139.56 23.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.797 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.66 -25.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.44 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -76.21 -23.76 54.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -84.23 -20.9 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.237 0.541 . . . . 0.0 109.673 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 67.6 m -69.83 -49.87 48.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.639 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.8 t -60.69 -36.79 79.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.43 -22.45 61.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.79 -28.49 60.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 109.87 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 23.8 mtp -72.76 -14.64 61.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.192 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -18.15 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.489 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.476 ' CG ' ' HE2' ' A' ' 219' ' ' PHE . 11.4 m-85 -84.56 5.19 28.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.57 107.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.466 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.51 13.54 59.68 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.017 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -94.56 154.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.151 0.476 . . . . 0.0 110.818 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.8 mm -97.73 100.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.132 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.672 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.9 m-85 -105.03 103.39 12.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.69 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 60.54 37.63 19.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.95 -13.57 63.47 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.155 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.8 pt20 -100.96 132.83 46.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.604 0.702 . . . . 0.0 110.344 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.0 t -98.7 90.41 4.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 224' ' ' LEU . 1.3 pp -91.71 144.69 25.25 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.46 143.25 47.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.153 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.4 mp -130.65 115.41 31.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.9 tpt180 . . . . . 0 C--N 1.318 -0.788 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.2 m -81.39 147.88 29.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 67.2 p -93.27 4.08 54.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.554 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 4.3 p -109.12 106.64 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.861 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.03 110.12 39.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.992 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 8.1 Cg_exo -72.53 139.72 31.81 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.996 2.464 . . . . 0.0 110.953 172.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.49 ' HA ' ' HG3' ' A' ' 260' ' ' LYS . 26.9 t70 -86.65 83.44 7.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.463 0.649 . . . . 0.0 110.479 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 33.1 t -89.55 -178.03 5.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.823 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.74 65.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.665 0.745 . . . . 0.0 110.023 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -102.46 31.63 3.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.377 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 256' ' ' ASP . 2.3 tmtp? -67.75 133.34 49.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.17 149.24 43.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.483 . . . . 0.0 112.251 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.403 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 45.2 t80 -119.62 132.12 55.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.796 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 305' ' ' CYS . 2.5 mp -116.25 120.05 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.02 0.438 . . . . 0.0 110.298 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.39 -174.43 13.84 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 87.47 -6.72 82.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.008 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.495 ' HB2' ' C ' ' A' ' 301' ' ' GLY . 91.9 mt -68.86 127.62 93.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -172.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.01 140.17 59.12 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.173 1.915 . . . . 0.0 109.803 166.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -64.55 -15.08 60.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -169.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -83.61 -7.56 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.021 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.35 126.47 42.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -104.4 176.15 5.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.699 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 12.6 t70 -40.22 -43.49 1.69 Allowed 'General case' 0 CA--C 1.534 0.327 0 O-C-N 123.644 0.59 . . . . 0.0 111.882 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.43 -47.9 74.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.896 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -73.74 -39.64 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.94 -32.6 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.671 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.9 mtmm -56.26 -33.98 65.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.651 0.262 . . . . 0.0 111.176 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.48 -31.53 72.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.406 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.74 -34.92 60.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.131 0.491 . . . . 0.0 110.174 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.93 -32.23 27.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.274 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 17.0 p -69.38 -13.8 62.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.753 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.4 m -49.63 -46.43 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.467 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.26 -41.12 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.158 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.19 164.34 35.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.915 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -70.48 166.17 29.36 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.776 2.317 . . . . 0.0 111.85 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.2 mt -112.22 133.18 54.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.732 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.35 -38.09 74.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.272 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -152.27 131.96 13.16 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.686 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -138.57 117.89 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.266 0.555 . . . . 0.0 110.559 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -121.39 102.37 8.22 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.789 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 6.5 tt -86.82 133.6 33.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.329 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.92 133.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.541 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -122.16 165.29 16.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 295' ' ' ALA . 20.5 t70 -110.0 133.35 53.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.74 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.7 t -83.86 -11.12 57.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.92 0.391 . . . . 0.0 110.537 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.483 ' HB3' ' OD2' ' A' ' 293' ' ' ASP . . . -88.31 -43.46 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.735 0.302 . . . . 0.0 111.003 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 70.0 p -83.39 -30.66 27.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.17 0.51 . . . . 0.0 110.787 176.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.46 13.52 80.16 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 42.2 mt -123.61 -175.43 3.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.709 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 290' ' ' LEU . 36.6 m -74.75 152.45 39.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.133 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.38 -10.9 50.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.544 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.495 ' C ' ' HB2' ' A' ' 266' ' ' LEU . . . 92.66 26.84 16.1 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.67 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -164.42 149.43 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.029 0.443 . . . . 0.0 110.615 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -149.37 170.27 18.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.912 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.435 ' CD1' ' HE2' ' A' ' 260' ' ' LYS . 98.5 m-85 -123.19 127.97 49.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.484 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 263' ' ' ILE . 12.4 p -122.42 162.48 21.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.101 0.476 . . . . 0.0 110.187 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 111.96 6.04 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -70.38 171.3 10.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.962 0.411 . . . . 0.0 110.995 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.83 -45.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.631 ' HB3' ' ND2' ' A' ' 311' ' ' ASN . 11.0 m-20 -85.6 142.15 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.96 -14.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.248 0.547 . . . . 0.0 110.498 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.631 ' ND2' ' HB3' ' A' ' 309' ' ' ASP . 9.1 p30 -86.89 -24.24 24.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.026 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' A' ' 309' ' ' ASP . 8.9 p -83.78 -18.27 10.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.116 0.484 . . . . 0.0 109.802 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 21.9 m -53.8 -49.23 68.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.257 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.31 -24.82 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -70.79 -36.04 72.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.173 0.511 . . . . 0.0 110.971 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.5 -52.32 14.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.019 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.463 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -61.45 -21.21 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.162 0.506 . . . . 0.0 110.968 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.48 -39.08 74.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.259 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.62 -35.96 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.243 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.5 -34.25 58.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.416 ' OD1' HD12 ' A' ' 331' ' ' LEU . 64.8 t30 -69.91 117.79 11.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.478 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 96.06 10.75 55.88 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.036 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . 0.461 ' O ' HD23 ' A' ' 330' ' ' LEU . 41.9 ttm -64.22 116.2 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 86.82 7.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.27 121.83 45.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.414 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.18 -117.63 4.52 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -116.37 -14.68 11.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 110.793 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.41 165.26 11.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -107.31 125.86 51.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.898 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 265' ' ' GLY . 2.6 mm? -73.21 133.97 44.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.814 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.416 HD12 ' OD1' ' A' ' 321' ' ' ASN . 33.6 tp -97.62 122.81 41.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 174.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.463 HG12 HG22 ' A' ' 317' ' ' ILE . 99.6 t -131.22 108.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.95 160.08 40.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.8 141.49 36.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.782 0 CA-C-O 121.137 0.494 . . . . 0.0 109.98 179.233 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.89 -19.13 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 110.613 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.74 -33.68 27.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.452 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.83 -25.95 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.51 -6.59 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.362 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 30.8 mtm180 -110.45 158.08 18.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.233 0.539 . . . . 0.0 111.542 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.34 153.53 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.562 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 15.5 t80 -79.61 118.97 21.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.585 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 200' ' ' LEU . 49.3 t -105.96 121.26 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -122.88 176.21 16.56 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.218 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.2 43.5 1.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.807 0.813 . . . . 0.0 109.866 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.8 pt -116.35 154.6 48.89 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.67 130.91 14.1 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.633 2.222 . . . . 0.0 111.378 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.82 117.64 9.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.657 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.29 6.49 29.41 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.514 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.71 147.93 11.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 110.2 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 m -93.48 144.89 24.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.546 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 189' ' ' VAL . 1.9 mp0 -49.54 -54.21 19.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 123.371 0.42 . . . . 0.0 111.397 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.26 -24.28 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.278 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 -58.39 5.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.704 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 ptp -72.06 -31.67 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.353 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.27 -54.83 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.309 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.62 -36.12 83.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.657 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.6 OUTLIER -56.95 -61.11 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.978 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -58.65 -42.37 88.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -59.79 -42.05 92.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 111.063 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.99 -43.93 77.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.988 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 23.1 mm-40 -64.34 -31.81 73.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.165 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.505 ' HB3' HG23 ' A' ' 179' ' ' THR . 11.9 mmt -57.07 -46.17 82.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 174' ' ' ARG . 52.3 mtm180 -73.69 -30.17 62.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 81.0 mt -66.85 -48.39 68.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.359 . . . . 0.0 110.278 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.82 74.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.476 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.56 36.75 10.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.174 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.479 HD12 ' SD ' ' A' ' 173' ' ' MET . 17.3 mt -90.89 -27.37 18.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -60.16 108.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.809 -177.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -22.97 14.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.13 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.7 127.78 27.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.46 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.86 142.17 98.07 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.723 2.282 . . . . 0.0 112.572 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 107.17 -143.16 15.83 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.39 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 18.4 p-10 -108.27 115.07 58.77 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-O 120.953 0.406 . . . . 0.0 110.801 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 19.3 Cg_endo -62.32 -37.8 58.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.817 2.345 . . . . 0.0 112.114 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.43 119.31 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.0 tm? -97.46 -34.96 10.82 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 -170.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.12 157.96 38.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 162' ' ' GLU . 97.2 t -138.0 128.81 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.809 0.338 . . . . 0.0 110.677 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -119.38 125.25 48.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.06 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 162' ' ' GLU . 15.9 mm -90.94 130.69 39.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.53 161.65 37.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.821 0.343 . . . . 0.0 111.049 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.49 121.3 43.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.066 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 1.0 OUTLIER -94.47 118.96 32.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.926 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 38.0 tt0 -102.64 126.8 49.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.363 0.601 . . . . 0.0 110.551 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.549 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 59.1 m-85 -106.52 157.29 17.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.443 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.54 ' HB3' ' HG ' ' A' ' 187' ' ' LEU . 17.9 ptt180 -79.18 -20.63 47.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.8 m -141.74 144.07 33.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.51 -26.63 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.007 0.432 . . . . 0.0 111.103 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 209' ' ' THR . 9.2 p-10 -75.58 -18.25 59.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.672 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 203' ' ' ARG . 44.5 mt-10 -86.01 -26.43 25.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 45.0 m -68.31 -44.74 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.816 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.5 t -61.56 -37.01 82.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.171 -174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -74.73 -18.22 60.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.55 -27.3 58.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.35 0.595 . . . . 0.0 109.955 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 9.8 mtt -68.36 -16.24 63.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.14 -24.85 64.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 217' ' ' ILE . 18.9 m-30 -75.33 -0.85 21.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.954 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.8 106.28 1.49 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.57 14.34 38.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.3 tt -106.84 153.94 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.28 99.56 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.141 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.754 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.1 m-85 -103.0 118.94 37.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.513 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 57.61 32.49 21.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.205 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.8 -13.34 64.64 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.593 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 24.7 pt20 -94.36 136.67 34.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.498 0.649 . . . . 0.0 110.438 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.0 t -90.35 124.73 35.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.638 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.48 121.98 42.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.798 0.333 . . . . 0.0 110.528 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -113.23 119.24 37.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.998 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.1 mp -121.75 130.78 74.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.115 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.049 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 13.5 m -69.34 139.38 54.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.173 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 p -87.92 1.71 53.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.347 0.594 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.74 108.08 22.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.748 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.26 107.51 59.18 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.822 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.15 160.49 49.41 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.811 2.341 . . . . 0.0 111.346 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.33 142.21 47.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.7 p -156.49 -177.07 6.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.026 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.38 0.69 55.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.243 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -131.52 16.03 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.4 125.99 30.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 0.8 OUTLIER -109.28 139.9 43.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -171.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.421 ' HD2' ' CE2' ' A' ' 304' ' ' PHE . 41.9 t80 -101.91 127.44 48.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.446 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.96 116.53 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.761 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -121.55 176.1 16.3 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.578 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.69 89.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.565 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.2 mt -68.87 129.69 92.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -174.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 139.88 91.09 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.688 2.259 . . . . 0.0 111.238 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.46 -18.66 62.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -98.03 8.2 45.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.57 122.92 48.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.219 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.78 -171.51 1.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.776 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 5.7 p-10 -48.81 -45.46 40.38 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.624 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.32 -47.64 78.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 111.619 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.19 -41.46 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.426 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.01 -31.68 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.441 0.639 . . . . 0.0 110.048 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 0.6 OUTLIER -55.11 -36.7 65.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.382 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.22 -26.34 68.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.663 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.68 -38.36 33.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.213 0.53 . . . . 0.0 109.711 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.74 -42.56 63.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.055 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 30.6 p -66.89 -11.38 55.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.016 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.1 t -59.72 -29.28 68.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.774 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.06 -40.61 6.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.026 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.48 160.48 32.75 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.054 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.31 168.43 23.43 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.151 2.567 . . . . 0.0 112.133 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 305' ' ' CYS . 89.2 mt -117.74 134.1 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.469 0.652 . . . . 0.0 111.729 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 308' ' ' VAL . 38.6 ttmt -70.51 -46.39 63.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.074 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -150.87 133.45 15.64 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.605 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 10.4 t80 -138.28 107.03 5.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.895 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.57 105.16 15.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.634 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 303' ' ' ALA . 0.6 OUTLIER -88.34 132.57 34.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 290' ' ' LEU . 27.8 t -98.57 119.07 46.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.161 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -114.41 167.3 10.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 13.6 t70 -96.27 118.49 32.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.3 t -72.12 -10.01 59.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.611 0.244 . . . . 0.0 110.847 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -91.91 -49.45 6.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.264 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 76.0 p -82.4 -27.68 31.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 111.026 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.31 82.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.121 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 29.8 mt -108.49 170.01 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.4 m -82.44 138.92 34.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 110.53 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -63.86 -31.42 72.6 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.133 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 105.55 26.85 6.0 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 17.1 p90 -156.69 141.4 16.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 110.185 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 290' ' ' LEU . . . -149.2 170.28 18.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.179 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 94.8 m-85 -131.45 130.29 42.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 30.7 p -130.26 175.68 8.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 111.465 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 129.32 11.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 308' ' ' VAL . 8.4 m-85 -89.06 -0.16 57.2 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 286' ' ' LYS . 44.3 t 75.37 -63.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.555 0.693 . . . . 0.0 109.603 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.548 ' HB3' HG12 ' A' ' 312' ' ' VAL . 15.1 t70 -75.51 135.48 40.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.131 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.26 -19.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.467 HD22 ' CG ' ' A' ' 309' ' ' ASP . 1.7 m-80 -80.53 -45.51 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.782 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 309' ' ' ASP . 7.1 p -65.4 -18.47 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.205 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 23.5 m -53.8 -50.15 66.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.444 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.77 -35.87 62.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 0.0 110.627 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' A' ' 312' ' ' VAL . 20.3 mt-30 -67.27 -31.04 71.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.096 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 320' ' ' LEU . . . -75.48 -55.16 5.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.899 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.418 HG22 HG12 ' A' ' 332' ' ' VAL . 2.3 pp -61.08 -21.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.762 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.32 79.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.049 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.66 -28.97 6.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 316' ' ' ALA . 78.8 mt -76.44 -36.82 57.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -175.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.05 110.05 2.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.51 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.95 11.47 56.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.277 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 43.6 ttm -60.94 117.19 5.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 110.521 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 94.45 6.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 120.01 40.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.589 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.69 -115.12 4.45 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.85 -3.91 12.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 110.559 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -111.94 156.14 22.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.771 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.79 125.64 49.61 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.26 141.88 41.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.123 0.487 . . . . 0.0 111.081 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.99 121.6 36.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.344 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 320' ' ' LEU . 59.2 t -130.8 111.41 20.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.016 0.436 . . . . 0.0 110.34 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -151.8 149.71 29.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.243 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -64.29 129.65 40.75 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.083 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.357 0.599 . . . . 0.0 110.408 -178.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 9.1 t . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -70.93 -24.59 62.48 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.229 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -79.75 -31.87 41.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.011 0.434 . . . . 0.0 110.021 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -72.57 -31.95 65.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.607 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 145' ' ' THR . 19.9 mtm180 -74.04 -13.2 60.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.82 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.7 ttp180 -110.98 137.35 48.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.979 0.419 . . . . 0.0 110.631 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.13 153.98 38.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.4 t80 -85.53 121.04 27.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.201 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.466 HG21 HD12 ' A' ' 200' ' ' LEU . 21.2 t -108.62 127.63 64.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 0.0 110.942 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -128.72 -178.22 15.26 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.331 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.574 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 3.5 t30 67.82 28.01 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.773 0.797 . . . . 0.0 109.706 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.5 pt -102.13 150.2 37.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.51 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.14 132.03 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.634 2.223 . . . . 0.0 111.388 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -65.92 123.89 21.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.73 -5.0 30.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.099 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.13 145.23 9.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.253 0.549 . . . . 0.0 110.883 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 m -101.02 148.69 24.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.144 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.435 ' HG3' HD13 ' A' ' 191' ' ' ILE . 1.7 mp0 -47.73 -55.16 10.16 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.454 0.471 . . . . 0.0 110.859 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -54.41 -38.38 66.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.226 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.26 -56.58 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.6 ttm -64.52 -36.82 85.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.259 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.2 ttt -62.49 -55.85 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.15 -36.94 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.316 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -55.49 25.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -60.45 -33.87 73.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.016 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.569 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 6.7 m-80 -59.99 -46.41 89.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.411 . . . . 0.0 110.489 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.664 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -65.7 -43.46 89.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.643 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -47.26 75.96 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.556 ' HE1' ' HB2' ' A' ' 211' ' ' ALA . 0.0 OUTLIER -55.4 -44.71 76.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 111.085 177.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.5 mtm-85 -69.78 -33.41 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 83.2 mt -62.07 -35.78 79.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.948 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.99 -8.87 55.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.714 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.19 58.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.552 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.6 -21.82 18.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.19 . . . . 0.0 111.441 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -59.26 107.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.32 . . . . 0.0 110.83 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -90.03 -27.51 19.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.77 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.18 149.47 39.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.225 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.06 139.94 30.51 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.216 1.944 . . . . 0.0 111.417 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.34 -158.8 15.79 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.708 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 10.7 m120 -86.8 116.14 64.95 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 4.1 Cg_endo -52.3 -46.34 33.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.601 2.867 . . . . 0.0 112.289 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 200' ' ' LEU . 7.8 p -80.57 136.85 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.4 tp -93.75 -51.22 5.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.929 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.75 142.33 25.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.6 t -110.9 131.83 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.965 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -118.68 126.73 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.435 HD13 ' HG3' ' A' ' 162' ' ' GLU . 3.3 mp -115.65 119.7 62.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.884 0.373 . . . . 0.0 110.398 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 0.0 111.468 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 C--O 1.233 0.218 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -137.6 167.25 22.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.978 0.418 . . . . 0.0 111.297 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -127.95 130.29 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 186' ' ' VAL . 15.3 mt -110.67 117.83 34.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.335 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 37.7 tt0 -104.37 129.76 52.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.593 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 43.0 m-85 -104.98 159.64 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.134 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 38.3 ptt180 -77.34 -20.94 54.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.422 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 m -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.69 -29.1 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.228 0.537 . . . . 0.0 110.044 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 209' ' ' THR . 3.5 m-20 -67.92 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.792 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.16 -21.15 50.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.29 0.567 . . . . 0.0 109.922 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 86.4 m -72.45 -47.94 44.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 206' ' ' ASP . 7.5 t -62.27 -36.02 80.8 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.555 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -73.91 -25.09 59.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.198 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HB2' ' HE1' ' A' ' 173' ' ' MET . . . -68.81 -34.58 75.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.272 0.558 . . . . 0.0 109.956 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.411 ' HE2' ' HB3' ' A' ' 212' ' ' MET . 27.8 mtp -68.54 -14.74 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.171 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.26 67.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 110.633 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.4 m-85 -78.55 6.18 9.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.97 106.74 1.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.93 13.84 38.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.036 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.0 tt -103.65 155.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.107 0.454 . . . . 0.0 111.116 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.74 102.3 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.1 m-85 -106.39 117.48 34.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.957 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 57.32 31.73 20.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 0.0 111.443 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.47 -12.81 64.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.873 174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.8 pt20 -105.93 144.95 31.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.318 0.559 . . . . 0.0 110.501 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.574 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 23.3 t -102.46 128.89 48.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -101.76 120.66 40.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 4.9 mmmp? -114.24 123.08 48.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 17.9 mt -130.8 118.79 43.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.01 -171.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.407 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.0 tpt180 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.718 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.733 0.302 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 32.6 m -69.84 146.92 50.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.289 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.1 p -96.49 19.65 11.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 57.9 t -122.85 105.04 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.76 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.54 111.13 51.03 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 25.5 Cg_exo -63.72 153.58 74.45 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.807 2.338 . . . . 0.0 110.892 173.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -78.98 77.03 5.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.124 0.964 . . . . 0.0 110.8 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -91.22 158.28 16.69 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.63 48.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.088 0.471 . . . . 0.0 110.367 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -90.41 0.38 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.218 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.413 ' HG3' ' HB3' ' A' ' 335' ' ' ALA . 19.2 pttm -72.16 139.05 48.07 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.476 HD12 ' SG ' ' A' ' 305' ' ' CYS . 10.5 mt -112.42 149.27 32.79 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.798 -170.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -107.03 129.57 54.78 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.52 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -116.08 115.15 48.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.909 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.87 175.38 15.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.5 -1.2 83.85 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.442 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.483 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.2 mt -64.35 127.73 92.48 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 27.9 Cg_exo -63.35 149.1 92.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.893 2.395 . . . . 0.0 111.757 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 -18.08 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.529 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -92.76 1.15 57.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.1 mt -112.13 119.73 39.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.032 0.444 . . . . 0.0 109.935 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -104.54 -178.5 3.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.566 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER -40.31 -48.66 2.69 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.77 0.668 . . . . 0.0 112.561 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -65.26 -45.58 83.96 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.05 -49.52 72.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.478 . . . . 0.0 110.652 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 83.0 t -63.94 -33.79 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.341 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 24.9 mtmm -53.19 -46.73 69.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.496 0.188 . . . . 0.0 111.078 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.54 -43.96 76.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.008 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.27 -43.89 89.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.81 -44.35 73.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 34.6 p -62.74 -12.21 22.56 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.7 m -55.61 -35.35 65.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.715 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -90.4 -41.96 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 110.693 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.91 167.79 39.37 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.412 ' HG3' ' HA ' ' A' ' 175' ' ' LEU . 4.1 Cg_endo -77.95 155.8 30.35 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 66.5 mt -106.02 134.48 49.07 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.778 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -77.3 -31.87 54.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -151.76 127.19 10.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.53 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 29.3 t80 -138.48 114.48 10.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.487 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -120.95 107.49 12.74 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 10.0 tt -86.9 123.68 32.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.88 111.19 13.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.436 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.2 165.44 11.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.741 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.3 t70 -98.82 133.72 42.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.7 m -78.04 -15.4 58.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.335 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.94 -44.91 10.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.8 p -89.2 -25.92 21.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.188 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.99 13.98 82.65 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.526 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.9 162.65 16.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 111.303 -172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.3 m -71.87 123.15 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.146 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -63.75 -30.06 71.2 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 109.09 25.12 5.72 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.74 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 19.2 p90 -155.08 144.35 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.11 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -148.97 169.95 19.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.567 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 97.5 m-85 -126.37 131.14 51.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.868 176.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.51 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 21.8 p -129.03 158.95 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.618 0.247 . . . . 0.0 110.668 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 260' ' ' LYS . 0.3 OUTLIER -142.54 125.21 15.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -81.59 156.73 25.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.48 -51.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.683 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.04 153.94 17.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 110.326 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 311' ' ' ASN . 2.9 pp -85.14 -22.37 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.17 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.437 ' N ' HD12 ' A' ' 310' ' ' ILE . 8.0 p30 -79.76 -28.7 40.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.557 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -17.79 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.981 0.419 . . . . 0.0 110.448 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 m -55.91 -52.17 65.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.225 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.14 -19.32 51.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -77.48 -35.91 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.99 -52.53 16.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.731 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -60.69 -21.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.013 0.435 . . . . 0.0 111.091 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.12 83.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.46 -34.67 4.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.301 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.77 -33.55 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.679 0.276 . . . . 0.0 111.628 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -68.81 122.92 19.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.01 10.23 60.02 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.846 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . 0.445 ' SD ' HD23 ' A' ' 325' ' ' LEU . 33.4 ttm -59.62 116.44 4.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.619 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.62 85.19 6.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' SD ' ' A' ' 323' ' ' MET . 0.2 OUTLIER -103.06 129.85 50.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.25 -118.51 8.02 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.142 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.98 1.82 12.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.927 0.394 . . . . 0.0 110.904 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -110.05 172.58 6.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -117.13 119.77 36.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.06 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.6 145.36 50.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.447 0.641 . . . . 0.0 112.029 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 331' ' ' LEU . 3.1 tm? -91.4 120.18 32.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.801 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 317' ' ' ILE . 41.3 t -129.24 108.93 17.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.558 . . . . 0.0 109.507 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -145.27 161.41 39.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.691 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -64.12 136.36 57.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.413 ' HB3' ' HG3' ' A' ' 260' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.274 0.559 . . . . 0.0 109.994 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 13.5 tpt -140.44 110.31 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.5 t 61.49 47.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 122.075 0.941 . . . . 0.0 109.353 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.68 166.07 26.3 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.6 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 t 65.64 26.93 11.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.869 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.42 -41.57 89.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.763 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.6 ttm -60.4 -54.82 41.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.527 0.203 . . . . 0.0 110.898 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . 8.3 t -74.02 -20.15 60.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.994 -175.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -59.59 -54.32 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 110.068 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -87.9 -11.45 47.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.57 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 145' ' ' THR . . . -83.72 -33.24 25.15 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.055 0.455 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 96.7 mtt180 -92.95 4.58 53.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 22.8 ttp180 -126.2 129.94 49.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 110.943 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.405 ' HB3' ' HE3' ' A' ' 212' ' ' MET . 3.8 pp -114.04 153.17 29.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.108 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 59.5 t80 -84.96 119.67 25.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.434 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.65 124.15 57.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.541 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.26 177.87 16.78 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.905 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 4.8 t30 66.02 30.97 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.784 0.802 . . . . 0.0 109.967 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.67 154.44 37.17 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.184 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.02 130.84 12.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.518 2.145 . . . . 0.0 111.259 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.33 108.79 2.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.107 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.52 3.31 7.92 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.585 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.36 145.6 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.082 0.467 . . . . 0.0 110.192 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.2 m -105.32 154.19 20.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.397 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.93 -58.65 4.13 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.477 0.486 . . . . 0.0 111.465 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.11 -35.86 67.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.892 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.89 -56.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.021 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 32.6 ttm -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.7 ttt -59.02 -56.89 16.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.086 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -37.44 81.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.49 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.642 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.4 m-85 -60.5 -51.8 67.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.63 -39.97 88.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -55.75 -42.46 75.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.072 0.463 . . . . 0.0 110.603 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.29 -45.96 78.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.22 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 68.5 mm-40 -59.25 -41.15 88.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.386 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.604 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -56.7 -42.66 79.5 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.875 0.369 . . . . 0.0 111.046 176.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -66.14 -41.66 90.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 58.7 mt -64.86 -49.94 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.293 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.62 0.09 86.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.906 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.3 37.84 91.09 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.771 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.5 mt -93.67 -31.17 14.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.581 0.229 . . . . 0.0 110.386 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.27 108.4 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.278 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -85.71 -29.25 24.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.028 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.0 148.95 38.44 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.619 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.13 157.06 61.66 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.246 1.964 . . . . 0.0 111.901 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.68 -147.55 18.64 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.593 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -102.29 119.52 56.14 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.861 0.363 . . . . 0.0 111.0 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -32.9 34.12 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.911 2.407 . . . . 0.0 112.227 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.73 128.8 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.92 -45.14 7.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.697 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.01 143.54 21.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.789 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.05 131.42 63.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.26 118.91 32.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.69 118.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -78.25 131.14 36.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.66 135.77 56.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.536 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.7 25.9 14.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.531 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.49 144.19 48.13 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.13 33.27 0.97 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.773 0.321 . . . . 0.0 110.776 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.01 163.05 39.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.68 170.82 15.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 74.6 m-85 -127.84 134.47 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.5 mt -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.25 131.3 48.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.202 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.582 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 45.8 m-85 -110.65 156.99 20.21 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.658 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -74.5 -19.65 60.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.19 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 m -141.89 135.75 29.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.04 -31.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -70.78 -31.35 68.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.372 . . . . 0.0 110.419 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.63 -20.15 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 109.95 173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.4 m -75.59 -48.67 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.945 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 t -63.77 -31.63 72.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.925 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 210' ' ' GLN . 2.6 pt20 -74.39 -18.1 60.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.595 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.07 -22.58 58.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 109.611 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 226' ' ' ILE . 14.5 mtt -71.29 -17.65 62.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.589 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.53 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.492 ' O ' HG22 ' A' ' 217' ' ' ILE . 10.1 m-85 -81.57 4.12 22.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.577 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.07 106.64 2.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.843 0.354 . . . . 0.0 110.713 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.23 5.58 57.09 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.194 -0.526 . . . . 0.0 112.7 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 214' ' ' PHE . 11.3 tt -96.84 153.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.882 0.372 . . . . 0.0 110.648 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 36.4 mm -108.13 100.53 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.3 m-85 -102.07 108.73 20.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.731 0.3 . . . . 0.0 110.573 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.54 36.34 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.225 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.01 -13.57 66.86 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.916 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.0 pt20 -99.4 138.94 35.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.584 0.692 . . . . 0.0 110.267 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.557 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 21.6 t -96.5 126.03 41.41 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.95 132.33 51.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.53 125.57 48.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.6 mp -128.62 126.44 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.421 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 32.3 tpt180 -99.36 144.93 27.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.419 ' HD3' ' SD ' ' A' ' 212' ' ' MET . 17.2 tpp180 -89.08 110.41 37.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.398 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 9.9 Cg_exo -71.56 122.45 8.61 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.386 2.057 . . . . 0.0 110.909 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -94.3 27.17 3.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -94.29 -1.64 53.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.276 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 29.7 p90 -149.81 174.22 12.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.349 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -129.3 116.38 18.68 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.8 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.34 138.67 27.8 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.599 2.199 . . . . 0.0 111.565 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.88 125.83 40.74 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.829 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.56 137.35 68.73 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.717 2.278 . . . . 0.0 111.954 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.1 56.36 4.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -108.36 125.42 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 31.9 p -87.18 119.36 27.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.563 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.98 133.92 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.259 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -83.92 131.37 51.75 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.421 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -73.48 176.7 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 170.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.5 p -78.43 60.09 2.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.183 0.516 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.37 25.24 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.756 0.789 . . . . 0.0 110.543 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.404 ' HB3' ' OG1' ' A' ' 252' ' ' THR . 41.4 p90 -132.22 160.97 34.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.653 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 249' ' ' VAL . 59.8 t -112.92 116.86 47.03 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.813 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.61 126.52 17.71 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.053 1.835 . . . . 0.0 111.497 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.31 2.04 24.75 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 250' ' ' VAL . 3.1 p -143.43 -172.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.615 ' H ' HG22 ' A' ' 249' ' ' VAL . 7.6 p -63.55 127.12 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.233 0.54 . . . . 0.0 110.241 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 28.3 m -83.15 149.45 26.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 245' ' ' TYR . 11.7 p -92.9 19.55 7.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 111.318 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.77 113.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.221 0.534 . . . . 0.0 110.53 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 304' ' ' PHE . 21.4 t -107.98 108.19 61.07 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.54 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.89 152.12 82.32 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.923 2.415 . . . . 0.0 111.796 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.92 79.48 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.861 0.838 . . . . 0.0 109.945 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.0 p -87.05 -176.44 5.72 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.379 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -81.67 1.06 35.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -123.76 30.82 6.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.263 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -70.63 133.71 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.008 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.8 mt -122.87 142.01 51.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.466 ' HE1' HD23 ' A' ' 331' ' ' LEU . 55.1 t80 -118.38 130.06 55.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.067 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.408 ' CG2' HD21 ' A' ' 266' ' ' LEU . 2.3 mp -117.6 126.8 74.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -130.54 168.65 21.61 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.04 5.91 60.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.379 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 275' ' ' VAL . 78.4 mt -71.48 132.73 85.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.921 0.391 . . . . 0.0 111.881 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 34.2 Cg_exo -59.31 134.55 59.58 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.876 2.384 . . . . 0.0 111.858 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.08 -22.47 64.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.238 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -90.54 4.84 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.79 139.19 49.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.707 0.289 . . . . 0.0 110.351 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -105.65 -177.77 3.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.81 -41.96 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.326 0.391 . . . . 0.0 111.648 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.59 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 33.1 t70 -63.07 -47.97 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 0.0 111.353 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.54 ' HA ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -65.53 -40.81 93.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.727 179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 266' ' ' LEU . 77.5 t -68.41 -30.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.795 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 273' ' ' ASP . 6.9 mtmp? -53.26 -39.51 63.94 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.453 0.168 . . . . 0.0 111.293 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -52.75 -34.95 55.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.761 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.31 -40.48 62.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.88 -38.43 53.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.069 0.461 . . . . 0.0 111.042 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 25.2 p -65.92 -12.49 55.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.043 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.9 m -52.63 -34.21 50.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.166 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -100.58 -40.83 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.9 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.86 162.0 35.51 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.207 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -76.84 160.1 34.25 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.962 2.441 . . . . 0.0 112.28 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 305' ' ' CYS . 77.5 mt -110.44 136.58 49.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.632 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 306' ' ' GLU . 18.9 ptpt -80.18 -27.92 38.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.675 0.75 . . . . 0.0 109.008 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -153.86 124.58 7.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.188 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 17.1 t80 -139.13 112.72 8.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.019 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -118.73 115.91 25.47 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.415 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.07 123.47 38.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.9 t -82.25 106.03 12.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.751 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -95.31 159.41 15.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.347 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.473 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 8.7 t70 -94.87 133.47 38.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.0 m -72.36 -18.37 61.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.382 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.42 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.263 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 82.5 p -99.44 -28.31 13.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 74.84 15.68 80.76 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.58 157.65 39.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 111.298 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.5 m -65.08 123.06 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.442 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -68.4 -18.77 64.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.406 . . . . 0.0 110.646 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 106.45 26.4 5.94 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.76 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -157.24 148.02 21.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.503 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.54 170.12 19.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.81 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.491 ' O ' HG21 ' A' ' 254' ' ' VAL . 98.1 m-85 -125.83 136.55 53.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.66 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 19.6 p -133.97 166.68 22.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.878 0.37 . . . . 0.0 110.897 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 286' ' ' LYS . 10.6 tt0 -143.62 120.29 11.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -74.36 147.24 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.376 0.608 . . . . 0.0 110.886 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.49 -30.26 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.858 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -116.41 151.61 35.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 310' ' ' ILE . 2.9 pp -84.05 -21.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -41.46 60.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.46 -18.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.815 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 50.5 m -52.93 -56.82 13.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.338 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.99 -22.45 36.56 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.152 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.06 -34.68 64.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.962 0.411 . . . . 0.0 111.001 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.15 -50.9 17.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 HG12 ' A' ' 332' ' ' VAL . 2.6 pp -61.42 -21.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.084 0.468 . . . . 0.0 110.733 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.49 86.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.023 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.34 -33.84 5.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.169 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.67 -35.85 75.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.794 0.297 . . . . 0.0 111.579 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.26 109.59 3.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.453 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.3 3.71 29.22 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 46.3 ttm -61.64 115.32 3.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.724 0.297 . . . . 0.0 110.37 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.0 OUTLIER -85.54 90.53 8.0 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.89 119.76 40.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.12 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.82 -110.76 3.61 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.868 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -106.55 -13.5 15.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -114.23 147.96 38.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 47.1 mtpt -93.01 120.83 33.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 164.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.49 129.24 37.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.188 0.518 . . . . 0.0 110.879 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 262' ' ' PHE . 23.5 tp -88.53 124.82 34.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.528 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.567 HG12 HG22 ' A' ' 317' ' ' ILE . 65.9 t -131.15 108.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.53 HE22 HG21 ' A' ' 337' ' ' VAL . 0.0 OUTLIER -143.17 143.65 31.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.47 -168.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -69.81 117.63 11.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.122 0.487 . . . . 0.0 110.61 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -76.44 -8.23 56.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 38.5 m -78.07 8.89 4.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.565 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.53 HG21 HE22 ' A' ' 333' ' ' GLN . 19.0 m -98.71 -0.65 10.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.761 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.33 80.17 1.22 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.505 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.02 2.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.799 0.333 . . . . 0.0 111.532 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 62.52 22.66 13.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.846 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -169.35 133.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.265 179.613 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.777 0.322 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.13 -61.14 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.117 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.38 65.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.421 0.629 . . . . 0.0 110.109 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.53 49.29 15.18 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.854 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.7 m -141.45 24.27 2.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.077 0.465 . . . . 0.0 110.43 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -69.65 -14.55 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.836 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.4 ttt -87.45 -55.25 3.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.902 0.382 . . . . 0.0 111.053 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 13.6 t -69.77 -9.93 56.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.259 -172.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NE ' ' HG3' ' A' ' 147' ' ' GLN . 0.3 OUTLIER -60.99 -22.71 64.76 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.23 -0.294 . . . . 0.0 111.57 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HG3' ' NE ' ' A' ' 146' ' ' ARG . 82.1 mt-30 -87.3 -35.36 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.012 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.46 -31.85 67.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.902 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 145' ' ' THR . 34.0 mtm180 -80.62 2.23 26.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.686 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 34.4 ttp180 -122.02 130.54 53.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.304 0.573 . . . . 0.0 111.652 -172.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 212' ' ' MET . 3.9 pp -118.48 154.24 32.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.077 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.8 t80 -81.45 124.4 29.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.607 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG21 HD23 ' A' ' 200' ' ' LEU . 44.0 t -112.43 131.34 64.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 110.738 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.29 177.85 16.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.945 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.81 38.15 2.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.462 0.649 . . . . 0.0 110.359 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.3 pt -109.25 150.94 41.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.69 130.82 9.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.766 2.311 . . . . 0.0 111.641 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.48 118.89 10.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.39 -2.93 22.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.535 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.6 tt -65.48 146.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 110.229 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 m -105.18 156.64 17.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 189' ' ' VAL . 24.8 mt-10 -47.51 -59.51 3.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.434 0.459 . . . . 0.0 111.715 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.88 -21.37 66.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.253 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.62 -53.12 30.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.299 0.571 . . . . 0.0 110.284 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.7 ttm -75.79 -33.96 60.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.102 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 14.5 ttt -59.55 -46.47 88.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.535 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.36 -44.51 88.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.449 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.1 m-85 -62.12 -55.66 26.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.707 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -58.71 -43.01 89.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.532 0.206 . . . . 0.0 111.368 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -59.82 -33.75 72.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.388 . . . . 0.0 111.18 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -79.16 -34.56 43.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.381 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 25.8 mm-40 -62.52 -37.76 87.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.868 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.5 -35.48 76.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 0.0 111.022 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.464 ' HD2' ' OG1' ' A' ' 179' ' ' THR . 28.2 mmm180 -78.41 -23.8 46.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.1 mt -76.73 -41.84 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.34 -5.55 75.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.636 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.43 36.05 83.16 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.859 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.94 -22.15 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.718 0.294 . . . . 0.0 110.772 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.71 108.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.325 -178.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -87.88 -33.11 18.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.614 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -106.85 151.17 40.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.805 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 148.86 81.35 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.504 2.136 . . . . 0.0 111.938 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.09 -144.9 17.39 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.608 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.14 124.79 38.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.709 0.29 . . . . 0.0 111.118 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.516 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 41.2 Cg_endo -67.04 -29.51 40.15 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.153 2.569 . . . . 0.0 113.135 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.36 134.47 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.231 0.539 . . . . 0.0 110.86 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.5 mt -89.77 -49.37 6.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.134 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.14 171.26 19.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 0.2 OUTLIER -143.87 139.57 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.14 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -122.53 127.93 50.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.606 0.241 . . . . 0.0 110.786 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.68 127.56 63.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 48.0 m-80 -83.66 108.1 16.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.011 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -68.57 -23.54 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -97.99 5.85 48.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.625 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 192' ' ' ASN . 75.2 mmtt -131.1 -170.8 2.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.881 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -126.71 29.99 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.158 0.504 . . . . 0.0 110.404 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -144.41 164.75 29.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.434 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -132.36 170.96 14.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.055 0.455 . . . . 0.0 111.087 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.44 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . 73.0 m-85 -127.3 133.44 50.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.922 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -109.78 129.32 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.3 130.12 56.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 0.0 110.499 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.646 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.4 m-85 -108.53 165.57 11.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.124 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.4 ptt180 -80.75 -18.93 46.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.276 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.9 m -138.7 132.69 31.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.156 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.6 -28.11 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.15 -32.6 72.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.361 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.409 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 53.2 mt-10 -82.66 -20.89 35.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.205 0.526 . . . . 0.0 110.039 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 98.0 m -71.21 -51.32 25.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 173.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.7 t -60.0 -37.63 80.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.662 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.409 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 3.2 pt20 -71.88 -19.65 61.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.4 -28.73 52.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 110.075 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.406 ' HG2' HD22 ' A' ' 151' ' ' LEU . 28.0 mtp -71.63 -14.38 62.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.079 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.2 -22.64 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.861 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.8 m-85 -76.91 2.82 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.999 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.09 106.68 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.99 0.424 . . . . 0.0 110.735 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.44 37.36 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.725 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -108.33 153.36 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.868 0.366 . . . . 0.0 110.523 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.0 mm -105.95 101.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.728 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.3 m-85 -112.82 129.57 56.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.477 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 60.81 21.5 11.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 111.48 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 90.54 -11.63 70.92 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.959 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.728 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 28.5 pt20 -97.31 140.83 31.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.031 0.416 . . . . 0.0 110.277 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.7 t -93.97 118.41 31.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.23 128.92 38.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.26 122.82 40.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.885 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.5 mp -128.03 125.77 65.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.919 0.39 . . . . 0.0 110.027 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 28.6 tpt180 -99.63 148.13 24.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 234' ' ' PRO . 20.4 mtp180 -92.79 108.56 32.84 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.464 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 6.6 Cg_exo -74.03 126.85 10.88 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.647 2.232 . . . . 0.0 110.768 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.9 53.15 1.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.359 0.6 . . . . 0.0 111.916 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.65 -29.89 14.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 171.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -152.77 175.94 12.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -109.75 102.41 50.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.621 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 228' ' ' ARG . 28.7 Cg_endo -66.1 138.96 53.96 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.443 2.095 . . . . 0.0 112.33 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.5 155.42 78.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.316 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.52 78.01 2.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.018 2.478 . . . . 0.0 112.031 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.44 104.82 1.66 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.205 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -149.77 152.91 36.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.713 0.292 . . . . 0.0 110.507 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 18.3 m -115.02 46.52 1.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 69.41 120.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.953 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 83.2 m-20 -85.03 125.27 70.93 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.194 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 25.2 Cg_exo -62.7 -56.04 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.228 2.619 . . . . 0.0 112.842 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.2 m -158.13 91.49 1.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 34.6 m -78.64 174.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 48.3 t80 68.08 119.5 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.541 0.686 . . . . 0.0 112.318 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.56 119.23 68.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.698 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.69 131.98 48.94 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.654 2.236 . . . . 0.0 112.04 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.29 24.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.931 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.39 129.63 62.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.522 HG11 ' HD3' ' A' ' 276' ' ' LYS . 21.9 t -76.34 111.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.109 0.481 . . . . 0.0 110.662 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 14.7 m -76.49 146.92 38.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.641 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 18.78 9.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.44 121.93 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.5 t -109.58 104.86 56.31 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.545 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.82 169.6 8.51 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.485 2.79 . . . . 0.0 112.218 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.6 79.92 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.72 . . . . 0.0 110.03 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.6 t -91.8 151.85 20.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.328 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.98 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.345 0.593 . . . . 0.0 110.063 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -113.78 31.88 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.367 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -68.07 141.09 56.26 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 16.3 mt -122.68 143.37 49.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.98 0.419 . . . . 0.0 111.635 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 331' ' ' LEU . 22.7 t80 -117.89 132.38 56.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.855 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 331' ' ' LEU . 2.5 mp -120.0 116.6 50.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.466 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -112.22 -176.89 19.96 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.1 69.75 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.147 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.497 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.1 mt -62.93 130.16 93.81 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.29 144.84 98.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.794 2.329 . . . . 0.0 111.285 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -67.16 -18.6 65.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -92.25 -8.8 44.27 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.773 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.82 128.3 43.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.9 -175.77 2.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.9 p-10 -50.67 -41.1 55.24 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.185 0.303 . . . . 0.0 111.082 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 19.2 t70 -70.79 -32.9 70.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.99 0.424 . . . . 0.0 111.495 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.67 -41.77 26.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.065 0.46 . . . . 0.0 110.441 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.83 -29.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 25.5 mtmm -50.69 -40.26 53.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.009 0.433 . . . . 0.0 110.845 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.94 -21.68 66.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.39 -32.01 19.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 110.264 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.4 -28.98 28.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.143 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.1 p -67.97 -12.2 60.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 16.8 m -50.57 -40.25 51.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.961 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.66 -39.12 10.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.15 155.69 27.21 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.994 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.0 Cg_endo -72.16 155.94 56.06 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.04 1.827 . . . . 0.0 111.865 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 250' ' ' VAL . 78.7 mt -102.48 138.3 39.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.927 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 308' ' ' VAL . 0.1 OUTLIER -85.65 -24.4 27.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.44 0.638 . . . . 0.0 109.338 176.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.62 124.61 6.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.053 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 9.9 t80 -139.27 111.39 7.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.077 0.465 . . . . 0.0 110.246 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.95 108.34 17.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.536 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -99.24 133.96 42.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 13.5 t -94.13 109.78 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.691 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 58.8 mtpt -90.09 164.5 14.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.212 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.558 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -104.34 127.49 52.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.886 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 t -76.65 -11.95 59.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.31 -31.37 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.629 0.252 . . . . 0.0 111.372 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 69.7 p -93.46 -27.69 16.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.028 0.442 . . . . 0.0 111.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.22 14.17 82.85 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.03 -172.97 2.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.254 -0.473 . . . . 0.0 109.764 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 61.4 m -81.94 147.18 29.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.174 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.26 -19.5 56.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.107 0.479 . . . . 0.0 110.381 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 96.68 27.38 9.74 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.753 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 14.4 p90 -154.13 144.08 21.88 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.275 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.06 19.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.337 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 92.9 m-85 -128.14 133.18 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.396 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 29.5 p -130.05 166.11 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.265 0.555 . . . . 0.0 111.251 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.66 125.79 21.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.715 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -80.86 154.88 26.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 286' ' ' LYS . 46.5 t -68.09 -35.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.955 -175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.81 158.02 28.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.073 0.463 . . . . 0.0 110.263 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.89 -19.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.511 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 -30.11 57.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.55 -26.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.321 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.464 HG23 HD21 ' A' ' 261' ' ' LEU . 15.6 m -54.62 -53.48 54.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.481 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.34 -31.04 68.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.14 -36.5 72.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.83 -52.79 10.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.183 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.461 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -59.61 -25.28 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.136 0.493 . . . . 0.0 110.705 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.18 -45.21 81.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.455 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.11 -27.36 7.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.612 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.12 -36.27 40.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.984 0.392 . . . . 0.0 111.703 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 2.3 t-20 -68.26 112.13 4.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.68 5.14 26.09 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.745 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 40.7 ttm -62.39 115.25 4.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 0.0 110.198 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.48 ' HG2' ' HG3' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -85.06 96.55 9.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 111.28 22.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.538 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.54 -109.47 2.8 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.341 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.82 6.4 11.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.925 0.393 . . . . 0.0 111.176 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -120.74 149.08 43.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.774 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.48 ' HG3' ' HG2' ' A' ' 324' ' ' GLN . 42.6 mtpt -98.66 119.61 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.39 134.06 45.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.443 0.64 . . . . 0.0 111.388 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -88.16 121.49 30.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 53.3 t -130.48 107.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.68 160.67 42.43 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.899 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.66 130.65 40.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -80.51 -5.31 56.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.318 0.58 . . . . 0.0 110.122 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 2.8 p -87.03 -1.11 57.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.84 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.82 -47.35 70.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.099 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 171.86 154.65 10.16 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.672 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -133.25 67.88 1.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.128 0.49 . . . . 0.0 110.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -123.12 63.39 1.0 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 0.0 110.27 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -94.54 3.79 54.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.477 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 178.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.769 0.318 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 53.0 tpp -69.89 113.91 7.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.839 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.18 -24.54 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 0.0 109.971 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.1 32.84 3.96 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.657 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m -83.56 45.22 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.122 0.487 . . . . 0.0 110.685 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 mt-30 -100.62 119.56 38.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.259 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.71 -30.96 69.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.52 0.676 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 t -89.67 5.88 43.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.425 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -66.84 -31.03 71.38 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.014 -0.429 . . . . 0.0 111.081 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.61 ' HB2' ' HB3' ' A' ' 232' ' ' TYR . 10.9 mm100 -87.51 -5.69 58.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.904 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.03 12.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.906 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 202' ' ' PHE . 83.5 mtt180 -79.43 -6.12 56.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.95 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 18.4 mtm180 -110.37 150.91 28.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.14 0.495 . . . . 0.0 111.1 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 226' ' ' ILE . 2.5 pp -135.06 153.09 52.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.967 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -82.03 110.3 17.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.674 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 51.1 t -96.55 116.19 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.306 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.51 171.72 14.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.468 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 225' ' ' LYS . 4.9 t30 62.36 55.33 2.35 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.809 0.814 . . . . 0.0 109.451 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.0 pt -112.42 147.67 37.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.476 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 57.1 Cg_endo -80.26 130.79 8.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.711 2.274 . . . . 0.0 111.318 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.73 124.95 22.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.253 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.32 -0.67 53.87 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.134 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.437 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 16.1 tt -60.88 144.69 13.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 110.202 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 m -96.98 150.0 21.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.18 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.488 ' HB3' HG13 ' A' ' 189' ' ' VAL . 42.1 mt-10 -48.1 -59.87 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 166' ' ' MET . 8.4 pt-20 -66.16 -15.72 63.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.72 -58.32 4.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.0 ptp -76.17 -29.84 57.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.128 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.44 ' HB2' HG11 ' A' ' 189' ' ' VAL . 21.0 ttt -60.07 -54.93 40.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.37 -36.59 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.2 m-85 -60.0 -52.23 66.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.283 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -64.85 -38.82 92.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.206 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -59.69 -40.28 87.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.16 -49.69 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.93 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 70.0 mm-40 -60.47 -33.47 72.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.156 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 8.4 mmt -61.63 -41.87 98.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -72.15 -38.62 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.232 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 72.2 mt -63.68 -50.6 68.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.667 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.17 -10.13 86.45 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.571 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.16 40.08 56.78 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.479 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 22.0 mt -93.34 -24.33 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -58.38 114.72 2.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.956 0.407 . . . . 0.0 111.519 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.84 -34.3 15.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.107 0.479 . . . . 0.0 110.683 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -107.65 150.44 40.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.544 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.71 132.57 40.8 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.051 1.834 . . . . 0.0 111.489 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.97 -162.12 12.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.545 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.77 124.18 73.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.497 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 49.4 Cg_endo -70.83 -31.96 14.93 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.882 2.388 . . . . 0.0 111.957 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.78 116.73 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 245' ' ' TYR . 44.8 tp -85.06 -45.12 12.4 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.381 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.01 165.44 32.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.196 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 162' ' ' GLU . 0.6 OUTLIER -145.09 131.04 14.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.673 178.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.44 121.23 38.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 162' ' ' GLU . 4.5 mp -97.22 111.0 26.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -66.11 114.59 5.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.14 52.74 0.75 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.535 0.684 . . . . 0.0 110.818 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -124.96 10.04 8.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.823 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 83.0 tttt 53.63 65.46 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.287 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -157.14 -57.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.362 -0.535 . . . . 0.0 112.147 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.45 ' HE2' ' CE1' ' A' ' 199' ' ' PHE . 8.7 p90 -150.85 166.09 31.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.278 0.561 . . . . 0.0 112.254 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -131.83 164.67 25.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.258 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 25.7 m-85 -124.11 123.97 41.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.724 0.297 . . . . 0.0 110.732 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 189' ' ' VAL . 66.2 mt -95.68 131.41 41.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 32.3 tt0 -107.03 141.7 37.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.855 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.407 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 65.0 m-85 -126.47 152.85 45.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.432 0.634 . . . . 0.0 111.581 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 39.3 ptt180 -78.05 -13.03 60.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.639 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 33.3 t -148.18 132.84 17.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.834 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.92 -24.24 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.608 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.29 -34.9 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -82.8 -21.82 34.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.095 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.6 m -65.67 -50.97 62.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.2 t -62.59 -36.86 84.06 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 111.687 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -76.06 -18.51 59.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.332 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.49 62.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.442 0.639 . . . . 0.0 109.631 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.544 ' HA ' HG21 ' A' ' 226' ' ' ILE . 31.0 mtp -68.89 -14.01 62.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.856 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.51 65.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.49 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.512 ' O ' HG22 ' A' ' 217' ' ' ILE . 13.1 m-85 -80.82 7.27 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.66 105.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.881 0.372 . . . . 0.0 111.387 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.71 59.58 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.196 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.7 tt -95.62 153.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 110.544 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.74 103.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 9.5 m-85 -102.88 111.96 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.734 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 59.61 30.97 20.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.321 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.71 -13.02 66.99 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.504 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 26.5 pt20 -94.89 137.82 33.46 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.778 0.789 . . . . 0.0 110.778 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.9 p -103.54 118.51 36.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.777 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.64 136.25 54.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 111.064 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 155' ' ' ASN . 47.5 mtmt -109.65 135.02 51.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.66 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 212' ' ' MET . 4.2 mp -121.44 105.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.258 0.552 . . . . 0.0 109.815 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -100.84 151.71 21.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.556 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.457 ' HA ' ' HE1' ' A' ' 212' ' ' MET . 14.1 ptm180 -87.04 121.53 71.53 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 111.229 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 12.4 Cg_exo -70.65 166.24 29.35 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.775 2.317 . . . . 0.0 111.24 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.87 175.0 6.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.011 0.434 . . . . 0.0 110.554 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -82.18 56.78 3.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.192 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' A' ' 147' ' ' GLN . 25.0 p90 46.71 -163.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.405 1.082 . . . . 0.0 113.415 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -158.18 130.6 4.28 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.23 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.58 148.8 26.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.119 2.546 . . . . 0.0 112.447 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.6 mt 68.61 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.16 0 O-C-N 123.87 0.731 . . . . 0.0 110.65 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.21 90.11 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.303 2.002 . . . . 0.0 111.992 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.91 70.48 2.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.094 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.1 ptp -152.44 158.27 42.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.812 0.339 . . . . 0.0 110.089 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 12.8 m -84.89 -33.63 22.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.645 0.736 . . . . 0.0 109.188 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -178.93 140.44 0.17 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.509 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 57.4 t30 -73.83 120.03 79.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 7.9 Cg_exo -71.25 132.94 21.86 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.81 2.34 . . . . 0.0 113.184 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.7 m 60.24 45.49 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.642 170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.1 m -70.65 153.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.112 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 187' ' ' LEU . 80.0 t80 -80.32 127.48 32.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.485 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.6 p -93.66 113.38 60.2 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.06 0.457 . . . . 0.0 110.359 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.98 150.69 82.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.37 2.047 . . . . 0.0 111.594 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.57 22.85 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.111 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.29 93.98 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 276' ' ' LYS . 12.6 p -90.08 134.46 29.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.762 -170.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 73.5 m -101.21 159.47 15.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.287 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 p -97.22 6.26 48.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.466 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 43.0 t -103.23 100.01 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.731 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.64 107.95 27.97 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.752 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 31.6 Cg_exo -60.24 169.59 4.89 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.424 2.749 . . . . 0.0 112.667 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.67 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' LYS . 26.7 t -69.24 155.77 39.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.949 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.7 -0.61 57.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.233 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -99.68 -6.36 27.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 257' ' ' SER . 23.7 pttp -72.43 154.94 40.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 334' ' ' ARG . 11.0 mt -128.99 150.58 50.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.235 -172.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -107.3 131.14 54.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.67 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.41 121.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.929 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.62 171.54 18.31 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.574 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.91 2.27 84.19 Favored Glycine 0 N--CA 1.454 -0.15 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.662 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.547 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.4 mt -66.41 136.98 95.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 17.0 Cg_exo -67.22 145.27 71.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.786 2.324 . . . . 0.0 111.386 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 3.0 m-20 -65.53 -20.98 66.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.633 -174.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -90.51 1.4 56.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.1 mt -113.53 122.27 46.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -93.01 -175.93 4.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.986 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 290' ' ' LEU . 3.9 p30 -47.54 -48.17 27.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 29.0 t70 -63.35 -46.99 84.02 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.2 -28.97 65.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 54.7 t -85.27 -38.38 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.439 0.638 . . . . 0.0 110.382 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.642 ' HB2' ' CD1' ' A' ' 288' ' ' PHE . 15.7 ttpp -60.92 -30.67 70.33 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.68 -30.42 68.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.081 0.467 . . . . 0.0 110.689 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.86 -31.74 35.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.92 -34.99 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.547 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.8 p -71.19 -12.25 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.036 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.0 m -50.51 -43.2 55.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.077 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -86.17 -41.28 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.599 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.55 154.91 26.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.055 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 280' ' ' THR . 30.7 Cg_endo -71.95 155.44 57.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.138 1.892 . . . . 0.0 112.252 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 276' ' ' LYS . 81.8 mt -104.26 140.64 37.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.692 -176.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -84.75 -25.27 28.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -155.26 127.83 7.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.941 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 276' ' ' LYS . 17.2 t80 -138.73 108.91 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -114.83 111.69 21.61 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 272' ' ' ASP . 9.7 tt -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.14 116.97 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -102.71 168.2 9.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.131 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.5 130.09 47.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 13.3 m -75.43 -12.71 60.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.573 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.42 12.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.4 p -89.07 -27.85 20.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.204 0.526 . . . . 0.0 111.185 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.15 9.17 86.44 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 56.1 mt -121.23 -179.47 4.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.652 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.8 m -80.34 146.95 31.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.143 0.497 . . . . 0.0 111.435 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.56 -24.85 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.778 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 107.75 27.0 5.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.327 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.86 139.0 18.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 117.465 0.632 . . . . 0.0 110.921 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -150.02 169.51 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.537 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -127.18 134.86 50.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.664 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 261' ' ' LEU . 23.0 p -127.79 165.18 20.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.308 . . . . 0.0 110.947 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -147.98 129.35 14.8 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -84.94 163.74 18.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 0.0 111.547 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.79 -23.67 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.846 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.04 157.35 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.875 0.369 . . . . 0.0 110.082 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.37 -29.0 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.397 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.04 -27.0 62.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.543 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.461 HG21 ' HA3' ' A' ' 283' ' ' GLY . 14.9 p -84.17 -18.39 9.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.99 0.424 . . . . 0.0 110.713 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 37.0 m -61.98 -47.98 82.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.99 -24.66 43.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.78 -32.54 59.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.32 -53.44 12.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.114 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -60.37 -21.69 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 110.878 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.03 -37.43 69.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.369 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.64 -36.78 3.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.32 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.25 -34.58 65.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -66.08 117.28 8.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.66 8.56 45.65 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' A' ' 330' ' ' LEU . 48.0 ttm -64.35 116.0 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.974 0.416 . . . . 0.0 110.317 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 86.09 7.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.16 112.62 25.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.23 -112.01 3.75 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.638 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.94 -14.1 10.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -113.32 168.42 9.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.51 124.87 50.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.674 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 323' ' ' MET . 13.9 mt -74.03 138.13 43.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.129 -173.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.9 124.18 35.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.698 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 317' ' ' ILE . 41.9 t -130.54 113.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 335' ' ' ALA . 3.5 pt20 -137.69 168.14 20.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.447 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.605 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 mmm180 -74.56 34.61 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.951 0.5 . . . . 0.0 112.103 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 333' ' ' GLN . . . 57.7 -41.03 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.843 1.339 . . . . 0.0 113.419 -172.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 334' ' ' ARG . 15.0 t -90.52 -12.49 37.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.918 -169.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.14 -26.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.164 0.507 . . . . 0.0 110.298 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -81.09 47.25 3.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.858 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.86 -157.01 0.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 340' ' ' LYS . 3.2 mptp? -69.13 -38.07 78.64 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.992 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 65.84 -81.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 0.0 111.459 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.923 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -105.26 99.7 9.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.926 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.5 p -136.09 150.01 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.216 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.98 -169.55 33.1 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -81.8 24.23 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.858 0.329 . . . . 0.0 111.277 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.66 42.92 28.9 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.286 0.565 . . . . 0.0 110.909 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 ttt -86.29 -54.23 4.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.883 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.0 t -76.76 -13.61 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.843 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -65.97 -17.96 65.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.147 -0.346 . . . . 0.0 111.331 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -87.31 -19.05 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.743 0.306 . . . . 0.0 110.788 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.99 -29.48 14.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 110.372 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.07 -6.16 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.855 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 40.0 ttp180 -114.28 130.11 56.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.034 0.445 . . . . 0.0 110.943 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.18 154.21 31.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.643 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 54.1 t80 -83.7 118.37 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.373 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG21 HD12 ' A' ' 200' ' ' LEU . 23.1 t -104.2 132.6 50.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.73 176.66 17.9 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.831 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 t30 68.28 30.58 5.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.443 0.639 . . . . 0.0 110.589 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 15.1 pt -92.65 150.24 39.38 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.82 134.1 17.71 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.502 2.134 . . . . 0.0 111.332 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -62.05 113.92 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.6 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 110.44 2.03 29.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.641 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.454 HD13 ' HE2' ' A' ' 165' ' ' MET . 18.7 tt -57.66 146.23 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.211 0.529 . . . . 0.0 110.39 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.6 m -102.28 152.15 21.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.411 ' HA ' HD11 ' A' ' 191' ' ' ILE . 38.1 mt-10 -48.93 -58.6 4.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.515 0.509 . . . . 0.0 110.98 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.52 -37.16 72.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.885 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.28 -57.8 11.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.758 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.454 ' HE2' HD13 ' A' ' 160' ' ' ILE . 33.3 ttm -67.79 -39.54 84.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.502 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 189' ' ' VAL . 15.6 ttt -60.01 -56.74 17.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.675 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.82 -38.39 85.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.053 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 1.4 m-85 -59.99 -57.81 11.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.972 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.451 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -60.36 -42.38 95.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 110.749 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -66.65 -44.12 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 21.8 mm-40 -62.74 -37.69 87.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.324 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 179' ' ' THR . 10.3 mmt -55.82 -42.92 76.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.921 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -75.79 -33.61 60.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.726 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 92.7 mt -62.81 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.47 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.86 -16.03 68.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.468 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.97 37.22 26.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.06 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.494 ' HB2' ' SD ' ' A' ' 173' ' ' MET . 17.6 mt -90.33 -26.96 19.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 0.0 110.66 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -59.53 108.77 0.77 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 111.762 -176.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.78 -33.22 25.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.6 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -108.68 154.47 41.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.509 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 14.2 Cg_exo -69.8 143.93 52.22 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.608 2.205 . . . . 0.0 111.544 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.02 -151.85 16.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.369 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 93.6 m-20 -98.23 117.01 65.43 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_endo -61.3 -35.43 84.46 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.427 2.084 . . . . 0.0 111.534 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -78.76 131.5 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.525 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.6 tp -98.9 -40.8 7.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.812 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.64 150.16 27.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.788 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.481 HG22 HD23 ' A' ' 200' ' ' LEU . 7.3 t -126.26 125.75 68.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.627 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -118.3 112.14 19.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.444 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 191' ' ' ILE . 4.2 mp -104.62 104.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -85.63 114.14 22.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.717 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -81.64 49.58 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.964 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -108.42 -47.92 3.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.17 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -144.48 34.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.395 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.36 72.17 0.5 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.817 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.428 ' HE1' ' CE2' ' A' ' 199' ' ' PHE . 15.2 p90 -153.21 155.83 37.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.09 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 160.1 39.68 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.428 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 54.0 m-85 -117.76 122.59 43.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.614 174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 14.2 mt -103.93 110.22 22.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.902 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -93.92 126.36 39.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.519 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 50.1 m-85 -103.03 165.11 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -84.65 -15.65 44.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.474 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 m -148.24 136.96 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.07 -30.32 49.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.114 0.483 . . . . 0.0 110.512 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 209' ' ' THR . 4.9 m-20 -64.29 -36.23 83.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.11 -21.14 40.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.378 0.608 . . . . 0.0 109.924 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 85.9 m -70.1 -48.61 56.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.151 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 206' ' ' ASP . 14.9 t -62.5 -36.1 81.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.966 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -74.62 -18.38 60.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.729 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.8 59.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.477 0.656 . . . . 0.0 109.552 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 228' ' ' ARG . 10.4 mtt -67.75 -17.33 64.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.961 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.36 63.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 217' ' ' ILE . 11.8 m-30 -77.51 -2.86 37.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.624 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.96 106.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 0.0 110.513 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.21 4.33 59.85 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.569 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.467 HD13 ' CZ ' ' A' ' 219' ' ' PHE . 7.9 tt -92.31 156.74 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.763 0.316 . . . . 0.0 110.579 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.05 99.19 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.284 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.731 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.4 m-85 -104.5 122.82 46.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.374 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 61.59 20.08 10.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 111.383 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 93.46 -11.15 72.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.082 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.731 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 19.9 pt20 -94.98 142.95 26.88 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.336 0.589 . . . . 0.0 110.288 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.1 p -103.51 124.39 48.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.557 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.5 mt -108.34 136.77 47.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -120.99 126.68 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.866 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.01 125.5 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 12.7 tpt180 -99.31 146.19 26.51 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.524 ' HB3' ' SD ' ' A' ' 212' ' ' MET . 0.0 OUTLIER -120.98 104.62 41.31 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.371 -174.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.94 124.12 9.41 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.614 2.209 . . . . 0.0 111.848 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -94.86 -41.51 9.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.777 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.61 28.47 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.178 0.513 . . . . 0.0 110.552 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 233' ' ' GLN . 26.2 p90 -67.19 136.49 55.1 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 232' ' ' TYR . 28.3 mm-40 -159.81 98.09 1.52 Allowed Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.574 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.99 127.87 17.67 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.97 2.446 . . . . 0.0 111.262 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.0 mt -142.8 134.56 13.08 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.716 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.56 154.49 31.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.438 2.092 . . . . 0.0 111.515 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 145.68 45.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.423 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -157.84 -40.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.3 p -147.98 59.56 1.11 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 111.334 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -108.24 155.61 20.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -148.81 149.97 31.8 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.653 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.62 -69.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.043 1.828 . . . . 0.0 112.243 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 65.6 m -152.24 56.46 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.238 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 244' ' ' VAL . 18.8 t -96.2 6.53 7.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 122.631 1.205 . . . . 0.0 109.4 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.569 ' O ' ' HD3' ' A' ' 247' ' ' PRO . 85.0 t80 -134.69 145.95 49.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.468 178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.65 104.69 13.49 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 245' ' ' TYR . 73.2 Cg_endo -83.36 125.72 4.02 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.707 2.271 . . . . 0.0 111.134 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.18 0.8 54.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.608 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 250' ' ' VAL . 87.2 t 64.61 175.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 122.466 0.307 . . . . 0.0 110.711 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.501 ' N ' HG12 ' A' ' 249' ' ' VAL . 84.6 t -62.89 120.87 10.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 12.9 m -63.92 129.22 39.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.626 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.5 p -89.28 4.22 49.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.411 0.624 . . . . 0.0 110.626 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 3.5 p -107.52 104.45 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.836 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.62 109.63 39.88 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.73 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.8 Cg_exo -60.73 144.79 99.6 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.856 2.371 . . . . 0.0 111.066 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.53 90.62 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.723 0.773 . . . . 0.0 110.627 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.7 m -96.06 168.89 10.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.585 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.89 57.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.14 0.495 . . . . 0.0 110.701 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -111.47 27.79 9.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.868 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -55.45 144.86 24.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.709 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 313' ' ' THR . 14.8 mt -122.36 134.45 54.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -111.6 125.81 54.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.752 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.6 mp -113.32 114.09 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.64 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -120.5 -177.79 15.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.1 89.41 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.365 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.474 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 95.7 mt -69.01 130.67 91.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.963 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.17 139.43 85.67 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.764 2.309 . . . . 0.0 111.226 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.88 -1.2 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -103.12 -6.43 22.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.3 mt -96.84 128.61 43.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -104.56 -177.18 3.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 5.5 p-10 -48.71 -43.29 37.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -60.16 -44.4 95.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.616 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.7 -42.05 51.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.455 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.58 -28.63 43.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.687 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 50.2 mtmt -56.01 -33.77 65.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 110.997 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.81 -30.49 70.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.058 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.34 -40.82 29.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 0.0 110.285 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 48.0 mt -76.0 -30.42 58.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.358 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 7.4 p -67.5 -13.62 62.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.6 m -55.54 -30.42 60.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.856 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -103.79 -40.72 6.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.597 0.237 . . . . 0.0 111.435 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -164.2 163.06 35.79 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.369 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -72.03 162.32 42.18 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.304 2.67 . . . . 0.0 112.058 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' A' ' 305' ' ' CYS . 85.1 mt -112.27 129.19 56.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.531 0.681 . . . . 0.0 111.34 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.437 ' HB2' HG12 ' A' ' 308' ' ' VAL . 15.5 tppt? -71.09 -46.4 61.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.765 175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -143.3 128.0 18.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.842 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 21.1 t80 -138.14 109.49 6.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.17 117.28 31.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.351 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -102.9 126.64 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.453 HG12 ' HD3' ' A' ' 300' ' ' LYS . 21.7 t -81.99 121.99 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.266 0.555 . . . . 0.0 110.667 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -115.02 145.66 42.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.546 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.555 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.6 t70 -89.84 140.57 29.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.9 t -85.67 -16.09 40.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.99 -40.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 0.0 110.977 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.9 p -85.56 -28.31 24.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 110.611 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.69 20.89 77.83 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.741 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.98 174.64 9.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.05 0.452 . . . . 0.0 110.966 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 21.5 m -70.63 137.46 49.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.406 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.453 ' HD3' HG12 ' A' ' 291' ' ' VAL . 24.4 mtpp -86.05 -1.08 57.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.474 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 84.4 27.13 37.09 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.557 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 43.2 p90 -158.62 144.77 16.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.9 0.381 . . . . 0.0 110.308 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.11 168.45 23.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.033 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.58 128.68 48.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.62 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 24.4 p -124.15 158.84 31.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 110.963 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.09 110.2 10.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.697 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.34 137.57 50.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.986 0.422 . . . . 0.0 110.006 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 286' ' ' LYS . 4.5 m -60.57 -27.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.658 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 312' ' ' VAL . 13.8 m-20 -113.22 136.26 52.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.35 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -84.1 -14.08 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 111.306 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 309' ' ' ASP . 7.8 p30 -82.59 -19.62 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.822 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 309' ' ' ASP . 11.0 p -87.51 -18.49 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 109.879 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.411 HG23 HD21 ' A' ' 261' ' ' LEU . 45.4 m -51.25 -51.62 52.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.885 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.02 -18.78 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.636 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -83.86 -31.84 25.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.03 -53.99 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.636 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.564 HG22 HG12 ' A' ' 332' ' ' VAL . 2.9 pp -58.23 -25.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.121 0.486 . . . . 0.0 110.912 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' ' 317' ' ' ILE . . . -66.87 -42.9 84.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.172 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.98 -30.54 6.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.477 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.13 -35.87 59.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.872 0.336 . . . . 0.0 111.409 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 55.7 t30 -65.39 112.21 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 0.0 110.218 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.441 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 107.26 2.25 35.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.371 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.6 ttm -65.75 116.5 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.25 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 0.2 OUTLIER -81.51 87.14 6.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 110.63 21.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.865 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.03 -122.79 6.28 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.891 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -99.29 -13.65 19.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.784 0.326 . . . . 0.0 111.501 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -126.03 166.76 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.164 0.507 . . . . 0.0 111.64 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 51.8 mtpt -94.05 124.7 38.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.794 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.6 mt -72.23 129.84 39.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.11 120.19 30.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.409 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.564 HG12 HG22 ' A' ' 317' ' ' ILE . 61.0 t -130.82 108.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.285 0.565 . . . . 0.0 109.901 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -151.12 163.03 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.412 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 337' ' ' VAL . 0.3 OUTLIER -70.69 126.74 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.054 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.49 65.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.911 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.7 m -62.53 -30.12 71.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 334' ' ' ARG . 7.6 m -75.86 -17.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 110.342 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -95.06 5.03 68.27 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.025 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -73.09 109.98 7.03 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -78.58 67.74 4.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -167.08 -61.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.639 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.805 -178.739 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.587 0.232 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -114.17 42.69 2.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.035 0.445 . . . . 0.0 110.636 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 324' ' ' GLN . 28.7 t 67.37 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -157.69 -169.7 21.68 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.011 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.6 m -90.75 8.99 31.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.33 -17.44 64.76 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.68 0.276 . . . . 0.0 111.619 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 22.3 ttt -85.97 -50.88 6.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.76 0.314 . . . . 0.0 110.54 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 15.1 t -75.09 -17.22 60.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.652 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -19.71 65.76 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.968 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.21 -28.46 48.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.008 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.56 -32.37 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 145' ' ' THR . 24.0 mtm180 -72.47 -10.75 60.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.96 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 28.4 ttp180 -111.26 132.83 54.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.402 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 226' ' ' ILE . 3.9 pp -117.49 153.38 33.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.701 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -86.61 125.55 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.514 HG21 HD23 ' A' ' 200' ' ' LEU . 41.0 t -110.53 117.09 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 110.623 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.588 ' HA2' ' CD1' ' A' ' 197' ' ' PHE . . . -105.8 169.62 16.18 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.887 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.6 t30 66.89 50.06 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.632 0.729 . . . . 0.0 110.524 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 pt -116.37 150.82 46.06 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.494 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.43 131.02 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.857 2.371 . . . . 0.0 111.62 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 195' ' ' LYS . 47.0 t80 -64.14 131.7 48.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.882 0.372 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.95 8.41 58.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.641 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.5 tt -67.63 147.14 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -101.69 148.79 24.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -46.19 -59.09 3.1 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.679 0.391 . . . . 0.0 111.499 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.7 -34.24 64.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.281 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -57.07 12.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 0.0 110.67 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 4.6 ttm -69.31 -37.69 77.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.413 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.433 ' HG3' HG11 ' A' ' 186' ' ' VAL . 15.1 ttt -57.73 -49.43 76.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.227 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.44 -36.42 83.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.066 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.608 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.0 m-85 -59.26 -53.41 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.408 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -61.98 -41.67 98.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.265 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.07 -40.81 95.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.995 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -62.01 -43.41 98.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.916 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 56.0 mm-40 -64.13 -36.05 82.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.191 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 178' ' ' LEU . 11.4 mmt -59.62 -42.15 92.04 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.211 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.88 -44.31 81.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.673 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 60.9 mt -62.58 -47.6 83.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.956 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.14 -24.23 72.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.312 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.99 30.33 17.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.813 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.537 ' HB3' ' OE1' ' A' ' 210' ' ' GLN . 23.4 mt -87.72 -17.89 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.51 106.41 0.46 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 111.854 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.33 -4.44 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.592 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.417 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . -89.49 132.46 37.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.49 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.13 131.35 36.31 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.144 1.896 . . . . 0.0 110.426 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 76.98 -140.05 24.31 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.229 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -92.84 126.86 50.0 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.986 0.422 . . . . 0.0 110.373 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.93 -30.42 67.34 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.163 2.576 . . . . 0.0 112.991 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 166' ' ' MET . 91.1 t -73.12 131.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 203' ' ' ARG . 47.5 tp -90.29 -42.43 10.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.44 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.35 168.05 24.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.35 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.29 136.64 28.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.044 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -125.01 118.13 25.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.549 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.86 125.68 55.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.403 ' HB3' ' OD1' ' A' ' 194' ' ' ASP . 93.8 m-20 -64.78 140.9 58.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -82.62 41.5 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.294 0.569 . . . . 0.0 110.921 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.403 ' OD1' ' HB3' ' A' ' 192' ' ' ASN . 5.8 p-10 -147.22 161.31 41.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.785 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.527 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 24.0 pttm -80.48 45.49 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -168.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -118.07 -94.28 0.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.588 ' CD1' ' HA2' ' A' ' 154' ' ' GLY . 44.9 m-85 -139.1 171.55 14.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.781 0.324 . . . . 0.0 111.365 -168.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.08 172.24 11.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.397 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.8 139.81 51.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.509 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.514 HD23 HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -115.48 129.16 56.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.37 130.65 56.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.607 0.717 . . . . 0.0 111.133 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.592 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 56.6 m-85 -106.68 164.43 12.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.795 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 187' ' ' LEU . 14.7 ptt180 -68.06 -28.18 67.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.095 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 38.6 m -152.38 153.56 33.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.07 -30.12 47.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 209' ' ' THR . 2.6 m-20 -57.23 -45.44 83.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 202' ' ' PHE . 2.2 mm-40 -72.31 -32.28 66.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.569 0.7 . . . . 0.0 109.638 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 55.7 m -68.22 -47.2 68.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.537 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.2 t -64.85 -32.8 74.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.662 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.537 ' OE1' ' HB3' ' A' ' 178' ' ' LEU . 7.4 pt20 -75.52 -18.19 59.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.4 51.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.255 0.55 . . . . 0.0 109.816 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.459 ' HG2' HG21 ' A' ' 226' ' ' ILE . 9.9 mtt -66.41 -15.31 63.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.411 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -27.11 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.03 0.443 . . . . 0.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 217' ' ' ILE . 27.2 m-85 -83.93 17.22 2.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.462 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.64 117.44 13.21 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.976 -0.453 . . . . 0.0 110.985 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.97 12.67 61.73 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.904 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 214' ' ' PHE . 15.5 tt -100.58 151.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.916 0.389 . . . . 0.0 110.669 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.74 101.72 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.398 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.69 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 13.7 m-85 -104.81 122.46 45.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.73 20.25 8.99 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.688 0.395 . . . . 0.0 112.006 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 98.02 -12.02 63.97 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.202 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.1 pt20 -99.21 138.32 36.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.03 0.415 . . . . 0.0 109.941 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.5 t -92.37 130.01 38.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.986 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.62 118.99 38.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.313 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -109.89 122.77 48.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.459 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.1 mp -119.93 118.82 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.799 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -117.38 166.8 11.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 70.7 mtm-85 -103.11 113.74 65.63 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.469 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 19.4 Cg_exo -66.62 121.35 8.58 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.414 2.076 . . . . 0.0 111.496 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 55.9 m80 68.15 174.06 0.28 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.053 0.454 . . . . 0.0 110.791 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -100.6 55.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.296 0.57 . . . . 0.0 111.428 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -86.3 176.44 7.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -143.73 138.88 15.63 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 121.026 0.441 . . . . 0.0 110.691 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.99 176.68 9.57 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.117 2.545 . . . . 0.0 112.028 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.89 153.16 54.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.512 ' HA ' ' OG ' ' A' ' 239' ' ' SER . 74.5 Cg_endo -75.3 26.62 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.466 2.111 . . . . 0.0 114.424 -170.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.97 -41.74 11.94 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 25.4 ttt -147.8 80.21 1.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 236' ' ' PRO . 48.9 m -96.55 118.91 34.05 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.604 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.06 -38.02 87.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.9 130.87 24.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.282 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.93 88.55 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.508 2.139 . . . . 0.0 111.601 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 55.3 p 51.02 -168.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.457 0.703 . . . . 0.0 110.807 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 m -130.73 168.26 24.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.421 . . . . 0.0 111.173 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -137.71 129.03 27.88 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.866 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.8 p -95.94 124.86 50.71 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.78 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 120.41 7.75 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.659 2.239 . . . . 0.0 111.834 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 249' ' ' VAL . . . 107.92 -18.87 33.68 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.206 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 39.6 t 66.87 137.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.104 0.478 . . . . 0.0 111.499 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.16 111.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.8 m -71.34 146.34 48.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.782 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.0 p -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 110.305 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 61.2 t -97.64 100.66 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.124 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.596 HG12 ' HZ1' ' A' ' 260' ' ' LYS . 6.2 t -93.13 107.05 22.36 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.047 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 36.1 Cg_exo -58.38 149.18 75.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.336 2.69 . . . . 0.0 112.68 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.48 128.81 44.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.559 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 37.8 t -146.1 -178.72 6.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -78.92 -19.22 52.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 109.776 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -93.62 27.83 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.639 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HZ1' HG12 ' A' ' 254' ' ' VAL . 1.8 tmtm? -70.07 136.52 50.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.186 -176.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' N ' ' HD3' ' A' ' 260' ' ' LYS . 11.7 mt -121.96 149.19 43.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.947 0.403 . . . . 0.0 111.528 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -127.84 136.25 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.353 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 332' ' ' VAL . 2.1 mp -117.67 122.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.068 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.49 -179.55 15.88 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.31 1.17 90.38 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.457 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.0 mt -66.93 133.21 93.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.726 0.298 . . . . 0.0 111.617 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.78 143.42 99.62 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.935 2.424 . . . . 0.0 111.585 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -72.34 -5.67 37.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -102.03 0.67 35.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.7 133.86 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -105.2 -175.77 2.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.6 p-10 -51.83 -40.67 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.597 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.52 ' HA ' ' NZ ' ' A' ' 276' ' ' LYS . 9.5 t70 -69.69 -39.19 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.675 0.274 . . . . 0.0 111.131 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.13 -37.53 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.195 0.522 . . . . 0.0 110.605 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.2 -30.97 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.81 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 27.2 mtmm -50.81 -41.85 57.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.531 0.205 . . . . 0.0 111.257 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -56.51 -35.58 68.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.504 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.33 -38.03 71.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.902 0.382 . . . . 0.0 110.552 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.2 mt -81.45 -31.31 33.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.281 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 38.1 p -72.78 -12.49 61.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 59.4 p -54.17 -41.51 68.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 111.531 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -87.59 -41.41 13.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 0.0 110.373 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -167.86 154.95 25.4 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.072 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 280' ' ' THR . 31.7 Cg_endo -72.77 156.96 52.64 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.447 2.098 . . . . 0.0 112.643 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.57 136.19 45.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.495 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -75.37 -30.14 60.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.453 176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -154.92 126.3 7.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.226 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.86 113.16 8.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.38 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -117.37 120.55 38.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.543 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.4 tt -102.05 129.28 48.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.3 105.29 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.342 0.591 . . . . 0.0 110.82 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.51 164.34 14.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.56 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.47 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.5 t70 -100.55 130.56 46.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 37.9 m -81.79 -9.75 59.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.165 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.9 -40.65 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.966 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 68.2 p -88.21 -28.07 21.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 83.79 8.4 84.46 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.61 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 45.4 mt -118.33 159.42 23.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 111.001 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.8 m -71.62 127.01 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.675 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.92 -9.4 58.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 111.529 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 91.09 26.39 21.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.974 171.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -148.81 144.4 26.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.096 0.448 . . . . 0.0 110.034 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.44 170.78 17.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.4 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.17 135.81 52.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.763 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 13.9 p -134.9 159.12 42.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.718 0.294 . . . . 0.0 110.716 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 254' ' ' VAL . 73.0 mm-40 -133.36 128.85 36.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.645 173.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.75 144.12 26.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.296 0.569 . . . . 0.0 110.366 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.48 -32.9 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.493 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -121.46 157.01 31.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.33 -21.66 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.092 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -71.27 -31.94 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.034 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 283' ' ' GLY . 9.6 p -81.82 -23.75 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.509 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.3 m -54.73 -54.03 47.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.22 -23.26 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.278 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -34.3 53.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.812 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -74.26 -49.89 21.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.504 HG22 HG12 ' A' ' 332' ' ' VAL . 2.8 pp -61.86 -21.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.644 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.2 60.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.243 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -99.79 -36.74 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.162 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 332' ' ' VAL . 63.9 mt -75.75 -33.71 60.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.637 0.256 . . . . 0.0 111.296 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.79 112.48 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.75 11.36 56.86 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.453 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.1 ttm -68.65 119.81 13.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 0.0 110.125 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.486 ' HB2' HG21 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -84.46 86.57 7.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.61 114.74 28.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.667 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 87.11 -122.06 6.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.704 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.12 -13.75 15.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 0.0 111.085 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -122.28 173.29 7.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -103.3 128.91 50.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.324 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.452 HD22 HD23 ' A' ' 266' ' ' LEU . 15.6 mt -75.15 129.57 37.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.4 tp -90.18 119.65 30.68 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.455 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 263' ' ' ILE . 65.0 t -130.51 109.03 16.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.5 177.32 9.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -69.43 130.99 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.69 -14.26 62.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.193 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 340' ' ' LYS . 31.0 m -74.4 -15.94 60.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.442 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.97 -50.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 111.224 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -92.84 96.31 2.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.025 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . 52.64 67.93 0.91 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.099 0.56 . . . . 0.0 112.269 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 336' ' ' SER . 26.3 tptp -92.04 70.48 5.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.274 0.559 . . . . 0.0 110.185 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.96 139.52 53.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.227 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.272 179.032 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 45.5 tpp 57.34 76.79 0.3 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.467 0.651 . . . . 0.0 110.765 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.1 t -104.07 132.45 50.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.012 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.62 -146.62 10.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.704 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -112.86 14.45 19.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 111.026 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 240' ' ' GLU . 45.0 tt0 -65.61 -31.9 73.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.061 0.458 . . . . 0.0 110.635 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -61.86 -32.36 72.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -109.06 -20.13 13.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.523 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -35.07 79.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.164 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.4 -11.6 55.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.3 -29.05 20.66 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -79.85 7.9 7.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.882 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 53.7 ttp180 -127.84 130.07 47.99 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.05 153.03 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.314 0.578 . . . . 0.0 111.945 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 47.8 t80 -82.06 111.32 18.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.43 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.35 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.64 161.68 12.94 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.475 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.7 49.44 0.39 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.744 0.783 . . . . 0.0 110.258 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.2 pt -104.14 151.04 38.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.13 132.28 7.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.977 2.452 . . . . 0.0 111.475 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -66.5 120.27 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.53 -1.18 18.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.16 143.78 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.0 m -100.58 157.82 16.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -52.53 -58.9 5.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.742 0.306 . . . . 0.0 110.653 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.68 -23.61 64.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.57 -58.47 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.791 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.401 ' O ' ' HD1' ' A' ' 169' ' ' PHE . 19.9 ptp -77.96 -24.53 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.946 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.446 ' HB2' HG21 ' A' ' 189' ' ' VAL . 20.0 ttt -61.62 -56.19 22.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.372 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.89 -31.47 72.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.069 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.622 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 2.1 m-85 -61.13 -54.26 46.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 165' ' ' MET . 44.8 m-85 -65.64 -42.89 90.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -55.99 -34.09 65.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -73.05 -49.84 26.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 81.2 mm-40 -56.26 -39.72 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.434 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -57.15 -42.06 80.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.097 0.475 . . . . 0.0 110.732 177.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -77.56 -27.48 51.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.141 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 76.7 mt -72.84 -36.8 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.61 -23.85 35.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.14 36.39 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.392 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.9 mt -94.88 -26.58 16.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.806 0.336 . . . . 0.0 110.535 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -60.34 112.32 1.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.105 -178.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.2 -37.62 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.226 0.536 . . . . 0.0 109.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.91 39.74 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.215 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.14 142.18 54.99 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.278 1.986 . . . . 0.0 111.629 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.01 -157.95 15.11 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.79 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -96.23 124.45 51.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.225 0.536 . . . . 0.0 110.946 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.468 ' HA ' ' NE ' ' A' ' 203' ' ' ARG . 40.8 Cg_endo -67.94 -29.56 34.25 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.984 2.456 . . . . 0.0 112.624 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.54 132.81 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.187 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.4 mt -89.62 -49.52 6.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.424 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.47 157.69 32.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.758 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.517 HG22 HD23 ' A' ' 200' ' ' LEU . 6.7 t -124.23 128.92 74.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.613 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.55 118.97 35.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.6 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.39 126.92 56.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 195' ' ' LYS . 62.2 t30 -86.61 142.3 28.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.12 -40.54 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -76.31 -64.29 1.14 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.0 110.673 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.497 ' HB2' HD22 ' A' ' 192' ' ' ASN . 58.0 mttp -85.09 122.85 29.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.24 67.99 1.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 111.89 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.19 156.65 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.59 156.74 33.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.005 0.431 . . . . 0.0 110.59 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -127.14 124.19 38.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.948 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 13.4 mt -103.71 115.37 30.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.281 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -96.85 127.14 42.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.514 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 33.8 m-85 -109.39 158.63 17.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 185' ' ' PRO . 38.2 ptt180 -74.1 -18.4 60.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.874 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.0 m -148.49 144.98 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.091 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.81 -36.5 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.302 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.475 ' O ' HG22 ' A' ' 209' ' ' THR . 20.4 t70 -64.46 -40.26 95.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 110.067 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.557 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.0 mt-10 -72.23 -20.62 61.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.239 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 28.6 m -73.46 -50.44 21.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.235 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 206' ' ' ASP . 6.0 t -66.47 -29.2 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.713 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.557 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 1.8 pt20 -71.56 -20.88 61.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.632 0.253 . . . . 0.0 111.125 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.98 -22.98 48.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.685 0.755 . . . . 0.0 109.539 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.429 ' HG2' HG21 ' A' ' 226' ' ' ILE . 19.7 mtt -71.24 -17.34 62.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.12 -21.82 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.146 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 217' ' ' ILE . 22.8 m-85 -83.28 9.36 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.993 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.54 117.49 6.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.54 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.88 83.86 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 214' ' ' PHE . 7.1 tt -88.19 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.21 98.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.655 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.7 p90 -116.69 139.06 50.97 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.158 173.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 65.22 24.39 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 74.69 12.66 82.63 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.523 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.4 pt20 -113.55 145.81 40.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.103 0.452 . . . . 0.0 110.073 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.2 t -103.36 115.31 30.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.919 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.8 137.32 52.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.157 0.503 . . . . 0.0 111.269 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -122.8 133.8 54.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.612 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.7 mp -132.61 146.08 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 227' ' ' ARG . 20.6 mmt180 -97.54 143.86 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.895 -0.503 . . . . 0.0 111.001 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.0 mtm-85 -65.24 149.4 97.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.509 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 90.1 Cg_endo -89.15 122.0 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.673 2.249 . . . . 0.0 112.988 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 25.3 t60 167.98 -54.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.97 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.78 57.03 0.66 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.41 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -70.18 168.97 14.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -132.81 114.13 14.06 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.185 -176.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 49.3 Cg_exo -56.08 134.87 66.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.471 2.78 . . . . 0.0 113.552 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 235' ' ' LEU . 2.4 mm? -104.19 148.08 35.35 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.429 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.01 62.38 5.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.485 2.123 . . . . 0.0 111.7 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -117.01 71.13 0.28 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.56 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 94.8 mmm 70.28 122.6 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.309 0.644 . . . . 0.0 112.237 175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 48.0 m -83.79 130.12 34.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 143' ' ' GLN . 12.3 pt-20 -111.75 171.96 7.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.191 0.519 . . . . 0.0 111.49 -174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 244' ' ' VAL . 4.9 p-10 -174.63 158.26 2.4 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 47.1 Cg_endo -69.52 53.51 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 113.806 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t -159.54 8.23 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 241' ' ' ASN . 35.6 m -123.02 162.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.36 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 65.5 t80 59.24 99.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.966 0.791 . . . . 0.0 111.411 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.64 118.04 70.62 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.011 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.25 140.73 28.08 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.17 32.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.99 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.027 0.441 . . . . 0.0 109.921 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 p -104.1 147.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.047 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 66.3 m -104.23 150.69 24.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.23 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.7 p -86.16 8.1 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.8 112.94 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.357 0.598 . . . . 0.0 110.131 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.36 106.08 54.73 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.97 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.82 166.92 12.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.156 2.571 . . . . 0.0 112.34 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.22 83.6 4.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.252 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -79.62 154.44 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.789 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.8 -16.67 63.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.196 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -128.18 36.92 4.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.295 0.569 . . . . 0.0 110.111 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -74.08 150.43 40.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.008 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 313' ' ' THR . 12.6 mt -122.5 149.1 44.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.879 0.371 . . . . 0.0 111.62 -171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -113.75 128.77 56.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.768 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 332' ' ' VAL . 2.5 mp -114.94 120.93 65.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.645 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.93 166.41 21.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.893 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.63 5.02 63.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.456 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.538 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 90.1 mt -68.49 125.61 91.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.978 0.418 . . . . 0.0 112.056 -172.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 143.32 94.51 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.839 2.359 . . . . 0.0 111.648 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 298' ' ' LEU . 10.0 t30 -59.68 -26.71 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.442 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -81.84 -0.12 42.02 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.726 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.2 mt -113.9 124.28 51.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -104.29 -174.5 2.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.8 p-10 -47.78 -44.26 28.31 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.499 0.499 . . . . 0.0 111.842 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 276' ' ' LYS . 31.4 t70 -72.01 -36.93 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.735 0.303 . . . . 0.0 111.812 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.39 -42.89 67.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 110.719 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 266' ' ' LEU . 97.7 t -72.12 -29.67 33.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' CD1' ' A' ' 288' ' ' PHE . 1.0 OUTLIER -54.45 -39.36 67.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.795 176.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.87 -36.02 81.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.073 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.07 -41.74 67.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.3 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 320' ' ' LEU . 61.9 mt -71.24 -40.13 71.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.181 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 37.2 p -70.19 -11.87 61.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.794 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 35.3 t -53.11 -40.41 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.12 -41.0 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.21 150.81 20.03 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.707 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.484 ' HA ' HG22 ' A' ' 280' ' ' THR . 20.6 Cg_endo -69.03 156.3 65.68 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.432 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 305' ' ' CYS . 76.7 mt -107.17 134.75 49.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.31 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -28.95 33.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.235 0.54 . . . . 0.0 109.824 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -151.2 120.97 7.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 17.2 t80 -139.2 109.54 6.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.85 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.58 119.22 34.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.401 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 299' ' ' SER . 8.4 tt -98.76 124.49 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.3 126.85 36.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.432 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -122.86 148.72 45.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.403 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 25.1 t0 -77.74 116.35 18.2 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.5 t -70.1 -10.02 57.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.905 0.383 . . . . 0.0 110.511 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.403 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -85.68 -53.47 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 46.6 p -83.28 -23.69 32.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.498 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 78.21 18.34 76.55 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.512 ' HB3' ' OD1' ' A' ' 268' ' ' ASN . 59.6 mt -114.95 157.6 23.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.115 0.483 . . . . 0.0 110.881 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 290' ' ' LEU . 49.5 m -73.48 134.29 43.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 302' ' ' TYR . 18.3 mmtp -61.66 -34.27 75.42 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.344 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 99.82 21.7 13.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.8 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 300' ' ' LYS . 32.0 p90 -153.68 145.0 23.03 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.68 168.25 24.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.911 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.82 132.84 53.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.995 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 32.0 p -127.16 166.35 17.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.964 0.411 . . . . 0.0 111.054 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 127.03 15.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.263 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.21 149.23 25.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.78 -21.03 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.279 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -133.77 159.85 39.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.256 0.551 . . . . 0.0 110.895 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.71 -25.93 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.218 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.8 -34.36 71.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.633 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.505 HG21 ' HA3' ' A' ' 283' ' ' GLY . 10.0 p -79.53 -18.14 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.792 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.465 HG23 HD21 ' A' ' 261' ' ' LEU . 55.5 m -55.48 -48.38 74.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.114 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.94 -37.87 67.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.137 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.403 . . . . 0.0 110.838 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.56 -56.92 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.34 -21.53 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.127 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.89 96.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.225 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.12 -36.28 4.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.015 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.402 HD13 HD22 ' A' ' 279' ' ' LEU . 84.4 mt -67.83 -35.71 79.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 111.304 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -64.44 109.29 1.89 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.433 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.439 ' O ' ' HE3' ' A' ' 329' ' ' LYS . . . 99.95 11.53 42.85 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.359 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 47.8 ttm -59.0 115.24 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 110.739 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.71 89.17 6.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.687 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 tp -112.72 122.86 48.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 77.73 -125.45 7.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.83 -1.49 25.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.058 0.456 . . . . 0.0 110.097 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -111.14 169.92 8.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.822 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 322' ' ' GLY . 47.2 mtpt -118.11 117.48 29.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.866 168.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.84 137.21 51.56 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.152 0.501 . . . . 0.0 111.412 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.14 121.78 31.8 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 263' ' ' ILE . 60.0 t -131.25 110.51 17.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -145.5 146.25 31.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.3 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -62.1 125.76 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.634 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.83 -15.67 63.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.764 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 8.6 m -76.42 -9.53 58.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.302 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 69.9 t -70.63 -33.07 51.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 111.306 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 154.53 62.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.625 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -110.64 45.85 1.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.558 . . . . 0.0 110.329 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -69.61 -36.6 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -151.22 -49.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.536 -178.749 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.944 0.402 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -51.92 10.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.6 p -98.59 -40.17 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.626 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.68 60.74 6.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.215 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.8 m -57.0 114.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.446 0.298 . . . . 0.0 111.391 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 71.31 -12.32 0.62 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.662 0.785 . . . . 0.0 111.922 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.0 tpp -88.01 -49.57 6.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.634 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.2 t -70.44 -20.77 62.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.639 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.403 ' HD2' HE21 ' A' ' 147' ' ' GLN . 1.9 ppt_? -70.47 -18.59 62.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 110.243 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.403 HE21 ' HD2' ' A' ' 146' ' ' ARG . 24.3 mm-40 -90.13 -37.03 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.69 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.86 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.73 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -91.33 9.77 30.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.0 ttp180 -127.24 129.49 47.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.03 153.48 34.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.299 0.571 . . . . 0.0 111.786 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -82.86 115.66 21.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.057 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.8 123.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.749 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.98 172.42 15.15 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.97 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 2.7 t30 69.07 49.52 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.543 0.687 . . . . 0.0 109.713 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.6 pt -123.01 153.49 64.21 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.7 131.07 15.46 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.319 2.013 . . . . 0.0 111.366 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.55 124.76 21.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.01 16.6 40.71 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.087 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.24 148.45 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.929 0.395 . . . . 0.0 110.321 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 m -94.2 148.03 22.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -48.13 -58.52 4.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.088 -175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -55.68 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.279 . . . . 0.0 110.675 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.6 ptp -81.08 -26.16 36.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.438 ' HB2' HG21 ' A' ' 189' ' ' VAL . 18.4 ttt -61.56 -58.54 7.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -31.94 72.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.504 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -63.96 -57.71 8.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.022 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -57.63 -41.11 80.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.545 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -59.39 -27.85 66.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -85.54 -43.48 13.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.47 -41.13 89.03 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.567 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.1 -36.12 76.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.096 0.474 . . . . 0.0 110.882 177.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.52 -39.56 74.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.344 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 84.7 mt -65.22 -42.2 93.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.302 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.18 -12.96 78.14 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.607 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 33.17 46.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.676 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.47 -23.9 19.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.59 0.233 . . . . 0.0 110.902 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -59.09 107.97 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -83.43 -28.66 28.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 0.0 109.946 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -107.9 150.78 40.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.601 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.45 135.53 26.72 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.166 1.911 . . . . 0.0 111.578 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 109.34 -167.96 13.1 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.27 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -80.34 120.86 80.72 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 111.096 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.04 -31.24 46.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.945 2.43 . . . . 0.0 112.572 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.2 t -77.75 131.0 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 109.969 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.1 tp -99.33 -43.09 6.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.578 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.43 28.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.368 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.456 HG22 HD23 ' A' ' 200' ' ' LEU . 5.1 t -125.41 139.72 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.838 0.351 . . . . 0.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -124.6 121.55 35.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.959 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.03 122.82 67.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -72.27 130.39 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -87.5 -10.58 51.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.923 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -104.87 -14.33 15.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.18 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -145.8 147.72 32.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -78.19 57.26 1.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -141.62 154.97 45.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 109.995 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.15 167.16 21.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.454 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 73.8 m-85 -127.99 125.85 40.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.144 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 12.9 mt -106.95 122.16 45.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.713 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -100.96 129.72 46.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.43 . . . . 0.0 110.136 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.542 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 53.3 m-85 -108.21 151.52 25.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.952 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.62 -23.38 63.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.932 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -138.22 142.84 39.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.668 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.46 -29.84 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.523 ' O ' HG22 ' A' ' 209' ' ' THR . 14.4 t70 -63.37 -40.51 97.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.453 0.644 . . . . 0.0 109.779 175.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.612 ' HA ' ' CD ' ' A' ' 210' ' ' GLN . 49.6 mt-10 -77.66 -19.96 54.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.55 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 26.1 m -73.02 -48.26 37.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 110.216 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 206' ' ' ASP . 4.9 t -67.22 -30.55 70.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.471 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.612 ' CD ' ' HA ' ' A' ' 207' ' ' GLU . 2.5 pt20 -73.15 -20.55 60.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.052 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.97 -29.02 62.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.387 0.613 . . . . 0.0 109.515 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 226' ' ' ILE . 12.2 mtt -68.64 -15.95 63.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.833 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.1 74.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 110.465 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 217' ' ' ILE . 32.5 m-85 -80.61 5.08 16.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.426 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.5 106.47 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.992 0.425 . . . . 0.0 111.072 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.07 14.43 57.66 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 214' ' ' PHE . 9.6 tt -103.61 159.62 4.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.876 0.338 . . . . 0.0 110.232 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mm -106.91 98.98 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.1 m-85 -109.12 136.59 48.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.14 173.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 58.62 28.79 17.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 111.393 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 75.73 5.44 79.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.319 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 14.1 pt20 -118.68 145.45 45.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.033 0.416 . . . . 0.0 110.254 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 42.6 t -94.93 127.63 41.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.032 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 123.03 40.4 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.95 134.44 54.83 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' A' ' 212' ' ' MET . 4.5 mp -124.87 123.51 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 -173.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -114.14 153.88 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.71 120.99 67.88 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.7 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.66 132.27 42.1 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.49 2.126 . . . . 0.0 111.674 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -91.23 21.13 4.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.771 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -80.33 -9.16 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.635 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -142.52 175.52 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.731 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -133.23 116.77 14.38 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.199 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.16 161.74 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.582 2.188 . . . . 0.0 111.999 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.6 145.81 37.19 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.43 69.21 5.11 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.772 2.315 . . . . 0.0 112.989 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.03 13.37 66.68 Favored Glycine 0 C--O 1.236 0.224 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.937 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 53.43 58.04 5.59 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.365 0.602 . . . . 0.0 110.475 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.9 m -150.08 121.64 7.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.063 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.65 38.14 18.74 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.573 0.546 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.96 143.9 48.11 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.2 174.36 10.05 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.839 2.36 . . . . 0.0 111.856 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.0 m -79.04 87.98 4.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.977 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 t -88.7 23.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.271 1.034 . . . . 0.0 109.643 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -126.01 141.75 51.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.361 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.8 t -92.41 110.15 42.87 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.693 0.282 . . . . 0.0 110.534 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 122.72 9.48 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.441 2.094 . . . . 0.0 111.611 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.37 -22.23 31.31 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.802 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.6 t 64.07 125.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.153 0.581 . . . . 0.0 112.04 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.18 111.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.4 m -85.18 147.72 26.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 32.9 p -94.08 24.4 4.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.304 0.573 . . . . 0.0 110.719 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.51 108.49 19.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.512 0.673 . . . . 0.0 110.163 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 306' ' ' GLU . 24.5 t -104.37 102.28 32.32 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.845 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 170.05 21.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.084 2.523 . . . . 0.0 112.32 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.72 102.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.317 0.58 . . . . 0.0 109.758 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.6 t -118.42 148.74 42.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.598 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.21 55.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.279 0.561 . . . . 0.0 109.749 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.647 ' CE1' ' HB ' ' A' ' 310' ' ' ILE . 23.0 m-70 -120.18 34.1 5.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.797 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.36 146.34 55.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.327 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.44 HD11 HG23 ' A' ' 313' ' ' THR . 6.2 mt -132.93 139.44 47.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.987 0.422 . . . . 0.0 111.751 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.429 ' C ' HD12 ' A' ' 263' ' ' ILE . 23.2 t80 -119.78 133.47 55.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.019 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.8 mp -121.11 115.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -115.2 -171.97 16.97 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.34 -1.31 85.79 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.824 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 330' ' ' LEU . 89.5 mt -70.74 125.99 92.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -173.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 25.6 Cg_exo -63.71 142.44 83.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.667 2.245 . . . . 0.0 111.115 172.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -62.67 -17.89 61.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -86.03 -9.16 57.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.7 mt -102.85 130.06 49.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.156 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -104.38 -177.32 3.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.413 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.686 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 3.9 p-10 -48.6 -46.88 40.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.383 0.427 . . . . 0.0 111.744 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.14 -44.0 87.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.487 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.6 -38.34 59.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.48 -30.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 0.0 109.914 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 14.4 ttpp -50.45 -38.95 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.722 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.45 -35.05 79.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.591 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.41 -27.61 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.89 0.376 . . . . 0.0 110.228 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 77.1 mt -82.98 -38.8 22.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.116 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 33.3 p -68.41 -11.66 60.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.952 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 74.6 p -50.31 -48.08 55.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.9 -40.99 21.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.775 0.321 . . . . 0.0 110.723 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -163.75 151.4 20.81 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 280' ' ' THR . 25.3 Cg_endo -67.08 156.08 67.93 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 112.3 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.18 132.98 45.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.646 0.736 . . . . 0.0 111.244 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -78.89 -42.46 27.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.354 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -142.44 128.12 19.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.419 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 10.5 t80 -138.74 107.06 5.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 110.14 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -116.24 108.57 16.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.424 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 299' ' ' SER . 9.4 tt -94.44 125.69 39.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.31 131.77 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.863 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -117.83 157.84 25.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.544 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 6.0 t70 -100.17 125.18 46.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.2 t -76.3 -14.28 60.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.796 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.28 -37.81 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 111.458 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 81.7 p -86.24 -28.08 24.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.201 0.524 . . . . 0.0 110.563 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.74 18.4 77.35 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 48.5 mt -130.18 179.53 5.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.456 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.509 ' HB3' HD21 ' A' ' 290' ' ' LEU . 69.2 m -74.77 147.36 41.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.63 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 302' ' ' TYR . 35.4 mmtt -73.32 -25.6 60.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.147 0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 97.14 22.54 17.06 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.068 -176.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 1.9 p90 -157.42 146.81 20.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 110.978 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.37 18.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.222 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -129.84 137.84 50.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 288' ' ' PHE . 31.7 p -139.65 166.88 23.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 112.079 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 254' ' ' VAL . 31.1 mt-10 -133.21 134.04 43.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.366 168.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -83.24 149.52 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.233 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.64 -36.61 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -115.62 149.08 38.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.252 174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 259' ' ' HIS . 2.8 pp -84.66 -13.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.749 -171.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -78.99 -41.21 29.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.008 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.87 -17.0 21.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.44 HG23 HD11 ' A' ' 261' ' ' LEU . 31.3 m -50.83 -44.41 59.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.893 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.88 -39.51 50.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.433 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -61.29 -37.39 83.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 111.507 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -68.81 -52.36 31.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.54 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.486 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -64.8 -20.88 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.61 67.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.262 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.19 -37.01 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.79 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.97 -28.27 55.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.928 0.364 . . . . 0.0 111.86 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 332' ' ' VAL . 49.6 t-20 -66.8 108.8 2.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 329' ' ' LYS . . . 104.65 12.68 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.827 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 35.0 ttm -68.52 113.62 6.22 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 103.55 4.25 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.467 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.44 111.01 15.23 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 86.61 -116.38 4.42 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.0 5.15 12.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.433 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -122.97 165.74 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.768 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 322' ' ' GLY . 24.7 mtmm -109.86 127.94 55.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 266' ' ' LEU . 27.4 mt -75.93 137.98 40.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -173.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 263' ' ' ILE . 3.0 tm? -89.14 115.42 26.65 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 321' ' ' ASN . 67.5 t -124.19 107.0 17.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.322 0.582 . . . . 0.0 109.506 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -147.46 145.53 29.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.001 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.455 ' O ' HG22 ' A' ' 337' ' ' VAL . 55.1 mtp180 -63.44 129.05 38.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.02 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -73.06 5.8 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.5 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 1.9 p -67.32 -22.79 65.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 334' ' ' ARG . 20.6 m -83.11 -3.06 7.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.765 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -86.81 131.43 10.56 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.069 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -79.83 -20.82 45.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -88.31 143.48 26.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.106 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -106.95 -179.85 4.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.527 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.654 -0.688 . . . . 0.0 110.202 178.765 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -73.33 -44.53 58.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.983 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.4 t 62.82 92.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.188 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 -177.91 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.675 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.9 t -65.63 -53.11 45.97 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' HG3' HG22 ' A' ' 145' ' ' THR . 7.4 tp-100 -178.5 145.44 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.351 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -60.45 -18.88 54.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.073 179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 143' ' ' GLN . 8.9 t -119.47 18.64 12.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.649 0.738 . . . . 0.0 110.254 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -66.72 -41.98 87.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.841 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -87.6 -4.53 58.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.783 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.423 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -86.32 -32.04 21.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -87.95 -12.97 43.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.024 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 99.6 mtt180 -110.9 156.49 21.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.556 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.97 152.61 42.16 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 20.0 t80 -81.08 113.09 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.216 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -99.3 125.89 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.974 0.416 . . . . 0.0 111.283 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.17 176.19 22.48 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 65.84 52.29 1.28 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.647 0.737 . . . . 0.0 109.409 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 4.2 pt -119.2 150.92 50.11 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 11.5 Cg_endo -91.8 146.57 3.19 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.425 2.75 . . . . 0.0 112.17 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 195' ' ' LYS . 86.6 t80 -66.13 111.47 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.76 15.56 36.55 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.161 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 148.53 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.187 0.518 . . . . 0.0 110.287 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.5 m -99.63 144.83 28.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.037 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 162' ' ' GLU . 1.5 mp0 -42.49 -54.51 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.865 0.728 . . . . 0.0 111.545 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.17 -37.37 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.803 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.85 -55.25 36.79 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.343 0.592 . . . . 0.0 111.088 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -78.24 -29.33 48.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.388 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.0 ttt -61.22 -54.54 42.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.695 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.52 -33.32 75.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.858 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.558 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.1 OUTLIER -63.13 -49.9 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.139 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 29.6 m-85 -72.68 -40.04 66.59 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 72.8 m-20 -56.35 -34.79 66.94 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -68.1 -39.67 82.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.057 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 62.6 mm-40 -64.12 -38.65 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.469 ' HB3' HG23 ' A' ' 179' ' ' THR . 0.0 OUTLIER -60.27 -41.72 93.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 83.4 mtt180 -69.4 -36.01 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.438 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 97.9 mt -61.75 -50.43 72.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.64 65.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.667 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.03 30.97 24.41 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.304 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 71.3 mt -82.82 -22.45 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.3 . . . . 0.0 110.22 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -59.23 108.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.097 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -88.19 -30.04 20.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.031 0.443 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . . . -108.56 149.03 38.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.968 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.48 145.03 95.55 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.291 1.994 . . . . 0.0 111.421 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.15 -149.95 19.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.463 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.51 123.91 42.75 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.817 0.341 . . . . 0.0 111.12 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.4 -37.82 22.15 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.201 2.601 . . . . 0.0 112.398 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.55 123.53 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.44 -46.72 8.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.305 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.74 40.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.515 HG22 HD23 ' A' ' 200' ' ' LEU . 3.5 t -127.82 140.12 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -119.15 117.81 29.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.014 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.456 ' CD1' ' HG3' ' A' ' 162' ' ' GLU . 3.8 mp -106.58 129.19 60.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.529 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -76.69 151.7 36.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.468 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.4 -3.76 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.19 161.7 14.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.082 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 158' ' ' PHE . 17.9 ptpt -80.48 34.89 0.33 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.249 0.547 . . . . 0.0 110.864 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.38 -65.27 1.01 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.388 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -153.78 167.94 27.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.328 0.585 . . . . 0.0 112.143 -173.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.55 155.96 49.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.131 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.5 125.35 50.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.878 0.371 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 189' ' ' VAL . 20.2 mt -94.62 125.29 39.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.686 174.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -105.05 130.62 53.2 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.531 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 61.5 m-85 -109.79 157.48 19.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 181' ' ' ALA . 37.3 ptt180 -78.16 -18.98 54.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.787 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 54.7 m -147.91 139.56 23.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.797 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.66 -25.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.44 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -76.21 -23.76 54.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.757 0.313 . . . . 0.0 110.664 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -84.23 -20.9 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.237 0.541 . . . . 0.0 109.673 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 67.6 m -69.83 -49.87 48.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.639 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.8 t -60.69 -36.79 79.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -71.43 -22.45 61.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.79 -28.49 60.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 109.87 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 23.8 mtp -72.76 -14.64 61.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.192 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -18.15 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.489 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.476 ' CG ' ' HE2' ' A' ' 219' ' ' PHE . 11.4 m-85 -84.56 5.19 28.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.57 107.6 0.53 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.466 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.51 13.54 59.68 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.017 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.6 tt -94.56 154.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.151 0.476 . . . . 0.0 110.818 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.8 mm -97.73 100.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.132 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.672 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 2.9 m-85 -105.03 103.39 12.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.69 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 60.54 37.63 19.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.95 -13.57 63.47 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 114.155 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 29.8 pt20 -100.96 132.83 46.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.604 0.702 . . . . 0.0 110.344 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.0 t -98.7 90.41 4.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 224' ' ' LEU . 1.3 pp -91.71 144.69 25.25 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.185 0.517 . . . . 0.0 111.023 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.46 143.25 47.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.153 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.4 mp -130.65 115.41 31.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 152' ' ' TYR . 25.9 tpt180 -97.8 144.33 27.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -103.82 113.02 65.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.396 . . . . 0.0 111.158 -174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.17 148.9 89.29 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.524 2.149 . . . . 0.0 111.54 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -123.34 10.83 9.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -100.47 41.4 1.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.191 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -161.31 157.35 25.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.153 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -158.9 115.49 1.65 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 123.283 0.365 . . . . 0.0 110.531 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 58.7 Cg_endo -74.0 131.53 15.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.41 2.073 . . . . 0.0 111.346 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 235' ' ' LEU . 2.1 pp -147.53 151.58 39.92 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 111.466 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.79 -159.47 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.41 2.74 . . . . 0.0 111.854 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 128.63 -53.39 0.8 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.08 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.2 mtm -116.4 24.42 11.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.516 0.674 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 72.65 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.0 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.85 106.39 17.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.457 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -115.4 115.48 42.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.598 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -45.8 -74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.443 2.762 . . . . 0.0 113.802 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 18.6 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 110.477 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.1 m -75.03 171.12 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.345 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -140.8 131.38 25.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.66 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.31 117.81 25.15 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 121.084 0.469 . . . . 0.0 111.527 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.82 119.42 6.43 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 111.535 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.55 26.16 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.735 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 94.8 t 58.89 87.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.765 0.793 . . . . 0.0 112.2 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.16 127.03 61.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.039 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 19.2 m -81.39 147.88 29.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 67.2 p -93.27 4.08 54.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.459 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.554 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 4.3 p -109.12 106.64 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.861 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.03 110.12 39.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.992 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 8.1 Cg_exo -72.53 139.72 31.81 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.996 2.464 . . . . 0.0 110.953 172.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.49 ' HA ' ' HG3' ' A' ' 260' ' ' LYS . 26.9 t70 -86.65 83.44 7.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.463 0.649 . . . . 0.0 110.479 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 260' ' ' LYS . 33.1 t -89.55 -178.03 5.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.823 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.74 65.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.665 0.745 . . . . 0.0 110.023 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -102.46 31.63 3.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.377 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 256' ' ' ASP . 2.3 tmtp? -67.75 133.34 49.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.17 149.24 43.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.483 . . . . 0.0 112.251 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.403 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 45.2 t80 -119.62 132.12 55.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.796 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 305' ' ' CYS . 2.5 mp -116.25 120.05 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.02 0.438 . . . . 0.0 110.298 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.39 -174.43 13.84 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 87.47 -6.72 82.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.008 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.495 ' HB2' ' C ' ' A' ' 301' ' ' GLY . 91.9 mt -68.86 127.62 93.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -172.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.01 140.17 59.12 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.173 1.915 . . . . 0.0 109.803 166.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -64.55 -15.08 60.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -169.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -83.61 -7.56 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.021 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.35 126.47 42.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -104.4 176.15 5.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.699 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 12.6 t70 -40.22 -43.49 1.69 Allowed 'General case' 0 CA--C 1.534 0.327 0 O-C-N 123.644 0.59 . . . . 0.0 111.882 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.43 -47.9 74.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.896 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -73.74 -39.64 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.94 -32.6 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.671 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.9 mtmm -56.26 -33.98 65.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.651 0.262 . . . . 0.0 111.176 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.48 -31.53 72.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.406 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.74 -34.92 60.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.131 0.491 . . . . 0.0 110.174 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.93 -32.23 27.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.274 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 17.0 p -69.38 -13.8 62.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.753 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.4 m -49.63 -46.43 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.467 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.26 -41.12 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.158 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.19 164.34 35.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.915 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -70.48 166.17 29.36 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.776 2.317 . . . . 0.0 111.85 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.2 mt -112.22 133.18 54.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.732 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.35 -38.09 74.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.272 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -152.27 131.96 13.16 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.686 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -138.57 117.89 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.266 0.555 . . . . 0.0 110.559 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -121.39 102.37 8.22 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.789 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 6.5 tt -86.82 133.6 33.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.329 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.92 133.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.541 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -122.16 165.29 16.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 295' ' ' ALA . 20.5 t70 -110.0 133.35 53.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.74 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 9.7 t -83.86 -11.12 57.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.92 0.391 . . . . 0.0 110.537 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.483 ' HB3' ' OD2' ' A' ' 293' ' ' ASP . . . -88.31 -43.46 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.735 0.302 . . . . 0.0 111.003 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 70.0 p -83.39 -30.66 27.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.17 0.51 . . . . 0.0 110.787 176.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.46 13.52 80.16 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 42.2 mt -123.61 -175.43 3.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.709 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 290' ' ' LEU . 36.6 m -74.75 152.45 39.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.133 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.38 -10.9 50.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.544 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.495 ' C ' ' HB2' ' A' ' 266' ' ' LEU . . . 92.66 26.84 16.1 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.67 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -164.42 149.43 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.029 0.443 . . . . 0.0 110.615 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -149.37 170.27 18.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.912 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.435 ' CD1' ' HE2' ' A' ' 260' ' ' LYS . 98.5 m-85 -123.19 127.97 49.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.484 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 263' ' ' ILE . 12.4 p -122.42 162.48 21.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.101 0.476 . . . . 0.0 110.187 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 111.96 6.04 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -70.38 171.3 10.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.962 0.411 . . . . 0.0 110.995 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.83 -45.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.631 ' HB3' ' ND2' ' A' ' 311' ' ' ASN . 11.0 m-20 -85.6 142.15 29.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.9 pp -82.96 -14.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.248 0.547 . . . . 0.0 110.498 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.631 ' ND2' ' HB3' ' A' ' 309' ' ' ASP . 9.1 p30 -86.89 -24.24 24.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.026 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' A' ' 309' ' ' ASP . 8.9 p -83.78 -18.27 10.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.116 0.484 . . . . 0.0 109.802 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 21.9 m -53.8 -49.23 68.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.257 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.31 -24.82 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -70.79 -36.04 72.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.173 0.511 . . . . 0.0 110.971 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -73.5 -52.32 14.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.019 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.463 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -61.45 -21.21 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.162 0.506 . . . . 0.0 110.968 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.48 -39.08 74.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.259 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.62 -35.96 4.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.243 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.5 -34.25 58.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.416 ' OD1' HD12 ' A' ' 331' ' ' LEU . 64.8 t30 -69.91 117.79 11.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.478 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 96.06 10.75 55.88 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.036 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . 0.461 ' O ' HD23 ' A' ' 330' ' ' LEU . 41.9 ttm -64.22 116.2 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 86.82 7.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.27 121.83 45.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.414 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.18 -117.63 4.52 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -116.37 -14.68 11.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 110.793 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.41 165.26 11.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -107.31 125.86 51.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.898 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 265' ' ' GLY . 2.6 mm? -73.21 133.97 44.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.814 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.416 HD12 ' OD1' ' A' ' 321' ' ' ASN . 33.6 tp -97.62 122.81 41.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 174.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.463 HG12 HG22 ' A' ' 317' ' ' ILE . 99.6 t -131.22 108.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.95 160.08 40.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.8 141.49 36.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -72.04 -14.95 62.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.137 0.494 . . . . 0.0 109.98 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 12.9 t -97.6 46.76 1.02 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.087 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.19 25.46 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.376 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 146.35 162.45 9.82 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . 72.48 -50.39 0.7 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.644 0.778 . . . . 0.0 112.109 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -79.16 77.2 5.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -94.81 78.71 3.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.397 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.728 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 121.231 0.538 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 14.1 tpt -154.96 90.9 1.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.2 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.01 -44.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.591 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.47 -66.98 3.18 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.879 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -151.33 -177.79 6.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -74.61 53.19 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 33.8 ttm -88.62 -47.69 8.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t -72.1 -8.4 54.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.076 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.89 -19.13 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 110.613 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.74 -33.68 27.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.452 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.83 -25.95 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.51 -6.59 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.362 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 30.8 mtm180 -110.45 158.08 18.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.233 0.539 . . . . 0.0 111.542 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.34 153.53 42.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.562 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 15.5 t80 -79.61 118.97 21.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.585 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 200' ' ' LEU . 49.3 t -105.96 121.26 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -122.88 176.21 16.56 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.218 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.2 43.5 1.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.807 0.813 . . . . 0.0 109.866 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.8 pt -116.35 154.6 48.89 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.67 130.91 14.1 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.633 2.222 . . . . 0.0 111.378 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.82 117.64 9.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.657 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.29 6.49 29.41 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.514 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.71 147.93 11.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 110.2 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 m -93.48 144.89 24.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.546 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 189' ' ' VAL . 1.9 mp0 -49.54 -54.21 19.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 123.371 0.42 . . . . 0.0 111.397 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.26 -24.28 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.278 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 -58.39 5.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.704 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 ptp -72.06 -31.67 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.353 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.27 -54.83 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.309 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.62 -36.12 83.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.657 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 0.6 OUTLIER -56.95 -61.11 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.978 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -58.65 -42.37 88.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -59.79 -42.05 92.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 111.063 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.99 -43.93 77.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.988 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 23.1 mm-40 -64.34 -31.81 73.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.165 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.505 ' HB3' HG23 ' A' ' 179' ' ' THR . 11.9 mmt -57.07 -46.17 82.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 174' ' ' ARG . 52.3 mtm180 -73.69 -30.17 62.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 81.0 mt -66.85 -48.39 68.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.359 . . . . 0.0 110.278 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.82 74.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.476 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.56 36.75 10.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.174 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.479 HD12 ' SD ' ' A' ' 173' ' ' MET . 17.3 mt -90.89 -27.37 18.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -60.16 108.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.809 -177.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.46 -22.97 14.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.13 175.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.7 127.78 27.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.46 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.86 142.17 98.07 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.723 2.282 . . . . 0.0 112.572 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 107.17 -143.16 15.83 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.39 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 18.4 p-10 -108.27 115.07 58.77 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-O 120.953 0.406 . . . . 0.0 110.801 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 19.3 Cg_endo -62.32 -37.8 58.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.817 2.345 . . . . 0.0 112.114 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.43 119.31 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 203' ' ' ARG . 2.0 tm? -97.46 -34.96 10.82 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.623 -170.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.12 157.96 38.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 162' ' ' GLU . 97.2 t -138.0 128.81 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.809 0.338 . . . . 0.0 110.677 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -119.38 125.25 48.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.06 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 162' ' ' GLU . 15.9 mm -90.94 130.69 39.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.49 127.69 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -85.8 -12.31 51.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.726 0.298 . . . . 0.0 110.889 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -84.47 -62.47 1.55 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.31 170.41 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.993 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -82.49 52.41 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.102 0.477 . . . . 0.0 111.502 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.6 167.36 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.53 161.65 37.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.821 0.343 . . . . 0.0 111.049 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.49 121.3 43.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.066 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 1.0 OUTLIER -94.47 118.96 32.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.926 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 150' ' ' ARG . 38.0 tt0 -102.64 126.8 49.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.363 0.601 . . . . 0.0 110.551 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.549 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 59.1 m-85 -106.52 157.29 17.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.443 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.54 ' HB3' ' HG ' ' A' ' 187' ' ' LEU . 17.9 ptt180 -79.18 -20.63 47.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.8 m -141.74 144.07 33.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.51 -26.63 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.007 0.432 . . . . 0.0 111.103 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 209' ' ' THR . 9.2 p-10 -75.58 -18.25 59.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.672 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 203' ' ' ARG . 44.5 mt-10 -86.01 -26.43 25.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 45.0 m -68.31 -44.74 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.816 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 206' ' ' ASP . 12.5 t -61.56 -37.01 82.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.171 -174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -74.73 -18.22 60.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -75.55 -27.3 58.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.35 0.595 . . . . 0.0 109.955 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.546 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 9.8 mtt -68.36 -16.24 63.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.14 -24.85 64.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 217' ' ' ILE . 18.9 m-30 -75.33 -0.85 21.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.954 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.8 106.28 1.49 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.57 14.34 38.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 214' ' ' PHE . 10.3 tt -106.84 153.94 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.28 99.56 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.141 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.754 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 8.1 m-85 -103.0 118.94 37.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.513 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 57.61 32.49 21.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.205 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.8 -13.34 64.64 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.593 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 24.7 pt20 -94.36 136.67 34.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.498 0.649 . . . . 0.0 110.438 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.0 t -90.35 124.73 35.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.638 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.48 121.98 42.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.798 0.333 . . . . 0.0 110.528 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -113.23 119.24 37.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.998 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 152' ' ' TYR . 4.1 mp -121.75 130.78 74.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.115 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -114.5 149.73 35.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.546 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 9.3 mpt_? -89.67 113.52 57.1 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.366 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.01 129.6 13.46 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.583 2.189 . . . . 0.0 111.813 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.24 36.42 3.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.8 -34.14 71.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.443 0.64 . . . . 0.0 109.543 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -83.05 159.81 22.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -129.5 112.93 17.96 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 23.1 Cg_exo -64.98 150.97 87.38 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.809 2.339 . . . . 0.0 111.667 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 234' ' ' PRO . 91.2 mt 70.84 132.21 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.287 0 O-C-N 123.841 0.713 . . . . 0.0 111.402 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 151.51 49.85 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.48 77.25 1.75 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.355 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 96.1 mmm -79.71 172.78 13.32 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 61.1 m 71.67 -10.3 0.85 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.677 0.611 . . . . 0.0 111.651 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 292' ' ' LYS . 33.9 mt-10 -86.94 -48.0 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -99.05 136.58 20.51 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.941 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.35 143.63 97.99 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.466 2.111 . . . . 0.0 111.33 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -72.25 81.52 1.01 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.743 0.782 . . . . 0.0 109.363 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 m -116.77 174.86 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.792 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -86.36 132.95 33.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.443 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.83 103.55 49.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.12 119.24 6.22 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.502 2.134 . . . . 0.0 111.744 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 97.26 -3.49 61.81 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 89.2 t 41.94 82.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.708 0.766 . . . . 0.0 112.036 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.86 120.89 34.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.465 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 13.5 m -69.34 139.38 54.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.173 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 p -87.92 1.71 53.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.347 0.594 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.74 108.08 22.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.748 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 3.7 p -105.26 107.51 59.18 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.822 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.15 160.49 49.41 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.811 2.341 . . . . 0.0 111.346 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.33 142.21 47.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.7 p -156.49 -177.07 6.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.026 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -88.38 0.69 55.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.243 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -131.52 16.03 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.4 125.99 30.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 304' ' ' PHE . 0.8 OUTLIER -109.28 139.9 43.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -171.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.421 ' HD2' ' CE2' ' A' ' 304' ' ' PHE . 41.9 t80 -101.91 127.44 48.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.446 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -114.96 116.53 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.761 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -121.55 176.1 16.3 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.578 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.69 89.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.565 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 92.2 mt -68.87 129.69 92.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -174.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 139.88 91.09 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.688 2.259 . . . . 0.0 111.238 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.46 -18.66 62.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -98.03 8.2 45.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.57 122.92 48.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.219 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.78 -171.51 1.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.776 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 276' ' ' LYS . 5.7 p-10 -48.81 -45.46 40.38 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.624 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.32 -47.64 78.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 111.619 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.19 -41.46 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.426 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.01 -31.68 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.441 0.639 . . . . 0.0 110.048 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 272' ' ' ASP . 0.6 OUTLIER -55.11 -36.7 65.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.382 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.22 -26.34 68.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.663 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.68 -38.36 33.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.213 0.53 . . . . 0.0 109.711 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.74 -42.56 63.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.055 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 30.6 p -66.89 -11.38 55.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.016 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.1 t -59.72 -29.28 68.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.774 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.06 -40.61 6.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.026 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -162.48 160.48 32.75 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.054 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.31 168.43 23.43 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.151 2.567 . . . . 0.0 112.133 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 305' ' ' CYS . 89.2 mt -117.74 134.1 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.469 0.652 . . . . 0.0 111.729 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 308' ' ' VAL . 38.6 ttmt -70.51 -46.39 63.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.074 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -150.87 133.45 15.64 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.605 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 10.4 t80 -138.28 107.03 5.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.895 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.57 105.16 15.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.634 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 303' ' ' ALA . 0.6 OUTLIER -88.34 132.57 34.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 290' ' ' LEU . 27.8 t -98.57 119.07 46.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.161 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.429 ' NZ ' ' HB3' ' A' ' 240' ' ' GLU . 46.4 mtpt -114.41 167.3 10.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 295' ' ' ALA . 13.6 t70 -96.27 118.49 32.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.3 t -72.12 -10.01 59.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.611 0.244 . . . . 0.0 110.847 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 293' ' ' ASP . . . -91.91 -49.45 6.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.264 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 76.0 p -82.4 -27.68 31.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 111.026 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.31 82.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.121 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 29.8 mt -108.49 170.01 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.4 m -82.44 138.92 34.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 110.53 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -63.86 -31.42 72.6 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.133 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 105.55 26.85 6.0 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 17.1 p90 -156.69 141.4 16.92 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.888 0.375 . . . . 0.0 110.185 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 290' ' ' LEU . . . -149.2 170.28 18.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.179 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 94.8 m-85 -131.45 130.29 42.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 30.7 p -130.26 175.68 8.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 111.465 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 129.32 11.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 308' ' ' VAL . 8.4 m-85 -89.06 -0.16 57.2 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -171.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 286' ' ' LYS . 44.3 t 75.37 -63.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.555 0.693 . . . . 0.0 109.603 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.548 ' HB3' HG12 ' A' ' 312' ' ' VAL . 15.1 t70 -75.51 135.48 40.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.131 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.26 -19.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.467 HD22 ' CG ' ' A' ' 309' ' ' ASP . 1.7 m-80 -80.53 -45.51 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.782 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 309' ' ' ASP . 7.1 p -65.4 -18.47 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.205 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 23.5 m -53.8 -50.15 66.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.444 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.77 -35.87 62.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 0.0 110.627 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' A' ' 312' ' ' VAL . 20.3 mt-30 -67.27 -31.04 71.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.096 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 320' ' ' LEU . . . -75.48 -55.16 5.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.899 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.418 HG22 HG12 ' A' ' 332' ' ' VAL . 2.3 pp -61.08 -21.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.762 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.32 79.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.049 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.66 -28.97 6.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 316' ' ' ALA . 78.8 mt -76.44 -36.82 57.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -175.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.05 110.05 2.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.51 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 94.95 11.47 56.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.277 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 43.6 ttm -60.94 117.19 5.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 110.521 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 94.45 6.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 120.01 40.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.589 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.69 -115.12 4.45 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.85 -3.91 12.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 110.559 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -111.94 156.14 22.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.771 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.79 125.64 49.61 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.26 141.88 41.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.123 0.487 . . . . 0.0 111.081 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.99 121.6 36.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.344 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 320' ' ' LEU . 59.2 t -130.8 111.41 20.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.016 0.436 . . . . 0.0 110.34 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -151.8 149.71 29.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.243 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.536 ' O ' HG22 ' A' ' 337' ' ' VAL . 0.0 OUTLIER -64.29 129.65 40.75 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.083 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -70.29 -8.15 48.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.357 0.599 . . . . 0.0 110.408 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.417 ' HA ' ' ND2' ' A' ' 341' ' ' ASN . 6.0 m -67.43 -13.27 61.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.455 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 334' ' ' ARG . 32.3 m -81.09 -6.19 9.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.99 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -88.51 -178.94 46.64 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.336 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 167.11 15.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.48 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 72.01 -36.46 0.36 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.423 0.689 . . . . 0.0 111.754 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' A' ' 336' ' ' SER . 6.8 t30 -67.55 -58.42 4.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.162 0.506 . . . . 0.0 110.348 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.316 -178.197 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 69.24 125.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.856 0.722 . . . . 0.0 111.556 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t 69.2 -75.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.287 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -88.01 64.3 3.64 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.192 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.1 p -154.81 110.62 3.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.808 0.337 . . . . 0.0 110.535 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.03 4.38 8.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.9 ptp -61.72 -30.33 70.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 9.1 t -120.5 21.67 11.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.819 -171.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -70.93 -24.59 62.48 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.229 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' A' ' 231' ' ' ASP . 66.6 mt-30 -79.75 -31.87 41.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.011 0.434 . . . . 0.0 110.021 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . -72.57 -31.95 65.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.607 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 145' ' ' THR . 19.9 mtm180 -74.04 -13.2 60.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.82 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 23.7 ttp180 -110.98 137.35 48.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.979 0.419 . . . . 0.0 110.631 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.13 153.98 38.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 226' ' ' ILE . 40.4 t80 -85.53 121.04 27.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.201 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.466 HG21 HD12 ' A' ' 200' ' ' LEU . 21.2 t -108.62 127.63 64.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 0.0 110.942 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -128.72 -178.22 15.26 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.331 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.574 ' ND2' ' HB3' ' A' ' 223' ' ' SER . 3.5 t30 67.82 28.01 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.773 0.797 . . . . 0.0 109.706 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.5 pt -102.13 150.2 37.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.51 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.14 132.03 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.634 2.223 . . . . 0.0 111.388 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -65.92 123.89 21.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 109.73 -5.0 30.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.099 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.13 145.23 9.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.253 0.549 . . . . 0.0 110.883 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 m -101.02 148.69 24.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.144 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.435 ' HG3' HD13 ' A' ' 191' ' ' ILE . 1.7 mp0 -47.73 -55.16 10.16 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.454 0.471 . . . . 0.0 110.859 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -54.41 -38.38 66.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.226 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.26 -56.58 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.6 ttm -64.52 -36.82 85.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.259 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 13.2 ttt -62.49 -55.85 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.15 -36.94 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.316 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -55.49 25.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -60.45 -33.87 73.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.016 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.569 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 6.7 m-80 -59.99 -46.41 89.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.964 0.411 . . . . 0.0 110.489 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.664 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -65.7 -43.46 89.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.643 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -47.26 75.96 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.556 ' HE1' ' HB2' ' A' ' 211' ' ' ALA . 0.0 OUTLIER -55.4 -44.71 76.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 111.085 177.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.5 mtm-85 -69.78 -33.41 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 83.2 mt -62.07 -35.78 79.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.948 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -97.99 -8.87 55.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.714 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.19 58.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.552 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.6 -21.82 18.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.19 . . . . 0.0 111.441 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 246' ' ' VAL . 0.2 OUTLIER -59.26 107.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.32 . . . . 0.0 110.83 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.446 ' HB2' HG21 ' A' ' 244' ' ' VAL . 6.4 pt20 -90.03 -27.51 19.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.77 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.18 149.47 39.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.225 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.06 139.94 30.51 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.216 1.944 . . . . 0.0 111.417 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.34 -158.8 15.79 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.708 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 10.7 m120 -86.8 116.14 64.95 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 4.1 Cg_endo -52.3 -46.34 33.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.601 2.867 . . . . 0.0 112.289 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 200' ' ' LEU . 7.8 p -80.57 136.85 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.4 tp -93.75 -51.22 5.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.929 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.75 142.33 25.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.6 t -110.9 131.83 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.965 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -118.68 126.73 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.435 HD13 ' HG3' ' A' ' 162' ' ' GLU . 3.3 mp -115.65 119.7 62.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.884 0.373 . . . . 0.0 110.398 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -85.54 144.05 28.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 0.0 111.468 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -107.4 3.23 25.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.794 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.31 -45.34 19.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.844 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.12 154.73 45.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.549 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -81.41 52.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.69 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.15 171.01 15.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.975 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -137.6 167.25 22.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.978 0.418 . . . . 0.0 111.297 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -127.95 130.29 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 186' ' ' VAL . 15.3 mt -110.67 117.83 34.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.335 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 37.7 tt0 -104.37 129.76 52.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.593 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 43.0 m-85 -104.98 159.64 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.134 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 38.3 ptt180 -77.34 -20.94 54.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.422 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 m -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.69 -29.1 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.228 0.537 . . . . 0.0 110.044 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 209' ' ' THR . 3.5 m-20 -67.92 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.792 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.16 -21.15 50.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.29 0.567 . . . . 0.0 109.922 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 86.4 m -72.45 -47.94 44.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 206' ' ' ASP . 7.5 t -62.27 -36.02 80.8 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.555 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -73.91 -25.09 59.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.198 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HB2' ' HE1' ' A' ' 173' ' ' MET . . . -68.81 -34.58 75.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.272 0.558 . . . . 0.0 109.956 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.639 ' HE2' HG22 ' A' ' 226' ' ' ILE . 27.8 mtp -68.54 -14.74 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.171 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.26 67.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 110.633 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 217' ' ' ILE . 17.4 m-85 -78.55 6.18 9.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.97 106.74 1.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.93 13.84 38.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.036 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 214' ' ' PHE . 13.0 tt -103.65 155.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.107 0.454 . . . . 0.0 111.116 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.74 102.3 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 7.1 m-85 -106.39 117.48 34.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.957 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 57.32 31.73 20.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 0.0 111.443 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 97.47 -12.81 64.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.873 174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 219' ' ' PHE . 13.8 pt20 -105.93 144.95 31.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.318 0.559 . . . . 0.0 110.501 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.574 ' HB3' ' ND2' ' A' ' 155' ' ' ASN . 23.3 t -102.46 128.89 48.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -101.76 120.66 40.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 4.9 mmmp? -114.24 123.08 48.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.639 HG22 ' HE2' ' A' ' 212' ' ' MET . 17.9 mt -130.8 118.79 43.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.01 -171.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.595 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 25.0 tpt180 -105.99 154.18 20.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.718 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -102.45 98.68 11.23 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.079 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 20.4 Cg_exo -66.42 122.85 10.39 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.309 2.006 . . . . 0.0 110.571 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -114.36 57.55 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.271 0.558 . . . . 0.0 110.145 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.569 ' HB2' ' OE1' ' A' ' 147' ' ' GLN . 11.4 m-20 -93.49 33.24 1.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.595 0.712 . . . . 0.0 109.6 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 234' ' ' PRO . 43.3 p90 -160.68 170.98 19.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.944 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.6 ' HA ' HE21 ' A' ' 233' ' ' GLN . 0.1 OUTLIER -117.6 109.28 41.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 232' ' ' TYR . 16.9 Cg_exo -65.24 150.21 87.72 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.031 2.487 . . . . 0.0 112.066 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.67 131.26 29.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.25 71.9 4.3 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.379 2.053 . . . . 0.0 112.129 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.31 -17.24 76.72 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.098 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 69.2 mtm 68.87 -75.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.257 0.623 . . . . 0.0 110.983 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 43.1 t -128.67 105.8 8.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.879 0.371 . . . . 0.0 110.267 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -98.29 -8.91 26.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.493 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -144.79 109.8 4.78 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.395 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.32 -51.12 0.28 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.226 2.618 . . . . 0.0 112.558 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.9 t -172.97 133.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 180' ' ' GLN . 17.2 m -131.48 161.38 41.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.201 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -76.62 103.56 6.67 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 179' ' ' THR . 2.7 p -75.49 119.03 75.16 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.926 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 179' ' ' THR . 37.1 Cg_endo -67.85 142.62 58.05 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.373 2.049 . . . . 0.0 111.405 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 112.93 11.53 13.92 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.99 136.75 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.57 121.88 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 287' ' ' ALA . 32.6 m -69.84 146.92 50.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.289 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.1 p -96.49 19.65 11.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 255' ' ' PRO . 57.9 t -122.85 105.04 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.76 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.54 111.13 51.03 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 253' ' ' VAL . 25.5 Cg_exo -63.72 153.58 74.45 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.807 2.338 . . . . 0.0 110.892 173.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -78.98 77.03 5.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.124 0.964 . . . . 0.0 110.8 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -91.22 158.28 16.69 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.63 48.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.088 0.471 . . . . 0.0 110.367 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -90.41 0.38 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.218 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.413 ' HG3' ' HB3' ' A' ' 335' ' ' ALA . 19.2 pttm -72.16 139.05 48.07 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.476 HD12 ' SG ' ' A' ' 305' ' ' CYS . 10.5 mt -112.42 149.27 32.79 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.798 -170.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -107.03 129.57 54.78 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.52 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 2.5 mp -116.08 115.15 48.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.909 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.87 175.38 15.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.5 -1.2 83.85 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.442 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.483 ' HB2' ' HA2' ' A' ' 301' ' ' GLY . 96.2 mt -64.35 127.73 92.48 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 27.9 Cg_exo -63.35 149.1 92.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.893 2.395 . . . . 0.0 111.757 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 -18.08 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.529 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -92.76 1.15 57.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.1 mt -112.13 119.73 39.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.032 0.444 . . . . 0.0 109.935 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -104.54 -178.5 3.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.566 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 0.0 OUTLIER -40.31 -48.66 2.69 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.77 0.668 . . . . 0.0 112.561 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -65.26 -45.58 83.96 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.05 -49.52 72.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.478 . . . . 0.0 110.652 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 83.0 t -63.94 -33.79 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.341 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 24.9 mtmm -53.19 -46.73 69.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.496 0.188 . . . . 0.0 111.078 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.54 -43.96 76.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.008 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.27 -43.89 89.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.81 -44.35 73.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 34.6 p -62.74 -12.21 22.56 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.7 m -55.61 -35.35 65.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.715 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -90.4 -41.96 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 0.0 110.693 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -165.91 167.79 39.37 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.412 ' HG3' ' HA ' ' A' ' 175' ' ' LEU . 4.1 Cg_endo -77.95 155.8 30.35 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 66.5 mt -106.02 134.48 49.07 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.778 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -77.3 -31.87 54.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 251' ' ' SER . . . -151.76 127.19 10.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.53 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 305' ' ' CYS . 29.3 t80 -138.48 114.48 10.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.487 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -120.95 107.49 12.74 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 303' ' ' ALA . 10.0 tt -86.9 123.68 32.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.88 111.19 13.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.436 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.2 165.44 11.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.741 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 296' ' ' THR . 7.3 t70 -98.82 133.72 42.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.7 m -78.04 -15.4 58.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.335 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.94 -44.91 10.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 293' ' ' ASP . 72.8 p -89.2 -25.92 21.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.188 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.99 13.98 82.65 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.526 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.9 162.65 16.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 111.303 -172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.3 m -71.87 123.15 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.146 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -63.75 -30.06 71.2 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 266' ' ' LEU . . . 109.09 25.12 5.72 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.74 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 19.2 p90 -155.08 144.35 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.11 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 290' ' ' LEU . . . -148.97 169.95 19.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.567 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 261' ' ' LEU . 97.5 m-85 -126.37 131.14 51.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.868 176.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.51 ' HB3' ' CD2' ' A' ' 288' ' ' PHE . 21.8 p -129.03 158.95 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.618 0.247 . . . . 0.0 110.668 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 260' ' ' LYS . 0.3 OUTLIER -142.54 125.21 15.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -81.59 156.73 25.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.48 -51.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.683 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.04 153.94 17.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 110.326 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 311' ' ' ASN . 2.9 pp -85.14 -22.37 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.17 -174.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.437 ' N ' HD12 ' A' ' 310' ' ' ILE . 8.0 p30 -79.76 -28.7 40.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.557 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -17.79 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.981 0.419 . . . . 0.0 110.448 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 m -55.91 -52.17 65.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.225 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.14 -19.32 51.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -77.48 -35.91 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.99 -52.53 16.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.731 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 332' ' ' VAL . 2.7 pp -60.69 -21.26 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.013 0.435 . . . . 0.0 111.091 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.89 -41.12 83.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -100.46 -34.67 4.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.301 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.77 -33.55 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.679 0.276 . . . . 0.0 111.628 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -68.81 122.92 19.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.01 10.23 60.02 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.846 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . 0.445 ' SD ' HD23 ' A' ' 325' ' ' LEU . 33.4 ttm -59.62 116.44 4.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.619 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.62 85.19 6.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' SD ' ' A' ' 323' ' ' MET . 0.2 OUTLIER -103.06 129.85 50.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.25 -118.51 8.02 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.142 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.98 1.82 12.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.927 0.394 . . . . 0.0 110.904 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -110.05 172.58 6.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.488 . . . . 0.0 110.991 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -117.13 119.77 36.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.06 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.9 mt -70.6 145.36 50.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.447 0.641 . . . . 0.0 112.029 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 331' ' ' LEU . 3.1 tm? -91.4 120.18 32.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.801 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 317' ' ' ILE . 41.3 t -129.24 108.93 17.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.558 . . . . 0.0 109.507 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -145.27 161.41 39.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.691 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -64.12 136.36 57.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.413 ' HB3' ' HG3' ' A' ' 260' ' ' LYS . . . -70.54 -14.43 62.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.274 0.559 . . . . 0.0 109.994 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.1 p -88.15 -7.45 56.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.69 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 19.4 m 37.52 40.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.182 1.393 . . . . 0.0 113.412 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -176.31 171.15 44.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.52 18.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.028 0.414 . . . . 0.0 111.036 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 69.62 -54.97 0.59 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.837 0.711 . . . . 0.0 110.517 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -152.14 -52.58 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.348 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.023 179.844 . . . . . . . . 0 0 . 1 stop_ save_